WO1998053055A1 - Grapevine leafroll virus (type 2) proteins and their uses - Google Patents

Grapevine leafroll virus (type 2) proteins and their uses Download PDF

Info

Publication number
WO1998053055A1
WO1998053055A1 PCT/US1998/010313 US9810313W WO9853055A1 WO 1998053055 A1 WO1998053055 A1 WO 1998053055A1 US 9810313 W US9810313 W US 9810313W WO 9853055 A1 WO9853055 A1 WO 9853055A1
Authority
WO
WIPO (PCT)
Prior art keywords
protein
leu
ser
val
ala
Prior art date
Application number
PCT/US1998/010313
Other languages
French (fr)
Inventor
Hai-Ying Zhu
Kai-Shu Ling
Dennis Gonsalves
Original Assignee
Cornell Research Foundation, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cornell Research Foundation, Inc. filed Critical Cornell Research Foundation, Inc.
Priority to MDA20000034A priority Critical patent/MD20000034A/en
Priority to SK1585-99A priority patent/SK158599A3/en
Priority to CA002290551A priority patent/CA2290551A1/en
Priority to EP98923568A priority patent/EP0986641A4/en
Priority to AU75831/98A priority patent/AU746187B2/en
Priority to BR9809450-5A priority patent/BR9809450A/en
Priority to DE0986641T priority patent/DE986641T1/en
Priority to IL13297598A priority patent/IL132975A0/en
Publication of WO1998053055A1 publication Critical patent/WO1998053055A1/en
Priority to BG103906A priority patent/BG103906A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
    • C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
    • C12N15/8279—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
    • C12N15/8283—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for virus resistance
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56961—Plant cells or fungi
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/00022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses

Definitions

  • the present invention relates to grapevine leafroll virus (type 2) proteins
  • grapevine leafroll complex is the most widely distributed throughout the world. According to Goheen ("Grape Leafroll,” in Frazier et al., eds.. Virus Diseases of Small Fruits and Grapevines (A Handbook), University of California, Division of Agricultural Sciences, Berkeley, Calif, USA, pp. 209-212 (1970) ("Goheen (1970)”), grapevine leafroll-like disease was described as early as the 1850s in German and French literature. However, the viral nature of the disease was first demonstrated by Scheu (Scheu, "Die RoUkrankheit des Rebstockes (Leafroll of grapevine),” P. D. Weinbau 14:222- 358 (1935) (“Scheu (1935)”)).
  • Leafroll is a serious viral disease of grapes and occurs wherever grapes are grown. This wide distribution of the disease has come about through the propagation of diseased vines. It affects almost all cultivated and rootstock varieties of Vitis . Although the disease is not lethal, it causes yield losses and reduction of sugar content. Scheu estimated in 1936 that 80 per cent of all grapevines planted in Germany were infected (Scheu, Mein Winzerbuch, BerlimReichsnahrstand-Verlags (1936)). In many California wine grape vineyards, the incidence of leafroll (based on a survey of field symptoms conducted in 1959) agrees with Scheu's initial observation in German vineyards (Goheen et al., "Studies of Grape Leafroll in California,” Amer. J. Enol.
  • Leafroll disease Symptoms of leafroll disease vary considerably depending upon the cultivar, environment, and time of the year. On red or dark-colored fruit varieties, the typical downward rolling and interveinal reddening of basal, mature leaves is the most prevalent in autumn; but not in spring or early summer. On light-colored fruit varieties however, symptoms are less conspicuous, usually with downward rolling accompanied by interveinal chlorosis. Moreover, many infected rootstock cultivars do not develop symptoms. In these cases, the disease is usually diagnosed with a woody indicator indexing assay using Vitis vivifera cv. Carbernet Franc (Goheen (1988)).
  • GLRaV grapevine leafroll associated viruses
  • Gugerli (1984) has been shown to be an apparent mixture of at least two components, Ila and lib (Gugerli et al, "Grapevine Leafroll Associated Virus II Analyzed by Monoclonal Antibodies," 11th Meeting of the International Council for the Study of Viruses and Virus Diseases of the Grapevine, Montreux, Switzerland, pp. 23-24 (1993) ("Gugerli (1993)”)).
  • Ila and lib Gugerli et al, "Grapevine Leafroll Associated Virus II Analyzed by Monoclonal Antibodies," 11th Meeting of the International Council for the Study of Viruses and Virus Diseases of the Grapevine, Montreux, Switzerland, pp. 23-24 (1993) (“Gugerli (1993)”)
  • Recent investigation with comparative serological assays (Boscia (1995)) demonstrated that the lib component of cv.
  • Chasselas 8/22 is the same as the GLRaV-2 isolate from France (Zimmermann (1990)) which also include the isolates of grapevine corky bark associated closteroviruses from Italy (GCBaV-BA) (Boscia (1995)) and from the United States (GCBaV-NY) (Namba et al., "Purification and Properties of Closterovirus-like Particles Associated with Grapevine Corky Bark Disease," Phytopathology, 81 :964-970 (1991) (“Namba (1991)”)).
  • the Ila component of cv. Chasselas 8/22 was given the provisional name of grapevine leafroll associated virus 6 (GLRaV-6).
  • the antiserum to the CA-5 isolate of GLRaV-2 produced by Boscia et al. (Boscia et al, "Characterization of
  • Virions of GLRaV-2 are flexuous, filamentous particles about 1 ,400-1 ,800 nm in length (Gugerli et al., "L'enroulement de la Vigne: Mise en Evidence de Particles Virales et Development d'une Methode Immuno-enzymatique Pour le Diagnostic Rapide (Grapevine Leafroll: Presence of Virus Particles and Development of an Immuno-enzyme Method for Diagnosis and Detection)," Rev. foundedizat. Arboricult. Horticult. 16:299-304 (1984)).
  • dsRNA double-stranded RNA
  • GLRaV-2 Associated Virus 2
  • the coat protein of GLRaV-2 is ca 22-26 kDa (Zimmermann et al., "Characterization and Serological Detection of Four Closterovirus-like Particles Associated with Leafroll Disease on Grapevine," J. Phytopathology 130:205-18 (1990); Gugerli and Ramel, Extended abstracts: “Grapevine Leafroll Associated Virus II Analyzed by Monoclonal Antibodies," 11th ICVG at Montreux, Switzerland, Gugerli, ed., Federal Agricultural Research Station of Changins, CH-1260 Nyon, Switzerland, p.
  • GLRaV-2 has been classified as a member of the genus Closterovirus based on particle morphology and cytopathology (Martelli, Circular of ICTV-Plant Virus Subcommittee Study Group on Closterolike Viruses" (1996)), its molecular and biochemical properties are not well characterized.
  • BYV beet yellows virus
  • Agranovsky et al. "Nucleotide Sequence of the 3 '-Terminal Half of Beet Yellows Closterovirus RNA Genome Unique Arrangement of Eight Virus Genes," J. General Virology 72:15-24 (1991); Agranovsky et al., "Beet Yellows Closterovirus: Complete Genome Structure and
  • Grapevine virus A (GVA) has also been found associated, though inconsistently, with the leafroll disease (Agran et al., "Occurrence of Grapevine Virus A (GVA) and Other Closteroviruses in Tunisian Grapevines Affected by Leafroll Disease," Vitis, 29:43-48 (1990), Conti, et al, “Closterovirus Associated with Leafroll and Stem Pitting in Grapevine,” Phytopathol. Mediterr.. 24: 110-113 (1985), and Conti et al., "A Closterovirus from a Stem-pitting-diseased Grapevine,” Phytopathology. 70:394-399 (1980)).
  • GVB grapevine virus B
  • leafroll symptoms may be induced by more than one virus or they may be simply a general plant physiological response to invasion by an array of phloem-inhabiting viruses.
  • Grapevine leafroll is transmitted primarily by contaminated scions and rootstocks.
  • several species of mealybugs have been shown to be the vector of leafroll (Engelbrecht et al, "Transmission of Grapevine Leafroll Disease and Associated Closteroviruses by the Vine Mealybug Planococcus-ficus," Phytophylactica, 22:341-346 (1990), Rosciglione, et al., “Transmission of Grapevine Leafroll Disease and an Associated Closterovirus to Healthy Grapevine by the Mealybug Planococcus ficus," (Abstract), Phvtoparasitica, 17:63-63 (1989), and Tanne, "Evidence for the Transmission by Mealybugs to Healthy Grapevines of a Closter-like Particle Associated with Grapevine Leafroll Disease," Phvtoparasitica, 16:288 (1988)).
  • the present invention is directed to overcoming this deficiency in the art.
  • the present invention relates to an isolated protein or polypeptide corresponding to a protein or polypeptide of a grapevine leafroll virus (type 2).
  • the encoding RNA and DNA molecules in either isolated form or incorporated in an expression system, a host cell, a transgenic Vitis or citrus scion or rootstock cultivar, or a transgenic Nicotiana plant or beet plant are also disclosed.
  • Another aspect of the present invention relates to a method of imparting grapevine leafroll virus (type 2) resistance to Vitis scion or rootstock cultivars or Nicotiana plants by transforming them with a DNA molecule encoding the protein or polypeptide corresponding to a protein or polypeptide of a grapevine leafroll virus (type 2).
  • Other aspects of the present invention relate to a method of imparting beet yellows virus resistance to beet plants and a method of imparting tristeza virus resistance to citrus scion or rootstock cultivars, both by transforming the plants or cultivars with a DNA molecule encoding the protein or polypeptide corresponding to a protein or polypeptide of a grapevine leafroll virus (type 2).
  • the present invention also relates to an antibody or binding portion thereof or probe which recognizes the protein or polypeptide.
  • Grapevine leafroll virus resistant transgenic variants of the current commercial grape cultivars and rootstocks allows for more complete control of the virus, while retaining the varietal characteristics of specific cultivars. Furthermore, these variants permit control of GLRaV-2 transmitted either by contaminated scions or rootstocks or by a presently uncharacterized insect vector. With respect to the latter mode of transmission, the present invention circumvents increased restriction of pesticide use which has made chemical control of insect infestation increasingly difficult. In this manner, the interests of the environment and the economics of grape cultivation and wine making are all furthered by the present invention.
  • Figures 1 A and IB are a comparison of a double-stranded RNA (dsRNA) profile (Figure 1A) of GLRaV-2 and its Northern hybridization analysis ( Figure IB).
  • Figure 1A lane M, lambda Hind III DNA marker; and lane 1, dsRNA pattern in 1% agarose gel stained with ethidium bromide.
  • Figure IB is a northern hybridization of isolated high molecular weight dsRNA of GLRaV-2 with a probe prepared with 32 P [ ⁇ -dATP] labeled cDNA insert from GLRaV-2 specific cDNA clone TC-1.
  • Lane 1 high molecular weight dsRNA of GLRaV-2.
  • Lane 2 total RNA extracted from healthy grapevine.
  • Figure 2 displays the genome organization of GLRaV-2 and its sequencing strategy. Boxes represent ORFs encoded by deduced amino acid sequences of GLRaV-2, numbered lines represent nucleotide coordinates, beginning from 5'-terminal of RNA in kilobases (kb). The lines below GLRaV-2 RNA genome represent the cDNA clones used to determine the nucleotide sequences.
  • Figure 3A-3D are comparisons between ORFla/ORFlb of GLRaV-2 and BYV.
  • Figure 3A-3D show the conserved domains of two papain-like proteases (P-PRO), methyltransferase (MT/MTR), helicase (HEL), and RNA-dependent RNA polymerase (RdRP), respectively. Exclamation marks indicate the predicted catalytic residues of the leader papain-like protease; slashes indicate the predicted cleavage sites.
  • the conserved motifs of the MT, HEL, and RdRP domains are highlighted with overlines marked with respective letters. The alignment is constructed using the MegAlign program in DNASTAR.
  • Figures 4A and 4B are alignments of the nucleotide ( Figure 4A) and deduced amino acid ( Figure 4B) sequences of ORFla/ORFlb overlapping region of GLRaV-2, BYV, BYSV, and CTV. Identical nucleotides and amino acids are shown in consensus. GLRaV-2 putative + 1 frameshift site (TAGC) and its corresponding sites of BYV (TAGC) and BYSV (TAGC) and CTV (CGGC) at nucleotide and amino acid sequences are highlighted with underlines.
  • TAGC + 1 frameshift site
  • TAGC BYV
  • TAGC BYSV
  • CTV CTV
  • Figure 5 is an alignment of the amino acid sequence of HSP70 protein of GLRaV-2 and BYV.
  • the conserved motifs (A to H) are indicated with overlines and marked with respective letters.
  • the alignment was conducted with the MegAlign program of DNASTAR.
  • Figure 6 A is a comparison of the coat protein (CP) and coat protein duplicate (CPd) of GLRaV-2 with other closteroviruses.
  • the amino acid sequence of the GLRaV-2 CP and CPd are aligned with the CP and CPd of BYV, BYSV, and CTV. The conserved amino acid residues are in bold and the consensus sequences are indicated. Sequence alignment and phylogenetic tree were constructed by Clustal Method in the MegAlign Program of DNASTAR.
  • Figure 6B is a tentative phylogenetic tree of the CP and CPd of GLRaV-2 with BYV, BYSV, CTV, LIYV, LChV, and GLRaV-3.
  • Figure 7 is a comparison of the genome organization of GLRaV-2, BYV, BYSV, CTV, LIYV, LChV, and GLRaV-3.
  • P-PRO papain-like protease
  • MT/MTR methyltransferase
  • HEL helicase
  • RdRP RNA-dependent RNA polymerase
  • HSP70 heat shock protein 70
  • CP coat protein
  • CPd coat protein duplicate.
  • Figure 8 is a tentative phylogenetic tree showing the relationship of RdRP of GLRaV-2 with respect to BYV, BYSV, CTV, and LIYV.
  • the phylogenetic tree was constructed using the Clustal method with the MegAlign program in DNASTAR.
  • Figure 9 is an alignment of the amino acid sequence of HSP90 protein of
  • GLRaV-2 with respect to other closteroviruses, BYS, BYSV, and CTV.
  • the most conserved motifs (I to II) are indicated with the highlighted lines and marked with respective letters.
  • Figure 10 is an alignment of the nucleotide sequence of 3'-terminal untranslated region of GLRaV-2 with respect to the closteroviruses BYV (Agranovsky et al., "Beet Yellows Closterovirus: Complete Genome Structure and Identification of a Papain-like Thiol Protease," Virology 198:311-24 (1994), which is hereby incorporated by reference), BYSV (Karasev et al., Organization of the 3 '-Terminal Half of Beet Yellow Stunt Virus Genome and Implications for the Evolution of Closteroviruses," Virology 221 : 199-207 (1996), which is hereby inco ⁇ orated by reference), and CTV (Karasev et al., "Complete Sequence of the Citrus Tristeza Virus RNA Genome,” Virology 208:511-20 (1995), which is hereby incorporated by reference). The consensus sequences are shown, and the distance to the 3'-end is indicated
  • FIGs 11 A and 1 IB are genetic maps of the transformation vectors pGA482GG/EPT8CP-GLRaV-2 and pGA482G/EPT8CP-GLRaV-2, respectively.
  • the plant expression cassette EPT8CP-GLRaV-2
  • the plant expression cassette which consists of a double cauliflower mosaic virus (CaMV) 35S-enhancer, a CaMV 35S-promoter, an alfalfa mosaic virus (ALMV) RNA4 5' leader sequence, a coat protein gene of GLRaV-2 (CP-GLRaV-2), and a CaMV 35 S 3' untranslated region as a terminator, was cloned into the transformation vector by EcoR I restriction site.
  • the CP of GLRaV-2 was cloned into the plant expression vector by Nco I restriction site.
  • Figure 12 is a PCR analysis of DNA molecules extracted from the leaves of putative transgenic plants using both the CP gene of GLRaV-2 and NPT II gene specific primers.
  • An ethidium bromide-stained gel shows a 720 bp amplified DNA fragment for NPT II gene, and a 653 bp DNA fragment for the entire coding sequence of the CP gene.
  • Figure 13 is a comparison of resistant (right side 3 plants) and susceptible (left side 3 plants) transgenic Nicotiana benthamiana plants. Plants are shown 48 days after inoculation with GLRaV-2.
  • Figure 14 is a northern blot analysis of transgenic Nicotiana benthamiana plants. An aliquot of 10 g of total RNA extracted from putative transgenic plants was denatured and loaded onto 1% agarose gel containing formaldehyde. The separated RNAs were transferred to Gene Screen Plus membrane and hybridized with a P-labeled DNA probe containing the 3' one third CP gene sequence. Lanes 1, 3, and 4 represent nontransformed control plants without RNA expression. The remaining lanes represent transgenic plants from different lines: lanes 2, 14-17, and 22-27 represent plants with high RNA expression level which are susceptible to GLRaV-2; all other lanes represent plants with undetectable or low RNA expression level which are resistant to GLRaV -2.
  • the present invention relates to isolated DNA molecules encoding for the proteins or polypeptides of a grapevine leafroll virus (type 2).
  • a substantial portion of the grapevine leafroll virus (ty ⁇ e-2) (“GLRaV-2”) genome has been sequenced.
  • ty ⁇ e-2 grapevine leafroll virus
  • ORFs open reading frames
  • UTR 3' untranscribed region
  • the DNA molecule which constitutes a substantial portion of the GLRaV-2 genome comprises the nucleotide sequence corresponding to SEQ. ID. No. 1 as follows:
  • GCTCAGGTTA TTTATTTCGG CAGTTTCACG CAGCCCTTCG CGTTGTATCC GCGCCAAGAG 120
  • AAATTTCCAC TCGTCCTCAT GAGTAGAGTT ATTTACCCGG ATGGGCGCTG TTACTTGGCC 600
  • GCCAAGCTCA GAAACCGTAT GGTTTCGGAG CTTGGTGAAA GAAGTTTAGG TTTGAACTTG 1560
  • AATTCAGTCG ACGATTTAGT CCCCGACGTG GGTTCCACGT TTCTGTGTAT GCTTCAGTCG 7380
  • CAGAAGTTGT CATCAAATCA TTTGCGCTCC AGCGGGGGCA CCGATCCCCT TTTCAGGAAG 10800
  • AAAGTAGCAA TCCCCGTCTA TCGACAGCGC AACTATGGGT TGGTTTCTTT TGTTACTATG 12360
  • GGTAGTCATA CGTACGTGGT CGACGGAAAA ACGTACACCG TTCTTGACGC TTGGGTATTC 13200
  • Another DNA molecule of the present invention includes nucleotides 4-7923 of SEQ. ID. No. 1 and is believed to code for a large, grapevine leafroll virus polyprotein containing the conserved domains characteristic of two papain-like proteases, a methyltransferase, and a helicase.
  • This DNA molecule comprises the nucleotide sequence corresponding to SEQ. ID. No. 2 as follows:
  • ACATTGCGAG AGAACCCCAT TAGCGTCTCC GGGGTGAACT TGGGAAGGTC TGCCGCCGCT 60 CAGGTTATTT ATTTCGGCAG TTTCACGCAG CCCTTCGCGT TGTATCCGCG CCAAGAGAGC 120 GCGATCGTAA AAACGCAACT TCCACCGGTC AGTGTAGTGA AGGTGGAGTG CGTAGCTGCG 180 GAGGTAGCTC CCGACAGGGG CGTGGTCGAC AAGAAACCTA CGTCTGTTGG CGTTCCCG 240 CAGCGCGGTG TGCTTTCTTT TCCGACGGTG GTTCGGAACC GCGGCGACGT GATAATCACA 300 GGGGTGGTGC ATGAAGCCCT GAAGAAAATT AAAGACGGGC TCTTACGCTT CCGCGTAGGC 360 GGTGACATGC GTTTTTCGAG ATTTTTCTCA TCGAACTACG GCTGCAGATT CGTCGCGAGC 420 GTGCGTACGA ACACTACAGT TTGGCTAAAT
  • AACTACGATA ATCTATCGTT TATACTGCGA GTGCTTTCGG AAGGTTATTC GTGTATGTTC 3540
  • GATCGTTCCG TAGCACCATG CAGCGAAGAT GCTCAGCTGT ACGTACGGAA GAACGGCTCA 6540
  • the large polyprotein (papain-like proteases, methyltransferase, and helicase) has an amino acid sequence corresponding to SEQ. ID. No. 3 as follows:
  • Another such DNA molecule includes nucleotides 7922-9301 of SEQ. ID. No. 1 and codes for a grapevine leafroll virus RNA-dependent RNA polymerase (RdRP).
  • This DNA molecule comprises the nucleotide sequence corresponding to SEQ. ID. No. 4 as follows:
  • RNA-dependent RNA polymerase has an amino acid sequence corresponding to SEQ. ID. No. 5 as follows:
  • GLRAV-2 ORF2 Another such DNA molecule (GLRAV-2 ORF2) includes nucleotides 9365-9535 of SEQ. ID. No. 1 and codes for a small, grapevine leafroll virus hydrophobic protein or polypeptide.
  • This DNA molecule comprises the nucleotide sequence corresponding to SEQ. ID. No. 6 as follows: ATGAATCAGG TTTTGCAGTT TGAATGTTTG TTTCTGCTGA ATCTCGCGGT TTTTGCTGTG 60 ACTTTCATTT TCATTCTTCT GGTCTTCCGC GTGATTAAGT CTTTTCGCCA GAAGGGTCAC 120 GAAGCACCTG TTCCCGTTGT TCGTGGCGGG GGTTTTTCAA CCGTAGTGTA G 171
  • the small hydrophobic protein or polypeptide has an amino acid sequence corresponding to SEQ. ID. No. 7 as follows:
  • Another such DNA molecule includes nucleotides 9551 - 11350 of SEQ. ID. No. 1 and encodes for a grapevine leafroll virus heat shock 70 protein.
  • This DNA molecule comprises the nucleotide sequence corresponding to SEQ. ID. No. 8 as follows:
  • GCGTTTCTCA CGCACCTCTT CTCTTTAACA TCGCTGGAAC CTGACCTCAC TTTGGATATC 780 R17098 8 .l TCGAATCTGA AAGAATCTTT ATCAAAAACG GACGCAGAGA TAGTTTACAC TTTGAGAGGT 840
  • the heat shock 70 protein is believed to function as a chaperone protein and has an amino acid sequence corresponding to SEQ. ID. No. 9 as follows:
  • Another such DNA molecule includes nucleotides 11277-12932 of SEQ. ID. No. 1 and codes for a putative grapevine leafroll virus heat shock 90 protein.
  • This DNA molecule comprises a nucleotide sequence corresponding to SEQ. ID. No. 10 as follows:
  • the heat shock 90 protein has an amino acid sequence corresponding to SEQ. ID. No. 1 1 as follows:
  • DNA molecule of the present invention includes nucleotides 12844-13515 of SEQ. ID. No. 1 and codes for a diverged coat protein.
  • This DNA molecule comprises a nucleotide sequence corresponding to SEQ. ID. No. 12 as follows:
  • ATGAGTTCCA ACACAAGCGT GCCGGTTGGG GGTCTCGAAG CACTCGAGAC CTCGGGAGTC 60
  • GGAACTAGCA AACTGATGAG CGATCACGAC AGGGCGGTCT CCATCGTTGC AGCGAAAAAC 600 GCTGTCGATC GTAGCGCTTT CACGGGTGGG GAGAGAAAGA TAGTTAGTTT GTATGATCTA 660 GGGAGGTACT AA 672
  • the diverged coat protein has an amino acid sequence corresponding to SEQ. ID. No. 13 as follows:
  • Another such DNA molecule includes nucleotides 13584-14180 of SEQ. ID. No. 1 and codes for a grapevine leafroll virus coat protein.
  • This DNA molecule comprises a nucleotide sequence corresponding to SEQ. ID. No. 14 as follows: ATGGAGTTGA TGTCCGACAG CAACCTTAGC AACCTGGTGA TAACCGACGC CTCTAGTCTA 60
  • the coat protein has an amino acid sequence corresponding to SEQ. ID. No. 15 as follows:
  • Gly Arg Arg Glu Val Met 195 and a molecular weight from about 20 to about 24 kDa, preferably about 22 kDa.
  • Another such DNA molecule includes nucleotides 14180-14665 of SEQ. ID. No. 1 and codes for a second undefined grapevine leafroll virus protein or polypeptide.
  • This DNA molecule comprises a nucleotide sequence corresponding to SEQ. ID. No. 16 as follows:
  • the second undefined grapevine leafroll virus protein or polypeptide has a deduced amino acid sequence corresponding to SEQ. ID. No. 17 as follows:
  • Arg and a molecular weight from about 17 to about 21 kDa, preferably about 19 kDa.
  • DNA molecule includes nucleotides 14667-15284 of SEQ. ID. No. 1 and codes for a third undefined grapevine leafroll virus protein or polypeptide.
  • This DNA molecule comprises a nucleotide sequence corresponding to SEQ. ID. No. 18 as follows:
  • the third undefined protein or polypeptide has a deduced amino acid sequence corresponding to SEQ. ID. No. 19 as follows:
  • Another DNA molecule of the present invention includes nucleotides 15285-15500 of SEQ. ID. No. 1 and comprises a nucleotide sequence corresponding to SEQ. ID. No. 23 as follows:
  • fragments of the DNA molecules of the present invention are constructed by using appropriate restriction sites, revealed by inspection of the DNA molecule's sequence, to: (i) insert an interposon (Felley et al, "Interposon Mutagenesis of Soil and Water Bacteria: a Family of DNA Fragments Designed for in vitro Insertion Mutagenesis of Gram-negative Bacteria,"
  • the sequence can be used to amplify any portion of the coding region, such that it can be cloned into a vector supplying both transcription and translation start signals.
  • Suitable DNA molecules are those that hybridize to a DNA molecule comprising a nucleotide sequence of at least 15 continuous bases of SEQ. ID. No. 1 under stringent conditions characterized by a hybridization buffer comprising 0.9M sodium citrate ("SSC") buffer at a temperature of 37°C and remaining bound when subject to washing with SSC buffer at 37°C; and preferably in a hybridization buffer comprising 20%) formamide in 0.9M saline/0.9M SSC buffer at a temperature of 42°C and remaining bound when subject to washing at 42°C with 0.2x SSC buffer at 42°C.
  • SSC sodium citrate
  • Variants may also (or alternatively) be modified by, for example, the deletion or addition of nucleotides that have minimal influence on the properties, secondary structure and hydropathic nature of the encoded polypeptide.
  • the nucleotides encoding a polypeptide may be conjugated to a signal (or leader) sequence at the N-terminal end of the protein which co-translationally or post-translationally directs transfer of the protein.
  • the nucleotide sequence may also be altered so that the encoded polypeptide is conjugated to a linker or other sequence for ease of synthesis, purification, or identification of the polypeptide.
  • the protein or polypeptide of the present invention is preferably produced in purified form (preferably, at least about 80%, more preferably 90%>, pure) by conventional techniques.
  • the protein or polypeptide of the present invention is isolated by lysing and sonication. After washing, the lysate pellet is resuspended in buffer containing Tris-HCl. During dialysis, a precipitate forms from this protein solution. The solution is centrifuged, and the pellet is washed and resuspended in the buffer containing Tris-HCl. Proteins are resolved by electrophoresis through an SDS 12%) polyacrylamide gel.
  • the DNA molecule encoding the grapevine leafroll virus (type 2) protein or polypeptide of the present invention can be incorporated in cells using conventional recombinant DNA technology. Generally, this involves inserting the DNA molecule into an expression system to which the DNA molecule is heterologous (i.e. not normally present). The heterologous DNA molecule is inserted into the expression system or vector in proper sense orientation and correct reading frame. The vector contains the necessary elements for the transcription and translation of the inserted protein-coding sequences.
  • Recombinant genes may also be introduced into viruses, such as vaccinia virus.
  • Recombinant viruses can be generated by transfection of plasmids into cells infected with virus.
  • Suitable vectors include, but are not limited to, the following viral vectors such as lambda vector system gtl 1, gt WES.tB, Charon 4, and plasmid vectors such as pBR322, pBR325, pACYC177, pACYC184, pUC8, pUC9, pUC18, pUC19, pLG339, pR290, pKC37, pKClOl, SV 40, pBluescript II SK +/- or KS +/- (see "Stratagene Cloning Systems” Catalog (1993) from Stratagene, La Jolla, Calif, which is hereby incorporated by reference), pQE, pIH821, pGEX, pET series (see Studier et.
  • viral vectors such as lambda vector system gtl 1, gt WES.tB, Charon 4, and plasmid vectors such as pBR322, pBR325, pACYC
  • host-vector systems include but are not limited to the following: bacteria transformed with bacteriophage DNA, plasmid DNA, or cosmid DNA; microorganisms such as yeast containing yeast vectors; mammalian cell systems infected with virus (e.g., vaccinia virus, adenovirus, etc.); insect cell systems infected with virus (e.g., baculovirus); and plant cells infected by bacteria or transformed via particle bombardment (i.e. biolistics).
  • the expression elements of these vectors vary in their strength and specificities. Depending upon the host-vector system utilized, any one of a number of suitable transcription and translation elements can be used.
  • RNA transcription and messenger RNA Transcription of DNA is dependent upon the presence of a promoter which is a DNA sequence that directs the binding of RNA polymerase and thereby promotes mRNA synthesis.
  • the DNA sequences of eucaryotic promoters differ from those of procaryotic promoters.
  • eucaryotic promoters and accompanying genetic signals may not be recognized in or may not function in a procaryotic system, and, further, procaryotic promoters are not recognized and do not function in eucaryotic cells.
  • Promoters vary in their "strength" (i.e. their ability to promote transcription). For the purposes of expressing a cloned gene, it is desirable to use strong promoters in order to obtain a high level of transcription and, hence, expression of the gene. Depending upon the host cell system utilized, any one of a number of suitable promoters may be used. For instance, when cloning in E.
  • promoters such as the T7 phage promoter, lac promoter, trp promoter, recA promoter, ribosomal RNA promoter, the P R and P L promoters of coliphage lambda and others, including but not limited, to / ⁇ cUV5, ompF, bla, Ipp, and the like, may be used to direct high levels of transcription of adjacent DNA segments. Additionally, a hybrid trp- / ⁇ cUV5 (tac) promoter or other E. coli promoters produced by recombinant DNA or other synthetic DNA techniques may be used to provide for transcription of the inserted gene.
  • promoters such as the T7 phage promoter, lac promoter, trp promoter, recA promoter, ribosomal RNA promoter, the P R and P L promoters of coliphage lambda and others, including but not limited, to / ⁇ cUV5, ompF, bla, Ipp, and the like, may be used to direct high
  • Bacterial host cell strains and expression vectors may be chosen which inhibit the action of the promoter unless specifically induced.
  • the addition of specific inducers is necessary for efficient transcription of the inserted DNA.
  • the lac operon is induced by the addition of lactose or IPTG (isopropylthio- beta-D-galactoside).
  • IPTG isopropylthio- beta-D-galactoside.
  • Other operons, such as trp, pro, etc. are under different controls.
  • Specific initiation signals are also required for efficient gene transcription and translation in procaryotic cells. These transcription and translation initiation signals may vary in "strength” as measured by the quantity of gene specific messenger RNA and protein synthesized, respectively.
  • the DNA expression vector which contains a promoter, may also contain any combination of various "strong" transcription and/or translation initiation signals. For instance, efficient translation in E. coli requires a Shine- Dalgarno ("SD") sequence about 7-9 bases 5' to the initiation codon ("ATG”) to provide a ribosome binding site. Thus, any SD-ATG combination that can be utilized by host cell ribosomes may be employed.
  • Such combinations include but are not limited to the SD- ATG combination from the cro gene or the N gene of coliphage lambda, or from the E. coli tryptophan ⁇ , D, C, B or A genes. Additionally, any SD-ATG combination produced by recombinant D ⁇ A or other techniques involving incorporation of synthetic nucleotides may be used.
  • D ⁇ A molecules encoding the various grapevine leafroll virus (type 2) proteins or polypeptides, as described above, have been cloned into an expression system, they are ready to be incorporated into a host cell. Such incorporation can be carried out by the various forms of transformation noted above, depending upon the vector/host cell system.
  • Suitable host cells include, but are not limited to, bacteria, virus, yeast, mammalian cells, insect, plant, and the like.
  • the present invention also relates to R ⁇ A molecules which encode the various grapevine leafroll virus (type 2) proteins or polypeptides described above.
  • the transcripts can be synthesized using the host cells of the present invention by any of the conventional techniques.
  • the mR ⁇ A can be translated either in vitro or in vivo.
  • Cell- free systems typically include wheat-germ or reticulocyte extracts. In vivo translation can be effected, for example, by microinjection into frog oocytes.
  • One aspect of the present invention involves using one or more of the above D ⁇ A molecules encoding the various proteins or polypeptides of a grapevine leafroll virus (type 2) to transform grape plants in order to impart grapevine leafroll resistance to the plants.
  • the mechanism by which resistance is imparted is not known.
  • the transformed plant can express a protein or polypeptide of grapevine leafroll virus (type 2), and, when the transformed plant is inoculated by a grapevine leafroll virus, such as GLRaV-1, GLRaV-2, GLRav-3, GLRaV-4, GLRaV-5, or GLRaV-6, or combinations of these, the expressed protein or polypeptide prevents translation of the viral DNA.
  • the subject DNA molecule incorporated in the plant can be constitutively expressed.
  • expression can be regulated by a promoter which is activated by the presence of grapevine leafroll virus.
  • Suitable promoters for these purposes include those from genes expressed in response to grapevine leafroll virus infiltration.
  • the isolated DNA molecules of the present invention can be utilized to impart grapevine leafroll virus resistance for a wide variety of grapevine plants.
  • the DNA molecules are particularly well suited to imparting resistance to Vitis scion or rootstock cultivars.
  • Scion cultivars which can be protected include those commonly referred to as Table or Raisin Grapes, such as Alden, Almeria, Anab-E-Shahi, Autumn Black, Beauty Seedless, Black Corinth, Black Damascus, Black Malvoisie, Black Prince, Blackrose, Bronx Seedless, Burgrave, Calmeria, Campbell Early, Canner, Cardinal, Catawba, Christmas, Concord, Dattier, Delight, Diamond, Dizmar, Duchess, Early Muscat, Emerald Seedless, Emperor, Exotic, Anthony de Lesseps, Fiesta, Flame seedless, Flame Tokay, Gasconade, Gold, Himrod, Hunisa, Hussiene, Isabella, Italia, July Muscat, Khandahar, Katta, Kourgan
  • Rootstock cultivars which can be protected include Couderc 1202, Couderc 1613, Couderc 1616, Couderc 3309, Dog Ridge, Foex 33 EM, Freedom, Ganzin 1 (A x R #1), Harmony, Kober 5BB, LN33, Millardet & de Grasset 4 IB, Millardet & de Grasset 420A, Millardet & de Grasset 101- 14, Oppenheim 4 (S04), Paulsen 775, Paulsen 1045, Paulsen 1103, Richter 99, Richter 1 10, Riparia Gloire, Ruggeri 225, Saint-George, Salt Creek, Teleki 5A, Vitis rupestris Constantia, Vitis California, and Vitis girdiana.
  • GLRaV-2 hsp70-related gene can also be used to produce transgenic plants or cultivars other than grape, such as citrus or sugar beet, which are resistant to closteroviruses other than grapevine leafroll, such as tristeza virus and beet yellows virus.
  • Suitable citrus cultivars include lemon, lime, orange, grapefruit, pineapple, tangerine, and the like, such as Joppa, Maltaise Ovale, Parson (Parson Brown), Pera, Pineapple, Queen, Shamouti, Valencia, Tenerife, Imperial Doblefina, Washington Sanguine, Moro, Sanguinello Moscato, Spanish Sanguinelli, Tarocco, Atwood, Australian, Bahia, Baiana, Cram, Dalmau, Eddy, Fisher, Frost Washington, Gillette, LengNavelina, Washington, Satsuma Mandarin, Dancy, Robinson, Ponkan, Duncan, Marsh, Pink Marsh, Ruby Red, Red Seedless, Smooth Seville, Orlando Tangelo, Eureka, Portugal, Meyer Lemon, Rough Lemon, Sour Orange, Persian Lime, West Indian Lime, Bearss, Sweet Lime, Troyer Citrange, and Citrus Trifoliata. Each of these citrus cultivars is suitable for producing transgenic citrus plants resistant to tristeza virus.
  • Beta vulgaris L. which has four important cultivar types: sugar beet, table beet, fodder beet, and Swiss chard. Each of these beet cultivars is suitable for producing transgenic beet plants resistant to beet yellows virus, as described above. Because GLRaV-2 has been known to infect tobacco plants (e.g.,
  • Nicotiana benthamiana it is also desirable to produce transgenic tobacco plants which are resistant to grapevine leafroll viruses, such as GLRaV-2.
  • Plant tissue suitable for transformation include leaf tissue, root tissue, meristems, zygotic and somatic embryos, and anthers. It is particularly preferred to utilize embryos obtained from anther cultures.
  • the expression system of the present invention can be used to transform virtually any plant tissue under suitable conditions.
  • Tissue cells transformed in accordance with the present invention can be grown in vitro in a suitable medium to impart grapevine leafroll virus resistance.
  • Transformed cells can be regenerated into whole plants such that the protein or polypeptide imparts resistance to grapevine leafroll virus in the intact transgenic plants.
  • the plant cells transformed with the recombinant DNA expression system of the present invention are grown and caused to express that DNA molecule to produce one of the above-described grapevine leafroll virus proteins or polypeptides and, thus, to impart grapevine leafroll virus resistance.
  • the DNA construct in a vector described above can be microinjected directly into plant cells by use of micropipettes to transfer mechanically the recombinant DNA.
  • Crossway Mol. Gen. Genetics. 202:179-85 (1985), which is hereby incorporated by reference.
  • the genetic material may also be transferred into the plant cell using polyethylene glycol. Krens, et al., Nature, 296:72-74 (1982), which is hereby incorporated by reference.
  • One technique of transforming plants with the DNA molecules in accordance with the present invention is by contacting the tissue of such plants with an inoculum of a bacteria transformed with a vector comprising a gene in accordance with the present invention which imparts grapevine leafroll resistance.
  • this procedure involves inoculating the plant tissue with a suspension of bacteria and incubating the tissue for 48 to 72 hours on regeneration medium without antibiotics at 25- 28°C.
  • Bacteria from the genus Agrobacterium can be utilized to transform plant cells. Suitable species of such bacterium include Agrobacterium tumefaciens and Agrobacterium rhizogenes. Agrobacterium tumefaciens (e.g., strains C58, LBA4404, or EHA105) is particularly useful due to its well-known ability to transform plants. Heterologous genetic sequences can be introduced into appropriate plant cells, by means of the Ti plasmid of A. tumefaciens or the Ri plasmid of A. rhizogenes. The Ti or Ri plasmid is transmitted to plant cells on infection by Agrobacterium and is stably integrated into the plant genome. J.
  • Means for regeneration vary from species to species of plants, but generally a suspension of transformed protoplasts or a petri plate containing explants is first provided. Callus tissue is formed and shoots may be induced from callus and subsequently rooted. Alternatively, embryo formation can be induced in the callus tissue. These embryos germinate as natural embryos to form plants.
  • the culture media will generally contain various amino acids and hormones, such as auxin and cytokinins. It is also advantageous to add glutamic acid and proiine to the medium. Efficient regeneration will depend on the medium, on the genotype, and on the history of the culture. If these three variables are controlled, then regeneration is usually reproducible and repeatable.
  • the expression cassette After the expression cassette is stably incorporated in transgenic plants, it can be transferred to other plants by sexual crossing. Any of a number of standard breeding techniques can be used, depending upon the species to be crossed.
  • transgenic plants of this type are produced, the plants themselves can be cultivated in accordance with conventional procedure so that the DNA construct is present in the resulting plants.
  • transgenic seeds are recovered from the transgenic plants. These seeds can then be planted in the soil and cultivated using conventional procedures to produce transgenic plants.
  • particle bombardment also known as biolistic transformation
  • particle bombardment also known as biolistic transformation
  • This technique is disclosed in U.S. Patent Nos. 4,945,050, 5,036,006, and 5,100,792, all to Sanford et al., and in Emerschad et al., "Somatic Embryogenesis and Plant Development from Immature Zygotic Embryos of Seedless Grapes (Vitis vinifera)0 Plant Cell Reports, 14:6-12 (1995) ("Emerschad (1995)”), which are hereby inco ⁇ orated by reference.
  • this procedure involves propelling inert or biologically active particles at the cells under conditions effective to penetrate the outer surface of the cell and to be incorporated within the interior thereof.
  • the vector can be introduced into the cell by coating the particles with the vector containing the heterologous DNA.
  • the target cell can be surrounded by the vector so that the vector is carried into the cell by the wake of the particle.
  • Biologically active particles e.g., dried bacterial cells containing the vector and heterologous DNA
  • the transformed tissue is regenerated to form a transgenic plant.
  • RNA-mediated resistance RNA-mediated resistance
  • the DNA molecule can be transcribed under conditions effective to maintain the messenger RNA in the plant cell at low level density readings. Density readings of between 15 and 50 using a Hewlet ScanJet and Image Analysis Program are preferred.
  • a portion of one or more DNA molecules of the present invention as well as other DNA molecules can be used in a transgenic grape plant, citrus plant, beet plant, or tobacco plant in accordance with U.S. Patent Application Serial No. 09/025,635, which is hereby incorporated herein by reference.
  • the grapevine leafroll virus (type 2) protein or polypeptide of the present invention can also be used to raise antibodies or binding portions thereof or probes.
  • the antibodies can be monoclonal or polyclonal.
  • Monoclonal antibody production may be effected by techniques which are well-known in the art. Basically, the process involves first obtaining immune cells (lymphocytes) from the spleen of a mammal (e.g., mouse) which has been previously immunized with the antigen of interest either in vivo or in vitro.
  • the antibody-secreting lymphocytes are then fused with (mouse) myeloma cells or transformed cells, which are capable of replicating indefinitely in cell culture, thereby producing an immortal, immunoglobulin-secreting cell line.
  • the resulting fused cells, or hybridomas are cultured, and the resulting colonies screened for the production of the desired monoclonal antibodies. Colonies producing such antibodies are cloned, and grown either in vivo or in vitro to produce large quantities of antibody. A description of the theoretical basis and practical methodology of fusing such cells is set forth in Kohler and Milstein, Nature, 256:495 (1975), which is hereby incorporated by reference.
  • Mammalian lymphocytes are immunized by in vivo immunization of the animal (e.g., a mouse) with the protein or polypeptide of the present invention. Such immunizations are repeated as necessary at intervals of up to several weeks to obtain a sufficient titer of antibodies. Following the last antigen boost, the animals are sacrificed and spleen cells removed.
  • Fusion with mammalian myeloma cells or other fusion partners capable of replicating indefinitely in cell culture is effected by standard and well-known techniques, for example, by using polyethylene glycol ("PEG”) or other fusing agents.
  • PEG polyethylene glycol
  • This immortal cell line which is preferably murine, but may also be derived from cells of other mammalian species, including but not limited to rats and humans, is selected to be deficient in enzymes necessary for the utilization of certain nutrients, to be capable of rapid growth, and to have good fusion capability. Many such cell lines are known to those skilled in the art, and others are regularly described.
  • Procedures for raising polyclonal antibodies are also well known. Typically, such antibodies can be raised by administering the protein or polypeptide of the present invention subcutaneously to New Zealand white rabbits which have first been bled to obtain pre-immune serum.
  • the antigens can be injected at a total volume of 100 ⁇ l per site at six different sites. Each injected material will contain synthetic surfactant adjuvant pluronic polyols, or pulverized acrylamide gel containing the protein or polypeptide after SDS-polyacrylamide gel electrophoresis.
  • the rabbits are then bled two weeks after the first injection and periodically boosted with the same antigen three times every six weeks. A sample of serum is then collected 10 days after each boost.
  • Polyclonal antibodies are then recovered from the serum by affinity chromatography using the corresponding antigen to capture the antibody. Ultimately, the rabbits are euthenized with pentobarbital 150 mg/Kg IV. This and other procedures for raising polyclonal antibodies are disclosed in Harlow et. al., editors, Antibodies: A Laboratory Manual (1988), which is hereby inco ⁇ orated by reference.
  • binding portions of such antibodies can be used.
  • binding portions include Fab fragments, F(ab') 2 fragments, and Fv fragments.
  • These antibody fragments can be made by conventional procedures, such as proteolytic fragmentation procedures, as described in Goding, Monoclonal Antibodies: Principles and Practice, New York:Academic Press, pp. 98-118 (1983), which is hereby inco ⁇ orated by reference.
  • the present invention also relates to probes found either in nature or prepared synthetically by recombinant DNA procedures or other biological procedures.
  • Suitable probes are molecules which bind to grapevine leafroll (type 2) viral antigens identified by the monoclonal antibodies of the present invention.
  • Such probes can be, for example, proteins, peptides, lectins, or nucleic acid probes.
  • the antibodies or binding portions thereof or probes can be administered to grapevine leafroll virus infected scion cultivars or rootstock cultivars. Alternatively, at least the binding portions of these antibodies can be sequenced, and the encoding DNA synthesized.
  • the encoding DNA molecule can be used to transform plants together with a promoter which causes expression of the encoded antibody when the plant is infected by grapevine leafroll virus. In either case, the antibody or binding portion thereof or probe will bind to the virus and help prevent the usual leafroll response.
  • Antibodies raised against the GLRaV-2 proteins or polypeptides of the present invention or binding portions of these antibodies can be utilized in a method for detection of grapevine leafroll virus in a sample of tissue, such as tissue (e.g., scion or rootstock) from a grape plant or tobacco plant.
  • Antibodies or binding portions thereof suitable for use in the detection method include those raised against a helicase, a methyltransferase, a papain-like protease, an RNA-dependent RNA polymerase, a heat shock 70 protein, a heat shock 90 protein, a coat protein, a diverged coat protein, or other proteins or polypeptides in accordance with the present invention.
  • any reaction of the sample with the antibody is detected using an assay system which indicates the presence of grapevine leafroll virus in the sample.
  • assay systems can be employed, such as enzyme-linked immunosorbent assays, radioimmunoassays, gel diffusion precipitin reaction assays, immunodiffusion assays, agglutination assays, fluorescent immunoassays, protein A immunoassays, or immunoelectrophoresis assays.
  • grapevine leafroll virus can be detected in such a sample using a nucleotide sequence of the DNA molecule, or a fragment thereof, encoding for a protein or polypeptide of the present invention.
  • the nucleotide sequence is provided as a probe in a nucleic acid hybridization assay or a gene amplification detection procedure (e.g., using a polymerase chain reaction procedure).
  • the nucleic acid probes of the present invention may be used in any nucleic acid hybridization assay system known in the art, including, but not limited to, Southern blots (Southern, E.M., "Detection of Specific Sequences Among DNA Fragments Separated by Gel Electrophoresis," J. Mol.
  • the probes can be used in a gene amplification detection procedure (e.g., a polymerase chain reaction). Erlich, H.A., et. al.,
  • Suitable labels include a radioactive compound, a fluorescent compound, a chemiluminescent compound, an enzymatic compound, or other equivalent nucleic acid labels.
  • probes having nucleotide sequences that correspond with conserved or variable regions of the ORF or UTR For example, to distinguish a grapevine leafroll virus from other related viruses (e.g., other closteroviruses), it is desirable to use probes which contain nucleotide sequences that correspond to sequences more highly conserved among all grapevine leafroll viruses.
  • Nucleic acid (DNA or RNA) probes of the present invention will hybridize to complementary GLRaV -2 nucleic acid under stringent conditions.
  • stringent conditions are selected to be about 50°C lower than the thermal melting point (T m ) for the specific sequence at a defined ionic strength and pH.
  • T m is the temperature (under defined ionic strength and pH) at which 50%> of the target sequence hybridizes to a perfectly matched probe.
  • Nonspecific binding may also be controlled using any one of a number of known techniques such as, for example, blocking the membrane with protein-containing solutions, addition of heterologous RNA, DNA, and SDS to the hybridization buffer, and treatment with RNase.
  • wash conditions are typically performed at or below stringency.
  • suitable stringent conditions for nucleic acid hybridization assays or gene amplification detection procedures are asas set forth above. More or less stringent conditions may also be selected.
  • Northern hybridization was performed after electrophoresis of the dsRNA of GLRaV-2 in 1% agarose non-denaturing condition gel.
  • the agarose gel was denatured by soaking in 50 mM NaOH containing 0.4 M NaCl for 30 min, and then neutralized with 0.1 M Tris-HCl (PH7.5 ) containing 0.5 M NaCl for another 30 min.
  • RNA was sandwich blotted overnight onto GenescreenTM plus membrane (Dupont NEN Research Product) in 10 X SSC buffer and hybridized as described by the manufacturer's instructions (DuPont, NEN).
  • DNA inserts were sequenced in pBluescript SK+ by using T3 and T7 universal primers for the terminal region sequence and additional oligonucleotide primers designed according to the known sequence for the internal region sequence.
  • Purification of plasmid DNA was performed by a modified mini alkaline-lysis/PEG precipitation procedure described by the manufacturer (Applied Biosystems, Inc.).
  • Nucleotide sequencing was performed on both strands of cDNA by using ABI TaqDyeDeoxy Terminator Cycle Sequencing Kit (Applied Biosystems, Inc.). Automatic sequencing was performed on an ABI373 Automated Sequencer (Applied Biosynstems, Inc.) at Cornell University, Geneva, NY.
  • nucleotide sequences of GLRaV-2 were assembled and analyzed with the programs of EditSeq and SeqMan, respectively, of DNASTAR package (Madison, Wl). Amino acid sequences deduced from nucleotide sequences and its encoding open reading frames were conducted using the MapDraw program. Multiple alignments of amino acid sequences, identification of consensus amino acid sequences, and generation of phylogenetic trees were performed using the Clustal method in the MegAlign program. The nucleotide and amino acid sequences of other closteroviruses were obtained with the Entrez Program; and sequence comparisons with nonredundant databases were searched with the Blast Program from the National Center for Biotechnology Information.
  • dsRNA was extracted from phloem tissue of infected grapevines according to the method described by Hu et al., "Characterization of Closterovirus-Like Particles Associated with Grapevine Leafroll Disease," J. Phytopathology 128: 1-14 (1990), which is hereby incorporated by reference.
  • cDNA synthesis was performed following the method initially described by Jelkmann et al., "Cloning of Four Plant Viruses From Small Quantities of Double- Stranded RNA," Phytopathology 79:1250-53 (1989) and modified by Ling et al., "The Coat Protein Gene of Grapevine Leafroll Associated Clostero virus-3 : Cloning, Nucleotide Sequencing and Expression in Transgenic Plants," Arch. Virology 142: 1 101-16 (1997), both of which are hereby incorporated by reference.
  • Second strand cDNA was obtained by using RNase H and E.coli DNA polymerase I. Double- stranded cDNA was blunt ended with T4 DNA polymerase and ligated with EcoR I adapters.
  • the cDNA which had EcoR I adapters at the ends, was activated by kinase reaction and ligated into Lambda ZAP II/EcoR I prepared arms following the manufacturer's instruction (Stratagene). The recombinant DNA was then packaged in vitro to Gigapack* II packaging extract (Stratagene). The packaged phage particles were amplified and titered according to the manufacturer's instruction.
  • Two kinds of probes were used to identify GLRaV-2 specific clones from the library.
  • One type was prepared from the synthesized cDNA that was amplified by PCR after ligation to the specific EcoR I Uni-AmpTM adapters (Clontech); and the other type was DNA inserts or PCR products from already sequenced clones.
  • Clones from the cDNA library were selected by colony-lifting hybridization onto the colony/plaque Screen membrane (NEN Research Product) with the probe described above.
  • the probe was prepared by labeling with P [ ⁇ -dATP] using Klenow fragment of E.coli DNA polymerase I. Prehybridization, hybridization, and washing steps were carried out at 65 °C according to the manufacturer's instruction (Dupont, NEN Research Product).
  • Selected plaques were converted to recombinant pBluescript by in vivo excision method according to the manufacturer's instruction (Stratagene).
  • dsRNA was polyadenylated by yeast poly(A) polymerase.
  • cDNA was amplified by RT-PCR with oligo(dT)18 and a specific primer, CP-1/T7R, which is derived from the clone CP-1 and has a nucleotide sequence according to SEQ. ID. No. 20 as follows:
  • the resulting PCR product (3' -PCR) was cloned into a TA vector (Invitrogen) and sequenced.
  • dsRNA As shown in Figure 1A, a high molecular weight dsRNA of ca. 15 kb was consistently identified from GLRaV-2 infected grapevines, but not from healthy vines. In addition, several low molecular weight dsRNAs were also detected from infected tissue.
  • the yield of dsRNA of GLRaV-2 was estimated between 5-10 ng/15 g phloem tissue, which was much lower than that of GLRaV-3 (Hu et al., "Characterization of Closterovirus-Like Particles Associated with Grapevine Leafroll Disease,” J. Phytopathology 128: 1-14 (1990), which is hereby inco ⁇ orated by reference). Only the high molecular weight dsRNA that was purified from low melting point agarose gel was used for cDNA synthesis, cloning and establishment of the Lambda/ZAP II cDNA library.
  • the initial clones were identified by hybridization with Uni-AmpTM PCR- amplified cDNA as probes.
  • the specificity of these clones e.g., TC-1 ranging from 200 to 1,800 bp in size was confirmed by Northern hybridization to dsRNA of GLRaV-2 as shown in Figure IB.
  • ORF6 was the coat protein gene of GLRaV-2
  • the complete ORF6 DNA molecule was subcloned from a PCR product and inserted into the fusion protein expression vector pMAL-C2 (New England Biolabs, Inc.).
  • the specific primers used for the PCR reaction were CP-96F and CP-96R, in which an EcoR I or BamH I site was included to facilitate cloning.
  • CP-96F was designed to include the start codon of the CP and comprises a nucleotide sequence according to SEQ. ID. NO. 21 as follows:
  • CGGAATTCAC CATGGAGTTG ATGTCCGACA G 31
  • CP-96R was 66 nucleotides downstream of the stop codon of the CP and comprises the nucleotide sequence corresponding to SEQ. ID. No. 22 as follows:
  • the coat protein was expressed as a fusion protein with maltose binding protein (MBP) of E. coli under the control of a "tac" promoter and suppressed by the "lac” repressor.
  • MBP maltose binding protein
  • the MBP- CP fusion protein was induced by adding 0.3 mM isopropyl- ⁇ -D-thio-gloactopyranoside (IPTG) and purified by a one step affinity column according to the manufacturer's instruction (New England, Biolabs, Inc ).
  • IPTG isopropyl- ⁇ -D-thio-gloactopyranoside
  • the MBP-CP fusion protein or the coat protein cleaved from the fusion protein was tested to react with specific antiserum of GLRaV-2 (kindly provided by Dr.
  • RNA genome of GLRaV-2 was sequenced and deposited in GenBank (accession number AF039204). About 85%> of the total RNA genome was revealed from at least two different clones. The sequence in the coat protein gene region was determined and confirmed from several different overlapping clones.
  • GenBank accession number AF0392064
  • the genome organization of GLRaV-2, shown in Figure 2 includes nine open reading frames (e.g., ORFla, lb-8).
  • ORFla and ORFlb Analysis of the amino acid sequence of the N-terminal portion of GLRaV-2 ORFla encoded product revealed two putative papain-like protease domains, which showed significant similarity to the papain-like leader protease of BYV (Agranovsky et al., "Beet Yellows Closterovirus: Complete Genome Structure and Identification of a Papain-like Thiol Protease," Virology 198:311-24 (1994), which is hereby incorporated by reference). Thus, it allowed prediction of the catalytic cysteine and histidine residues for the putative GLRaV-2 protease.
  • the C-terminal portion of the ORFla was identified as a helicase domain, the sequence of which showed a high similarity (57.1 % identity in a 315-residues alignment) to the helicase domain of BYV and contained the seven conserved motifs characteristic of the Superfamily I helicase of positive-strand RNA viruses (Figure 3C) (Hodgman, "A New Superfamily of Replicative Proteins," Nature 333:22-23 (1988); Koonin and Dolja, "Evolution and Taxonomy of Positive-strand RNA Viruses: Implications of Comparative Analysis of Amino Acid Sequences," Crit. Rev, in Biochem. and Mol. Biol.
  • ORF lb encoded a 460 amino acid polypeptide with a molecular mass of 52,486 Da, counting from the frameshifting site.
  • Database searching with the RdRP showed a significant similarity to the RdRP domains of positive strand RNA viruses.
  • Comparison of the RdRP domains of GLRaV-2 and BYV showed the presence of the eight conserved motifs of RdRP ( Figure 3D).
  • a tentative phylogenetic tree of the RdRP of GLRaV-2 with respect to other closteroviruses shows that it is closely related to the monopartite closteroviruses BYV, BYSV, and CTV.
  • ORF2 encodes a small protein consisting of 171 bp (57 amino acid) with a molecular mass of 6,297 Da. As predicted, the deduced amino acid sequence includes a stretch of nonpolar amino acids, which is presumed to form a transmembrane helix.
  • a small hydrophobic analogous protein is also present in BYV, BYSV, CTV, LIYV, and LChV (Agranovsky et al. "Nucleotide Sequence of the 3'-Terminal Half of Beet Yellows Closterovirus RNA Genome Unique Arrangement of Eight Virus Genes," J.
  • ORF3 encodes a 600 amino acid polypeptide with a molecular mass of 65,111 Da, which is homologous to the HSP70 cellular heat shock protein.
  • HSP70 is highly conserved among closteroviruses and is probably involved in ATPase activity and the protein to protein interaction for chaperone activity (Agranovsky et al. "The Beet Yellows Closterovirus p65 Homologue of HSP70 Chaperones has ATPase Activity Associated with its conserveed N-terminal Domain but Interact with Unfolded Protein Chains," J.
  • ORF4 encodes a 551 amino acid protein with a molecular mass of 63,349 Da.
  • Database searching with the ORF4 protein product did not identify similar proteins except those of its counterparts in closteroviruses, BYV (P64), BYSV (P61), CTV (P61), LIYV (P59), and LChV (P61) .
  • This protein is believed to be a putative heat shock 90 protein.
  • Figure 9 two conserved motifs which were present in BYV (Agranovsky et al. "Nucleotide Sequence of the 3 '-Terminal Half of Beet Yellows Closterovirus RNA Genome Unique Arrangement of Eight Virus Genes," J.
  • ORF6 was identified as the coat protein gene of GLRaV-2 based on the sequence comparison with other closteroviruses.
  • the calculated molecular mass of the protein product of ORF 6 (21,662 Da) is in good agreement with the previously estimated 22-26 kDa based on SDS-PAGE (Zimmermann et al., "Characterization and Serological Detection of Four Closterovirus-like Particles Associated with Leafroll Disease on Grapevine," Phytopathology 130:205-18 (1990); Boscia et al., “Nomenclature of Grapevine Leafroll- Associated Putative Closteroviruses,” Vitis 34:171-75 (1995), both of which are hereby incorporated by reference).
  • ORF6 were present in both ORF5 and ORF6 of GLRaV-2. Two of these amino acid residues (R and D) are believed to be involved in stabilization of molecules by salt bridge formation and proper folding in the most conserved core region of coat proteins of all filamentous plant viruses (Dolja et al., "Phylogeny of Capsid Proteins of Rod-Shaped and Filamentous RNA Plant Viruses Two Families With Distinct Patterns of Sequence and Probably Structure Conservation," Virology 184:79-86 (1991), which is hereby inco ⁇ orated by reference). Identification of ORF6 as the coat protein gene was further confirmed by
  • ORF7 and ORF8 encode polypeptides of 162 amino acid with a molecular mass of 18,800 Da and of 206 amino acid with a molecular mass of 23,659 Da, respectively.
  • Database searching with the ORF7 and ORF8 showed no significant similarity with any other proteins. Nevertheless, these genes were of similar in size and location as those observed in the sequence of other closteroviruses, BYV (P20, P21), BYSV (P18, P22), and LChV (P21 , P27) ( Figure 7). However, conserved regions were not observed between the ORF7 or ORF8 and its counte ⁇ arts in BYV, BYSV, and LChV.
  • the 3' terminal untranslated region (3'-UTR) consists of 216 nucleotides. Nucleotide sequence analysis revealed a long oligo(A) tract close to the end of the GLRaV-2 genome which is similar to that observed in the genome of BYV and BYSV (Agranovsky et al. "Nucleotide Sequence of the 3'-Terminal Half of Beet Yellows Closterovirus RNA Genome Unique Arrangement of Eight Virus Genes," J.
  • BYV ends in CCC, BYSV, and CTV ends in CC with an additional G or A in the double-stranded replicative form of BYSV (Karasev et al., "Organization of the 3'-Terminal Half of Beet Yellow Stunt Virus Genome and Implications for the Evolution of Closteroviruses," Virology 221 :199-207 (1996), which is hereby inco ⁇ orated by reference) and CTV (Karasev et al, "Complete Sequence of the Citrus Tristeza Virus RNA Genome," Virology 208:511-20 (1995), which is hereby inco ⁇ orated by reference), respectively .
  • GLRaV-2 had CGC at the 3' terminus of the genome.
  • GLRaV-2 with the same regions of BYV, BYSV, and CTV showed the presence of the same conserved 60 nt stretch. Besides this cis-element, conserved sequences were not found in the 3' UTRs of GLRaV-2, BYV, BYSV, and CTV.
  • the closteroviruses studied so far e.g., BYV, BYSV, CTV, LIYV, LChV, and GLRaV-3) have apparent similarities in genome organization, which include replication associated genes that consist of MT, HEL, and RdRP conserved domains and a five-gene array unique for closteroviruses (Dolja et al. "Molecular Biology and Evolution of Closteroviruses: Sophisticated Build-up of Large RNA Genomes," Annual Rev.
  • GLRaV-2 is a closterovirus.
  • two putative papain-like proteases were identified and an autoproteolytic cleavage process was predicted.
  • the replication associated proteins consisting of MT, HEL, and RdRP conserved motifs were also identified, which were phylogenetically closely related to the replication associated proteins of other closteroviruses.
  • ORFs downstream of the CP are of similar, in size and location, to those observed in the genome of BYV. Furthermore, lack of a poly(A) tail at the 3' end of GLRaV-2 is also in good agreement with other closteroviruses. Like all other closteroviruses, the expression of ORFlb is suspected to occur via a +1 ribosomal frameshift and the 3 'proximal ORFs are probably expressed via formation of a nested set of subgenomic RNAs.
  • GLRaV-2 Since the slippery sequence, stem-loop and pseudoknot structure involved in the frameshift of BYV were absent in GLRaV-2, the +1 frameshift of GLRaV-2 might be the same as proposed for CTV (Karasev et al., "Complete Sequence of the Citrus Tristeza Virus RNA Genome,” Virology 208:511-20 (1995), which is hereby incorporated by reference) and BYSV (Karasev et al., "Organization of the 3'- Terminal Half of Beet Yellow Stunt Virus Genome and Implications for the Evolution of Closteroviruses," Virology 221 : 199-207 (1996), which is hereby incorporated by reference). Overall, GLRaV-2 is more closely related to monopartite closteroviruses
  • GLRaV-2 is the only closterovirus that matches with the genome organization of BYV, the type member of the genus Closterovirus.
  • genomic RNA of GLRaV-2 is about the same size as that of BYV; however, the transmission vector of GLRaV-2 is unknown.
  • the genome organization of GLRaV-2 is more closely related to the aphid transmissible closteroviruses (BYV and CTV) than to whitefly (LIYV) or mealybug transmissible closteroviruses (LChV and GLRaV-3). Thus, it is possible that GLRaV-2 is transmitted by aphids.
  • GLRaV-2 and GLRaV-3 are the first grapevine leafroll associated closteroviruses that have been almost completely sequenced.
  • GLRaV-2 infected Vitis vinifera, cv Pinot Noir grapevines originated from a vineyard in central New York was used as the virus isolate, from which the cp gene of GLRaV-2 was identified.
  • the sense primer CP-96F (SEQ. ID. No. 21) starts from the ATG initiation codon of the coat protein gene and the complementary primer CP-96R (SEQ. ID. No. 22) starts from 56 nucleotides downstream of the stop codon of the CP gene.
  • a Nco I restriction site (11 bp in SEQ. ID. No. 21 and 13 bp in SEQ. ID. No.
  • the coat protein gene of GLRaV-2 was amplified from dsRNA extracted from GLRaV-2 infected grapevine using reverse transcriptase polymerase chain reaction (RT-PCR).
  • RT-PCR reverse transcriptase polymerase chain reaction
  • the PCR- amplified CP product was purified from low melting temperature agarose gel, digested with Nco I and cloned into the same enzyme digested plant expression vector pEPT8 (shown at Figure 1 1). After screening, the orientation of recombinant construct was checked by using the internal restriction site of the CP gene and directly sequencing the CP gene.
  • the plant expression cassette which consisted of a double cauliflower mosaic virus (CaMV) 35S-enhancer, a CaMV 35S-promoter, an alfalfa mosaic virus (ALMV) RNA4 5' leader sequence, a coat protein gene of GLRaV-2 (CP-GLRaV-2), and a CaMV 35S 3' untranslated region as a terminator, was cut using the EcoR I restriction enzyme, isolated from low melting point temperature agarose gel, and cloned into the same restriction enzyme treated binary vector pGA482GG or pGA482G (a derivative of pGA482 (An et al., "Binary Vectors," in Plant Molecular Biology Manual, pp.
  • the resulting recombinants constructs are pGA482GG/EPT8CP-GLRaV2 (shown at Figure 11 A), which contain both neomycin phosphotransferase (npt II) and ⁇ -glucuronidase (GUS) at the internal region of the T-DNA, and pGA482G/EPT8CP-GLRaV2 (shown at Figure 1 IB) without GUS.
  • npt II neomycin phosphotransferase
  • GUS ⁇ -glucuronidase
  • the Agrobacterium tumefaciens containing the vector was used to infect Nicotiana benthamiana wounded leaf disks according to the procedure essentially described by Horsch et al., "A Simple and General Method for Transferring Genes into Plants," Science 277:1229-1231 (1985), which is incorporated herein by reference.
  • NPT II-ELISA Double-antibody sandwich enzyme linked immnuosorbent assay (DAS-ELISA) was used to detect the npt II enzyme with an NPT II-ELISA kit (5' prime to 3' prime, Inc., Boulder, Co.).
  • Indirect ELISA Polyclonal antibodies to GLRaV-2, which were prepared from the coat protein expressed in E. coli, were used. Plates were coated with homogenized samples in extraction buffer (1 :10, w/v) (phosphate buffered saline containing 0.05%> Tween 20 and 2%o polyvinyl pyrrolidone) and incubated overnight at 4°C.

Abstract

The present invention relates to isolated proteins or polypeptides of grapevine leafroll virus (type 2). The encoding DNA molecules either alone in isolated form or in an expression system, a host cell, or a transgenic grape plant are also disclosed. Other aspects of the present invention relates to a method of imparting grapevine leafroll resistance to grape and tobacco plants by transforming them with the DNA molecules of the present invention, a method of imparting beet yellows virus resistance to a beet plant, a method of imparting tristeza virus resistance to a citrus plant, and a method of detecting the presence of a grapevine leafroll virus, such as GRLaV-2, in a sample.

Description

GRAPEVINE LEAFROLL VIRUS (TYPE 2) PROTEINS AND THEIR USES
This application claims the benefit of U.S. Provisional Patent Application Serial No. 60/047,194, filed May 20, 1997. This work was supported by the U.S. Department of Agriculture Cooperative Grant No. 58-2349-9-01. The U.S. Government may have certain rights in the invention.
FIELD OF THE INVENTION
The present invention relates to grapevine leafroll virus (type 2) proteins,
DNA molecules encoding these proteins, and their uses.
BACKGROUND OF THE INVENTION
The world's most widely grown fruit crop, the grape (Vitis sp.), is cultivated on all continents except Antarctica. However, major grape production centers are in European countries (including Italy, Spain, and France), which constitute about 70% of the world grape production (Mullins et al., Biology of the Grapevine, Cambridge, U. .:University Press (1992)). The United States, with 300,000 hectares of grapevines, is the eighth largest grape grower in the world. Although grapes have many uses, a major portion of grape production (-80%) is used for wine production. Unlike cereal crops, most of the world's vineyards are planted with traditional grapevine cultivars, which have been perpetuated for centuries by vegetative propagation. Several important grapevine virus and virus-like diseases, such as grapevine leafroll, corky bark, and Rupestris stem pitting, are transmitted and spread through the use of infected vegetatively propagated materials. Thus, propagation of certified, virus-free materials is one of the most important disease control measures. Traditional breeding for disease resistance is difficult due to the highly heterozygous nature and outcrossing behavior of grapevines, and due to polygenic patterns of inheritance. Moreover, introduction of a new cultivar may be prohibited by custom or law. Recent biotechnology developments have made possible the introduction of special traits, such as disease resistance, into an established cultivar without altering its horticultural characteristics.
Many plant pathogens, such as fungi, bacteria, phytoplasmas, viruses, and nematodes can infect grapes, and the resultant diseases can cause substantial losses in production (Pearson et al, Compendium of Grape Diseases, American Phytopathological Society Press (1988)). Among these, viral diseases constitute a major hindrance to profitable growing of grapevines. About 34 viruses have been isolated and characterized from grapevines. The major virus diseases are grouped into: (1) the grapevine degeneration caused by the fanleaf nepovirus, other European nepoviruses, and American nepoviruses, (2) the leafroll complex, and (3) the rugose wood complex (Martelli, ed., Graft Transmissible Diseases of Grapevines. Handbook for Detection and Diagnosis, FAO, UN, Rome, Italy (1993)).
Of the major virus diseases, the grapevine leafroll complex is the most widely distributed throughout the world. According to Goheen ("Grape Leafroll," in Frazier et al., eds.. Virus Diseases of Small Fruits and Grapevines (A Handbook), University of California, Division of Agricultural Sciences, Berkeley, Calif, USA, pp. 209-212 (1970) ("Goheen (1970)"), grapevine leafroll-like disease was described as early as the 1850s in German and French literature. However, the viral nature of the disease was first demonstrated by Scheu (Scheu, "Die RoUkrankheit des Rebstockes (Leafroll of grapevine)," P. D. Weinbau 14:222- 358 (1935) ("Scheu (1935)")). In 1946, Harmon and Snyder (Harmon et al., "Investigations on the Occurrence, Transmission, Spread and Effect of 'White' Fruit Colour in the Emperor Grape," Proc. Am. Soc. Hort. Sci. 74:190-194 (1946)) determined the viral nature of White Emperor disease in California. It was later proven by Goheen et al. (Goheen et al, "Leafroll (White Emperor Disease) of Grapes in California, Phytopathology, 48:51-54 (1958) ("Goheen (1958)")) that both leafroll and "White Emperor" diseases were the same, and only the name "leafroll" was retained.
Leafroll is a serious viral disease of grapes and occurs wherever grapes are grown. This wide distribution of the disease has come about through the propagation of diseased vines. It affects almost all cultivated and rootstock varieties of Vitis . Although the disease is not lethal, it causes yield losses and reduction of sugar content. Scheu estimated in 1936 that 80 per cent of all grapevines planted in Germany were infected (Scheu, Mein Winzerbuch, BerlimReichsnahrstand-Verlags (1936)). In many California wine grape vineyards, the incidence of leafroll (based on a survey of field symptoms conducted in 1959) agrees with Scheu's initial observation in German vineyards (Goheen et al., "Studies of Grape Leafroll in California," Amer. J. Enol. Vitic, 10:78-84 (1959)). The current situation on leafroll disease does not seem to be any better (Goheen, "Diseases Caused by Viruses and Viruslike Agents," The American Phvtopathological Society, St. Paul, Minnesota:APS Press, 1 :47-54 (1988) ("Goheen (1988)"). Goheen also estimated that the disease causes an annual loss of about 5-20 per cent of the total grape production (Goheen (1970) and Goheen (1988)). The amount of sugar in individual berries of infected vines is only about 1/2 to 2/3 that of berries from noninfected vines (Goheen (1958)).
Symptoms of leafroll disease vary considerably depending upon the cultivar, environment, and time of the year. On red or dark-colored fruit varieties, the typical downward rolling and interveinal reddening of basal, mature leaves is the most prevalent in autumn; but not in spring or early summer. On light-colored fruit varieties however, symptoms are less conspicuous, usually with downward rolling accompanied by interveinal chlorosis. Moreover, many infected rootstock cultivars do not develop symptoms. In these cases, the disease is usually diagnosed with a woody indicator indexing assay using Vitis vivifera cv. Carbernet Franc (Goheen (1988)).
Ever since Scheu demonstrated that leafroll was graft transmissible, a virus etiology has been suspected (Scheu (1935)). Several virus particle types have been isolated from leafroll diseased vines. These include potyvirus-like (Tanne et al, "Purification and Characterization of a Virus Associated with the Grapevine Leafroll Disease," Phytopathology, 67:442-447 (1977)), isometric virus-like (Castellano et al., "Virus-like
Particles and Ultrastructural Modifications in the Phloem of Leafroll-affected Grapevines," Vitis, 22:23-39 (1983) ("Castellano (1983)") and Namba et al., "A Small Spherical Virus Associated with the Ajinashika Disease of Koshu Grapevine, Ann. Phytopathol. Soc. Japan, 45:70-73 (1979)), and closterovirus-like (Namba, "Grapevine Leafroll Virus, a Possible Member of Clostero viruses, Ann. Phytopathol. Soc. Japan, 45:497-502 (1979)) particles. In recent years, however, long flexuous closteroviruses ranging from 1 ,400 to 2,200 nm have been most consistently associated with leafroll disease (Figure 1) (Castellano (1983), Faoro et al., "Association of a Possible Closterovirus with Grapevine Leafroll in Northern Italy," Riv. Patol. Veg„ Ser IV. 17:183-189 (1981), Gugerli et al., "L'enroulement de la vigne: mise en evidence de particules virales et developpement d'une methode immuno-enzymatique pour le diagnostic rapide (Grapevine Leafroll: Presence of Virus Particles and Development of an Immuno-enzyme method for Diagnosis and Detection)," Rev. Suisse Viticult. Arboricult. Hort, 16:299-304 (1984) ("Gugerli (1984)"), Hu et al., "Characterization of Closterovirus-like Particles Associated with Grapevine Leafroll Disease," J. Phytopathol, 128:1-14 (1990) ("Hu (1990)"), Milne et al, "Closterovirus-like Particles of Two Types Associated with Diseased Grapevines," Phytopathol. Z., 110:360-368 (1984), Zee et al, "Cytopathology of Leafroll-diseased Grapevines and the Purification and Serology of Associated Closteroviruslike Particles," Phytopathology, 77:1427-1434 (1987) ("Zee (1987)"), and Zimmermann et al, "Characterization and Serological Detection of Four Closterovirus-like Particles Associated with Leafroll Disease on Grapevine," J. Phytopathol.. 130:205-218 (1990) ("Zimmermann (1990)")). These closteroviruses are referred to as grapevine leafroll associated viruses ("GLRaV"). At least six serologically distinct types of GLRaV's (GLRaV- 1 to -6) have been detected from leafroll diseased vines (Table 1) (Boscia et al., "Nomenclature of Grapevine Leafroll-associated Putative Closteroviruses, Vitis, 34:171-175 (1995) ("Boscia (1995)") and (Martelli, "Leafroll," pp. 37-44 in Martelli, ed., Graft Transmissible Diseases of Grapevines, Handbook for Detection and Diagnosis, FAO, Rome Italy, (1993) ("Martelli I")). The first five of these were confirmed in the 10th Meeting of the International Council for the Study of Virus and Virus Diseases of the Grapevine ("ICVG") (Volos, Greece, 1990).
TABLE 1
Type Particle length Coat Reference (nm) protein Mr (X103)
GLRaV- 1 1,400-2,200 39 Gugerli (1984)
GLRaV-2 1,400-1,800 26 Gugerli (1984) Zimmermann (1990)
GLRaV-3 1,400-2,200 43 Zee (1987)
GLRaV-4 1,400-2,200 36 Hu (1990)
GLRaV-5 1,400-2,200 36 Zimmermann (1990)
GLRaV-6 1,400-2,200 36 Gugerli (1993)
Through the use of monoclonal antibodies, however, the original GLRaV II described in
Gugerli (1984) has been shown to be an apparent mixture of at least two components, Ila and lib (Gugerli et al, "Grapevine Leafroll Associated Virus II Analyzed by Monoclonal Antibodies," 11th Meeting of the International Council for the Study of Viruses and Virus Diseases of the Grapevine, Montreux, Switzerland, pp. 23-24 (1993) ("Gugerli (1993)")). Recent investigation with comparative serological assays (Boscia (1995)) demonstrated that the lib component of cv. Chasselas 8/22 is the same as the GLRaV-2 isolate from France (Zimmermann (1990)) which also include the isolates of grapevine corky bark associated closteroviruses from Italy (GCBaV-BA) (Boscia (1995)) and from the United States (GCBaV-NY) (Namba et al., "Purification and Properties of Closterovirus-like Particles Associated with Grapevine Corky Bark Disease," Phytopathology, 81 :964-970 (1991) ("Namba (1991)")). The Ila component of cv. Chasselas 8/22 was given the provisional name of grapevine leafroll associated virus 6 (GLRaV-6). Furthermore, the antiserum to the CA-5 isolate of GLRaV-2 produced by Boscia et al. (Boscia et al, "Characterization of
Grape Leafroll Associated Closterovirus (GLRaV) Serotype II and Comparison with GLRaV Serotype III," Phytopathology, 80: 117 (1990)) was shown to contain antibodies to both GLRaV-2 and GLRaV- 1, with a prevalence of the latter (Boscia (1995)).
Virions of GLRaV-2 are flexuous, filamentous particles about 1 ,400-1 ,800 nm in length (Gugerli et al., "L'enroulement de la Vigne: Mise en Evidence de Particles Virales et Development d'une Methode Immuno-enzymatique Pour le Diagnostic Rapide (Grapevine Leafroll: Presence of Virus Particles and Development of an Immuno-enzyme Method for Diagnosis and Detection)," Rev. Suisse Viticult. Arboricult. Horticult. 16:299-304 (1984)). A double-stranded RNA (dsRNA) of about 15 kb was consistently isolated from GLRaV-2 infected tissues (Goszczynski et al., "Detection of Two Strains of Grapevine Leafroll-
Associated Virus 2," Vitis 35: 133-35 (1996)). The coat protein of GLRaV-2 is ca 22-26 kDa (Zimmermann et al., "Characterization and Serological Detection of Four Closterovirus-like Particles Associated with Leafroll Disease on Grapevine," J. Phytopathology 130:205-18 (1990); Gugerli and Ramel, Extended abstracts: "Grapevine Leafroll Associated Virus II Analyzed by Monoclonal Antibodies," 11th ICVG at Montreux, Switzerland, Gugerli, ed., Federal Agricultural Research Station of Changins, CH-1260 Nyon, Switzerland, p. 23-24 (1993); Boscia et al., "Nomenclature of Grapevine Leafroll-Associated Putative Closteroviruses," Vitis 34:171-75 (1995)), which is considerably smaller than other GLRaVs (35-43 kDa) (Zee et al., "Cytopathology of Leafroll-Diseased Grapevines and the Purification and Serology of Associated Closterovirus Like Particles," Phytopathology 77:1427-34
(1987); Hu et al., "Characterization of Clostero virus-Like Particles Associated with Grapevine Leafroll Disease," J. of Phytopathology 128:1-14 (1990); Ling et al., "The Coat Protein Gene of Grapevine Leafroll Associated Closterovirus-3 : Cloning, Nucleotide Sequencing and Expression in Transgenic Plants," Arch, of Virology 142:1101-16 (1997)). Although GLRaV-2 has been classified as a member of the genus Closterovirus based on particle morphology and cytopathology (Martelli, Circular of ICTV-Plant Virus Subcommittee Study Group on Closterolike Viruses" (1996)), its molecular and biochemical properties are not well characterized. In the closterovirus group, several viruses have recently been sequenced. The partial or complete genome sequences of beet yellows virus (BYV) ( Agranovsky et al. "Nucleotide Sequence of the 3 '-Terminal Half of Beet Yellows Closterovirus RNA Genome Unique Arrangement of Eight Virus Genes," J. General Virology 72:15-24 (1991); Agranovsky et al., "Beet Yellows Closterovirus: Complete Genome Structure and
Identification of a Papain-like Thiol Protease," Virology 198:311-24 (1994)), beet yellow stunt virus (BYSV) (Karasev et al., "Organization of the 3'-Terminal Half of Beet Yellow Stunt Virus Genome and Implications for the Evolution of Closteroviruses," Virology 221 :199-207 (1996)), citrus tristeza virus (CTV) (Pappu et al., "Nucleotide Sequence and Organization of Eight 3' Open Reading Frames of the Citrus Tristeza Closterovirus Genome," irology 199:35-46 (1994); Karasev et al., "Complete Sequence of the Citrus Tristeza Virus RNA Genome," Virology 208:51 1-20 (1995)), lettuce infectious yellows virus (LIYV) (Klaassen et al., "Partial Characterization of the Lettuce Infectious Yellows Virus Genomic RNAs, Identification of the Coat Protein Gene and Comparison of its Amino Acid Sequence With Those of Other Filamentous RNA Plant Viruses," J. General Virology 75: 1525-33
(1994); Klaassen et al., "Genome Structure and Phylogenetic Analysis of Lettuce Infectious Yellows Virus, a Whitefly-Transmitted, Bipartite Closterovirus," Virology 208:99-110 (1995)), little cherry virus (LChV) (Keim and Jelkmann, "Genome Analysis of the 3'- Terminal Part of the Little Cherry Disease Associated dsRNA Reveals a Monopartite Clostero-Like Virus," Arch. Virology 141 : 1437-51 (1996); Jelkmann et al., "Complete Genome Structure and Phylogenetic Analysis of Little Cherry Virus, a Mealybug- Transmissible Closterovirus," J. General Virology 78:2067-71 (1997)), and GLRaV-3 (Ling et al., "Nucleotide Sequence of the 3' Terminal Two-Thirds of the Grapevine Leafroll Associated Virus-3 Genome Reveals a Typical Monopartite Closterovirus," J. Gen. Virology 79(5):1289-1301 (1998)) revealed several common features of the closteroviruses, including the presence of HSP70 chaperone heat shock protein and a duplicate of the coat protein gene (Agranovsky "Principles of Molecular Organization, Expression, and Evolution of Closteroviruses: Over the Barriers," Adv. in Virus Res. 47:119-218 (1996); Dolja et al. "Molecular Biology and Evolution of Closteroviruses: Sophisticated Build-up of Large RNA Genomes," Annual Rev. Photopathology 32:261-85 (1994); Boyko et al., "Coat Protein Gene Duplication in a Filamentous RNA Virus of Plants," Proc. Nat. Acad. Sci. USA 89:9156-60 (1992)). Characterization of the genome organization of GLRaVs would provide molecular information on the serologically distinct closteroviruses that cause similar leafroll symptoms in grapevine. Several shorter closteroviruses (particle length 800 nm long) have also been isolated from grapevines. One of these, called grapevine virus A ("GVA") has also been found associated, though inconsistently, with the leafroll disease (Agran et al., "Occurrence of Grapevine Virus A (GVA) and Other Closteroviruses in Tunisian Grapevines Affected by Leafroll Disease," Vitis, 29:43-48 (1990), Conti, et al, "Closterovirus Associated with Leafroll and Stem Pitting in Grapevine," Phytopathol. Mediterr.. 24: 110-113 (1985), and Conti et al., "A Closterovirus from a Stem-pitting-diseased Grapevine," Phytopathology. 70:394-399 (1980)). The etiology of GVA is not really known; however, it appears to be more consistently associated with rugose wood sensu lato (Rosciglione at al., "Maladies de l'enroulement et du bois strie de la vigne: analyse microscopique et serologique (Leafroll and Stem Pitting of Grapevine: Microscopical and Serological Analysis)," Rev. Suisse Vitic Arboric. Hortic. 18:207-21 1 (1986) ("Rosciglione (1986)"), and Zimmermann (1990)). Moreover, another short closterovirus (800 nm long) named grapevine virus B ("GVB") has been isolated and characterized from corky bark-affected vines (Boscia et al., "Properties of a Filamentous Virus Isolated from Grapevines Affected by Corky Bark," Arch. Virol., 130:109-120 (1993) and Namba (1991)).
As suggested by Martelli I, leafroll symptoms may be induced by more than one virus or they may be simply a general plant physiological response to invasion by an array of phloem-inhabiting viruses. Evidence accumulated in the last 15 years strongly favors the idea that grapevine leafroll is induced by one (or a complex) of long closteroviruses (particle length 1 ,400 to 2,200 nm).
Grapevine leafroll is transmitted primarily by contaminated scions and rootstocks. However, under field conditions, several species of mealybugs have been shown to be the vector of leafroll (Engelbrecht et al, "Transmission of Grapevine Leafroll Disease and Associated Closteroviruses by the Vine Mealybug Planococcus-ficus," Phytophylactica, 22:341-346 (1990), Rosciglione, et al., "Transmission of Grapevine Leafroll Disease and an Associated Closterovirus to Healthy Grapevine by the Mealybug Planococcus ficus," (Abstract), Phvtoparasitica, 17:63-63 (1989), and Tanne, "Evidence for the Transmission by Mealybugs to Healthy Grapevines of a Closter-like Particle Associated with Grapevine Leafroll Disease," Phvtoparasitica, 16:288 (1988)). Natural spread of leafroll by insect vectors is rapid in various parts of the world. In New Zealand, observations of three vineyards showed that the number of infected vines nearly doubled in a single year (Jordan et al., "Spread of Grapevine Leafroll and its Associated Virus in New Zealand Vineyards," 11th Meeting of the International Council for the Study of Viruses and Virus Diseases of the Grapevine. Montreux, Switzerland, pp. 113-114 (1993)). One vineyard became 90% infected 5 years after GLRaV-3 was first observed. Prevalence of leafroll worldwide may increase as chemical control of mealybugs becomes more difficult due to the unavailability of effective insecticides.
In view of the serious risk grapevine leafroll virus poses to vineyards and the absence of an effective treatment of it, the need to prevent this affliction continues to exist. The present invention is directed to overcoming this deficiency in the art.
SUMMARY OF INVENTION
The present invention relates to an isolated protein or polypeptide corresponding to a protein or polypeptide of a grapevine leafroll virus (type 2). The encoding RNA and DNA molecules, in either isolated form or incorporated in an expression system, a host cell, a transgenic Vitis or citrus scion or rootstock cultivar, or a transgenic Nicotiana plant or beet plant are also disclosed.
Another aspect of the present invention relates to a method of imparting grapevine leafroll virus (type 2) resistance to Vitis scion or rootstock cultivars or Nicotiana plants by transforming them with a DNA molecule encoding the protein or polypeptide corresponding to a protein or polypeptide of a grapevine leafroll virus (type 2). Other aspects of the present invention relate to a method of imparting beet yellows virus resistance to beet plants and a method of imparting tristeza virus resistance to citrus scion or rootstock cultivars, both by transforming the plants or cultivars with a DNA molecule encoding the protein or polypeptide corresponding to a protein or polypeptide of a grapevine leafroll virus (type 2). The present invention also relates to an antibody or binding portion thereof or probe which recognizes the protein or polypeptide.
Grapevine leafroll virus resistant transgenic variants of the current commercial grape cultivars and rootstocks allows for more complete control of the virus, while retaining the varietal characteristics of specific cultivars. Furthermore, these variants permit control of GLRaV-2 transmitted either by contaminated scions or rootstocks or by a presently uncharacterized insect vector. With respect to the latter mode of transmission, the present invention circumvents increased restriction of pesticide use which has made chemical control of insect infestation increasingly difficult. In this manner, the interests of the environment and the economics of grape cultivation and wine making are all furthered by the present invention.
BRIEF DESCRIPTION OF THE DRAWINGS
Figures 1 A and IB are a comparison of a double-stranded RNA (dsRNA) profile (Figure 1A) of GLRaV-2 and its Northern hybridization analysis (Figure IB). In Figure 1A: lane M, lambda Hind III DNA marker; and lane 1, dsRNA pattern in 1% agarose gel stained with ethidium bromide. Figure IB is a northern hybridization of isolated high molecular weight dsRNA of GLRaV-2 with a probe prepared with 32P [α-dATP] labeled cDNA insert from GLRaV-2 specific cDNA clone TC-1. Lane 1, high molecular weight dsRNA of GLRaV-2. Lane 2, total RNA extracted from healthy grapevine.
Figure 2 displays the genome organization of GLRaV-2 and its sequencing strategy. Boxes represent ORFs encoded by deduced amino acid sequences of GLRaV-2, numbered lines represent nucleotide coordinates, beginning from 5'-terminal of RNA in kilobases (kb). The lines below GLRaV-2 RNA genome represent the cDNA clones used to determine the nucleotide sequences.
Figure 3A-3D are comparisons between ORFla/ORFlb of GLRaV-2 and BYV. Figure 3A-3D show the conserved domains of two papain-like proteases (P-PRO), methyltransferase (MT/MTR), helicase (HEL), and RNA-dependent RNA polymerase (RdRP), respectively. Exclamation marks indicate the predicted catalytic residues of the leader papain-like protease; slashes indicate the predicted cleavage sites. The conserved motifs of the MT, HEL, and RdRP domains are highlighted with overlines marked with respective letters. The alignment is constructed using the MegAlign program in DNASTAR. Figures 4A and 4B are alignments of the nucleotide (Figure 4A) and deduced amino acid (Figure 4B) sequences of ORFla/ORFlb overlapping region of GLRaV-2, BYV, BYSV, and CTV. Identical nucleotides and amino acids are shown in consensus. GLRaV-2 putative + 1 frameshift site (TAGC) and its corresponding sites of BYV (TAGC) and BYSV (TAGC) and CTV (CGGC) at nucleotide and amino acid sequences are highlighted with underlines.
Figure 5 is an alignment of the amino acid sequence of HSP70 protein of GLRaV-2 and BYV. The conserved motifs (A to H) are indicated with overlines and marked with respective letters. The alignment was conducted with the MegAlign program of DNASTAR.
Figure 6 A is a comparison of the coat protein (CP) and coat protein duplicate (CPd) of GLRaV-2 with other closteroviruses. The amino acid sequence of the GLRaV-2 CP and CPd are aligned with the CP and CPd of BYV, BYSV, and CTV. The conserved amino acid residues are in bold and the consensus sequences are indicated. Sequence alignment and phylogenetic tree were constructed by Clustal Method in the MegAlign Program of DNASTAR. Figure 6B is a tentative phylogenetic tree of the CP and CPd of GLRaV-2 with BYV, BYSV, CTV, LIYV, LChV, and GLRaV-3. To facilitate the alignment, only the C- terminal 250 amino acids of CP and CPd of LIYV, LChV, and GLRaV-3 were used. The scale beneath the phylogenetic tree represents the distance between sequences. Units indicate the number of substitution events.
Figure 7 is a comparison of the genome organization of GLRaV-2, BYV, BYSV, CTV, LIYV, LChV, and GLRaV-3. P-PRO, papain-like protease; MT/MTR, methyltransferase; HEL, helicase; RdRP, RNA-dependent RNA polymerase; HSP70, heat shock protein 70; CP, coat protein; CPd, coat protein duplicate.
Figure 8 is a tentative phylogenetic tree showing the relationship of RdRP of GLRaV-2 with respect to BYV, BYSV, CTV, and LIYV. The phylogenetic tree was constructed using the Clustal method with the MegAlign program in DNASTAR. Figure 9 is an alignment of the amino acid sequence of HSP90 protein of
GLRaV-2 with respect to other closteroviruses, BYS, BYSV, and CTV. The most conserved motifs (I to II) are indicated with the highlighted lines and marked with respective letters.
Figure 10 is an alignment of the nucleotide sequence of 3'-terminal untranslated region of GLRaV-2 with respect to the closteroviruses BYV (Agranovsky et al., "Beet Yellows Closterovirus: Complete Genome Structure and Identification of a Papain-like Thiol Protease," Virology 198:311-24 (1994), which is hereby incorporated by reference), BYSV (Karasev et al., Organization of the 3 '-Terminal Half of Beet Yellow Stunt Virus Genome and Implications for the Evolution of Closteroviruses," Virology 221 : 199-207 (1996), which is hereby incoφorated by reference), and CTV (Karasev et al., "Complete Sequence of the Citrus Tristeza Virus RNA Genome," Virology 208:511-20 (1995), which is hereby incorporated by reference). The consensus sequences are shown, and the distance to the 3'-end is indicated. A complementary region capable of forming a "hair-pin" structure is underlined.
Figures 11 A and 1 IB are genetic maps of the transformation vectors pGA482GG/EPT8CP-GLRaV-2 and pGA482G/EPT8CP-GLRaV-2, respectively. As shown in Figures 11 A and 1 IB, the plant expression cassette (EPT8CP-GLRaV-2), which consists of a double cauliflower mosaic virus (CaMV) 35S-enhancer, a CaMV 35S-promoter, an alfalfa mosaic virus (ALMV) RNA4 5' leader sequence, a coat protein gene of GLRaV-2 (CP-GLRaV-2), and a CaMV 35 S 3' untranslated region as a terminator, was cloned into the transformation vector by EcoR I restriction site. The CP of GLRaV-2 was cloned into the plant expression vector by Nco I restriction site.
Figure 12 is a PCR analysis of DNA molecules extracted from the leaves of putative transgenic plants using both the CP gene of GLRaV-2 and NPT II gene specific primers. An ethidium bromide-stained gel shows a 720 bp amplified DNA fragment for NPT II gene, and a 653 bp DNA fragment for the entire coding sequence of the CP gene. Lane 1, Φ174 / Hae III DNA Marker; lanes 2-6, transgenic plants from different lines; lane 7, the cp gene of GLRaV-2 of positive control; and lane 8, NPT II gene of positive control.
Figure 13 is a comparison of resistant (right side 3 plants) and susceptible (left side 3 plants) transgenic Nicotiana benthamiana plants. Plants are shown 48 days after inoculation with GLRaV-2.
Figure 14 is a northern blot analysis of transgenic Nicotiana benthamiana plants. An aliquot of 10 g of total RNA extracted from putative transgenic plants was denatured and loaded onto 1% agarose gel containing formaldehyde. The separated RNAs were transferred to Gene Screen Plus membrane and hybridized with a P-labeled DNA probe containing the 3' one third CP gene sequence. Lanes 1, 3, and 4 represent nontransformed control plants without RNA expression. The remaining lanes represent transgenic plants from different lines: lanes 2, 14-17, and 22-27 represent plants with high RNA expression level which are susceptible to GLRaV-2; all other lanes represent plants with undetectable or low RNA expression level which are resistant to GLRaV -2.
DETAILED DESCRIPTION OF THE INVENTION
The present invention relates to isolated DNA molecules encoding for the proteins or polypeptides of a grapevine leafroll virus (type 2). A substantial portion of the grapevine leafroll virus (tyρe-2) ("GLRaV-2") genome has been sequenced. Within the genome are a plurality of open reading frames ("ORFs") and a 3' untranscribed region ("UTR"), each containing DNA molecules in accordance with the present invention. The DNA molecule which constitutes a substantial portion of the GLRaV-2 genome comprises the nucleotide sequence corresponding to SEQ. ID. No. 1 as follows:
TAAACATTGC GAGAGAACCC CATTAGCGTC TCCGGGGTGA ACTTGGGAAG GTCTGCCGCC 60
GCTCAGGTTA TTTATTTCGG CAGTTTCACG CAGCCCTTCG CGTTGTATCC GCGCCAAGAG 120
AGCGCGATCG TAAAAACGCA ACTTCCACCG GTCAGTGTAG TGAAGGTGGA GTGCGTAGCT 180
GCGGAGGTAG CTCCCGACAG GGGCGTGGTC GACAAGAAAC CTACGTCTGT TGGCGTTCCC 240
CCGCAGCGCG GTGTGCTTTC TTTTCCGACG GTGGTTCGGA ACCGCGGCGA CGTGATAATC 300
ACAGGGGTGG TGCATGAAGC CCTGAAGAAA ATTAAAGACG GGCTCTTACG CTTCCGCGTA 360
GGCGGTGACA TGCGTTTTTC GAGATTTTTC TCATCGAACT ACGGCTGCAG ATTCGTCGCG 420
AGCGTGCGTA CGAACACTAC AGTTTGGCTA AATTGCACGA AAGCGAGTGG TGAGAAATTC 480
TCACTCGCCG CCGCGTGCAC GGCGGATTAC GTGGCGATGC TGCGTTATGT GTGTGGCGGG 540
AAATTTCCAC TCGTCCTCAT GAGTAGAGTT ATTTACCCGG ATGGGCGCTG TTACTTGGCC 600
CATATGAGGT ATTTGTGCGC CTTTTACTGT CGCCCGTTTA GAGAGTCGGA TTATGCCCTC 660
GGAATGTGGC CTACGGTGGC GCGTCTCAGG GCATGCGTTG AGAAGAACTT CGGTGTCGAA 720
GCTTGTGGCA TAGCTCTTCG TGGCTATTAC ACCTCTCGCA ATGTTTATCA CTGTGATTAT 780
GACTCTGCTT ATGTAAAATA TTTTAGAAAC CTTTCCGGCC GCATTGGCGG TGGTTCGTTC 840
GATCCGACAT CTTTAACCTC CGTAATAACG GTGAAGATTA GCGGTCTTCC AGGTGGTCTT 900
CCTAAAAATA TAGCGTTTGG TGCCTTCCTG TGCGATATAC GTTACGTCGA ACCGGTAGAC 960
TCGGGCGGCA TTCAATCGAG CGTTAAGACG AAACGTGAAG ATGCGCACCG AACCGTAGAG 1020
GAACGGGCGG CCGGCGGATC CGTCGAGCAA CCGCGACAAA AGAGGATAGA TGAGAAAGGT 1080
TGCGGCAGAG TTCCTAGTGG AGGTTTTTCG CATCTCCTGG TCGGCAACCT TAACGAAGTT 1140
AGGAGGAAGG TAGCTGCCGG ACTTCTACGC TTTCGCGTTG GCGGTGATAT GGATTTTCAT 1200
CGCTCGTTCT CCACCCAAGC GGGCCACCGC TTGCTGGTGT GGCGCCGCTC GAGCCGGAGC 1260
GTGTGCCTTG AACTTTACTC ACCATCTAAA AACTTTTTGC GTTACGATGT CTTGCCCTGT 1320
TCTGGAGACT ATGCAGCGAT GTTTTCTTTC GCGGCGGGCG GCCGTTTCCC TTTAGTTTTG 1380
ATGACTAGAA TTAGATACCC GAACGGGTTT TGTTACTTGG CTCACTGCCG GTACGCGTGC 1440
GCGTTTCTCT TAAGGGGTTT TGATCCGAAG CGTTTCGACA TCGGTGCTTT CCCCACCGCG 1500
GCCAAGCTCA GAAACCGTAT GGTTTCGGAG CTTGGTGAAA GAAGTTTAGG TTTGAACTTG 1560
TACGGCGCAT ATACGTCACG CGGCGTCTTT CACTGCGATT ATGACGCTAA GTTTATAAAG 1620
GATTTGCGTC TTATGTCAGC AGTTATAGCT GGAAAGGACG GGGTGGAAGA GGTGGTACCT 1680 TCTGACATAA CTCCTGCCAT GAAGCAGAAA ACGATCGAAG CCGTGTATGA TAGATTATAT 1740
GGCGGCACTG ACTCGTTGCT GAAACTGAGC ATCGAGAAAG ACTTAATCGA TTTCAAAAAT 1800
GACGTGCAGA GTTTGAAGAA AGATCGGCCG ATTGTCAAAG TGCCCTTTTA CATGTCGGAA 1860
GCAACACAGA ATTCGCTGAC GCGTTTCTAC CCTCAGTTCG AACTTAAGTT TTCGCACTCC 1920
TCGCATTCAG ATCATCCCGC CGCCGCCGCT TCTAGACTGC TGGAAAATGA AACGTTAGTG 1980
CGCTTATGTG GTAATAGCGT TTCAGATATT GGAGGTTGTC CTCTTTTCCA TTTGCATTCC 2040
AAGACGCAAA GACGGGTTCA CGTATGTAGG CCTGTGTTGG ATGGCAAGGA TGCGCAGCGT 2100
CGCGTGGTGC GTGATTTGCA GTATTCCAAC GTGCGTTTGG GAGACGATGA TAAAATTTTG 2160
GAAGGGCCAC GCAATATCGA CATTTGCCAC TATCCTCTGG GCGCGTGTGA CCACGAAAGT 2220
AGTGCTATGA TGATGGTGCA GGTGTATGAC GCGTCCCTTT ATGAGATATG TGGCGCCATG 2280
ATCAAGAAGA AAAGCCGCAT AACGTACTTA ACCATGGTCA CGCCCGGCGA GTTTCTTGAC 2340
GGACGCGAAT GCGTCTACAT GGAGTCGTTA GACTGTGAGA TTGAAGTTGA TGTGCACGCG 2400
GACGTCGTAA TGTACAAATT CGGTAGTTCT TGCTATTCGC ACAAGCTTTC AATCATCAAG 2460
GACATCATGA CCACTCCGTA CTTGACACTA GGTGGTTTTC TATTCAGCGT GGAGATGTAT 2520
GAGGTGCGTA TGGGCGTGAA TTACTTCAAG ATTACGAAGT CCGAAGTATC GCCTAGCATT 2580
AGCTGCACCA AGCTCCTGAG ATACCGAAGA GCTAATAGTG ACGTGGTTAA AGTTAAACTT 2640
CCACGTTTCG ATAAGAAACG TCGCATGTGT CTGCCTGGGT ATGACACCAT ATACCTAGAT 2700
TCGAAGTTTG TGAGTCGCGT TTTCGATTAT GTCGTGTGTA ATTGCTCTGC CGTGAACTCA 2760
AAAACTTTCG AGTGGGTGTG GAGTTTCATT AAGTCTAGTA AGTCGAGGGT GATTATTAGC 2820
GGTAAAATAA TTCACAAGGA TGTGAATTTG GACCTCAAGT ACGTCGAGAG TTTCGCCGCG 2880
GTTATGTTGG CCTCTGGCGT GCGCAGTAGA CTAGCGTCCG AGTACCTTGC TAAGAACCTT 2940
AGTCATTTTT CGGGAGATTG CTCCTTTATT GAAGCCACGT CTTTCGTGTT GCGTGAGAAA 3000
ATCAGAAACA TGACTCTGAA TTTTAACGAA AGACTTTTAC AGTTAGTGAA GCGCGTTGCC 3060
TTTGCGACCT TGGACGTGAG TTTTCTAGAT TTAGATTCAA CTCTTGAATC AATAACTGAT 3120
TTTGCCGAGT GTAAGGTAGC GATTGAACTC GACGAGTTGG GTTGCTTGAG AGCGGAGGCC 3180
GAGAATGAAA AAATCAGGAA TCTGGCGGGA GATTCGATTG CGGCTAAACT CGCGAGCGAG 3240
ATAGTGGTCG ATATTGACTC TAAGCCTTCA CCGAAGCAGG TGGGTAATTC GTCATCCGAA 3300
AACGCCGATA AGCGGGAAGT TCAGAGGCCC GGTTTGCGTG GTGGTTCTAG AAACGGGGTT 3360
GTTGGGGAGT TCCTTCACTT CGTCGTGGAT TCTGCCTTGC GTCTTTTCAA ATACGCGACG 3420
GATCAACAAC GGATCAAGTC TTACGTGCGT TTCTTGGACT CGGCGGTCTC ATTCTTGGAT 3480
TACAACTACG ATAATCTATC GTTTATACTG CGAGTGCTTT CGGAAGGTTA TTCGTGTATG 3540 TTCGCGTTTT TGGCGAATCG CGGCGACTTA TCTAGTCGTG TCCGTAGCGC GGTGTGTGCT 3600
GTGAAAGAAG TTGCTACCTC ATGCGCGAAC GCGAGCGTTT CTAAAGCCAA GGTTATGATT 3660
ACCTTCGCAG CGGCCGTGTG TGCTATGATG TTTAATAGCT GCGGTTTTTC AGGCGACGGT 3720
CGGGAGTATA AATCGTATAT ACATCGTTAC ACGCAAGTAT TGTTTGACAC TATCTTTTTT 3780
GAGGACAGCA GTTACCTACC CATAGAAGTT CTGAGTTCGG CGATATGCGG TGCTATCGTC 3840
ACACTTTTCT CCTCGGGCTC GTCCATAAGT TTAAACGCCT TCTTACTTCA AATTACCAAA 3900
GGATTCTCCC TAGAGGTTGT CGTCCGGAAT GTTGTGCGAG TCACGCATGG TTTGAGCACC 3960
ACAGCGACCG ACGGCGTCAT ACGTGGGGTT TTCTCCCAAA TTGTGTCTCA CTTACTTGTT 4020
GGAAATACGG GTAATGTGGC TTACCAGTCA GCTTTCATTG CCGGGGTGGT GCCTCTTTTA 4080
GTTAAAAAGT GTGTGAGCTT AATCTTCATC TTGCGTGAAG ATACTTATTC CGGTTTTATT 4140
AAGCACGGAA TCAGTGAATT CTCTTTCCTT AGTAGTATTC TGAAGTTCTT GAAGGGTAAG 4200
CTTGTGGACG AGTTGAAATC GATTATTCAA GGGGTTTTTG ATTCCAACAA GCACGTGTTT 4260
AAAGAAGCTA CTCAGGAAGC GATTCGTACG ACGGTCATGC AAGTGCCTGT CGCTGTAGTG 4320
GATGCCCTTA AGAGCGCCGC GGGAAAAATT TATAACAATT TTACTAGTCG ACGTACCTTT 4380
GGTAAGGATG AAGGCTCCTC TAGCGACGGC GCATGTGAAG AGTATTTCTC ATGCGACGAA 4440
GGTGAAGGTC CGGGTCTGAA AGGGGGTTCC AGCTATGGCT TCTCAATTTT AGCGTTCTTT 4500
TCACGCATTA TGTGGGGAGC TCGTCGGCTT ATTGTTAAGG TGAAGCATGA GTGTTTTGGG 4560
AAACTTTTTG AATTTCTATC GCTCAAGCTT CACGAATTCA GGACTCGCGT TTTTGGGAAG 4620
AATAGAACGG ACGTGGGAGT TTACGATTTT TTGCCCACGG GCATCGTGGA AACGCTCTCA 4680
TCGATAGAAG AGTGCGACCA AATTGAAGAA CTTCTCGGCG ACGACCTGAA AGGTGACAAG 4740
GATGCTTCGT TGACCGATAT GAATTACTTT GAGTTCTCAG AAGACTTCTT AGCCTCTATC 4800
GAGGAGCCGC CTTTCGCTGG ATTGCGAGGA GGTAGCAAGA ACATCGCGAT TTTGGCGATT 4860
TTGGAATACG CGCATAATTT GTTTCGCATT GTCGCAAGCA AGTGTTCGAA ACGACCTTTA 4920
TTTCTTGCTT TCGCCGAACT CTCAAGCGCC CTTATCGAGA AATTTAAGGA GGTTTTCCCT 4980
CGTAAGAGCC AGCTCGTCGC TATCGTGCGC GAGTATACTC AGAGATTCCT CCGAAGTCGC 5040
ATGCGTGCGT TGGGTTTGAA TAACGAGTTC GTGGTAAAAT CTTTCGCCGA TTTGCTACCC 5100
GCATTAATGA AGCGGAAGGT TTCAGGTTCG TTCTTAGCTA GTGTTTATCG CCCACTTAGA 5160
GGTTTCTCAT ATATGTGTGT TTCAGCGGAG CGACGTGAAA AGTTTTTTGC TCTCGTGTGT 5220
TTAATCGGGT TAAGTCTCCC TTTCTTCGTG CGCATCGTAG GAGCGAAAGC GTGCGAAGAA 5280
CTCGTGTCCT CAGCGCGTCG CTTTTATGAG CGTATTAAAA TTTTTCTAAG GCAGAAGTAT 5340 GTCTCTCTTT CTAATTTCTT TTGTCACTTG TTTAGCTCTG ACGTTGATGA CAGTTCCGCA 5400
TCTGCAGGGT TGAAAGGTGG TGCGTCGCGA ATGACGCTCT TCCACCTTCT GGTTCGCCTT 5460
GCTAGTGCCC TCCTATCGTT AGGGTGGGAA GGGTTAAAGC TACTCTTATC GCACCACAAC 5520
TTGTTATTTT TGTGTTTTGC ATTGGTTGAC GATGTGAACG TCCTTATCAA AGTTCTTGGG 5580
GGTCTTTCTT TCTTTGTGCA ACCAATCTTT TCCTTGTTTG CGGCGATGCT TCTACAACCG 5640
GACAGGTTTG TGGAGTATTC CGAGAAACTT GTTACAGCGT TTGAATTTTT CTTAAAATGT 5700
TCGCCTCGCG CGCCTGCACT ACTCAAAGGG TTTTTTGAGT GCGTGGCGAA CAGCACTGTG 5760
TCAAAAACCG TTCGAAGACT TCTTCGCTGT TTCGTGAAGA TGCTCAAACT TCGAAAAGGG 5820
CGAGGGTTGC GTGCGGATGG TAGGGGTCTC CATCGGCAGA AAGCCGTACC CGTCATACCT 5880
TCTAATCGGG TCGTGACCGA CGGGGTTGAA AGACTTTCGG TAAAGATGCA AGGAGTTGAA 5940
GCGTTGCGTA CCGAATTGAG AATCTTAGAA GATTTAGATT CTGCCGTGAT CGAAAAACTC 6000
AATAGACGCA GAAATCGTGA CACTAATGAC GACGAATTTA CGCGCCCTGC TCATGAGCAG 6060
ATGCAAGAAG TCACCACTTT CTGTTCGAAA GCCAACTCTG CTGGTTTGGC CCTGGAAAGG 6120
GCAGTGCTTG TGGAAGACGC TATAAAGTCG GAGAAACTTT CTAAGACGGT TAATGAGATG 6180
GTGAGGAAAG GGAGTACCAC CAGCGAAGAA GTGGCCGTCG CTTTGTCGGA CGATGAAGCC 6240
GTGGAAGAAA TCTCTGTTGC TGACGAGCGA GACGATTCGC CTAAGACAGT CAGGATAAGC 6300
GAATACCTAA ATAGGTTAAA CTCAAGCTTC GAATTCCCGA AGCCTATTGT TGTGGACGAC 6360
AACAAGGATA CCGGGGGTCT AACGAACGCC GTGAGGGAGT TTTATTATAT GCAAGAACTT 6420
GCTCTTTTCG AAATCCACAG CAAACTGTGC ACCTACTACG ATCAACTGCG CATAGTCAAC 6480
TTCGATCGTT CCGTAGCACC ATGCAGCGAA GATGCTCAGC TGTACGTACG GAAGAACGGC 6540
TCAACGATAG TGCAGGGTAA AGAGGTACGT TTGCACATTA AGGATTTCCA CGATCACGAT 6600
TTCCTGTTTG ACGGAAAAAT TTCTATTAAC AAGCGGCGGC GAGGCGGAAA TGTTTTATAT 6660
CACGACAACC TCGCGTTCTT GGCGAGTAAT TTGTTCTTAG CCGGCTACCC CTTTTCAAGG 6720
AGCTTCGTCT TCACGAATTC GTCGGTCGAT ATTCTCCTCT ACGAAGCTCC ACCCGGAGGT 6780
GGTAAGACGA CGACGCTGAT TGACTCGTTC TTGAAGGTCT TCAAGAAAGG TGAGGTTTCC 6840
ACCATGATCT TAACCGCCAA CAAAAGTTCG CAGGTTGAGA TCCTAAAGAA AGTGGAGAAG 6900
GAAGTGTCTA ACATTGAATG CCAGAAACGT AAAGACAAAA GATCTCCGAA AAAGAGCATT 6960
TACACCATCG ACGCTTATTT AATGCATCAC CGTGGTTGTG ATGCAGACGT TCTTTTCATC 7020
GATGAGTGTT TCATGGTTCA TGCGGGTAGC GTACTAGCTT GCATTGAGTT CACGAGGTGT 7080
CATAAAGTAA TGATCTTCGG GGATAGCCGG CAGATTCACT ACATTGAAAG GAACGAATTG 7140
GACAAGTGTT TGTATGGGGA TCTCGACAGG TTCGTGGACC TGCAGTGTCG GGTTTATGGT 7200 AATATTTCGT ACCGTTGTCC ATGGGATGTG TGCGCTTGGT TAAGCACAGT GTATGGCAAC 7260
CTAATCGCCA CCGTGAAGGG TGAAAGCGAA GGTAAGAGCA GCATGCGCAT TAACGAAATT 7320
AATTCAGTCG ACGATTTAGT CCCCGACGTG GGTTCCACGT TTCTGTGTAT GCTTCAGTCG 7380
GAGAAGTTGG AAATCAGCAA GCACTTTATT CGCAAGGGTT TGACTAAACT TAACGTTCTA 7440
ACGGTGCATG AGGCGCAAGG TGAGACGTAT GCGCGTGTGA ACCTTGTGCG ACTTAAGTTT 7500
CAGGAGGATG AACCCTTTAA ATCTATCAGG CACATAACCG TCGCTCTTTC TCGTCACACC 7560
GACAGCTTAA CTTATAACGT CTTAGCTGCT CGTCGAGGTG ACGCCACTTG CGATGCCATC 7620
CAGAAGGCTG CGGAATTGGT GAACAAGTTT CGCGTTTTTC CTACATCTTT TGGTGGTAGT 7680
GTTATCAATC TCAACGTGAA GAAGGACGTG GAAGATAACA GTAGGTGCAA GGCTTCGTCG 7740
GCACCATTGA GCGTAATCAA CGACTTTTTG AACGAAGTTA ATCCCGGTAC TGCGGTGATT 7800
GATTTTGGTG ATTTGTCCGC GGACTTCAGT ACTGGGCCTT TTGAGTGCGG TGCCAGCGGT 7860
ATTGTGGTGC GGGACAACAT CTCCTCCAGC AACATCACTG ATCACGATAA GCAGCGTGTT 7920
TAGCGTAGTT CGGTCGCAGG CGATTCCGCG TAGAAAACCT TCTCTACAAG AAAATTTGTA 7980
TTCGTTTGAA GCGCGGAATT ATAACTTCTC GACTTGCGAC CGTAACACAT CTGCTTCAAT 8040
GTTCGGAGAG GCTATGGCGA TGAACTGTCT TCGTCGTTGC TTCGACCTAG ATGCCTTTTC 8100
GTCCCTGCGT GATGATGTGA TTAGTATCAC ACGTTCAGGC ATCGAACAAT GGCTGGAGAA 8160
ACGTACTCCT AGTCAGATTA AAGCATTAAT GAAGGATGTT GAATCGCCTT TGGAAATTGA 8220
CGATGAAATT TGTCGTTTTA AGTTGATGGT GAAGCGTGAC GCTAAGGTGA AGTTAGACTC 8280
TTCTTGTTTA ACTAAACACA GCGCCGCTCA AAATATCATG TTTCATCGCA AGAGCATTAA 8340
TGCTATCTTC TCTCCTATCT TTAATGAGGT GAAAAACCGA ATAATGTGCT GTCTTAAGCC 8400
TAACATAAAG TTTTTTACGG AGATGACTAA CAGGGATTTT GCTTCTGTTG TCAGCAACAT 8460
GCTTGGTGAC GACGATGTGT ACCATATAGG TGAAGTTGAT TTCTCAAAGT ACGACAAGTC 8520
TCAAGATGCT TTCGTGAAGG CTTTTGAAGA AGTAATGTAT AAGGAACTCG GTGTTGATGA 8580
AGAGTTGCTG GCTATCTGGA TGTGCGGCGA GCGGTTATCG ATAGCTAACA CTCTCGATGG 8640
TCAGTTGTCC TTCACGATCG AGAATCAAAG GAAGTCGGGA GCTTCGAACA CTTGGATTGG 8700
TAACTCTCTC GTCACTTTGG GTATTTTAAG TCTTTACTAC GACGTTAGAA ATTTCGAGGC 8760
GTTGTACATC TCGGGCGATG ATTCTTTAAT TTTTTCTCGC AGCGAGATTT CGAATTATGC 8820
CGACGACATA TGCACTGACA TGGGTTTTGA GACAAAATTT ATGTCCCCAA GTGTCCCGTA 8880
CTTTTGTTCT AAATTTGTTG TTATGTGTGG TCATAAGACG TTTTTTGTTC CCGACCCGTA 8940
CAAGCTTTTT GTCAAGTTGG GAGCAGTCAA AGAGGATGTT TCAATGGATT TCCTTTTCGA 9000 GACTTTTACC TCCTTTAAAG ACTTAACCTC CGATTTTAAC GACGAGCGCT TAATTCAAAA 9060
GCTCGCTGAA CTTGTGGCTT TAAAATATGA GGTTCAAACC GGCAACACCA CCTTGGCGTT 9120
AAGTGTGATA CATTGTTTGC GTTCGAATTT CCTCTCGTTT AGCAAGTTAT ATCCTCGCGT 9180
GAAGGGATGG CAGGTTTTTT ACACGTCGGT TAAGAAAGCG CTTCTCAAGA GTGGGTGTTC 9240
TCTCTTCGAC AGTTTCATGA CCCCTTTTGG TCAGGCTGTC ATGGTTTGGG ATGATGAGTA 9300
GCGCTAACTT GTGCGCAGTT TCTTTGTTCG TGACATACAC CTTGTGTGTC ACCGTGCGTT 9360
TATAATGAAT CAGGTTTTGC AGTTTGAATG TTTGTTTCTG CTGAATCTCG CGGTTTTTGC 9420
TGTGACTTTC ATTTTCATTC TTCTGGTCTT CCGCGTGATT AAGTCTTTTC GCCAGAAGGG 9480
TCACGAAGCA CCTGTTCCCG TTGTTCGTGG CGGGGGTTTT TCAACCGTAG TGTAGTCAAA 9540
AGACGCGCAT ATGGTAGTTT TCGGTTTGGA CTTTGGCACC ACATTCTCTA CGGTGTGTGT 9600
GTACAAGGAT GGACGAGTTT TTTCATTCAA GCAGAATAAT TCGGCGTACA TCCCCACTTA 9660
CCTCTATCTC TTCTCCGATT CTAACCACAT GACTTTTGGT TACGAGGCCG AATCACTGAT 9720
GAGTAATCTG AAAGTTAAAG GTTCGTTTTA TAGAGATTTA AAACGTTGGG TGGGTTGCGA 9780
TTCGAGTAAC CTCGACGCGT ACCTTGACCG TTTAAAACCT CATTACTCGG TCCGCTTGGT 9840
TAAGATCGGC TCTGGCTTGA ACGAAACTGT TTCAATTGGA AACTTCGGGG GCACTGTTAA 9900
GTCTGAGGCT CATCTGCCAG GGTTGATAGC TCTCTTTATT AAGGCTGTCA TTAGTTGCGC 9960
GGAGGGCGCG TTTGCGTGCA CTTGCACCGG GGTTATTTGT TCAGTACCTG CCAATTATGA 10020
TAGCGTTCAA AGGAATTTCA CTGATCAGTG TGTTTCACTC AGCGGTTATC AGTGCGTATA 10080
TATGATCAAT GAACCTTCAG CGGCTGCGCT ATCTGCGTGT AATTCGATTG GAAAGAAGTC 10140
CGCAAATTTG GCTGTTTACG ATTTCGGTGG TGGGACCTTC GACGTGTCTA TCATTTCATA 10200
CCGCAACAAT ACTTTTGTTG TGCGAGCTTC TGGAGGCGAT CTAAATCTCG GTGGAAGGGA 10260
TGTTGATCGT GCGTTTCTCA CGCACCTCTT CTCTTTAACA TCGCTGGAAC CTGACCTCAC 10320
TTTGGATATC TCGAATCTGA AAGAATCTTT ATCAAAAACG GACGCAGAGA TAGTTTACAC 10380
TTTGAGAGGT GTCGATGGAA GAAAAGAAGA CGTTAGAGTA AACAAAAACA TTCTTACGTC 10440
GGTGATGCTC CCCTACGTGA ACAGAACGCT TAAGATATTA GAGTCAACCT TAAAATCGTA 10500
TGCTAAGAGT ATGAATGAGA GTGCGCGAGT TAAGTGCGAT TTAGTGCTGA TAGGAGGATC 10560
TTCATATCTT CCTGGCCTGG CAGACGTACT AACGAAGCAT CAGAGCGTTG ATCGTATCTT 10620
AAGAGTTTCG GATCCTCGGG CTGCCGTGGC CGTCGGTTGC GCATTATATT CTTCATGCCT 10680
CTCAGGATCT GGGGGGTTGC TACTGATCGA CTGTGCAGCT CACACTGTCG CTATAGCGGA 10740
CAGAAGTTGT CATCAAATCA TTTGCGCTCC AGCGGGGGCA CCGATCCCCT TTTCAGGAAG 10800
CATGCCTTTG TACTTAGCCA GGGTCAACAA GAACTCGCAG CGTGAAGTCG CCGTGTTTGA 10860 AGGGGAGTAC GTTAAGTGCC CTAAGAACAG AAAGATCTGT GGAGCAAATA TAAGATTTTT 10920
TGATATAGGA GTGACGGGTG ATTCGTACGC ACCCGTTACC TTCTATATGG ATTTCTCCAT 10980
TTCAAGCGTA GGAGCCGTTT CATTCGTGGT GAGAGGTCCT GAGGGTAAGC AAGTGTCACT 11040
CACTGGAACT CCAGCGTATA ACTTTTCGTC TGTGGCTCTC GGATCACGCA GTGTCCGAGA 11100
ATTGCATATT AGTTTAAATA ATAAAGTTTT TCTCGGTTTG CTTCTACATA GAAAGGCGGA 11160
TCGACGAATA CTTTTCACTA AGGATGAAGC GATTCGATAC GCCGATTCAA TTGATATCGC 11220
GGATGTGCTA AAGGAATATA AAAGTTACGC GGCCAGTGCC TTACCACCAG ACGAGGATGT 11280
CGAATTACTC CTGGGAAAGT CTGTTCAAAA AGTTTTACGG GGAAGCAGAC TGGAAGAAAT 113 0
ACCTCTCTAG GAGCATAGCA GCACACTCAA GTGAAATTAA AACTCTACCA GACATTCGAT 11400
TGTACGGCGG TAGGGTTGTA AAGAAGTCCG AATTCGAATC AGCACTTCCT AATTCTTTTG 11460
AACAGGAATT AGGACTGTTC ATACTGAGCG AACGGGAAGT GGGATGGAGC AAATTATGCG 11520
GAATAACGGT GGAAGAAGCA GCATACGATC TTACGAATCC CAAGGCTTAT AAATTCACTG 11580
CCGAGACATG TAGCCCGGAT GTAAAAGGTG AAGGACAAAA ATACTCTATG GAAGACGTGA 11640
TGAATTTCAT GCGTTTATCA AATCTGGATG TTAACGACAA GATGCTGACG GAACAGTGTT 11700
GGTCGCTGTC CAATTCATGC GGTGAATTGA TCAACCCAGA CGACAAAGGG CGATTCGTGG 11760
CTCTCACCTT TAAGGACAGA GACACAGCTG ATGACACGGG TGCCGCCAAC GTGGAATGTC 11820
GCGTGGGCGA CTATCTAGTT TACGCTATGT CCCTGTTTGA GCAGAGGACC CAAAAATCGC 11880
AGTCTGGCAA CATCTCTCTG TACGAAAAGT ACTGTGAATA CATCAGGACC TACTTAGGGA 11940
GTACAGACCT GTTCTTCACA GCGCCGGACA GGATTCCGTT ACTTACGGGC ATCCTATACG 12000
ATTTTTGTAA GGAATACAAC GTTTTCTACT CGTCATATAA GAGAAACGTC GATAATTTCA 12060
GATTCTTCTT GGCGAATTAT ATGCCTTTGA TATCTGACGT CTTTGTCTTC CAGTGGGTAA 12120
AACCCGCGCC GGATGTTCGG CTGCTTTTTG AGTTAAGTGC AGCGGAACTA ACGCTGGAGG 12180
TTCCCACACT GAGTTTGATA GATTCTCAAG TTGTGGTAGG TCATATCTTA AGATACGTAG 12240
AATCCTACAC ATCAGATCCA GCCATCGACG CGTTAGAAGA CAAACTGGAA GCGATACTGA 12300
AAAGTAGCAA TCCCCGTCTA TCGACAGCGC AACTATGGGT TGGTTTCTTT TGTTACTATG 12360
GTGAGTTTCG TACGGCTCAA AGTAGAGTAG TGCAAAGACC AGGCGTATAC AAAACACCTG 12420
ACTCAGTGGG TGGATTTGAA ATAAACATGA AAGATGTTGA GAAATTCTTC GATAAACTTC 12480
AGAGAGAATT GCCTAATGTA TCTTTGCGGC GTCAGTTTAA CGGAGCTAGA GCGCATGAGG 12540
CTTTCAAAAT ATTTAAAAAC GGAAATATAA GTTTCAGACC TATATCGCGT TTAAACGTGC 12600
CTAGAGAGTT CTGGTATCTG AACATAGACT ACTTCAGGCA CGCGAATAGG TCCGGGTTAA 12660 CCGAAGAAGA AATACTCATC CTAAACAACA TAAGCGTTGA TGTTAGGAAG TTATGCGCTG 12720
AGAGAGCGTG CAATACCCTA CCTAGCGCGA AGCGCTTTAG TAAAAATCAT AAGAGTAATA 12780
TACAATCATC ACGCCAAGAG CGGAGGATTA AAGACCCATT GGTAGTCCTG AAAGACACTT 12840
TATATGAGTT CCAACACAAG CGTGCCGGTT GGGGGTCTCG AAGCACTCGA GACCTCGGGA 12900
GTCGTGCTGA CCACGCGAAA GGAAGCGGTT GATAAGTTTT TTAATGAACT AAAAAACGAA 12960
AATTACTCAT CAGTTGACAG CAGCCGATTA AGCGATTCGG AAGTAAAAGA AGTGTTAGAG 13020
AAAAGTAAAG AAAGTTTCAA AAGCGAACTG GCCTCCACTG ACGAGCACTT CGTCTACCAC 13080
ATTATATTTT TCTTAATCCG ATGTGCTAAG ATATCGACAA GTGAAAAGGT GAAGTACGTT 13140
GGTAGTCATA CGTACGTGGT CGACGGAAAA ACGTACACCG TTCTTGACGC TTGGGTATTC 13200
AACATGATGA AAAGTCTCAC GAAGAAGTAC AAACGAGTGA ATGGTCTGCG TGCGTTCTGT 13260
TGCGCGTGCG AAGATCTATA TCTAACCGTC GCACCAATAA TGTCAGAACG CTTTAAGACT 13320
AAAGCCGTAG GGATGAAAGG TTTGCCTGTT GGAAAGGAAT ACTTAGGCGC CGACTTTCTT 13380
TCGGGAACTA GCAAACTGAT GAGCGATCAC GACAGGGCGG TCTCCATCGT TGCAGCGAAA 13440
AACGCTGTCG ATCGTAGCGC TTTCACGGGT GGGGAGAGAA AGATAGTTAG TTTGTATGAT 13500
CTAGGGAGGT ACTAAGCACG GTGTGCTATA GTGCGTGCTA TAATAATAAA CACTAGTGCT 13560
TAAGTCGCGC AGAAGAAAAC GCTATGGAGT TGATGTCCGA CAGCAACCTT AGCAACCTGG 13620
TGATAACCGA CGCCTCTAGT CTAAATGGTG TCGACAAGAA GCTTTTATCT GCTGAAGTTG 13680
AAAAAATGTT GGTGCAGAAA GGGGCTCCTA ACGAGGGTAT AGAAGTGGTG TTCGGTCTAC 13740
TCCTTTACGC ACTCGCGGCA AGAACCACGT CTCCTAAGGT TCAGCGCGCA GATTCAGACG 13800
TTATATTTTC AAATAGTTTC GGAGAGAGGA ATGTGGTAGT AACAGAGGGT GACCTTAAGA 13860
AGGTACTCGA CGGGTGTGCG CCTCTCACTA GGTTCACTAA TAAACTTAGA ACGTTCGGTC 13920
GTACTTTCAC TGAGGCTTAC GTTGACTTTT GTATCGCGTA TAAGCACAAA TTACCCCAAC 13980
TCAACGCCGC GGCGGAATTG GGGATTCCAG CTGAAGATTC GTACTTAGCT GCAGATTTTC 14040
TGGGTACTTG CCCGAAGCTC TCTGAATTAC AGCAAAGTAG GAAGATGTTC GCGAGTATGT 14100
ACGCTCTAAA AACTGAAGGT GGAGTGGTAA ATACACCAGT GAGCAATCTG CGTCAGCTAG 14160
GTAGAAGGGA AGTTATGTAA TGGAAGATTA CGAAGAAAAA TCCGAATCGC TCATACTGCT 14220
ACGCACGAAT CTGAACACTA TGCTTTTAGT GGTCAAGTCC GATGCTAGTG TAGAGCTGCC 14280
TAAACTACTA ATTTGCGGTT ACTTACGAGT GTCAGGACGT GGGGAGGTGA CGTGTTGCAA 14340
CCGTGAGGAA TTAACAAGAG ATTTTGAGGG CAATCATCAT ACGGTGATCC GTTCTAGAAT 14400
CATACAATAT GACAGCGAGT CTGCTTTTGA GGAATTCAAC AACTCTGATT GCGTAGTGAA 14460
GTTTTTCCTA GAGACTGGTA GTGTCTTTTG GTTTTTCCTT CGAAGTGAAA CCAAAGGTAG 14520 AGCGGTGCGA CATTTGCGCA CCTTCTTCGA AGCTAACAAT TTCTTCTTTG GATCGCATTG 14580
CGGTACCATG GAGTATTGTT TGAAGCAGGT ACTAACTGAA ACTGAATCTA TAATCGATTC 14640
TTTTTGCGAA GAAAGAAATC GTTAAGATGA GGGTTATAGT GTCTCCTTAT GAAGCTGAAG 14700
ACATTCTGAA AAGATCGACT GACATGTTAC GAAACATAGA CAGTGGGGTC TTGAGCACTA 14760
AAGAATGTAT CAAGGCATTC TCGACGATAA CGCGAGACCT ACATTGTGCG AAGGCTTCCT 14820
ACCAGTGGGG TGTTGACACT GGGTTATATC AGCGTAATTG CGCTGAAAAA CGTTTAATTG 14880
ACACGGTGGA GTCAAACATA CGGTTGGCTC AACCTCTCGT GCGTGAAAAA GTGGCGGTTC 14940
ATTTTTGTAA GGATGAACCA AAAGAGCTAG TAGCATTCAT CACGCGAAAG TACGTGGAAC 15000
TCACGGGCGT GGGAGTGAGA GAAGCGGTGA AGAGGGAAAT GCGCTCTCTT ACCAAAACAG 15060
TTTTAAATAA AATGTCTTTG GAAATGGCGT TTTACATGTC ACCACGAGCG TGGAAAAACG 15120
CTGAATGGTT AGAACTAAAA TTTTCACCTG TGAAAATCTT TAGAGATCTG CTATTAGACG 15180
TGGAAACGCT CAACGAATTG TGCGCCGAAG ATGATGTTCA CGTCGACAAA GTAAATGAGA 15240
ATGGGGACGA AAATCACGAC CTCGAACTCC AAGACGAATG TTAAACATTG GTTAAGTTTA 15300
ACGAAAATGA TTAGTAAATA ATAAATCGAA CGTGGGTGTA TCTACCTGAC GTATCAACTT 15360
AAGCTGTTAC TGAGTAATTA AACCAACAAG TGTTGGTGTA ATGTGTATGT TGATGTAGAG 15420
AAAAATCCGT TTGTAGAACG GTGTTTTTCT CTTCTTTATT TTTAAAAAAA AAATAAAAAA 15480
AAAAAAAAAA AAGCGGCCGC 15500
Another DNA molecule of the present invention (GLRaV-2 ORFla) includes nucleotides 4-7923 of SEQ. ID. No. 1 and is believed to code for a large, grapevine leafroll virus polyprotein containing the conserved domains characteristic of two papain-like proteases, a methyltransferase, and a helicase. This DNA molecule comprises the nucleotide sequence corresponding to SEQ. ID. No. 2 as follows:
ACATTGCGAG AGAACCCCAT TAGCGTCTCC GGGGTGAACT TGGGAAGGTC TGCCGCCGCT 60 CAGGTTATTT ATTTCGGCAG TTTCACGCAG CCCTTCGCGT TGTATCCGCG CCAAGAGAGC 120 GCGATCGTAA AAACGCAACT TCCACCGGTC AGTGTAGTGA AGGTGGAGTG CGTAGCTGCG 180 GAGGTAGCTC CCGACAGGGG CGTGGTCGAC AAGAAACCTA CGTCTGTTGG CGTTCCCCCG 240 CAGCGCGGTG TGCTTTCTTT TCCGACGGTG GTTCGGAACC GCGGCGACGT GATAATCACA 300 GGGGTGGTGC ATGAAGCCCT GAAGAAAATT AAAGACGGGC TCTTACGCTT CCGCGTAGGC 360 GGTGACATGC GTTTTTCGAG ATTTTTCTCA TCGAACTACG GCTGCAGATT CGTCGCGAGC 420 GTGCGTACGA ACACTACAGT TTGGCTAAAT TGCACGAAAG CGAGTGGTGA GAAATTCTCA 480 CTCGCCGCCG CGTGCACGGC GGATTACGTG GCGATGCTGC GTTATGTGTG TGGCGGGAAA 540
TTTCCACTCG TCCTCATGAG TAGAGTTATT TACCCGGATG GGCGCTGTTA CTTGGCCCAT 600
ATGAGGTATT TGTGCGCCTT TTACTGTCGC CCGTTTAGAG AGTCGGATTA TGCCCTCGGA 660
ATGTGGCCTA CGGTGGCGCG TCTCAGGGCA TGCGTTGAGA AGAACTTCGG TGTCGAAGCT 720
TGTGGCATAG CTCTTCGTGG CTATTACACC TCTCGCAATG TTTATCACTG TGATTATGAC 780
TCTGCTTATG TAAAATATTT TAGAAACCTT TCCGGCCGCA TTGGCGGTGG TTCGTTCGAT 840
CCGACATCTT TAACCTCCGT AATAACGGTG AAGATTAGCG GTCTTCCAGG TGGTCTTCCT 900
AAAAATATAG CGTTTGGTGC CTTCCTGTGC GATATACGTT ACGTCGAACC GGTAGACTCG 960
GGCGGCATTC AATCGAGCGT TAAGACGAAA CGTGAAGATG CGCACCGAAC CGTAGAGGAA 1020
CGGGCGGCCG GCGGATCCGT CGAGCAACCG CGACAAAAGA GGATAGATGA GAAAGGTTGC 1080
GGCAGAGTTC CTAGTGGAGG TTTTTCGCAT CTCCTGGTCG GCAACCTTAA CGAAGTTAGG 1140
AGGAAGGTAG CTGCCGGACT TCTACGCTTT CGCGTTGGCG GTGATATGGA TTTTCATCGC 1200
TCGTTCTCCA CCCAAGCGGG CCACCGCTTG CTGGTGTGGC GCCGCTCGAG CCGGAGCGTG 1260
TGCCTTGAAC TTTACTCACC ATCTAAAAAC TTTTTGCGTT ACGATGTCTT GCCCTGTTCT 1320
GGAGACTATG CAGCGATGTT TTCTTTCGCG GCGGGCGGCC GTTTCCCTTT AGTTTTGATG 1380
ACTAGAATTA GATACCCGAA CGGGTTTTGT TACTTGGCTC ACTGCCGGTA CGCGTGCGCG 1440
TTTCTCTTAA GGGGTTTTGA TCCGAAGCGT TTCGACATCG GTGCTTTCCC CACCGCGGCC 1500
AAGCTCAGAA ACCGTATGGT TTCGGAGCTT GGTGAAAGAA GTTTAGGTTT GAACTTGTAC 1560
GGCGCATATA CGTCACGCGG CGTCTTTCAC TGCGATTATG ACGCTAAGTT TATAAAGGAT 1620
TTGCGTCTTA TGTCAGCAGT TATAGCTGGA AAGGACGGGG TGGAAGAGGT GGTACCTTCT 1680
GACATAACTC CTGCCATGAA GCAGAAAACG ATCGAAGCCG TGTATGATAG ATTATATGGC 1740
GGCACTGACT CGTTGCTGAA ACTGAGCATC GAGAAAGACT TAATCGATTT CAAAAATGAC 1800
GTGCAGAGTT TGAAGAAAGA TCGGCCGATT GTCAAAGTGC CCTTTTACAT GTCGGAAGCA 1860
ACACAGAATT CGCTGACGCG TTTCTACCCT CAGTTCGAAC TTAAGTTTTC GCACTCCTCG 1920
CATTCAGATC ATCCCGCCGC CGCCGCTTCT AGACTGCTGG AAAATGAAAC GTTAGTGCGC 1980
TTATGTGGTA ATAGCGTTTC AGATATTGGA GGTTGTCCTC TTTTCCATTT GCATTCCAAG 2040
ACGCAAAGAC GGGTTCACGT ATGTAGGCCT GTGTTGGATG GCAAGGATGC GCAGCGTCGC 2100
GTGGTGCGTG ATTTGCAGTA TTCCAACGTG CGTTTGGGAG ACGATGATAA AATTTTGGAA 2160
GGGCCACGCA ATATCGACAT TTGCCACTAT CCTCTGGGCG CGTGTGACCA CGAAAGTAGT 2220
GCTATGATGA TGGTGCAGGT GTATGACGCG TCCCTTTATG AGATATGTGG CGCCATGATC 2280 AAGAAGAAAA GCCGCATAAC GTACTTAACC ATGGTCACGC CCGGCGAGTT TCTTGACGGA 2340
CGCGAATGCG TCTACATGGA GTCGTTAGAC TGTGAGATTG AAGTTGATGT GCACGCGGAC 2400
GTCGTAATGT ACAAATTCGG TAGTTCTTGC TATTCGCACA AGCTTTCAAT CATCAAGGAC 2460
ATCATGACCA CTCCGTACTT GACACTAGGT GGTTTTCTAT TCAGCGTGGA GATGTATGAG 2520
GTGCGTATGG GCGTGAATTA CTTCAAGATT ACGAAGTCCG AAGTATCGCC TAGCATTAGC 2580
TGCACCAAGC TCCTGAGATA CCGAAGAGCT AATAGTGACG TGGTTAAAGT TAAACTTCCA 2640
CGTTTCGATA AGAAACGTCG CATGTGTCTG CCTGGGTATG ACACCATATA CCTAGATTCG 2700
AAGTTTGTGA GTCGCGTTTT CGATTATGTC GTGTGTAATT GCTCTGCCGT GAACTCAAAA 2760
ACTTTCGAGT GGGTGTGGAG TTTCATTAAG TCTAGTAAGT CGAGGGTGAT TATTAGCGGT 2820
AAAATAATTC ACAAGGATGT GAATTTGGAC CTCAAGTACG TCGAGAGTTT CGCCGCGGTT 2880
ATGTTGGCCT CTGGCGTGCG CAGTAGACTA GCGTCCGAGT ACCTTGCTAA GAACCTTAGT 2940
CATTTTTCGG GAGATTGCTC CTTTATTGAA GCCACGTCTT TCGTGTTGCG TGAGAAAATC 3000
AGAAACATGA CTCTGAATTT TAACGAAAGA CTTTTACAGT TAGTGAAGCG CGTTGCCTTT 3060
GCGACCTTGG ACGTGAGTTT TCTAGATTTA GATTCAACTC TTGAATCAAT AACTGATTTT 3120
GCCGAGTGTA AGGTAGCGAT TGAACTCGAC GAGTTGGGTT GCTTGAGAGC GGAGGCCGAG 3180
AATGAAAAAA TCAGGAATCT GGCGGGAGAT TCGATTGCGG CTAAACTCGC GAGCGAGATA 3240
GTGGTCGATA TTGACTCTAA GCCTTCACCG AAGCAGGTGG GTAATTCGTC ATCCGAAAAC 3300
GCCGATAAGC GGGAAGTTCA GAGGCCCGGT TTGCGTGGTG GTTCTAGAAA CGGGGTTGTT 3360
GGGGAGTTCC TTCACTTCGT CGTGGATTCT GCCTTGCGTC TTTTCAAATA CGCGACGGAT 3420
CAACAACGGA TCAAGTCTTA CGTGCGTTTC TTGGACTCGG CGGTCTCATT CTTGGATTAC 3480
AACTACGATA ATCTATCGTT TATACTGCGA GTGCTTTCGG AAGGTTATTC GTGTATGTTC 3540
GCGTTTTTGG CGAATCGCGG CGACTTATCT AGTCGTGTCC GTAGCGCGGT GTGTGCTGTG 3600
AAAGAAGTTG CTACCTCATG CGCGAACGCG AGCGTTTCTA AAGCCAAGGT TATGATTACC 3660
TTCGCAGCGG CCGTGTGTGC TATGATGTTT AATAGCTGCG GTTTTTCAGG CGACGGTCGG 3720
GAGTATAAAT CGTATATACA TCGTTACACG CAAGTATTGT TTGACACTAT CTTTTTTGAG 3780
GACAGCAGTT ACCTACCCAT AGAAGTTCTG AGTTCGGCGA TATGCGGTGC TATCGTCACA 3840
CTTTTCTCCT CGGGCTCGTC CATAAGTTTA AACGCCTTCT TACTTCAAAT TACCAAAGGA 3900
TTCTCCCTAG AGGTTGTCGT CCGGAATGTT GTGCGAGTCA CGCATGGTTT GAGCACCACA 3960
GCGACCGACG GCGTCATACG TGGGGTTTTC TCCCAAATTG TGTCTCACTT ACTTGTTGGA 4020
AATACGGGTA ATGTGGCTTA CCAGTCAGCT TTCATTGCCG GGGTGGTGCC TCTTTTAGTT 4080
AAAAAGTGTG TGAGCTTAAT CTTCATCTTG CGTGAAGATA CTTATTCCGG TTTTATTAAG 4140 CACGGAATCA GTGAATTCTC TTTCCTTAGT AGTATTCTGA AGTTCTTGAA GGGTAAGCTT 4200
GTGGACGAGT TGAAATCGAT TATTCAAGGG GTTTTTGATT CCAACAAGCA CGTGTTTAAA 4260
GAAGCTACTC AGGAAGCGAT TCGTACGACG GTCATGCAAG TGCCTGTCGC TGTAGTGGAT 4320
GCCCTTAAGA GCGCCGCGGG AAAAATTTAT AACAATTTTA CTAGTCGACG TACCTTTGGT 4380
AAGGATGAAG GCTCCTCTAG CGACGGCGCA TGTGAAGAGT ATTTCTCATG CGACGAAGGT 4440
GAAGGTCCGG GTCTGAAAGG GGGTTCCAGC TATGGCTTCT CAATTTTAGC GTTCTTTTCA 4500
CGCATTATGT GGGGAGCTCG TCGGCTTATT GTTAAGGTGA AGCATGAGTG TTTTGGGAAA 4560
CTTTTTGAAT TTCTATCGCT CAAGCTTCAC GAATTCAGGA CTCGCGTTTT TGGGAAGAAT 4620
AGAACGGACG TGGGAGTTTA CGATTTTTTG CCCACGGGCA TCGTGGAAAC GCTCTCATCG 4680
ATAGAAGAGT GCGACCAAAT TGAAGAACTT CTCGGCGACG ACCTGAAAGG TGACAAGGAT 4740
GCTTCGTTGA CCGATATGAA TTACTTTGAG TTCTCAGAAG ACTTCTTAGC CTCTATCGAG 4800
GAGCCGCCTT TCGCTGGATT GCGAGGAGGT AGCAAGAACA TCGCGATTTT GGCGATTTTG 4860
GAATACGCGC ATAATTTGTT TCGCATTGTC GCAAGCAAGT GTTCGAAACG ACCTTTATTT 4920
CTTGCTTTCG CCGAACTCTC AAGCGCCCTT ATCGAGAAAT TTAAGGAGGT TTTCCCTCGT 4980
AAGAGCCAGC TCGTCGCTAT CGTGCGCGAG TATACTCAGA GATTCCTCCG AAGTCGCATG 5040
CGTGCGTTGG GTTTGAATAA CGAGTTCGTG GTAAAATCTT TCGCCGATTT GCTACCCGCA 5100
TTAATGAAGC GGAAGGTTTC AGGTTCGTTC TTAGCTAGTG TTTATCGCCC ACTTAGAGGT 5160
TTCTCATATA TGTGTGTTTC AGCGGAGCGA CGTGAAAAGT TTTTTGCTCT CGTGTGTTTA 5220
ATCGGGTTAA GTCTCCCTTT CTTCGTGCGC ATCGTAGGAG CGAAAGCGTG CGAAGAACTC 5280
GTGTCCTCAG CGCGTCGCTT TTATGAGCGT ATTAAAATTT TTCTAAGGCA GAAGTATGTC 5340
TCTCTTTCTA ATTTCTTTTG TCACTTGTTT AGCTCTGACG TTGATGACAG TTCCGCATCT 5400
GCAGGGTTGA AAGGTGGTGC GTCGCGAATG ACGCTCTTCC ACCTTCTGGT TCGCCTTGCT 5460
AGTGCCCTCC TATCGTTAGG GTGGGAAGGG TTAAAGCTAC TCTTATCGCA CCACAACTTG 5520
TTATTTTTGT GTTTTGCATT GGTTGACGAT GTGAACGTCC TTATCAAAGT TCTTGGGGGT 5580
CTTTCTTTCT TTGTGCAACC AATCTTTTCC TTGTTTGCGG CGATGCTTCT ACAACCGGAC 5640
AGGTTTGTGG AGTATTCCGA GAAACTTGTT ACAGCGTTTG AATTTTTCTT AAAATGTTCG 5700
CCTCGCGCGC CTGCACTACT CAAAGGGTTT TTTGAGTGCG TGGCGAACAG CACTGTGTCA 5760
AAAACCGTTC GAAGACTTCT TCGCTGTTTC GTGAAGATGC TCAAACTTCG AAAAGGGCGA 5820
GGGTTGCGTG CGGATGGTAG GGGTCTCCAT CGGCAGAAAG CCGTACCCGT CATACCTTCT 5880
AATCGGGTCG TGACCGACGG GGTTGAAAGA CTTTCGGTAA AGATGCAAGG AGTTGAAGCG 5940 TTGCGTACCG AATTGAGAAT CTTAGAAGAT TTAGATTCTG CCGTGATCGA AAAACTCAAT 6000
AGACGCAGAA ATCGTGACAC TAATGACGAC GAATTTACGC GCCCTGCTCA TGAGCAGATG 6060
CAAGAAGTCA CCACTTTCTG TTCGAAAGCC AACTCTGCTG GTTTGGCCCT GGAAAGGGCA 6120
GTGCTTGTGG AAGACGCTAT AAAGTCGGAG AAACTTTCTA AGACGGTTAA TGAGATGGTG 6180
AGGAAAGGGA GTACCACCAG CGAAGAAGTG GCCGTCGCTT TGTCGGACGA TGAAGCCGTG 6240
GAAGAAATCT CTGTTGCTGA CGAGCGAGAC GATTCGCCTA AGACAGTCAG GATAAGCGAA 6300
TACCTAAATA GGTTAAACTC AAGCTTCGAA TTCCCGAAGC CTATTGTTGT GGACGACAAC 6360
AAGGATACCG GGGGTCTAAC GAACGCCGTG AGGGAGTTTT ATTATATGCA AGAACTTGCT 6420
CTTTTCGAAA TCCACAGCAA ACTGTGCACC TACTACGATC AACTGCGCAT AGTCAACTTC 6480
GATCGTTCCG TAGCACCATG CAGCGAAGAT GCTCAGCTGT ACGTACGGAA GAACGGCTCA 6540
ACGATAGTGC AGGGTAAAGA GGTACGTTTG CACATTAAGG ATTTCCACGA TCACGATTTC 6600
CTGTTTGACG GAAAAATTTC TATTAACAAG CGGCGGCGAG GCGGAAATGT TTTATATCAC 6660
GACAACCTCG CGTTCTTGGC GAGTAATTTG TTCTTAGCCG GCTACCCCTT TTCAAGGAGC 6720
TTCGTCTTCA CGAATTCGTC GGTCGATATT CTCCTCTACG AAGCTCCACC CGGAGGTGGT 6780
AAGACGACGA CGCTGATTGA CTCGTTCTTG AAGGTCTTCA AGAAAGGTGA GGTTTCCACC 6840
ATGATCTTAA CCGCCAACAA AAGTTCGCAG GTTGAGATCC TAAAGAAAGT GGAGAAGGAA 6900
GTGTCTAACA TTGAATGCCA GAAACGTAAA GACAAAAGAT CTCCGAAAAA GAGCATTTAC 6960
ACCATCGACG CTTATTTAAT GCATCACCGT GGTTGTGATG CAGACGTTCT TTTCATCGAT 7020
GAGTGTTTCA TGGTTCATGC GGGTAGCGTA CTAGCTTGCA TTGAGTTCAC GAGGTGTCAT 7080
AAAGTAATGA TCTTCGGGGA TAGCCGGCAG ATTCACTACA TTGAAAGGAA CGAATTGGAC 7140
AAGTGTTTGT ATGGGGATCT CGACAGGTTC GTGGACCTGC AGTGTCGGGT TTATGGTAAT 7200
ATTTCGTACC GTTGTCCATG GGATGTGTGC GCTTGGTTAA GCACAGTGTA TGGCAACCTA 7260
ATCGCCACCG TGAAGGGTGA AAGCGAAGGT AAGAGCAGCA TGCGCATTAA CGAAATTAAT 7320
TCAGTCGACG ATTTAGTCCC CGACGTGGGT TCCACGTTTC TGTGTATGCT TCAGTCGGAG 7380
AAGTTGGAAA TCAGCAAGCA CTTTATTCGC AAGGGTTTGA CTAAACTTAA CGTTCTAACG 7440
GTGCATGAGG CGCAAGGTGA GACGTATGCG CGTGTGAACC TTGTGCGACT TAAGTTTCAG 7500
GAGGATGAAC CCTTTAAATC TATCAGGCAC ATAACCGTCG CTCTTTCTCG TCACACCGAC 7560
AGCTTAACTT ATAACGTCTT AGCTGCTCGT CGAGGTGACG CCACTTGCGA TGCCATCCAG 7620
AAGGCTGCGG AATTGGTGAA CAAGTTTCGC GTTTTTCCTA CATCTTTTGG TGGTAGTGTT 7680
ATCAATCTCA ACGTGAAGAA GGACGTGGAA GATAACAGTA GGTGCAAGGC TTCGTCGGCA 7740
CCATTGAGCG TAATCAACGA CTTTTTGAAC GAAGTTAATC CCGGTACTGC GGTGATTGAT 7800 TTTGGTGATT TGTCCGCGGA CTTCAGTACT GGGCCTTTTG AGTGCGGTGC CAGCGGTATT 7860 GTGGTGCGGG ACAACATCTC CTCCAGCAAC ATCACTGATC ACGATAAGCA GCGTGTTTAG 7920
The large polyprotein (papain-like proteases, methyltransferase, and helicase) has an amino acid sequence corresponding to SEQ. ID. No. 3 as follows:
Thr Leu Arg Glu Asn Pro lie Ser Val Ser Gly Val Asn Leu Gly Arg 1 5 10 15
Ser Ala Ala Ala Gin Val He Tyr Phe Gly Ser Phe Thr Gin Pro Phe 20 25 30
Ala Leu Tyr Pro Arg Gin Glu Ser Ala He Val Lys Thr Gin Leu Pro 35 40 45
Pro Val Ser Val Val Lys Val Glu Cys Val Ala Ala Glu Val Ala Pro 50 55 60
Asp Arg Gly Val Val Asp Lys Lys Pro Thr Ser Val Gly Val Pro Pro 65 70 75 80
Gin Arg Gly Val Leu Ser Phe Pro Thr Val Val Arg Asn Arg Gly Asp 85 90 95
Val He He Thr Gly Val Val His Glu Ala Leu Lys Lys He Lys Asp 100 105 110
Gly Leu Leu Arg Phe Arg Val Gly Gly Asp Met Arg Phe Ser Arg Phe 115 120 125
Phe Ser Ser Asn Tyr Gly Cys Arg Phe Val Ala Ser Val Arg Thr Asn 130 135 140
Thr Thr Val Trp Leu Asn Cys Thr Lys Ala Ser Gly Glu Lys Phe Ser 145 150 155 160
Leu Ala Ala Ala Cys Thr Ala Asp Tyr Val Ala Met Leu Arg Tyr Val 165 170 175
Cys Gly Gly Lys Phe Pro Leu Val Leu Met Ser Arg Val He Tyr Pro 180 185 190
Asp Gly Arg Cys Tyr Leu Ala His Met Arg Tyr Leu Cys Ala Phe Tyr 195 200 205
Cys Arg Pro Phe Arg Glu Ser Asp Tyr Ala Leu Gly Met Trp Pro Thr 210 215 220
Val Ala Arg Leu Arg Ala Cys Val Glu Lys Asn Phe Gly Val Glu Ala 225 230 235 240
Cys Gly He Ala Leu Arg Gly Tyr Tyr Thr Ser Arg Asn Val Tyr His 245 250 255
Cys Asp Tyr Asp Ser Ala Tyr Val Lys Tyr Phe Arg Asn Leu Ser Gly 260 265 270 Arg He Gly Gly Gly Ser Phe Asp Pro Thr Ser Leu Thr Ser Val He 275 280 285
Thr Val Lys He Ser Gly Leu Pro Gly Gly Leu Pro Lys Asn He Ala 290 295 300
Phe Gly Ala Phe Leu Cys Asp He Arg Tyr Val Glu Pro Val Asp Ser 305 310 315 320
Gly Gly He Gin Ser Ser Val Lys Thr Lys Arg Glu Asp Ala His Arg 325 330 335
Thr Val Glu Glu Arg Ala Ala Gly Gly Ser Val Glu Gin Pro Arg Gin 340 345 350
Lys Arg He Asp Glu Lys Gly Cys Gly Arg Val Pro Ser Gly Gly Phe 355 360 365
Ser His Leu Leu Val Gly Asn Leu Asn Glu Val Arg Arg Lys Val Ala 370 375 380
Ala Gly Leu Leu Arg Phe Arg Val Gly Gly Asp Met Asp Phe His Arg 385 390 395 400
Ser Phe Ser Thr Gin Ala Gly His Arg Leu Leu Val Trp Arg Arg Ser 405 410 415
Ser Arg Ser Val Cys Leu Glu Leu Tyr Ser Pro Ser Lys Asn Phe Leu 420 425 430
Arg Tyr Asp Val Leu Pro Cys Ser Gly Asp Tyr Ala Ala Met Phe Ser 435 440 445
Phe Ala Ala Gly Gly Arg Phe Pro Leu Val Leu Met Thr Arg He Arg 450 455 460
Tyr Pro Asn Gly Phe Cys Tyr Leu Ala His Cys Arg Tyr Ala Cys Ala 465 470 475 480
Phe Leu Leu Arg Gly Phe Asp Pro Lys Arg Phe Asp He Gly Ala Phe 485 490 495
Pro Thr Ala Ala Lys Leu Arg Asn Arg Met Val Ser Glu Leu Gly Glu 500 505 510
Arg Ser Leu Gly Leu Asn Leu Tyr Gly Ala Tyr Thr Ser Arg Gly Val 515 520 525
Phe His Cys Asp Tyr Asp Ala Lys Phe He Lys Asp Leu Arg Leu Met 530 535 540
Ser Ala Val He Ala Gly Lys Asp Gly Val Glu Glu Val Val Pro Ser 545 550 555 560
Asp He Thr Pro Ala Met Lys Gin Lys Thr He Glu Ala Val Tyr Asp 565 570 575
Arg Leu Tyr Gly Gly Thr Asp Ser Leu Leu Lys Leu Ser He Glu Lys 580 585 590 Asp Leu He Asp Phe Lys Asn Asp Val Gin Ser Leu Lys Lys Asp Arg 595 600 605
Pro He Val Lys Val Pro Phe Tyr Met Ser Glu Ala Thr Gin Asn Ser 610 615 620
Leu Thr Arg Phe Tyr Pro Gin Phe Glu Leu Lys Phe Ser His Ser Ser 625 630 635 640
His Ser Asp His Pro Ala Ala Ala Ala Ser Arg Leu Leu Glu Asn Glu 645 650 655
Thr Leu Val Arg Leu Cys Gly Asn Ser Val Ser Asp He Gly Gly Cys 660 665 670
Pro Leu Phe His Leu His Ser Lys Thr Gin Arg Arg Val His Val Cys 675 680 685
Arg Pro Val Leu Asp Gly Lys Asp Ala Gin Arg Arg Val Val Arg Asp 690 695 700
Leu Gin Tyr Ser Asn Val Arg Leu Gly Asp Asp Asp Lys He Leu Glu 705 710 715 720
Gly Pro Arg Asn He Asp He Cys His Tyr Pro Leu Gly Ala Cys Asp 725 730 735
His Glu Ser Ser Ala Met Met Met Val Gin Val Tyr Asp Ala Ser Leu 740 745 750
Tyr Glu He Cys Gly Ala Met He Lys Lys Lys Ser Arg He Thr Tyr 755 760 765
Leu Thr Met Val Thr Pro Gly Glu Phe Leu Asp Gly Arg Glu Cys Val 770 775 780
Tyr Met Glu Ser Leu Asp Cys Glu He Glu Val Asp Val His Ala Asp 785 790 795 800
Val Val Met Tyr Lys Phe Gly Ser Ser Cys Tyr Ser His Lys Leu Ser 805 810 815
He He Lys Asp He Met Thr Thr Pro Tyr Leu Thr Leu Gly Gly Phe 820 825 830
Leu Phe Ser Val Glu Met Tyr Glu Val Arg Met Gly Val Asn Tyr Phe 835 840 845
Lys He Thr Lys Ser Glu Val Ser Pro Ser He Ser Cys Thr Lys Leu 850 855 860
Leu Arg Tyr Arg Arg Ala Asn Ser Asp Val Val Lys Val Lys Leu Pro 865 870 875 880
Arg Phe Asp Lys Lys Arg Arg Met Cys Leu Pro Gly Tyr Asp Thr He 885 890 895
Tyr Leu Asp Ser Lys Phe Val Ser Arg Val Phe Asp Tyr Val Val Cys 900 905 910 Asn Cys Ser Ala Val Asn Ser Lys Thr Phe Glu Trp Val Trp Ser Phe 915 920 925
He Lys Ser Ser Lys Ser Arg Val He He Ser Gly Lys He He His 930 935 940
Lys Asp Val Asn Leu Asp Leu Lys Tyr Val Glu Ser Phe Ala Ala Val 945 950 955 960
Met Leu Ala Ser Gly Val Arg Ser Arg Leu Ala Ser Glu Tyr Leu Ala 965 970 975
Lys Asn Leu Ser His Phe Ser Gly Asp Cys Ser Phe He Glu Ala Thr 980 985 990
Ser Phe Val Leu Arg Glu Lys He Arg Asn Met Thr Leu Asn Phe Asn 995 1000 1005
Glu Arg Leu Leu Gin Leu Val Lys Arg Val Ala Phe Ala Thr Leu Asp 1010 1015 1020
Val Ser Phe Leu Asp Leu Asp Ser Thr Leu Glu Ser He Thr Asp Phe 1025 1030 1035 1040
Ala Glu Cys Lys Val Ala He Glu Leu Asp Glu Leu Gly Cys Leu Arg 1045 1050 1055
Ala Glu Ala Glu Asn Glu Lys He Arg Asn Leu Ala Gly Asp Ser He 1060 1065 1070
Ala Ala Lys Leu Ala Ser Glu He Val Val Asp He Asp Ser Lys Pro 1075 1080 1085
Ser Pro Lys Gin Val Gly Asn Ser Ser Ser Glu Asn Ala Asp Lys Arg 1090 1095 1100
Glu Val Gin Arg Pro Gly Leu Arg Gly Gly Ser Arg Asn Gly Val Val 1105 1110 1115 1120
Gly Glu Phe Leu His Phe Val Val Asp Ser Ala Leu Arg Leu Phe Lys 1125 1130 1135
Tyr Ala Thr Asp Gin Gin Arg He Lys Ser Tyr Val Arg Phe Leu Asp 1140 1145 1150
Ser Ala Val Ser Phe Leu Asp Tyr Asn Tyr Asp Asn Leu Ser Phe He 1155 1160 1165
Leu Arg Val Leu Ser Glu Gly Tyr Ser Cys Met Phe Ala Phe Leu Ala 1170 1175 1180
Asn Arg Gly Asp Leu Ser Ser Arg Val Arg Ser Ala Val Cys Ala Val 1185 1190 1195 1200
Lys Glu Val Ala Thr Ser Cys Ala Asn Ala Ser Val Ser Lys Ala Lys 1205 1210 1215
Val Met He Thr Phe Ala Ala Ala Val Cys Ala Met Met Phe Asn Ser 1220 1225 1230 Cys Gly Phe Ser Gly Asp Gly Arg Glu Tyr Lys Ser Tyr He His Arg 1235 1240 1245
Tyr Thr Gin Val Leu Phe Asp Thr He Phe Phe Glu Asp Ser Ser Tyr 1250 1255 1260
Leu Pro He Glu Val Leu Ser Ser Ala He Cys Gly Ala He Val Thr 1265 1270 1275 1280
Leu Phe Ser Ser Gly Ser Ser He Ser Leu Asn Ala Phe Leu Leu Gin 1285 1290 1295
He Thr Lys Gly Phe Ser Leu Glu Val Val Val Arg Asn Val Val Arg 1300 1305 1310
Val Thr His Gly Leu Ser Thr Thr Ala Thr Asp Gly Val He Arg Gly 1315 1320 1325
Val Phe Ser Gin He Val Ser His Leu Leu Val Gly Asn Thr Gly Asn 1330 1335 1340
Val Ala Tyr Gin Ser Ala Phe He Ala Gly Val Val Pro Leu Leu Val 1345 1350 1355 1360
Lys Lys Cys Val Ser Leu He Phe He Leu Arg Glu Asp Thr Tyr Ser 1365 1370 1375
Gly Phe He Lys His Gly He Ser Glu Phe Ser Phe Leu Ser Ser He 1380 1385 1390
Leu Lys Phe Leu Lys Gly Lys Leu Val Asp Glu Leu Lys Ser He He 1395 1400 1405
Gin Gly Val Phe Asp Ser Asn Lys His Val Phe Lys Glu Ala Thr Gin 1410 1415 1420
Glu Ala He Arg Thr Thr Val Met Gin Val Pro Val Ala Val Val Asp 1425 1430 1435 1440
Ala Leu Lys Ser Ala Ala Gly Lys He Tyr Asn Asn Phe Thr Ser Arg 1445 1450 1455
Arg Thr Phe Gly Lys Asp Glu Gly Ser Ser Ser Asp Gly Ala Cys Glu 1460 1465 1470
Glu Tyr Phe Ser Cys Asp Glu Gly Glu Gly Pro Gly Leu Lys Gly Gly 1475 1480 1485
Ser Ser Tyr Gly Phe Ser He Leu Ala Phe Phe Ser Arg He Met Trp 1490 1495 1500
Gly Ala Arg Arg Leu He Val Lys Val Lys His Glu Cys Phe Gly Lys 1505 1510 1515 1520
Leu Phe Glu Phe Leu Ser Leu Lys Leu His Glu Phe Arg Thr Arg Val 1525 1530 1535
Phe Gly Lys Asn Arg Thr Asp Val Gly Val Tyr Asp Phe Leu Pro Thr 1540 1545 1550 Gly He Val Glu Thr Leu Ser Ser He Glu Glu Cys Asp Gin He Glu 1555 1560 1565
Glu Leu Leu Gly Asp Asp Leu Lys Gly Asp Lys Asp Ala Ser Leu Thr 1570 1575 1580
Asp Met Asn Tyr Phe Glu Phe Ser Glu Asp Phe Leu Ala Ser He Glu 1585 1590 1595 1600
Glu Pro Pro Phe Ala Gly Leu Arg Gly Gly Ser Lys Asn He Ala He 1605 1610 1615
Leu Ala He Leu Glu Tyr Ala His Asn Leu Phe Arg He Val Ala Ser 1620 1625 1630
Lys Cys Ser Lys Arg Pro Leu Phe Leu Ala Phe Ala Glu Leu Ser Ser 1635 1640 1645
Ala Leu He Glu Lys Phe Lys Glu Val Phe Pro Arg Lys Ser Gin Leu 1650 1655 1660
Val Ala He Val Arg Glu Tyr Thr Gin Arg Phe Leu Arg Ser Arg Met 1665 1670 1675 1680
Arg Ala Leu Gly Leu Asn Asn Glu Phe Val Val Lys Ser Phe Ala Asp 1685 1690 1695
Leu Leu Pro Ala Leu Met Lys Arg Lys Val Ser Gly Ser Phe Leu Ala 1700 1705 1710
Ser Val Tyr Arg Pro Leu Arg Gly Phe Ser Tyr Met Cys Val Ser Ala 1715 1720 1725
Glu Arg Arg Glu Lys Phe Phe Ala Leu Val Cys Leu He Gly Leu Ser 1730 1735 1740
Leu Pro Phe Phe Val Arg He Val Gly Ala Lys Ala Cys Glu Glu Leu 1745 1750 1755 1760
Val Ser Ser Ala Arg Arg Phe Tyr Glu Arg He Lys He Phe Leu Arg 1765 1770 1775
Gin Lys Tyr Val Ser Leu Ser Asn Phe Phe Cys His Leu Phe Ser Ser 1780 1785 1790
Asp Val Asp Asp Ser Ser Ala Ser Ala Gly Leu Lys Gly Gly Ala Ser 1795 1800 1805
Arg Met Thr Leu Phe His Leu Leu Val Arg Leu Ala Ser Ala Leu Leu 1810 1815 1820
Ser Leu Gly Trp Glu Gly Leu Lys Leu Leu Leu Ser His His Asn Leu 1825 1830 1835 1840
Leu Phe Leu Cys Phe Ala Leu Val Asp Asp Val Asn Val Leu He Lys 1845 1850 1855
Val Leu Gly Gly Leu Ser Phe Phe Val Gin Pro He Phe Ser Leu Phe 1860 1865 1870 Ala Ala Met Leu Leu Gin Pro Asp Arg Phe Val Glu Tyr Ser Glu Lys 1875 1880 1885
Leu Val Thr Ala Phe Glu Phe Phe Leu Lys Cys Ser Pro Arg Ala Pro 1890 1895 1900
Ala Leu Leu Lys Gly Phe Phe Glu Cys Val Ala Asn Ser Thr Val Ser 1905 1910 1915 1920
Lys Thr Val Arg Arg Leu Leu Arg Cys Phe Val Lys Met Leu Lys Leu 1925 1930 1935
Arg Lys Gly Arg Gly Leu Arg Ala Asp Gly Arg Gly Leu His Arg Gin 1940 1945 1950
Lys Ala Val Pro Val He Pro Ser Asn Arg Val Val Thr Asp Gly Val 1955 1960 1965
Glu Arg Leu Ser Val Lys Met Gin Gly Val Glu Ala Leu Arg Thr Glu 1970 1975 1980
Leu Arg He Leu Glu Asp Leu Asp Ser Ala Val He Glu Lys Leu Asn 1985 1990 1995 2000
Arg Arg Arg Asn Arg Asp Thr Asn Asp Asp Glu Phe Thr Arg Pro Ala 2005 2010 2015
His Glu Gin Met Gin Glu Val Thr Thr Phe Cys Ser Lys Ala Asn Ser 2020 2025 2030
Ala Gly Leu Ala Leu Glu Arg Ala Val Leu Val Glu Asp Ala He Lys 2035 2040 2045
Ser Glu Lys Leu Ser Lys Thr Val Asn Glu Met Val Arg Lys Gly Ser 2050 2055 2060
Thr Thr Ser Glu Glu Val Ala Val Ala Leu Ser Asp Asp Glu Ala Val 2065 2070 2075 2080
Glu Glu He Ser Val Ala Asp Glu Arg Asp Asp Ser Pro Lys Thr Val 2085 2090 2095
Arg He Ser Glu Tyr Leu Asn Arg Leu Asn Ser Ser Phe Glu Phe Pro 2100 2105 2110
Lys Pro He Val Val Asp Asp Asn Lys Asp Thr Gly Gly Leu Thr Asn 2115 2120 2125
Ala Val Arg Glu Phe Tyr Tyr Met Gin Glu Leu Ala Leu Phe Glu He 2130 2135 2140
His Ser Lys Leu Cys Thr Tyr Tyr Asp Gin Leu Arg He Val Asn Phe 2145 2150 2155 2160
Asp Arg Ser Val Ala Pro Cys Ser Glu Asp Ala Gin Leu Tyr Val Arg 2165 2170 2175
Lys Asn Gly Ser Thr He Val Gin Gly Lys Glu Val Arg Leu His He 2180 2185 2190 Lys Asp Phe His Asp His Asp Phe Leu Phe Asp Gly Lys He Ser He 2195 2200 2205
Asn Lys Arg Arg Arg Gly Gly Asn Val Leu Tyr His Asp Asn Leu Ala 2210 2215 2220
Phe Leu Ala Ser Asn Leu Phe Leu Ala Gly Tyr Pro Phe Ser Arg Ser 2225 2230 2235 2240
Phe Val Phe Thr Asn Ser Ser Val Asp He Leu Leu Tyr Glu Ala Pro 2245 2250 2255
Pro Gly Gly Gly Lys Thr Thr Thr Leu He Asp Ser Phe Leu Lys Val 2260 2265 2270
Phe Lys Lys Gly Glu Val Ser Thr Met He Leu Thr Ala Asn Lys Ser 2275 2280 2285
Ser Gin Val Glu He Leu Lys Lys Val Glu Lys Glu Val Ser Asn He 2290 2295 2300
Glu Cys Gin Lys Arg Lys Asp Lys Arg Ser Pro Lys Lys Ser He Tyr 2305 2310 2315 2320
Thr He Asp Ala Tyr Leu Met His His Arg Gly Cys Asp Ala Asp Val 2325 2330 2335
Leu Phe He Asp Glu Cys Phe Met Val His Ala Gly Ser Val Leu Ala 2340 2345 2350
Cys He Glu Phe Thr Arg Cys His Lys Val Met He Phe Gly Asp Ser 2355 2360 2365
Arg Gin He His Tyr He Glu Arg Asn Glu Leu Asp Lys Cys Leu Tyr 2370 2375 2380
Gly Asp Leu Asp Arg Phe Val Asp Leu Gin Cys Arg Val Tyr Gly Asn 2385 2390 2395 2400
He Ser Tyr Arg Cys Pro Trp Asp Val Cys Ala Trp Leu Ser Thr Val 2405 2410 2415
Tyr Gly Asn Leu He Ala Thr Val Lys Gly Glu Ser Glu Gly Lys Ser 2420 2425 2430
Ser Met Arg He Asn Glu He Asn Ser Val Asp Asp Leu Val Pro Asp 2435 2440 2445
Val Gly Ser Thr Phe Leu Cys Met Leu Gin Ser Glu Lys Leu Glu He 2450 2455 2460
Ser Lys His Phe He Arg Lys Gly Leu Thr Lys Leu Asn Val Leu Thr 2465 2470 2475 2480
Val His Glu Ala Gin Gly Glu Thr Tyr Ala Arg Val Asn Leu Val Arg 2485 2490 2495
Leu Lys Phe Gin Glu Asp Glu Pro Phe Lys Ser He Arg His He Thr 2500 2505 2510 Val Ala Leu Ser Arg His Thr Asp Ser Leu Thr Tyr Asn Val Leu Ala 2515 2520 2525
Ala Arg Arg Gly Asp Ala Thr Cys Asp Ala He Gin Lys Ala Ala Glu 2530 2535 2540
Leu Val Asn Lys Phe Arg Val Phe Pro Thr Ser Phe Gly Gly Ser Val 2545 2550 2555 2560
He Asn Leu Asn Val Lys Lys Asp Val Glu Asp Asn Ser Arg Cys Lys 2565 2570 2575
Ala Ser Ser Ala Pro Leu Ser Val He Asn Asp Phe Leu Asn Glu Val 2580 2585 2590
Asn Pro Gly Thr Ala Val He Asp Phe Gly Asp Leu Ser Ala Asp Phe 2595 2600 2605
Ser Thr Gly Pro Phe Glu Cys Gly Ala Ser Gly He Val Val Arg Asp 2610 2615 2620
Asn He Ser Ser Ser Asn He Thr Asp His Asp Lys Gin Arg Val 2625 2630 2635
and has a molecular weight of about 290 to 300 kDa, preferably 294 kDa.
Another such DNA molecule (GLRaV-2 ORFlb) includes nucleotides 7922-9301 of SEQ. ID. No. 1 and codes for a grapevine leafroll virus RNA-dependent RNA polymerase (RdRP). This DNA molecule comprises the nucleotide sequence corresponding to SEQ. ID. No. 4 as follows:
AGCGTAGTTC GGTCGCAGGC GATTCCGCGT AGAAAACCTT CTCTACAAGA AAATTTGTAT 60
TCGTTTGAAG CGCGGAATTA TAACTTCTCG ACTTGCGACC GTAACACATC TGCTTCAATG 120
TTCGGAGAGG CTATGGCGAT GAACTGTCTT CGTCGTTGCT TCGACCTAGA TGCCTTTTCG 180
TCCCTGCGTG ATGATGTGAT TAGTATCACA CGTTCAGGCA TCGAACAATG GCTGGAGAAA 240
CGTACTCCTA GTCAGATTAA AGCATTAATG AAGGATGTTG AATCGCCTTT GGAAATTGAC 300
GATGAAATTT GTCGTTTTAA GTTGATGGTG AAGCGTGACG CTAAGGTGAA GTTAGACTCT 360
TCTTGTTTAA CTAAACACAG CGCCGCTCAA AATATCATGT TTCATCGCAA GAGCATTAAT 420
GCTATCTTCT CTCCTATCTT TAATGAGGTG AAAAACCGAA TAATGTGCTG TCTTAAGCCT 480
AACATAAAGT TTTTTACGGA GATGACTAAC AGGGATTTTG CTTCTGTTGT CAGCAACATG 540
CTTGGTGACG ACGATGTGTA CCATATAGGT GAAGTTGATT TCTCAAAGTA CGACAAGTCT 600
CAAGATGCTT TCGTGAAGGC TTTTGAAGAA GTAATGTATA AGGAACTCGG TGTTGATGAA 660
GAGTTGCTGG CTATCTGGAT GTGCGGCGAG CGGTTATCGA TAGCTAACAC TCTCGATGGT 720
CAGTTGTCCT TCACGATCGA GAATCAAAGG AAGTCGGGAG CTTCGAACAC TTGGATTGGT 780 AACTCTCTCG TCACTTTGGG TATTTTAAGT CTTTACTACG ACGTTAGAAA TTTCGAGGCG 840
TTGTACATCT CGGGCGATGA TTCTTTAATT TTTTCTCGCA GCGAGATTTC GAATTATGCC 900
GACGACATAT GCACTGACAT GGGTTTTGAG ACAAAATTTA TGTCCCCAAG TGTCCCGTAC 960
TTTTGTTCTA AATTTGTTGT TATGTGTGGT CATAAGACGT TTTTTGTTCC CGACCCGTAC 1020
AAGCTTTTTG TCAAGTTGGG AGCAGTCAAA GAGGATGTTT CAATGGATTT CCTTTTCGAG 1080
ACTTTTACCT CCTTTAAAGA CTTAACCTCC GATTTTAACG ACGAGCGCTT AATTCAAAAG 1140
CTCGCTGAAC TTGTGGCTTT AAAATATGAG GTTCAAACCG GCAACACCAC CTTGGCGTTA 1200
AGTGTGATAC ATTGTTTGCG TTCGAATTTC CTCTCGTTTA GCAAGTTATA TCCTCGCGTG 1260
AAGGGATGGC AGGTTTTTTA CACGTCGGTT AAGAAAGCGC TTCTCAAGAG TGGGTGTTCT 1320
CTCTTCGACA GTTTCATGAC CCCTTTTGGT CAGGCTGTCA TGGTTTGGGA TGATGAGTAG 1380
The RNA-dependent RNA polymerase has an amino acid sequence corresponding to SEQ. ID. No. 5 as follows:
Ser Val Val Arg Ser Gin Ala He Pro Arg Arg Lys Pro Ser Leu Gin 1 5 10 15
Glu Asn Leu Tyr Ser Phe Glu Ala Arg Asn Tyr Asn Phe Ser Thr Cys 20 25 30
Asp Arg Asn Thr Ser Ala Ser Met Phe Gly Glu Ala Met Ala Met Asn 35 40 45
Cys Leu Arg Arg Cys Phe Asp Leu Asp Ala Phe Ser Ser Leu Arg Asp 50 55 60
Asp Val He Ser He Thr Arg Ser Gly He Glu Gin Trp Leu Glu Lys 65 70 75 80
Arg Thr Pro Ser Gin He Lys Ala Leu Met Lys Asp Val Glu Ser Pro 85 90 95
Leu Glu He Asp Asp Glu He Cys Arg Phe Lys Leu Met Val Lys Arg 100 105 110
Asp Ala Lys Val Lys Leu Asp Ser Ser Cys Leu Thr Lys His Ser Ala 115 120 125
Ala Gin Asn He Met Phe His Arg Lys Ser He Asn Ala He Phe Ser 130 135 140
Pro He Phe Asn Glu Val Lys Asn Arg He Met Cys Cys Leu Lys Pro 145 150 155 160
Asn He Lys Phe Phe Thr Glu Met Thr Asn Arg Asp Phe Ala Ser Val 165 170 175
Val Ser Asn Met Leu Gly Asp Asp Asp Val Tyr His He Gly Glu Val 180 185 190 Asp Phe Ser Lys Tyr Asp Lys Ser Gin Asp Ala Phe Val Lys Ala Phe 195 200 205
Glu Glu Val Met Tyr Lys Glu Leu Gly Val Asp Glu Glu Leu Leu Ala 210 215 220
He Trp Met Cys Gly Glu Arg Leu Ser He Ala Asn Thr Leu Asp Gly 225 230 235 240
Gin Leu Ser Phe Thr He Glu Asn Gin Arg Lys Ser Gly Ala Ser Asn 245 250 255
Thr Trp He Gly Asn Ser Leu Val Thr Leu Gly He Leu Ser Leu Tyr 260 265 270
Tyr Asp Val Arg Asn Phe Glu Ala Leu Tyr He Ser Gly Asp Asp Ser 275 280 285
Leu He Phe Ser Arg Ser Glu He Ser Asn Tyr Ala Asp Asp He Cys 290 295 300
Thr Asp Met Gly Phe Glu Thr Lys Phe Met Ser Pro Ser Val Pro Tyr 305 310 315 320
Phe Cys Ser Lys Phe Val Val Met Cys Gly His Lys Thr Phe Phe Val 325 330 335
Pro Asp Pro Tyr Lys Leu Phe Val Lys Leu Gly Ala Val Lys Glu Asp 340 345 350
Val Ser Met Asp Phe Leu Phe Glu Thr Phe Thr Ser Phe Lys Asp Leu 355 360 365
Thr Ser Asp Phe Asn Asp Glu Arg Leu He Gin Lys Leu Ala Glu Leu 370 375 380
Val Ala Leu Lys Tyr Glu Val Gin Thr Gly Asn Thr Thr Leu Ala Leu 385 390 395 400
Ser Val He His Cys Leu Arg Ser Asn Phe Leu Ser Phe Ser Lys Leu 405 410 415
Tyr Pro Arg Val Lys Gly Trp Gin Val Phe Tyr Thr Ser Val Lys Lys 420 425 430
Ala Leu Leu Lys Ser Gly Cys Ser Leu Phe Asp Ser Phe Met Thr Pro 435 440 445
Phe Gly Gin Ala Val Met Val Trp Asp Asp Glu 450 455 and a molecular weight from about 50 to about 54 kDa, preferably about 52 kDa.
Another such DNA molecule (GLRAV-2 ORF2) includes nucleotides 9365-9535 of SEQ. ID. No. 1 and codes for a small, grapevine leafroll virus hydrophobic protein or polypeptide. This DNA molecule comprises the nucleotide sequence corresponding to SEQ. ID. No. 6 as follows: ATGAATCAGG TTTTGCAGTT TGAATGTTTG TTTCTGCTGA ATCTCGCGGT TTTTGCTGTG 60 ACTTTCATTT TCATTCTTCT GGTCTTCCGC GTGATTAAGT CTTTTCGCCA GAAGGGTCAC 120 GAAGCACCTG TTCCCGTTGT TCGTGGCGGG GGTTTTTCAA CCGTAGTGTA G 171
The small hydrophobic protein or polypeptide has an amino acid sequence corresponding to SEQ. ID. No. 7 as follows:
Met Asn Gin Val Leu Gin Phe Glu Cys Leu Phe Leu Leu Asn Leu Ala 1 5 10 15
Val Phe Ala Val Thr Phe He Phe He Leu Leu Val Phe Arg Val He 20 25 30
Lys Ser Phe Arg Gin Lys Gly His Glu Ala Pro Val Pro Val Val Arg 35 40 45
Gly Gly Gly Phe Ser Thr Val Val 50 55 and a molecular weight from about 5 to about 7 kDa, preferably about 6 kDa.
Another such DNA molecule (GLRaV-2 ORF3) includes nucleotides 9551 - 11350 of SEQ. ID. No. 1 and encodes for a grapevine leafroll virus heat shock 70 protein. This DNA molecule comprises the nucleotide sequence corresponding to SEQ. ID. No. 8 as follows:
ATGGTAGTTT TCGGTTTGGA CTTTGGCACC ACATTCTCTA CGGTGTGTGT GTACAAGGAT 60
GGACGAGTTT TTTCATTCAA GCAGAATAAT TCGGCGTACA TCCCCACTTA CCTCTATCTC 120
TTCTCCGATT CTAACCACAT GACTTTTGGT TACGAGGCCG AATCACTGAT GAGTAATCTG 180
AAAGTTAAAG GTTCGTTTTA TAGAGATTTA AAACGTTGGG TGGGTTGCGA TTCGAGTAAC 240
CTCGACGCGT ACCTTGACCG TTTAAAACCT CATTACTCGG TCCGCTTGGT TAAGATCGGC 300
TCTGGCTTGA ACGAAACTGT TTCAATTGGA AACTTCGGGG GCACTGTTAA GTCTGAGGCT 360
CATCTGCCAG GGTTGATAGC TCTCTTTATT AAGGCTGTCA TTAGTTGCGC GGAGGGCGCG 420
TTTGCGTGCA CTTGCACCGG GGTTATTTGT TCAGTACCTG CCAATTATGA TAGCGTTCAA 480
AGGAATTTCA CTGATCAGTG TGTTTCACTC AGCGGTTATC AGTGCGTATA TATGATCAAT 540
GAACCTTCAG CGGCTGCGCT ATCTGCGTGT AATTCGATTG GAAAGAAGTC CGCAAATTTG 600
GCTGTTTACG ATTTCGGTGG TGGGACCTTC GACGTGTCTA TCATTTCATA CCGCAACAAT 660
ACTTTTGTTG TGCGAGCTTC TGGAGGCGAT CTAAATCTCG GTGGAAGGGA TGTTGATCGT 720
GCGTTTCTCA CGCACCTCTT CTCTTTAACA TCGCTGGAAC CTGACCTCAC TTTGGATATC 780 R170988.l TCGAATCTGA AAGAATCTTT ATCAAAAACG GACGCAGAGA TAGTTTACAC TTTGAGAGGT 840
GTCGATGGAA GAAAAGAAGA CGTTAGAGTA AACAAAAACA TTCTTACGTC GGTGATGCTC 900
CCCTACGTGA ACAGAACGCT TAAGATATTA GAGTCAACCT TAAAATCGTA TGCTAAGAGT 960
ATGAATGAGA GTGCGCGAGT TAAGTGCGAT TTAGTGCTGA TAGGAGGATC TTCATATCTT 1020
CCTGGCCTGG CAGACGTACT AACGAAGCAT CAGAGCGTTG ATCGTATCTT AAGAGTTTCG 1080
GATCCTCGGG CTGCCGTGGC CGTCGGTTGC GCATTATATT CTTCATGCCT CTCAGGATCT 1140
GGGGGGTTGC TACTGATCGA CTGTGCAGCT CACACTGTCG CTATAGCGGA CAGAAGTTGT 1200
CATCAAATCA TTTGCGCTCC AGCGGGGGCA CCGATCCCCT TTTCAGGAAG CATGCCTTTG 1260
TACTTAGCCA GGGTCAACAA GAACTCGCAG CGTGAAGTCG CCGTGTTTGA AGGGGAGTAC 1320
GTTAAGTGCC CTAAGAACAG AAAGATCTGT GGAGCAAATA TAAGATTTTT TGATATAGGA 1380
GTGACGGGTG ATTCGTACGC ACCCGTTACC TTCTATATGG ATTTCTCCAT TTCAAGCGTA 1440
GGAGCCGTTT CATTCGTGGT GAGAGGTCCT GAGGGTAAGC AAGTGTCACT CACTGGAACT 1500
CCAGCGTATA ACTTTTCGTC TGTGGCTCTC GGATCACGCA GTGTCCGAGA ATTGCATATT 1560
AGTTTAAATA ATAAAGTTTT TCTCGGTTTG CTTCTACATA GAAAGGCGGA TCGACGAATA 1620
CTTTTCACTA AGGATGAAGC GATTCGATAC GCCGATTCAA TTGATATCGC GGATGTGCTA 1680
AAGGAATATA AAAGTTACGC GGCCAGTGCC TTACCACCAG ACGAGGATGT CGAATTACTC 1740
CTGGGAAAGT CTGTTCAAAA AGTTTTACGG GGAAGCAGAC TGGAAGAAAT ACCTCTCTAG 1800
The heat shock 70 protein is believed to function as a chaperone protein and has an amino acid sequence corresponding to SEQ. ID. No. 9 as follows:
Met Val Val Phe Gly Leu Asp Phe Gly Thr Thr Phe Ser Thr Val Cys 1 5 10 15
Val Tyr Lys Asp Gly Arg Val Phe Ser Phe Lys Gin Asn Asn Ser Ala 20 25 30
Tyr He Pro Thr Tyr Leu Tyr Leu Phe Ser Asp Ser Asn His Met Thr 35 40 45
Phe Gly Tyr Glu Ala Glu Ser Leu Met Ser Asn Leu Lys Val Lys Gly 50 55 60
Ser Phe Tyr Arg Asp Leu Lys Arg Trp Val Gly Cys Asp Ser Ser Asn 65 70 75 80
Leu Asp Ala Tyr Leu Asp Arg Leu Lys Pro His Tyr Ser Val Arg Leu 85 90 95
Val Lys He Gly Ser Gly Leu Asn Glu Thr Val Ser He Gly Asn Phe 100 105 110 Gly Gly Thr Val Lys Ser Glu Ala His Leu Pro Gly Leu He Ala Leu 115 120 125
Phe He Lys Ala Val He Ser Cys Ala Glu Gly Ala Phe Ala Cys Thr 130 135 140
Cys Thr Gly Val He Cys Ser Val Pro Ala Asn Tyr Asp Ser Val Gin 145 150 155 160
Arg Asn Phe Thr Asp Gin Cys Val Ser Leu Ser Gly Tyr Gin Cys Val 165 170 175
Tyr Met He Asn Glu Pro Ser Ala Ala Ala Leu Ser Ala Cys Asn Ser 180 185 190
He Gly Lys Lys Ser Ala Asn Leu Ala Val Tyr Asp Phe Gly Gly Gly 195 200 205
Thr Phe Asp Val Ser He He Ser Tyr Arg Asn Asn Thr Phe Val Val 210 215 220
Arg Ala Ser Gly Gly Asp Leu Asn Leu Gly Gly Arg Asp Val Asp Arg 225 230 235 240
Ala Phe Leu Thr His Leu Phe Ser Leu Thr Ser Leu Glu Pro Asp Leu 245 250 255
Thr Leu Asp He Ser Asn Leu Lys Glu Ser Leu Ser Lys Thr Asp Ala 260 265 270
Glu He Val Tyr Thr Leu Arg Gly Val Asp Gly Arg Lys Glu Asp Val 275 280 285
Arg Val Asn Lys Asn He Leu Thr Ser Val Met Leu Pro Tyr Val Asn 290 295 300
Arg Thr Leu Lys He Leu Glu Ser Thr Leu Lys Ser Tyr Ala Lys Ser 305 310 315 320
Met Asn Glu Ser Ala Arg Val Lys Cys Asp Leu Val Leu He Gly Gly 325 330 335
Ser Ser Tyr Leu Pro Gly Leu Ala Asp Val Leu Thr Lys His Gin Ser 340 345 350
Val Asp Arg He Leu Arg Val Ser Asp Pro Arg Ala Ala Val Ala Val 355 360 365
Gly Cys Ala Leu Tyr Ser Ser Cys Leu Ser Gly Ser Gly Gly Leu Leu 370 375 380
Leu He Asp Cys Ala Ala His Thr Val Ala He Ala Asp Arg Ser Cys 385 390 395 400
His Gin He He Cys Ala Pro Ala Gly Ala Pro He Pro Phe Ser Gly 405 410 415
Ser Met Pro Leu Tyr Leu Ala Arg Val Asn Lys Asn Ser Gin Arg Glu 420 425 430 Val Ala Val Phe Glu Gly Glu Tyr Val Lys Cys Pro Lys Asn Arg Lys 435 440 445
He Cys Gly Ala Asn He Arg Phe Phe Asp He Gly Val Thr Gly Asp 450 455 460
Ser Tyr Ala Pro Val Thr Phe Tyr Met Asp Phe Ser He Ser Ser Val 465 470 475 480
Gly Ala Val Ser Phe Val Val Arg Gly Pro Glu Gly Lys Gin Val Ser 485 490 495
Leu Thr Gly Thr Pro Ala Tyr Asn Phe Ser Ser Val Ala Leu Gly Ser 500 505 510
Arg Ser Val Arg Glu Leu His He Ser Leu Asn Asn Lys Val Phe Leu 515 520 525
Gly Leu Leu Leu His Arg Lys Ala Asp Arg Arg He Leu Phe Thr Lys 530 535 540
Asp Glu Ala He Arg Tyr Ala Asp Ser He Asp He Ala Asp Val Leu 545 550 555 560
Lys Glu Tyr Lys Ser Tyr Ala Ala Ser Ala Leu Pro Pro Asp Glu Asp 565 570 575
Val Glu Leu Leu Leu Gly Lys Ser Val Gin Lys Val Leu Arg Gly Ser 580 585 590
Arg Leu Glu Glu He Pro Leu 595
and a molecular weight from about 63 to about 67 kDa, preferably about 65 kDa.
Another such DNA molecule (GLRaV-2 ORF4) includes nucleotides 11277-12932 of SEQ. ID. No. 1 and codes for a putative grapevine leafroll virus heat shock 90 protein. This DNA molecule comprises a nucleotide sequence corresponding to SEQ. ID. No. 10 as follows:
ATGTCGAATT ACTCCTGGGA AAGTCTGTTC AAAAAGTTTT ACGGGGAAGC AGACTGGAAG 60
AAATACCTCT CTAGGAGCAT AGCAGCACAC TCAAGTGAAA TTAAAACTCT ACCAGACATT 120
CGATTGTACG GCGGTAGGGT TGTAAAGAAG TCCGAATTCG AATCAGCACT TCCTAATTCT 180
TTTGAACAGG AATTAGGACT GTTCATACTG AGCGAACGGG AAGTGGGATG GAGCAAATTA 240
TGCGGAATAA CGGTGGAAGA AGCAGCATAC GATCTTACGA ATCCCAAGGC TTATAAATTC 300
ACTGCCGAGA CATGTAGCCC GGATGTAAAA GGTGAAGGAC AAAAATACTC TATGGAAGAC 360
GTGATGAATT TCATGCGTTT ATCAAATCTG GATGTTAACG ACAAGATGCT GACGGAACAG 420
TGTTGGTCGC TGTCCAATTC ATGCGGTGAA TTGATCAACC CAGACGACAA AGGGCGATTC 480
GTGGCTCTCA CCTTTAAGGA CAGAGACACA GCTGATGACA CGGGTGCCGC CAACGTGGAA 540 TGTCGCGTGG GCGACTATCT AGTTTACGCT ATGTCCCTGT TTGAGCAGAG GACCCAAAAA 600
TCGCAGTCTG GCAACATCTC TCTGTACGAA AAGTACTGTG AATACATCAG GACCTACTTA 660
GGGAGTACAG ACCTGTTCTT CACAGCGCCG GACAGGATTC CGTTACTTAC GGGCATCCTA 720
TACGATTTTT GTAAGGAATA CAACGTTTTC TACTCGTCAT ATAAGAGAAA CGTCGATAAT 780
TTCAGATTCT TCTTGGCGAA TTATATGCCT TTGATATCTG ACGTCTTTGT CTTCCAGTGG 840
GTAAAACCCG CGCCGGATGT TCGGCTGCTT TTTGAGTTAA GTGCAGCGGA ACTAACGCTG 900
GAGGTTCCCA CACTGAGTTT GATAGATTCT CAAGTTGTGG TAGGTCATAT CTTAAGATAC 960
GTAGAATCCT ACACATCAGA TCCAGCCATC GACGCGTTAG AAGACAAACT GGAAGCGATA 1020
CTGAAAAGTA GCAATCCCCG TCTATCGACA GCGCAACTAT GGGTTGGTTT CTTTTGTTAC 1080
TATGGTGAGT TTCGTACGGC TCAAAGTAGA GTAGTGCAAA GACCAGGCGT ATACAAAACA 1140
CCTGACTCAG TGGGTGGATT TGAAATAAAC ATGAAAGATG TTGAGAAATT CTTCGATAAA 1200
CTTCAGAGAG AATTGCCTAA TGTATCTTTG CGGCGTCAGT TTAACGGAGC TAGAGCGCAT 1260
GAGGCTTTCA AAATATTTAA AAACGGAAAT ATAAGTTTCA GACCTATATC GCGTTTAAAC 1320
GTGCCTAGAG AGTTCTGGTA TCTGAACATA GACTACTTCA GGCACGCGAA TAGGTCCGGG 1380
TTAACCGAAG AAGAAATACT CATCCTAAAC AACATAAGCG TTGATGTTAG GAAGTTATGC 1440
GCTGAGAGAG CGTGCAATAC CCTACCTAGC GCGAAGCGCT TTAGTAAAAA TCATAAGAGT 1500
AATATACAAT CATCACGCCA AGAGCGGAGG ATTAAAGACC CATTGGTAGT CCTGAAAGAC 1560
ACTTTATATG AGTTCCAACA CAAGCGTGCC GGTTGGGGGT CTCGAAGCAC TCGAGACCTC 1620
GGGAGTCGTG CTGACCACGC GAAAGGAAGC GGTTGA 1656
The heat shock 90 protein has an amino acid sequence corresponding to SEQ. ID. No. 1 1 as follows:
Met Ser Asn Tyr Ser Trp Glu Ser Leu Phe Lys Lys Phe Tyr Gly Glu 1 5 10 15
Ala Asp Trp Lys Lys Tyr Leu Ser Arg Ser He Ala Ala His Ser Ser 20 25 30
Glu He Lys Thr Leu Pro Asp He Arg Leu Tyr Gly Gly Arg Val Val 35 40 45
Lys Lys Ser Glu Phe Glu Ser Ala Leu Pro Asn Ser Phe Glu Gin Glu 50 55 60
Leu Gly Leu Phe He Leu Ser Glu Arg Glu Val Gly Trp Ser Lys Leu 65 70 75 80 Cys Gly He Thr Val Glu Glu Ala Ala Tyr Asp Leu Thr Asn Pro Lys 85 90 95
Ala Tyr Lys Phe Thr Ala Glu Thr Cys Ser Pro Asp Val Lys Gly Glu 100 105 110
Gly Gin Lys Tyr Ser Met Glu Asp Val Met Asn Phe Met Arg Leu Ser 115 120 125
Asn Leu Asp Val Asn Asp Lys Met Leu Thr Glu Gin Cys Trp Ser Leu 130 135 140
Ser Asn Ser Cys Gly Glu Leu He Asn Pro Asp Asp Lys Gly Arg Phe 145 150 155 160
Val Ala Leu Thr Phe Lys Asp Arg Asp Thr Ala Asp Asp Thr Gly Ala 165 170 175
Ala Asn Val Glu Cys Arg Val Gly Asp Tyr Leu Val Tyr Ala Met Ser 180 185 190
Leu Phe Glu Gin Arg Thr Gin Lys Ser Gin Ser Gly Asn He Ser Leu 195 200 205
Tyr Glu Lys Tyr Cys Glu Tyr He Arg Thr Tyr Leu Gly Ser Thr Asp 210 215 220
Leu Phe Phe Thr Ala Pro Asp Arg He Pro Leu Leu Thr Gly He Leu 225 230 235 240
Tyr Asp Phe Cys Lys Glu Tyr Asn Val Phe Tyr Ser Ser Tyr Lys Arg 245 250 255
Asn Val Asp Asn Phe Arg Phe Phe Leu Ala Asn Tyr Met Pro Leu He 260 265 270
Ser Asp Val Phe Val Phe Gin Trp Val Lys Pro Ala Pro Asp Val Arg 275 280 285
Leu Leu Phe Glu Leu Ser Ala Ala Glu Leu Thr Leu Glu Val Pro Thr 290 295 300
Leu Ser Leu He Asp Ser Gin Val Val Val Gly His He Leu Arg Tyr 305 310 315 320
Val Glu Ser Tyr Thr Ser Asp Pro Ala He Asp Ala Leu Glu Asp Lys 325 330 335
Leu Glu Ala He Leu Lys Ser Ser Asn Pro Arg Leu Ser Thr Ala Gin 340 345 350
Leu Trp Val Gly Phe Phe Cys Tyr Tyr Gly Glu Phe Arg Thr Ala Gin 355 360 365
Ser Arg Val Val Gin Arg Pro Gly Val Tyr Lys Thr Pro Asp Ser Val 370 375 380
Gly Gly Phe Glu He Asn Met Lys Asp Val Glu Lys Phe Phe Asp Lys 385 390 395 400 Leu Gin Arg Glu Leu Pro Asn Val Ser Leu Arg Arg Gin Phe Asn Gly 405 410 415
Ala Arg Ala His Glu Ala Phe Lys He Phe Lys Asn Gly Asn He Ser 420 425 430
Phe Arg Pro He Ser Arg Leu Asn Val Pro Arg Glu Phe Trp Tyr Leu 435 440 445
Asn He Asp Tyr Phe Arg His Ala Asn Arg Ser Gly Leu Thr Glu Glu 450 455 460
Glu He Leu He Leu Asn Asn He Ser Val Asp Val Arg Lys Leu Cys 465 470 475 480
Ala Glu Arg Ala Cys Asn Thr Leu Pro Ser Ala Lys Arg Phe Ser Lys 485 490 495
Asn His Lys Ser Asn He Gin Ser Ser Arg Gin Glu Arg Arg He Lys 500 505 510
Asp Pro Leu Val Val Leu Lys Asp Thr Leu Tyr Glu Phe Gin His Lys 515 520 525
Arg Ala Gly Trp Gly Ser Arg Ser Thr Arg Asp Leu Gly Ser Arg Ala 530 535 540
Asp His Ala Lys Gly Ser Gly 545 550 and a molecular weight from about 61 to about 65 kDa, preferably about 63 kDa.
Yet another DNA molecule of the present invention (GLRaV-2 ORF5) includes nucleotides 12844-13515 of SEQ. ID. No. 1 and codes for a diverged coat protein. This DNA molecule comprises a nucleotide sequence corresponding to SEQ. ID. No. 12 as follows:
ATGAGTTCCA ACACAAGCGT GCCGGTTGGG GGTCTCGAAG CACTCGAGAC CTCGGGAGTC 60
GTGCTGACCA CGCGAAAGGA AGCGGTTGAT AAGTTTTTTA ATGAACTAAA AAACGAAAAT 120
TACTCATCAG TTGACAGCAG CCGATTAAGC GATTCGGAAG TAAAAGAAGT GTTAGAGAAA 180
AGTAAAGAAA GTTTCAAAAG CGAACTGGCC TCCACTGACG AGCACTTCGT CTACCACATT 240
ATATTTTTCT TAATCCGATG TGCTAAGATA TCGACAAGTG AAAAGGTGAA GTACGTTGGT 300
AGTCATACGT ACGTGGTCGA CGGAAAAACG TACACCGTTC TTGACGCTTG GGTATTCAAC 360
ATGATGAAAA GTCTCACGAA GAAGTACAAA CGAGTGAATG GTCTGCGTGC GTTCTGTTGC 420
GCGTGCGAAG ATCTATATCT AACCGTCGCA CCAATAATGT CAGAACGCTT TAAGACTAAA 480
GCCGTAGGGA TGAAAGGTTT GCCTGTTGGA AAGGAATACT TAGGCGCCGA CTTTCTTTCG 540
GGAACTAGCA AACTGATGAG CGATCACGAC AGGGCGGTCT CCATCGTTGC AGCGAAAAAC 600 GCTGTCGATC GTAGCGCTTT CACGGGTGGG GAGAGAAAGA TAGTTAGTTT GTATGATCTA 660 GGGAGGTACT AA 672
The diverged coat protein has an amino acid sequence corresponding to SEQ. ID. No. 13 as follows:
Met Ser Ser Asn Thr Ser Val Pro Val Gly Gly Leu Glu Ala Leu Glu 1 5 10 15
Thr Ser Gly Val Val Leu Thr Thr Arg Lys Glu Ala Val Asp Lys Phe 20 25 30
Phe Asn Glu Leu Lys Asn Glu Asn Tyr Ser Ser Val Asp Ser Ser Arg 35 40 45
Leu Ser Asp Ser Glu Val Lys Glu Val Leu Glu Lys Ser Lys Glu Ser 50 55 60
Phe Lys Ser Glu Leu Ala Ser Thr Asp Glu His Phe Val Tyr His He 65 70 75 80
He Phe Phe Leu He Arg Cys Ala Lys He Ser Thr Ser Glu Lys Val 85 90 95
Lys Tyr Val Gly Ser His Thr Tyr Val Val Asp Gly Lys Thr Tyr Thr 100 105 110
Val Leu Asp Ala Trp Val Phe Asn Met Met Lys Ser Leu Thr Lys Lys 115 120 125
Tyr Lys Arg Val Asn Gly Leu Arg Ala Phe Cys Cys Ala Cys Glu Asp 130 135 140
Leu Tyr Leu Thr Val Ala Pro He Met Ser Glu Arg Phe Lys Thr Lys 145 150 155 160
Ala Val Gly Met Lys Gly Leu Pro Val Gly Lys Glu Tyr Leu Gly Ala 165 170 175
Asp Phe Leu Ser Gly Thr Ser Lys Leu Met Ser Asp His Asp Arg Ala 180 185 190
Val Ser He Val Ala Ala Lys Asn Ala Val Asp Arg Ser Ala Phe Thr 195 200 205
Gly Gly Glu Arg Lys He Val Ser Leu Tyr Asp Leu Gly Arg Tyr 210 215 220 and a molecular weight from about 23 to about 27 kDa, preferably about 25 kDa.
Another such DNA molecule (GLRaV-2 ORF6) includes nucleotides 13584-14180 of SEQ. ID. No. 1 and codes for a grapevine leafroll virus coat protein. This DNA molecule comprises a nucleotide sequence corresponding to SEQ. ID. No. 14 as follows: ATGGAGTTGA TGTCCGACAG CAACCTTAGC AACCTGGTGA TAACCGACGC CTCTAGTCTA 60
AATGGTGTCG ACAAGAAGCT TTTATCTGCT GAAGTTGAAA AAATGTTGGT GCAGAAAGGG 120
GCTCCTAACG AGGGTATAGA AGTGGTGTTC GGTCTACTCC TTTACGCACT CGCGGCAAGA 180
ACCACGTCTC CTAAGGTTCA GCGCGCAGAT TCAGACGTTA TATTTTCAAA TAGTTTCGGA 240
GAGAGGAATG TGGTAGTAAC AGAGGGTGAC CTTAAGAAGG TACTCGACGG GTGTGCGCCT 300
CTCACTAGGT TCACTAATAA ACTTAGAACG TTCGGTCGTA CTTTCACTGA GGCTTACGTT 360
GACTTTTGTA TCGCGTATAA GCACAAATTA CCCCAACTCA ACGCCGCGGC GGAATTGGGG 420
ATTCCAGCTG AAGATTCGTA CTTAGCTGCA GATTTTCTGG GTACTTGCCC GAAGCTCTCT 480
GAATTACAGC AAAGTAGGAA GATGTTCGCG AGTATGTACG CTCTAAAAAC TGAAGGTGGA 540
GTGGTAAATA CACCAGTGAG CAATCTGCGT CAGCTAGGTA GAAGGGAAGT TATGTAA 597
The coat protein has an amino acid sequence corresponding to SEQ. ID. No. 15 as follows:
Met Glu Leu Met Ser Asp Ser Asn Leu Ser Asn Leu Val He Thr Asp 1 5 10 15
Ala Ser Ser Leu Asn Gly Val Asp Lys Lys Leu Leu Ser Ala Glu Val 20 25 30
Glu Lys Met Leu Val Gin Lys Gly Ala Pro Asn Glu Gly He Glu Val 35 40 45
Val Phe Gly Leu Leu Leu Tyr Ala Leu Ala Ala Arg Thr Thr Ser Pro 50 55 60
Lys Val Gin Arg Ala Asp Ser Asp Val He Phe Ser Asn Ser Phe Gly 65 70 75 80
Glu Arg Asn Val Val Val Thr Glu Gly Asp Leu Lys Lys Val Leu Asp 85 90 95
Gly Cys Ala Pro Leu Thr Arg Phe Thr Asn Lys Leu Arg Thr Phe Gly 100 105 110
Arg Thr Phe Thr Glu Ala Tyr Val Asp Phe Cys He Ala Tyr Lys His 115 120 125
Lys Leu Pro Gin Leu Asn Ala Ala Ala Glu Leu Gly He Pro Ala Glu 130 135 140
Asp Ser Tyr Leu Ala Ala Asp Phe Leu Gly Thr Cys Pro Lys Leu Ser 145 150 155 160
Glu Leu Gin Gin Ser Arg Lys Met Phe Ala Ser Met Tyr Ala Leu Lys 165 170 175 Thr Glu Gly Gly Val Val Asn Thr Pro Val Ser Asn Leu Arg Gin Leu 180 185 190
Gly Arg Arg Glu Val Met 195 and a molecular weight from about 20 to about 24 kDa, preferably about 22 kDa.
Another such DNA molecule (GLRaV-2 ORF7) includes nucleotides 14180-14665 of SEQ. ID. No. 1 and codes for a second undefined grapevine leafroll virus protein or polypeptide. This DNA molecule comprises a nucleotide sequence corresponding to SEQ. ID. No. 16 as follows:
ATGGAAGATT ACGAAGAAAA ATCCGAATCG CTCATACTGC TACGCACGAA TCTGAACACT 60
ATGCTTTTAG TGGTCAAGTC CGATGCTAGT GTAGAGCTGC CTAAACTACT AATTTGCGGT 120
TACTTACGAG TGTCAGGACG TGGGGAGGTG ACGTGTTGCA ACCGTGAGGA ATTAACAAGA 180
GATTTTGAGG GCAATCATCA TACGGTGATC CGTTCTAGAA TCATACAATA TGACAGCGAG 240
TCTGCTTTTG AGGAATTCAA CAACTCTGAT TGCGTAGTGA AGTTTTTCCT AGAGACTGGT 300
AGTGTCTTTT GGTTTTTCCT TCGAAGTGAA ACCAAAGGTA GAGCGGTGCG ACATTTGCGC 360
ACCTTCTTCG AAGCTAACAA TTTCTTCTTT GGATCGCATT GCGGTACCAT GGAGTATTGT 420
TTGAAGCAGG TACTAACTGA AACTGAATCT ATAATCGATT CTTTTTGCGA AGAAAGAAAT 480
CGTTAA 486
The second undefined grapevine leafroll virus protein or polypeptide has a deduced amino acid sequence corresponding to SEQ. ID. No. 17 as follows:
Met Glu Asp Tyr Glu Glu Lys Ser Glu Ser Leu He Leu Leu Arg Thr 1 5 10 15
Asn Leu Asn Thr Met Leu Leu Val Val Lys Ser Asp Ala Ser Val Glu 20 25 30
Leu Pro Lys Leu Leu He Cys Gly Tyr Leu Arg Val Ser Gly Arg Gly 35 40 45
Glu Val Thr Cys Cys Asn Arg Glu Glu Leu Thr Arg Asp Phe Glu Gly 50 55 60
Asn His His Thr Val He Arg Ser Arg He He Gin Tyr Asp Ser Glu 65 70 75 80
Ser Ala Phe Glu Glu Phe Asn Asn Ser Asp Cys Val Val Lys Phe Phe 85 90 95
Leu Glu Thr Gly Ser Val Phe Trp Phe Phe Leu Arg Ser Glu Thr Lys 100 105 110 Gly Arg Ala Val Arg His Leu Arg Thr Phe Phe Glu Ala Asn Asn Phe 115 120 125
Phe Phe Gly Ser His Cys Gly Thr Met Glu Tyr Cys Leu Lys Gin Val 130 135 140
Leu Thr Glu Thr Glu Ser He He Asp Ser Phe Cys Glu Glu Arg Asn 145 150 155 160
Arg and a molecular weight from about 17 to about 21 kDa, preferably about 19 kDa.
Yet another such DNA molecule (GLRaV-2 ORF8) includes nucleotides 14667-15284 of SEQ. ID. No. 1 and codes for a third undefined grapevine leafroll virus protein or polypeptide. This DNA molecule comprises a nucleotide sequence corresponding to SEQ. ID. No. 18 as follows:
ATGAGGGTTA TAGTGTCTCC TTATGAAGCT GAAGACATTC TGAAAAGATC GACTGACATG 60
TTACGAAACA TAGACAGTGG GGTCTTGAGC ACTAAAGAAT GTATCAAGGC ATTCTCGACG 120
ATAACGCGAG ACCTACATTG TGCGAAGGCT TCCTACCAGT GGGGTGTTGA CACTGGGTTA 180
TATCAGCGTA ATTGCGCTGA AAAACGTTTA ATTGACACGG TGGAGTCAAA CATACGGTTG 240
GCTCAACCTC TCGTGCGTGA AAAAGTGGCG GTTCATTTTT GTAAGGATGA ACCAAAAGAG 300
CTAGTAGCAT TCATCACGCG AAAGTACGTG GAACTCACGG GCGTGGGAGT GAGAGAAGCG 360
GTGAAGAGGG AAATGCGCTC TCTTACCAAA ACAGTTTTAA ATAAAATGTC TTTGGAAATG 420
GCGTTTTACA TGTCACCACG AGCGTGGAAA AACGCTGAAT GGTTAGAACT AAAATTTTCA 480
CCTGTGAAAA TCTTTAGAGA TCTGCTATTA GACGTGGAAA CGCTCAACGA ATTGTGCGCC 540
GAAGATGATG TTCACGTCGA CAAAGTAAAT GAGAATGGGG ACGAAAATCA CGACCTCGAA 600
CTCCAAGACG AATGTTAA 618
The third undefined protein or polypeptide has a deduced amino acid sequence corresponding to SEQ. ID. No. 19 as follows:
Met Arg Val He Val Ser Pro Tyr Glu Ala Glu Asp He Leu Lys Arg 1 5 10 15
Ser Thr Asp Met Leu Arg Asn He Asp Ser Gly Val Leu Ser Thr Lys 20 25 30
Glu Cys He Lys Ala Phe Ser Thr He Thr Arg Asp Leu His Cys Ala 35 40 45 Lys Ala Ser Tyr Gin Trp Gly Val Asp Thr Gly Leu Tyr Gin Arg Asn 50 55 60
Cys Ala Glu Lys Arg Leu He Asp Thr Val Glu Ser Asn He Arg Leu 65 70 75 80
Ala Gin Pro Leu Val Arg Glu Lys Val Ala Val His Phe Cys Lys Asp 85 90 95
Glu Pro Lys Glu Leu Val Ala Phe He Thr Arg Lys Tyr Val Glu Leu 100 105 110
Thr Gly Val Gly Val Arg Glu Ala Val Lys Arg Glu Met Arg Ser Leu 115 120 125
Thr Lys Thr Val Leu Asn Lys Met Ser Leu Glu Met Ala Phe Tyr Met 130 135 140
Ser Pro Arg Ala Trp Lys Asn Ala Glu Trp Leu Glu Leu Lys Phe Ser 145 150 155 160
Pro Val Lys He Phe Arg Asp Leu Leu Leu Asp Val Glu Thr Leu Asn 165 170 175
Glu Leu Cys Ala Glu Asp Asp Val His Val Asp Lys Val Asn Glu Asn 180 185 190
Gly Asp Glu Asn His Asp Leu Glu Leu Gin Asp Glu Cys 195 200 205 and a molecular weight from about 22 to about 26 kDa, preferably about 24 kDa.
Another DNA molecule of the present invention (GLRaV-2 3 ' UTR) includes nucleotides 15285-15500 of SEQ. ID. No. 1 and comprises a nucleotide sequence corresponding to SEQ. ID. No. 23 as follows:
ACATTGGTTA AGTTTAACGA AAATGATTAG TAAATAATAA ATCGAACGTG GGTGTATCTA 60
CCTGACGTAT CAACTTAAGC TGTTACTGAG TAATTAAACC AACAAGTGTT GGTGTAATGT 120
GTATGTTGAT GTAGAGAAAA ATCCGTTTGT AGAACGGTGT TTTTCTCTTC TTTATTTTTA 180
AAAAAAAAAT AAAAAAAAAA AAAAAAAAGC GGCCGC 216
Also encompassed by the present invention are fragments of the DNA molecules of the present invention. Suitable fragments capable of imparting grapevine leafroll resistance to grape plants are constructed by using appropriate restriction sites, revealed by inspection of the DNA molecule's sequence, to: (i) insert an interposon (Felley et al, "Interposon Mutagenesis of Soil and Water Bacteria: a Family of DNA Fragments Designed for in vitro Insertion Mutagenesis of Gram-negative Bacteria,"
Gene, 52: 147-15 (1987), which is hereby incorporated by reference) such that truncated forms of the grapevine leafroll virus coat polypeptide or protein, that lack various amounts of the C-terminus, can be produced or (ii) delete various internal portions of the protein. Alternatively, the sequence can be used to amplify any portion of the coding region, such that it can be cloned into a vector supplying both transcription and translation start signals.
Suitable DNA molecules are those that hybridize to a DNA molecule comprising a nucleotide sequence of at least 15 continuous bases of SEQ. ID. No. 1 under stringent conditions characterized by a hybridization buffer comprising 0.9M sodium citrate ("SSC") buffer at a temperature of 37°C and remaining bound when subject to washing with SSC buffer at 37°C; and preferably in a hybridization buffer comprising 20%) formamide in 0.9M saline/0.9M SSC buffer at a temperature of 42°C and remaining bound when subject to washing at 42°C with 0.2x SSC buffer at 42°C.
Variants may also (or alternatively) be modified by, for example, the deletion or addition of nucleotides that have minimal influence on the properties, secondary structure and hydropathic nature of the encoded polypeptide. For example, the nucleotides encoding a polypeptide may be conjugated to a signal (or leader) sequence at the N-terminal end of the protein which co-translationally or post-translationally directs transfer of the protein. The nucleotide sequence may also be altered so that the encoded polypeptide is conjugated to a linker or other sequence for ease of synthesis, purification, or identification of the polypeptide.
The protein or polypeptide of the present invention is preferably produced in purified form (preferably, at least about 80%, more preferably 90%>, pure) by conventional techniques. Typically, the protein or polypeptide of the present invention is isolated by lysing and sonication. After washing, the lysate pellet is resuspended in buffer containing Tris-HCl. During dialysis, a precipitate forms from this protein solution. The solution is centrifuged, and the pellet is washed and resuspended in the buffer containing Tris-HCl. Proteins are resolved by electrophoresis through an SDS 12%) polyacrylamide gel.
The DNA molecule encoding the grapevine leafroll virus (type 2) protein or polypeptide of the present invention can be incorporated in cells using conventional recombinant DNA technology. Generally, this involves inserting the DNA molecule into an expression system to which the DNA molecule is heterologous (i.e. not normally present). The heterologous DNA molecule is inserted into the expression system or vector in proper sense orientation and correct reading frame. The vector contains the necessary elements for the transcription and translation of the inserted protein-coding sequences.
U.S. Patent No. 4,237,224 to Cohen and Boyer, which is hereby incorporated by reference, describes the production of expression systems in the form of recombinant plasmids using restriction enzyme cleavage and ligation with DNA ligase. These recombinant plasmids are then introduced by means of transformation and replicated in unicellular cultures including procaryotic organisms and eucaryotic cells grown in tissue culture.
Recombinant genes may also be introduced into viruses, such as vaccinia virus. Recombinant viruses can be generated by transfection of plasmids into cells infected with virus.
Suitable vectors include, but are not limited to, the following viral vectors such as lambda vector system gtl 1, gt WES.tB, Charon 4, and plasmid vectors such as pBR322, pBR325, pACYC177, pACYC184, pUC8, pUC9, pUC18, pUC19, pLG339, pR290, pKC37, pKClOl, SV 40, pBluescript II SK +/- or KS +/- (see "Stratagene Cloning Systems" Catalog (1993) from Stratagene, La Jolla, Calif, which is hereby incorporated by reference), pQE, pIH821, pGEX, pET series (see Studier et. al., "Use of T7 RNA Polymerase to Direct Expression of Cloned Genes," Gene Expression Technology, vol. 185 (1990), which is hereby incorporated by reference), and any derivatives thereof. Recombinant molecules can be introduced into cells via transformation, transduction, conjugation, mobilization, or electroporation. The DNA sequences are cloned into the vector using standard cloning procedures in the art, as described by Maniatis et al., Molecular Cloning: A Laboratory Manual, Cold Springs Laboratory, Cold Springs Harbor, New York (1982), which is hereby incorporated by reference.
A variety of host- vector systems may be utilized to express the protein- encoding sequence(s). Primarily, the vector system must be compatible with the host cell used. Host-vector systems include but are not limited to the following: bacteria transformed with bacteriophage DNA, plasmid DNA, or cosmid DNA; microorganisms such as yeast containing yeast vectors; mammalian cell systems infected with virus (e.g., vaccinia virus, adenovirus, etc.); insect cell systems infected with virus (e.g., baculovirus); and plant cells infected by bacteria or transformed via particle bombardment (i.e. biolistics). The expression elements of these vectors vary in their strength and specificities. Depending upon the host-vector system utilized, any one of a number of suitable transcription and translation elements can be used.
Different genetic signals and processing events control many levels of gene expression (e.g., DNA transcription and messenger RNA ("mRNA") translation). Transcription of DNA is dependent upon the presence of a promoter which is a DNA sequence that directs the binding of RNA polymerase and thereby promotes mRNA synthesis. The DNA sequences of eucaryotic promoters differ from those of procaryotic promoters. Furthermore, eucaryotic promoters and accompanying genetic signals may not be recognized in or may not function in a procaryotic system, and, further, procaryotic promoters are not recognized and do not function in eucaryotic cells. Similarly, translation of mRNA in procaryotes depends upon the presence of the proper procaryotic signals which differ from those of eucaryotes. Efficient translation of mRNA in procaryotes requires a ribosome binding site called the Shine - Dalgarno ("SD") sequence on the mRNA. This sequence is a short nucleotide sequence of mRNA that is located before the start codon, usually AUG, which encodes the amino- terminal methionine of the protein. The SD sequences are complementary to the 3 '-end of the 16S rR A (ribosomal RNA) and probably promote binding of mRNA to ribosomes by duplexing with the rRNA to allow correct positioning of the ribosome. For a review on maximizing gene expression, see Roberts and Lauer, Methods in Enzymology, 68:473 (1979), which is hereby incorporated by reference.
Promoters vary in their "strength" (i.e. their ability to promote transcription). For the purposes of expressing a cloned gene, it is desirable to use strong promoters in order to obtain a high level of transcription and, hence, expression of the gene. Depending upon the host cell system utilized, any one of a number of suitable promoters may be used. For instance, when cloning in E. coli, its bacteriophages, or plasmids, promoters such as the T7 phage promoter, lac promoter, trp promoter, recA promoter, ribosomal RNA promoter, the PR and PL promoters of coliphage lambda and others, including but not limited, to /αcUV5, ompF, bla, Ipp, and the like, may be used to direct high levels of transcription of adjacent DNA segments. Additionally, a hybrid trp- /αcUV5 (tac) promoter or other E. coli promoters produced by recombinant DNA or other synthetic DNA techniques may be used to provide for transcription of the inserted gene.
Bacterial host cell strains and expression vectors may be chosen which inhibit the action of the promoter unless specifically induced. In certain operons, the addition of specific inducers is necessary for efficient transcription of the inserted DNA. For example, the lac operon is induced by the addition of lactose or IPTG (isopropylthio- beta-D-galactoside). A variety of other operons, such as trp, pro, etc., are under different controls.
Specific initiation signals are also required for efficient gene transcription and translation in procaryotic cells. These transcription and translation initiation signals may vary in "strength" as measured by the quantity of gene specific messenger RNA and protein synthesized, respectively. The DNA expression vector, which contains a promoter, may also contain any combination of various "strong" transcription and/or translation initiation signals. For instance, efficient translation in E. coli requires a Shine- Dalgarno ("SD") sequence about 7-9 bases 5' to the initiation codon ("ATG") to provide a ribosome binding site. Thus, any SD-ATG combination that can be utilized by host cell ribosomes may be employed. Such combinations include but are not limited to the SD- ATG combination from the cro gene or the N gene of coliphage lambda, or from the E. coli tryptophan Ε, D, C, B or A genes. Additionally, any SD-ATG combination produced by recombinant DΝA or other techniques involving incorporation of synthetic nucleotides may be used.
Once the isolated DΝA molecules encoding the various grapevine leafroll virus (type 2) proteins or polypeptides, as described above, have been cloned into an expression system, they are ready to be incorporated into a host cell. Such incorporation can be carried out by the various forms of transformation noted above, depending upon the vector/host cell system. Suitable host cells include, but are not limited to, bacteria, virus, yeast, mammalian cells, insect, plant, and the like.
The present invention also relates to RΝA molecules which encode the various grapevine leafroll virus (type 2) proteins or polypeptides described above. The transcripts can be synthesized using the host cells of the present invention by any of the conventional techniques. The mRΝA can be translated either in vitro or in vivo. Cell- free systems typically include wheat-germ or reticulocyte extracts. In vivo translation can be effected, for example, by microinjection into frog oocytes.
One aspect of the present invention involves using one or more of the above DΝA molecules encoding the various proteins or polypeptides of a grapevine leafroll virus (type 2) to transform grape plants in order to impart grapevine leafroll resistance to the plants. The mechanism by which resistance is imparted is not known. In one hypothetical mechanism, the transformed plant can express a protein or polypeptide of grapevine leafroll virus (type 2), and, when the transformed plant is inoculated by a grapevine leafroll virus, such as GLRaV-1, GLRaV-2, GLRav-3, GLRaV-4, GLRaV-5, or GLRaV-6, or combinations of these, the expressed protein or polypeptide prevents translation of the viral DNA.
In this aspect of the present invention the subject DNA molecule incorporated in the plant can be constitutively expressed. Alternatively, expression can be regulated by a promoter which is activated by the presence of grapevine leafroll virus. Suitable promoters for these purposes include those from genes expressed in response to grapevine leafroll virus infiltration.
The isolated DNA molecules of the present invention can be utilized to impart grapevine leafroll virus resistance for a wide variety of grapevine plants. The DNA molecules are particularly well suited to imparting resistance to Vitis scion or rootstock cultivars. Scion cultivars which can be protected include those commonly referred to as Table or Raisin Grapes, such as Alden, Almeria, Anab-E-Shahi, Autumn Black, Beauty Seedless, Black Corinth, Black Damascus, Black Malvoisie, Black Prince, Blackrose, Bronx Seedless, Burgrave, Calmeria, Campbell Early, Canner, Cardinal, Catawba, Christmas, Concord, Dattier, Delight, Diamond, Dizmar, Duchess, Early Muscat, Emerald Seedless, Emperor, Exotic, Ferdinand de Lesseps, Fiesta, Flame seedless, Flame Tokay, Gasconade, Gold, Himrod, Hunisa, Hussiene, Isabella, Italia, July Muscat, Khandahar, Katta, Kourgane, Kishmishi, Loose Perlette, Malaga, Monukka, Muscat of Alexandria, Muscat Flame, Muscat Hamburg, New York Muscat, Niabell, Niagara, Olivette blanche, Ontario, Pierce, Queen, Red Malaga, Ribier, Rish Baba, Romulus, Ruby Seedless, Schuyler, Seneca, Suavis (IP 365), Thompson seedless, and Thomuscat. They also include those used in wine production, such as Aleatico, Alicante Bouschet, Aligote, Alvarelhao, Aramon, Baco blanc (22A), Burger, Cabernet franc, Cabernet, Sauvignon, Calzin, Carignane, Charbono, Chardonnay, Chasselas dore, Chenin blanc, Clairette blanche, Early Burgundy, Emerald Riesling, Feher Szagos, Fernao Pires, Flora, French Colombard, Fresia, Furmint, Gamay, Gewurztraminer, Grand noir, Gray Riesling, Green Hungarian, Green Veltliner, Grenache, Grillo, Helena, Inzolia, Lagrein, Lambrusco de Salamino, Malbec, Malvasia bianca, Mataro, Melon, Merlot, Meunier, Mission, Montua de Pilas, Muscadelle du Bordelais, Muscat blanc, Muscat Ottonel, Muscat Saint-Vallier, Nebbiolo, Nebbiolo fino, Nebbiolo Lampia, Orange Muscat, Palomino, Pedro Ximenes, Petit Bouschet, Petite Sirah, Peverella, Pinot noir, Pinot Saint- George, Primitivo di Gioa, Red Veltliner, Refosco, Rkatsiteli, Royalty, Rubired, Ruby Cabernet, Saint-Emilion, Saint Macaire, Salvador, Sangiovese, Sauvignon blanc, Sauvignon gris, Sauvignon vert, Scarlet, Seibel 5279, Seibel 9110, Seibel 13053, Semillon, Servant, Shiraz, Souzao, Sultana Crimson, Sylvaner, Tannat, Teroldico, Tinta Madeira, Tinto cao, Touriga, Traminer, Trebbiano Toscano, Trousseau, Valdepenas, Viognier, Walschriesling, White Riesling, and Zinfandel. Rootstock cultivars which can be protected include Couderc 1202, Couderc 1613, Couderc 1616, Couderc 3309, Dog Ridge, Foex 33 EM, Freedom, Ganzin 1 (A x R #1), Harmony, Kober 5BB, LN33, Millardet & de Grasset 4 IB, Millardet & de Grasset 420A, Millardet & de Grasset 101- 14, Oppenheim 4 (S04), Paulsen 775, Paulsen 1045, Paulsen 1103, Richter 99, Richter 1 10, Riparia Gloire, Ruggeri 225, Saint-George, Salt Creek, Teleki 5A, Vitis rupestris Constantia, Vitis California, and Vitis girdiana.
There exists an extensive similarity in the hsp70-related sequence regions of GLRaV-2 and other closteroviruses, such as tristeza virus and beet yellows virus. Consequently, the GLRaV-2 hsp70-related gene can also be used to produce transgenic plants or cultivars other than grape, such as citrus or sugar beet, which are resistant to closteroviruses other than grapevine leafroll, such as tristeza virus and beet yellows virus. Suitable citrus cultivars include lemon, lime, orange, grapefruit, pineapple, tangerine, and the like, such as Joppa, Maltaise Ovale, Parson (Parson Brown), Pera, Pineapple, Queen, Shamouti, Valencia, Tenerife, Imperial Doblefina, Washington Sanguine, Moro, Sanguinello Moscato, Spanish Sanguinelli, Tarocco, Atwood, Australian, Bahia, Baiana, Cram, Dalmau, Eddy, Fisher, Frost Washington, Gillette, LengNavelina, Washington, Satsuma Mandarin, Dancy, Robinson, Ponkan, Duncan, Marsh, Pink Marsh, Ruby Red, Red Seedless, Smooth Seville, Orlando Tangelo, Eureka, Lisbon, Meyer Lemon, Rough Lemon, Sour Orange, Persian Lime, West Indian Lime, Bearss, Sweet Lime, Troyer Citrange, and Citrus Trifoliata. Each of these citrus cultivars is suitable for producing transgenic citrus plants resistant to tristeza virus.
The economically important species of sugar beet is Beta vulgaris L. , which has four important cultivar types: sugar beet, table beet, fodder beet, and Swiss chard. Each of these beet cultivars is suitable for producing transgenic beet plants resistant to beet yellows virus, as described above. Because GLRaV-2 has been known to infect tobacco plants (e.g.,
Nicotiana benthamiana), it is also desirable to produce transgenic tobacco plants which are resistant to grapevine leafroll viruses, such as GLRaV-2. Plant tissue suitable for transformation include leaf tissue, root tissue, meristems, zygotic and somatic embryos, and anthers. It is particularly preferred to utilize embryos obtained from anther cultures.
The expression system of the present invention can be used to transform virtually any plant tissue under suitable conditions. Tissue cells transformed in accordance with the present invention can be grown in vitro in a suitable medium to impart grapevine leafroll virus resistance. Transformed cells can be regenerated into whole plants such that the protein or polypeptide imparts resistance to grapevine leafroll virus in the intact transgenic plants. In either case, the plant cells transformed with the recombinant DNA expression system of the present invention are grown and caused to express that DNA molecule to produce one of the above-described grapevine leafroll virus proteins or polypeptides and, thus, to impart grapevine leafroll virus resistance.
In producing transgenic plants, the DNA construct in a vector described above can be microinjected directly into plant cells by use of micropipettes to transfer mechanically the recombinant DNA. Crossway, Mol. Gen. Genetics. 202:179-85 (1985), which is hereby incorporated by reference. The genetic material may also be transferred into the plant cell using polyethylene glycol. Krens, et al., Nature, 296:72-74 (1982), which is hereby incorporated by reference.
One technique of transforming plants with the DNA molecules in accordance with the present invention is by contacting the tissue of such plants with an inoculum of a bacteria transformed with a vector comprising a gene in accordance with the present invention which imparts grapevine leafroll resistance. Generally, this procedure involves inoculating the plant tissue with a suspension of bacteria and incubating the tissue for 48 to 72 hours on regeneration medium without antibiotics at 25- 28°C.
Bacteria from the genus Agrobacterium can be utilized to transform plant cells. Suitable species of such bacterium include Agrobacterium tumefaciens and Agrobacterium rhizogenes. Agrobacterium tumefaciens (e.g., strains C58, LBA4404, or EHA105) is particularly useful due to its well-known ability to transform plants. Heterologous genetic sequences can be introduced into appropriate plant cells, by means of the Ti plasmid of A. tumefaciens or the Ri plasmid of A. rhizogenes. The Ti or Ri plasmid is transmitted to plant cells on infection by Agrobacterium and is stably integrated into the plant genome. J. Schell, Science, 237:1176-83 (1987), which is hereby incorporated by reference. After transformation, the transformed plant cells must be regenerated. Plant regeneration from cultured protoplasts is described in Evans et al., Handbook of Plant Cell Cultures, Vol. 1 : (MacMillan Publishing Co., New York, 1983); and Vasil I.R. (ed.), Cell Culture and Somatic Cell Genetics of Plants, Acad. Press, Orlando, Vol. I, 1984, and Vol. Ill (1986), which are hereby incorporated by reference.
It is known that practically all plants can be regenerated from cultured cells or tissues, including but not limited to, all major species of sugarcane, sugar beets, cotton, fruit trees, and legumes.
Means for regeneration vary from species to species of plants, but generally a suspension of transformed protoplasts or a petri plate containing explants is first provided. Callus tissue is formed and shoots may be induced from callus and subsequently rooted. Alternatively, embryo formation can be induced in the callus tissue. These embryos germinate as natural embryos to form plants. The culture media will generally contain various amino acids and hormones, such as auxin and cytokinins. It is also advantageous to add glutamic acid and proiine to the medium. Efficient regeneration will depend on the medium, on the genotype, and on the history of the culture. If these three variables are controlled, then regeneration is usually reproducible and repeatable.
After the expression cassette is stably incorporated in transgenic plants, it can be transferred to other plants by sexual crossing. Any of a number of standard breeding techniques can be used, depending upon the species to be crossed.
Once transgenic plants of this type are produced, the plants themselves can be cultivated in accordance with conventional procedure so that the DNA construct is present in the resulting plants. Alternatively, transgenic seeds are recovered from the transgenic plants. These seeds can then be planted in the soil and cultivated using conventional procedures to produce transgenic plants.
Another approach to transforming plant cells with a gene which imparts resistance to pathogens is particle bombardment (also known as biolistic transformation) of the host cell. This can be accomplished in one of several ways. The first involves propelling inert or biologically active particles at cells. This technique is disclosed in U.S. Patent Nos. 4,945,050, 5,036,006, and 5,100,792, all to Sanford et al., and in Emerschad et al., "Somatic Embryogenesis and Plant Development from Immature Zygotic Embryos of Seedless Grapes (Vitis vinifera)0 Plant Cell Reports, 14:6-12 (1995) ("Emerschad (1995)"), which are hereby incoφorated by reference. Generally, this procedure involves propelling inert or biologically active particles at the cells under conditions effective to penetrate the outer surface of the cell and to be incorporated within the interior thereof. When inert particles are utilized, the vector can be introduced into the cell by coating the particles with the vector containing the heterologous DNA. Alternatively, the target cell can be surrounded by the vector so that the vector is carried into the cell by the wake of the particle. Biologically active particles (e.g., dried bacterial cells containing the vector and heterologous DNA) can also be propelled into plant cells. Once a grape plant tissue, citrus plant tissue, beet plant tissue, or tobacco plant tissue is transformed in accordance with the present invention, the transformed tissue is regenerated to form a transgenic plant. Generally, regeneration is accomplished by culturing transformed tissue on medium containing the appropriate growth regulators and nutrients to allow for the initiation of shoot meristems. Appropriate antibiotics are added to the regeneration medium to inhibit the growth of Agrobacterium and to select for the development of transformed cells. Following shoot initiation, shoots are allowed to develop tissue culture and are screened for marker gene activity. The DNA molecules of the present invention can be made capable of transcription to a messenger RNA, which, although encoding for a grapevine leafroll virus (type 2) protein or polypeptide, does not translate to the protein. This is known as RNA-mediated resistance. When a Vitis scion or rootstock cultivar, or a citrus, beet, or tobacco cultivar, is transformed with such a DNA molecule, the DNA molecule can be transcribed under conditions effective to maintain the messenger RNA in the plant cell at low level density readings. Density readings of between 15 and 50 using a Hewlet ScanJet and Image Analysis Program are preferred.
A portion of one or more DNA molecules of the present invention as well as other DNA molecules can be used in a transgenic grape plant, citrus plant, beet plant, or tobacco plant in accordance with U.S. Patent Application Serial No. 09/025,635, which is hereby incorporated herein by reference.
The grapevine leafroll virus (type 2) protein or polypeptide of the present invention can also be used to raise antibodies or binding portions thereof or probes. The antibodies can be monoclonal or polyclonal. Monoclonal antibody production may be effected by techniques which are well-known in the art. Basically, the process involves first obtaining immune cells (lymphocytes) from the spleen of a mammal (e.g., mouse) which has been previously immunized with the antigen of interest either in vivo or in vitro. The antibody-secreting lymphocytes are then fused with (mouse) myeloma cells or transformed cells, which are capable of replicating indefinitely in cell culture, thereby producing an immortal, immunoglobulin-secreting cell line. The resulting fused cells, or hybridomas, are cultured, and the resulting colonies screened for the production of the desired monoclonal antibodies. Colonies producing such antibodies are cloned, and grown either in vivo or in vitro to produce large quantities of antibody. A description of the theoretical basis and practical methodology of fusing such cells is set forth in Kohler and Milstein, Nature, 256:495 (1975), which is hereby incorporated by reference.
Mammalian lymphocytes are immunized by in vivo immunization of the animal (e.g., a mouse) with the protein or polypeptide of the present invention. Such immunizations are repeated as necessary at intervals of up to several weeks to obtain a sufficient titer of antibodies. Following the last antigen boost, the animals are sacrificed and spleen cells removed.
Fusion with mammalian myeloma cells or other fusion partners capable of replicating indefinitely in cell culture is effected by standard and well-known techniques, for example, by using polyethylene glycol ("PEG") or other fusing agents. (See Milstein and Kohler, Eur. J. Immunol., 6:511 (1976), which is hereby incorporated by reference.) This immortal cell line, which is preferably murine, but may also be derived from cells of other mammalian species, including but not limited to rats and humans, is selected to be deficient in enzymes necessary for the utilization of certain nutrients, to be capable of rapid growth, and to have good fusion capability. Many such cell lines are known to those skilled in the art, and others are regularly described.
Procedures for raising polyclonal antibodies are also well known. Typically, such antibodies can be raised by administering the protein or polypeptide of the present invention subcutaneously to New Zealand white rabbits which have first been bled to obtain pre-immune serum. The antigens can be injected at a total volume of 100 μl per site at six different sites. Each injected material will contain synthetic surfactant adjuvant pluronic polyols, or pulverized acrylamide gel containing the protein or polypeptide after SDS-polyacrylamide gel electrophoresis. The rabbits are then bled two weeks after the first injection and periodically boosted with the same antigen three times every six weeks. A sample of serum is then collected 10 days after each boost.
Polyclonal antibodies are then recovered from the serum by affinity chromatography using the corresponding antigen to capture the antibody. Ultimately, the rabbits are euthenized with pentobarbital 150 mg/Kg IV. This and other procedures for raising polyclonal antibodies are disclosed in Harlow et. al., editors, Antibodies: A Laboratory Manual (1988), which is hereby incoφorated by reference.
In addition to utilizing whole antibodies, binding portions of such antibodies can be used. Such binding portions include Fab fragments, F(ab')2 fragments, and Fv fragments. These antibody fragments can be made by conventional procedures, such as proteolytic fragmentation procedures, as described in Goding, Monoclonal Antibodies: Principles and Practice, New York:Academic Press, pp. 98-118 (1983), which is hereby incoφorated by reference.
The present invention also relates to probes found either in nature or prepared synthetically by recombinant DNA procedures or other biological procedures. Suitable probes are molecules which bind to grapevine leafroll (type 2) viral antigens identified by the monoclonal antibodies of the present invention. Such probes can be, for example, proteins, peptides, lectins, or nucleic acid probes.
The antibodies or binding portions thereof or probes can be administered to grapevine leafroll virus infected scion cultivars or rootstock cultivars. Alternatively, at least the binding portions of these antibodies can be sequenced, and the encoding DNA synthesized. The encoding DNA molecule can be used to transform plants together with a promoter which causes expression of the encoded antibody when the plant is infected by grapevine leafroll virus. In either case, the antibody or binding portion thereof or probe will bind to the virus and help prevent the usual leafroll response.
Antibodies raised against the GLRaV-2 proteins or polypeptides of the present invention or binding portions of these antibodies can be utilized in a method for detection of grapevine leafroll virus in a sample of tissue, such as tissue (e.g., scion or rootstock) from a grape plant or tobacco plant. Antibodies or binding portions thereof suitable for use in the detection method include those raised against a helicase, a methyltransferase, a papain-like protease, an RNA-dependent RNA polymerase, a heat shock 70 protein, a heat shock 90 protein, a coat protein, a diverged coat protein, or other proteins or polypeptides in accordance with the present invention. Any reaction of the sample with the antibody is detected using an assay system which indicates the presence of grapevine leafroll virus in the sample. A variety of assay systems can be employed, such as enzyme-linked immunosorbent assays, radioimmunoassays, gel diffusion precipitin reaction assays, immunodiffusion assays, agglutination assays, fluorescent immunoassays, protein A immunoassays, or immunoelectrophoresis assays. Alternatively, grapevine leafroll virus can be detected in such a sample using a nucleotide sequence of the DNA molecule, or a fragment thereof, encoding for a protein or polypeptide of the present invention. The nucleotide sequence is provided as a probe in a nucleic acid hybridization assay or a gene amplification detection procedure (e.g., using a polymerase chain reaction procedure). The nucleic acid probes of the present invention may be used in any nucleic acid hybridization assay system known in the art, including, but not limited to, Southern blots (Southern, E.M., "Detection of Specific Sequences Among DNA Fragments Separated by Gel Electrophoresis," J. Mol. Biol, 98:503-17 (1975), which is hereby incoφorated by reference), Northern blots (Thomas, P.S., "Hybridization of Denatured RNA and Small DNA Fragments Transferred to Nitrocellulose," Proc. Nat'l Acad. Sci. USA, 77:5201-05 (1980), which is hereby incoφorated by reference), and Colony blots (Grunstein, M., et al., "Colony Hybridization: A Method for the Isolation of Cloned cDNAs that Contain a Specific Gene," Proc. Nat'l Acad. Sci. USA. 72:3961-65 (1975), which is hereby incoφorated by reference). Alternatively, the probes can be used in a gene amplification detection procedure (e.g., a polymerase chain reaction). Erlich, H.A., et. al.,
"Recent Advances in the Polymerase Chain Reaction," Science 252:1643-51 (1991), which is hereby incorporated by reference. Any reaction with the probe is detected so that the presence of a grapevine leafroll virus in the sample is indicated. Such detection is facilitated by providing the probe of the present invention with a label. Suitable labels include a radioactive compound, a fluorescent compound, a chemiluminescent compound, an enzymatic compound, or other equivalent nucleic acid labels.
Depending upon the desired scope of detection, it is possible to utilize probes having nucleotide sequences that correspond with conserved or variable regions of the ORF or UTR. For example, to distinguish a grapevine leafroll virus from other related viruses (e.g., other closteroviruses), it is desirable to use probes which contain nucleotide sequences that correspond to sequences more highly conserved among all grapevine leafroll viruses. Also, to distinguish between different grapevine leafroll viruses (i.e., GLRaV-2 from GLRaV-1 , GLRaV-3, GLRaV-4, GLRaV-5, and GLRaV-6), it is desirable to utilize probes containing nucleotide sequences that correspond to sequences less highly conserved among the different grapevine leafroll viruses.
Nucleic acid (DNA or RNA) probes of the present invention will hybridize to complementary GLRaV -2 nucleic acid under stringent conditions. Generally, stringent conditions are selected to be about 50°C lower than the thermal melting point (Tm) for the specific sequence at a defined ionic strength and pH. The Tm is the temperature (under defined ionic strength and pH) at which 50%> of the target sequence hybridizes to a perfectly matched probe. The Tm is dependent upon the solution conditions and the base composition of the probe, and may be calculated using the following equation: Tm = 79.8°C + (18.5 x Log[Na+]) + (58.4°C x %[G+C])
(820 / #bp in duplex) (0.5 x % formamide) Nonspecific binding may also be controlled using any one of a number of known techniques such as, for example, blocking the membrane with protein-containing solutions, addition of heterologous RNA, DNA, and SDS to the hybridization buffer, and treatment with RNase.
Wash conditions are typically performed at or below stringency. Generally, suitable stringent conditions for nucleic acid hybridization assays or gene amplification detection procedures are asas set forth above. More or less stringent conditions may also be selected.
EXAMPLES
The following examples are provided to illustrate embodiments of the present invention but are by no means intended to limit its scope.
Example 1 - Northern Hybridization
Specificity of the selected clones was confirmed by Northern hybridization. Northern hybridization was performed after electrophoresis of the dsRNA of GLRaV-2 in 1% agarose non-denaturing condition gel. The agarose gel was denatured by soaking in 50 mM NaOH containing 0.4 M NaCl for 30 min, and then neutralized with 0.1 M Tris-HCl (PH7.5 ) containing 0.5 M NaCl for another 30 min. RNA was sandwich blotted overnight onto Genescreen™ plus membrane (Dupont NEN Research Product) in 10 X SSC buffer and hybridized as described by the manufacturer's instructions (DuPont, NEN).
Example 2 - Sequencing and Computer Assisted Nucleotide and Amino Acid Sequence Analysis
DNA inserts were sequenced in pBluescript SK+ by using T3 and T7 universal primers for the terminal region sequence and additional oligonucleotide primers designed according to the known sequence for the internal region sequence. Purification of plasmid DNA was performed by a modified mini alkaline-lysis/PEG precipitation procedure described by the manufacturer (Applied Biosystems, Inc.). Nucleotide sequencing was performed on both strands of cDNA by using ABI TaqDyeDeoxy Terminator Cycle Sequencing Kit (Applied Biosystems, Inc.). Automatic sequencing was performed on an ABI373 Automated Sequencer (Applied Biosynstems, Inc.) at Cornell University, Geneva, NY.
The nucleotide sequences of GLRaV-2 were assembled and analyzed with the programs of EditSeq and SeqMan, respectively, of DNASTAR package (Madison, Wl). Amino acid sequences deduced from nucleotide sequences and its encoding open reading frames were conducted using the MapDraw program. Multiple alignments of amino acid sequences, identification of consensus amino acid sequences, and generation of phylogenetic trees were performed using the Clustal method in the MegAlign program. The nucleotide and amino acid sequences of other closteroviruses were obtained with the Entrez Program; and sequence comparisons with nonredundant databases were searched with the Blast Program from the National Center for Biotechnology Information.
Example 3 - Isolation of dsRNA
Several vines of GLRaV-2 infected Vitis vinifera cv Pinot Noir that originated from a central New York vineyard served as the source for dsRNA isolation and cDNA cloning. dsRNA was extracted from phloem tissue of infected grapevines according to the method described by Hu et al., "Characterization of Closterovirus-Like Particles Associated with Grapevine Leafroll Disease," J. Phytopathology 128: 1-14 (1990), which is hereby incorporated by reference. Purification of the high molecular weight dsRNA (ca 15 kb) was carried out by electrophoretic separation of the total dsRNA on a 0.7%) low melting point agarose gel and extraction by phenol/chloroform following the method described by Sambrook et al., Molecular Cloning: A Laboratory Manual. 2nd ed., Cold Sping Harbor Laboratory Press, New York (1989) , which is hereby incorporated by reference. Concentration of dsRNA was estimated with UV fluorescent density of an ethidium bromide stained dsRNA band in comparison with a known concentration of DNA marker. Example 4 - cDNA Synthesis and Cloning
cDNA synthesis was performed following the method initially described by Jelkmann et al., "Cloning of Four Plant Viruses From Small Quantities of Double- Stranded RNA," Phytopathology 79:1250-53 (1989) and modified by Ling et al., "The Coat Protein Gene of Grapevine Leafroll Associated Clostero virus-3 : Cloning, Nucleotide Sequencing and Expression in Transgenic Plants," Arch. Virology 142: 1 101-16 (1997), both of which are hereby incorporated by reference. About 100 ng of high molecular weight dsRNA purified from low melting agarose gel was denatured in 20 mM methylmercuric hydroxide and incubated at room temperature for 10 min with 350 ng of random primers. First strand cDNA was synthesized by using avian myeloblastosis virus (AMV) reverse transcriptase. Second strand cDNA was obtained by using RNase H and E.coli DNA polymerase I. Double- stranded cDNA was blunt ended with T4 DNA polymerase and ligated with EcoR I adapters. The cDNA, which had EcoR I adapters at the ends, was activated by kinase reaction and ligated into Lambda ZAP II/EcoR I prepared arms following the manufacturer's instruction (Stratagene). The recombinant DNA was then packaged in vitro to Gigapack* II packaging extract (Stratagene). The packaged phage particles were amplified and titered according to the manufacturer's instruction.
Two kinds of probes were used to identify GLRaV-2 specific clones from the library. One type was prepared from the synthesized cDNA that was amplified by PCR after ligation to the specific EcoR I Uni-Amp™ adapters (Clontech); and the other type was DNA inserts or PCR products from already sequenced clones. Clones from the cDNA library were selected by colony-lifting hybridization onto the colony/plaque Screen membrane (NEN Research Product) with the probe described above. The probe was prepared by labeling with P [α-dATP] using Klenow fragment of E.coli DNA polymerase I. Prehybridization, hybridization, and washing steps were carried out at 65 °C according to the manufacturer's instruction (Dupont, NEN Research Product). Selected plaques were converted to recombinant pBluescript by in vivo excision method according to the manufacturer's instruction (Stratagene). To obtain clones representing the extreme 3 '-terminus of GLRaV-2, dsRNA was polyadenylated by yeast poly(A) polymerase. Using poly(A)-tailed dsRNA as template, cDNA was amplified by RT-PCR with oligo(dT)18 and a specific primer, CP-1/T7R, which is derived from the clone CP-1 and has a nucleotide sequence according to SEQ. ID. No. 20 as follows:
TGCTGGAGCT TGAGGTTCTG C 21
The resulting PCR product (3' -PCR) was cloned into a TA vector (Invitrogen) and sequenced.
As shown in Figure 1A, a high molecular weight dsRNA of ca. 15 kb was consistently identified from GLRaV-2 infected grapevines, but not from healthy vines. In addition, several low molecular weight dsRNAs were also detected from infected tissue.
The yield of dsRNA of GLRaV-2 was estimated between 5-10 ng/15 g phloem tissue, which was much lower than that of GLRaV-3 (Hu et al., "Characterization of Closterovirus-Like Particles Associated with Grapevine Leafroll Disease," J. Phytopathology 128: 1-14 (1990), which is hereby incoφorated by reference). Only the high molecular weight dsRNA that was purified from low melting point agarose gel was used for cDNA synthesis, cloning and establishment of the Lambda/ZAP II cDNA library.
Two kinds of probes were used for screening the cDNA library. The initial clones were identified by hybridization with Uni-Amp™ PCR- amplified cDNA as probes. The specificity of these clones (e.g., TC-1) ranging from 200 to 1,800 bp in size was confirmed by Northern hybridization to dsRNA of GLRaV-2 as shown in Figure IB.
Additionally, over 40 different clones ranging form 800 to 7,500 bp in size were identified following hybridization with the probes generated from GLRaV-2 specific cDNA clones or from PCR products. Over 40 clones were then sequenced on the both strands (Figure 2).
Example 5 - Expression of the Coat Protein in E. coli and Immunoblotting
To determine that ORF6 was the coat protein gene of GLRaV-2, the complete ORF6 DNA molecule was subcloned from a PCR product and inserted into the fusion protein expression vector pMAL-C2 (New England Biolabs, Inc.). The specific primers used for the PCR reaction were CP-96F and CP-96R, in which an EcoR I or BamH I site was included to facilitate cloning. CP-96F was designed to include the start codon of the CP and comprises a nucleotide sequence according to SEQ. ID. NO. 21 as follows:
CGGAATTCAC CATGGAGTTG ATGTCCGACA G 31 CP-96R was 66 nucleotides downstream of the stop codon of the CP and comprises the nucleotide sequence corresponding to SEQ. ID. No. 22 as follows:
AGCGGATCCA TGGCAGATTC GTGCGTAGCA GTA 33
The coat protein was expressed as a fusion protein with maltose binding protein (MBP) of E. coli under the control of a "tac" promoter and suppressed by the "lac" repressor. The MBP- CP fusion protein was induced by adding 0.3 mM isopropyl-β-D-thio-gloactopyranoside (IPTG) and purified by a one step affinity column according to the manufacturer's instruction (New England, Biolabs, Inc ). The MBP-CP fusion protein or the coat protein cleaved from the fusion protein was tested to react with specific antiserum of GLRaV-2 (kindly provided by Dr. Charles Greif of INRA, Colmar, France) on Western blot according to the method described by Hu et al., "Characterization of Closterovirus-Like Particles Associated with Grapevine Leafroll Disease," J. Phytopathology 128:1-14 (1990), which is hereby incoφorated by reference. In contrast, the non-recombinant plasmids or uninduced cells did not react to the antiserum of GLRaV -2.
Example 6 - Sequence Analysis and Genome Organization of GLRaV-2
A total of 15,500 bp of the RNA genome of GLRaV-2 was sequenced and deposited in GenBank (accession number AF039204). About 85%> of the total RNA genome was revealed from at least two different clones. The sequence in the coat protein gene region was determined and confirmed from several different overlapping clones. The genome organization of GLRaV-2, shown in Figure 2, includes nine open reading frames (e.g., ORFla, lb-8).
ORFla and ORFlb: Analysis of the amino acid sequence of the N-terminal portion of GLRaV-2 ORFla encoded product revealed two putative papain-like protease domains, which showed significant similarity to the papain-like leader protease of BYV (Agranovsky et al., "Beet Yellows Closterovirus: Complete Genome Structure and Identification of a Papain-like Thiol Protease," Virology 198:311-24 (1994), which is hereby incorporated by reference). Thus, it allowed prediction of the catalytic cysteine and histidine residues for the putative GLRaV-2 protease. Upon alignment of the sequence of the papain- like protease of BYV with that of GLRaV-2, the cleavage site at residues Gly-Gly (amino acid 588-589) of BYV aligned with the corresponding alanine-glycine (Ala-Gly) and Gly-Gly dipeptide of GLRaV -2 (Figure 3 A). Cleavage at this site would result in a leader protein and a 234 kDa (2090 amino acid) C-terminal fragment consisting of MT and HEL domains. However, the region upstream of the papain-like protease domain in GLRaV-2 did not show similarity to the corresponding region of BYV. In addition, variability in the residues located at the scissible bond (Gly in the BYV and Ala in the GLRaV-2) was present. Similar variability of the cleavage site residue in the P-PRO domain has been described in LChV (Jelkmann et al., "Complete Genome Structure and Phylogenetic Analysis of Little Cherry Virus, a Mealybug-Transmissible Closterovirus. J. General Virology 78:2067-71 (1997), which is hereby incoφorated by reference).
Database searching with the deduced amino acid sequence of the ORF la/lb encoded protein revealed a significant similarity to the MT, HEL and RdRP domains of the other closteroviruses. The region downstream of the P-PRO cleavage site showed a significant similarity (57.4%> identity in a 266-residues alignment) to the putative methyltransferase domain of BYV and contained all the conserved motifs typical of positive- strand RNA viral type I MTs (Figure 3B). The C-terminal portion of the ORFla was identified as a helicase domain, the sequence of which showed a high similarity (57.1 % identity in a 315-residues alignment) to the helicase domain of BYV and contained the seven conserved motifs characteristic of the Superfamily I helicase of positive-strand RNA viruses (Figure 3C) (Hodgman, "A New Superfamily of Replicative Proteins," Nature 333:22-23 (1988); Koonin and Dolja, "Evolution and Taxonomy of Positive-strand RNA Viruses: Implications of Comparative Analysis of Amino Acid Sequences," Crit. Rev, in Biochem. and Mol. Biol. 28:375-430 (1993), both of which are hereby incoφorated by reference). ORF lb encoded a 460 amino acid polypeptide with a molecular mass of 52,486 Da, counting from the frameshifting site. Database searching with the RdRP showed a significant similarity to the RdRP domains of positive strand RNA viruses. Comparison of the RdRP domains of GLRaV-2 and BYV showed the presence of the eight conserved motifs of RdRP (Figure 3D).
As shown in Figure 8, a tentative phylogenetic tree of the RdRP of GLRaV-2 with respect to other closteroviruses shows that it is closely related to the monopartite closteroviruses BYV, BYSV, and CTV. In closteroviruses, a +1 ribosomal frameshift mechanism has been suggested to be involved in the expression of ORF lb as a large fusion protein with ORFla (Agranovsky et al., "Beet Yellows Closterovirus: Complete Genome Structure and Identification of a Papain-like Thiol Protease," Virology 198:311-24 (1994); Karasev et al., "Complete Sequence of the Citrus Tristeza Virus RNA Genome," Virology 208:511-20 (1995); Klaassen et al., "Genome Structure and Phylogenetic Analysis of Lettuce Infectious Yellows Virus, a Whitefly-Transmitted, Bipartite Closterovirus," Virology 208:99-110 (1995); Karasev et al., "Organization of the 3'-Terminal Half of Beet Yellow Stunt Virus Genome and Implications for the Evolution of Closteroviruses." Virology 221 : 199-207 (1996); Jelkmann et al., "Complete Genome Structure and Phylogenetic Analysis of Little Cherry Virus, a Mealybug- Transmissible Closterovirus," J. General Virology 78:2067-71 (1997), all of which are hereby incorporated by reference). In the overlapping ORF la lb region of BYV, the slippery sequence of GGGUUUA and two hairpins structure (stem-loop and pseudoknot) are believed to result in a +1 frameshift (Agranovsky et al., "Beet Yellows Closterovirus: Complete Genome Structure and Identification of a Papain-like Thiol Protease," Virology 198:311-24 (1994), which is hereby incorporated by reference). None of these features are conserved in CTV and BYSV (Karasev et al., "Complete Sequence of the Citrus Tristeza Virus RNA Genome," Virology 208:511-20 (1995); Karasev et al., "Organization of the 3'-Terminal Half of Beet Yellow Stunt Virus Genome and Implications for the Evolution of Closteroviruses," Virology 221 : 199-207 (1996), both of which are hereby incorporated by reference), in which a ribosomal pausing at a terminator or at a rare codon was suggested to perform the same function. Comparisons of the nucleotide sequence of the C-terminal region of the helicase and the N-terminal region of RdRP of GLRaV-2 with the same region of other closteroviruses revealed a significant similarity to BYV, BYSV, and CTV. As shown in Figure 4, the terminator UAG at the end of C'-terminal helicase of GLRaV-2 aligned with the terminator UAG of BYV and BYSV, and arginine CGG codon of CTV.
ORF2 encodes a small protein consisting of 171 bp (57 amino acid) with a molecular mass of 6,297 Da. As predicted, the deduced amino acid sequence includes a stretch of nonpolar amino acids, which is presumed to form a transmembrane helix. A small hydrophobic analogous protein is also present in BYV, BYSV, CTV, LIYV, and LChV (Agranovsky et al. "Nucleotide Sequence of the 3'-Terminal Half of Beet Yellows Closterovirus RNA Genome Unique Arrangement of Eight Virus Genes," J. General Virology 72:15-24 (1991); Karasev et al., "Organization of the 3'-Terminal Half of Beet Yellow Stunt Virus Genome and Implications for the Evolution of Closteroviruses," Virology 221 : 199-207 (1996); Pappu et al., "Nucleotide Sequence and Organization of Eight 3' Open Reading Frames of the Citrus Tristeza Closterovirus Genome," Virology 199:35-46 (1994); Klaassen et al., "Partial Characterization of the Lettuce Infectious Yellows Virus Genomic RNAs, Identification of the Coat Protein Gene and Comparison of its Amino Acid Sequence With Those of Other Filamentous RNA Plant Viruses," J. General Virology 75:1525-33 (1994); Jelkmann et al., "Complete Genome Structure and Phylogenetic Analysis of Little Cherry Virus, a Mealybug-Transmissible Closterovirus," J. General Virology 78:2067-71 (1997), all of which are hereby incoφorated by reference).
ORF3 encodes a 600 amino acid polypeptide with a molecular mass of 65,111 Da, which is homologous to the HSP70 cellular heat shock protein. HSP70 is highly conserved among closteroviruses and is probably involved in ATPase activity and the protein to protein interaction for chaperone activity (Agranovsky et al. "The Beet Yellows Closterovirus p65 Homologue of HSP70 Chaperones has ATPase Activity Associated with its Conserved N-terminal Domain but Interact with Unfolded Protein Chains," J. General Virology 78:535-42 (1997); Agranovsky et al., "Bacterial Expression and Some Properties of the p65, a Homologue of Cell Heat Shock Protein HSP70 Encoded in RNA Genome of Beet Yellows Closterovirus," Doklady Akademii Nauk. 340:416-18 (1995); Karasev et al., "HSP70-Related 65-kDa Protein of Beet Yellows Closterovirus is a Micro tubule-Binding Protein," FEBS Letters 304:12-14 (1992), all of which are hereby incorporated by reference). As shown in Figure 5, alignment of the complete ORF3 of GLRaV-2 with HSP70 homolog of BYV revealed the presence of the eight conserved motifs. The percentage similarity of the HSP70 between GLRaV-2 and that of BYV, BYSV, CTV, LIYV, and LChV is 47.8%, 47.2%, 38.6%, 20.9%, and 17.7%, respectively.
ORF4 encodes a 551 amino acid protein with a molecular mass of 63,349 Da. Database searching with the ORF4 protein product did not identify similar proteins except those of its counterparts in closteroviruses, BYV (P64), BYSV (P61), CTV (P61), LIYV (P59), and LChV (P61) . This protein is believed to be a putative heat shock 90 protein. As shown in Figure 9, two conserved motifs which were present in BYV (Agranovsky et al. "Nucleotide Sequence of the 3 '-Terminal Half of Beet Yellows Closterovirus RNA Genome Unique Arrangement of Eight Virus Genes," J. General Virology 72:15-24 (1991), which is hereby incoφorated by reference) and CTV (Pappu et al, "Nucleotide Sequence and Organization of Eight 3' Open Reading Frames of the Citrus Tristeza Closterovirus Genome," Virology 199:35-46 (1994), which is hereby incoφorated by reference) were also identified in the ORF4 of GLRaV-2. ORF5 and ORF6 encode polypeptides with molecular mass of 24,803 Da and
21,661 Da, respectively. The start codon for both ORFs is in a favorable context for translation. ORF6 was identified as the coat protein gene of GLRaV-2 based on the sequence comparison with other closteroviruses. The calculated molecular mass of the protein product of ORF 6 (21,662 Da) is in good agreement with the previously estimated 22-26 kDa based on SDS-PAGE (Zimmermann et al., "Characterization and Serological Detection of Four Closterovirus-like Particles Associated with Leafroll Disease on Grapevine," Phytopathology 130:205-18 (1990); Boscia et al., "Nomenclature of Grapevine Leafroll- Associated Putative Closteroviruses," Vitis 34:171-75 (1995), both of which are hereby incorporated by reference).
Database searching with the deduced amino acid sequence of the ORF6 of GLRaV-2 showed a similarity with the coat proteins of closteroviruses, BYV, BYSV, CTV, LIYV, LChV, and GLRaV-3. At the nucleotide level, the highest percentage similarity was with the coat protein of BYSV (34.8%); at the amino acid level, the highest percentage similarity was with the coat proteins of BYV (32.7%) and BYSV (32.7%o). As shown in Figure 6 A, alignment of the amino acid sequence of the coat protein and coat protein duplicate of GLRaV-2 with respect to other closteroviruses revealed that the invariant amino acid residues ( N. R. G. D.) were present in both ORF5 and ORF6 of GLRaV-2. Two of these amino acid residues (R and D) are believed to be involved in stabilization of molecules by salt bridge formation and proper folding in the most conserved core region of coat proteins of all filamentous plant viruses (Dolja et al., "Phylogeny of Capsid Proteins of Rod-Shaped and Filamentous RNA Plant Viruses Two Families With Distinct Patterns of Sequence and Probably Structure Conservation," Virology 184:79-86 (1991), which is hereby incoφorated by reference). Identification of ORF6 as the coat protein gene was further confirmed by
Western blot following expression of a fusion protein, consisting of a 22 kDa of ORF6 CP and a 42 kDa of maltose binding protein, produced by transformed E. coli as described in Example 5 supra. As shown in Figure 6B, the putative phylogenetic tree of the coat protein and coat protein duplicate of GLRaV-2 with those of other closteroviruses showed that GLRaV-2 is more closely related to aphid transmissible closteroviruses (BYV, BYSV, and CTV) (Candresse, "Closteroviruses and Clostero-like Elongated Plant Viruses," in Encyclopedia of Virology, pp. 242-48, Webster and Granoff, eds., Academic Press, New York (1994), which is hereby incoφorated by reference) than to whitefly (LIYV) or mealybug transmissible closteroviruses (LChV and GLRaV-3) (Raine et al., "Transmission of the Agent Causing Little Cherry Disease by the Apple Mealybug Phenacoccus aceris and the Dodder Cuscuta Lupuliformis," Canadian J. Plant Pathology 8:6-11 (1986); Jelkmann et al., "Complete Genome Structure and Phylogenetic Analysis of Little Cherry Virus, a Mealybug-Transmissible Closterovirus," J. General Virology 78:2067-71 (1997); Rosciglione and Gugerli, "Transmission of Grapevine Leafroll Disease and an Associated Closterovirus to Healthy Grapevine by the Mealybug Planococcus ficus," Phvtoparasitica 17:63 (1989); Engelbrecht and Kasdorf, "Transmission of Grapevine Leafroll Disease and Associated Closteroviruses by the Vine Mealybug planococcus-ficus," Phytophlactica, 22:341-46 (1990); Cabaleiro and Segura, 1997; Petersen and Charles, "Transmission of Grapevine Leafroll-Associated Closteroviruses by Pseudococcus longispinus and P. calceolariae. Plant Pathology 46:509-15 (1997), all of which are hereby incorporated by reference).
ORF7 and ORF8 encode polypeptides of 162 amino acid with a molecular mass of 18,800 Da and of 206 amino acid with a molecular mass of 23,659 Da, respectively. Database searching with the ORF7 and ORF8 showed no significant similarity with any other proteins. Nevertheless, these genes were of similar in size and location as those observed in the sequence of other closteroviruses, BYV (P20, P21), BYSV (P18, P22), and LChV (P21 , P27) (Figure 7). However, conserved regions were not observed between the ORF7 or ORF8 and its counteφarts in BYV, BYSV, and LChV.
The 3' terminal untranslated region (3'-UTR) consists of 216 nucleotides. Nucleotide sequence analysis revealed a long oligo(A) tract close to the end of the GLRaV-2 genome which is similar to that observed in the genome of BYV and BYSV (Agranovsky et al. "Nucleotide Sequence of the 3'-Terminal Half of Beet Yellows Closterovirus RNA Genome Unique Arrangement of Eight Virus Genes," J. General Virology 72:15-24 (1991); Karasev et al., "Organization of the 3'-Terminal Half of Beet Yellow Stunt Virus Genome and Implications for the Evolution of Closteroviruses," Virology 221 : 199-207 (1996), both of which are hereby incorporated by reference). The genome of BYV ends in CCC, BYSV, and CTV ends in CC with an additional G or A in the double-stranded replicative form of BYSV (Karasev et al., "Organization of the 3'-Terminal Half of Beet Yellow Stunt Virus Genome and Implications for the Evolution of Closteroviruses," Virology 221 :199-207 (1996), which is hereby incoφorated by reference) and CTV (Karasev et al, "Complete Sequence of the Citrus Tristeza Virus RNA Genome," Virology 208:511-20 (1995), which is hereby incoφorated by reference), respectively . GLRaV-2 had CGC at the 3' terminus of the genome. Recently, a conserved 60 nt cis-element was identified in the 3'-UTR of three monopartite closteroviruses, which included a prominent conserved stem and loop structure (Karasev et al., 1996). As shown in Figure 10, alignment of the 3'-UTR sequence of
GLRaV-2 with the same regions of BYV, BYSV, and CTV showed the presence of the same conserved 60 nt stretch. Besides this cis-element, conserved sequences were not found in the 3' UTRs of GLRaV-2, BYV, BYSV, and CTV. The closteroviruses studied so far (e.g., BYV, BYSV, CTV, LIYV, LChV, and GLRaV-3) have apparent similarities in genome organization, which include replication associated genes that consist of MT, HEL, and RdRP conserved domains and a five-gene array unique for closteroviruses (Dolja et al. "Molecular Biology and Evolution of Closteroviruses: Sophisticated Build-up of Large RNA Genomes," Annual Rev.
Photopathology 32:261-85 (1994); Agranovsky "Principles of Molecular Organization, Expression, and Evolution of Closteroviruses: Over the Barriers," Adv. in Virus Res. 47:119- 218 (1996); Jelkmann et al., "Complete Genome Structure and Phylogenetic Analysis of Little Cherry Virus, a Mealybug-Transmissible Closterovirus," J. General Virology 78:2067- 71 (1997); Ling et al., "Nucleotide Sequence of the 3' Terminal Two-Thirds of the Grapevine Leafroll Associated Virus-3 Genome Reveals a Typical Monopartite Closterovirus," J. General Virology 79(5):1289-1301 (1998), all of which are hereby incorporated by reference).
The above data clearly shows that GLRaV-2 is a closterovirus. In the genome of GLRaV-2, two putative papain-like proteases were identified and an autoproteolytic cleavage process was predicted. The replication associated proteins consisting of MT, HEL, and RdRP conserved motifs were also identified, which were phylogenetically closely related to the replication associated proteins of other closteroviruses. A unique gene array including a small hydrophobic transmembrane protein, HSP70 homolog, FISP90 homolog, diverged CP and CP was also preserved in GLRaV-2. In addition, the calculated molecular mass (21,661 Da) of the coat protein (ORF6) of GLRaV-2 is in good agreement with that of the other closteroviruses (22 to 28 kDa) (Martelli and Bar- Joseph, "Closteroviruses: Classification and Nomenclature of Viruses," Fifth Report of the International Committee on Taxonomy of Viruses, Francki et al., eds., Springer-Verlag Wein, New York, p. 345-47 (1991); Candresse and Martelli, "Genus Closterovirus 0 in Virus Taxonomy, Report of the International
Committee on Taxonomy of Viruses, Muφhy et al., eds., Springer-Verlag., NY, p. 461-63 (1995), both of which are hereby incoφorated by reference). Two ORFs downstream of the CP are of similar, in size and location, to those observed in the genome of BYV. Furthermore, lack of a poly(A) tail at the 3' end of GLRaV-2 is also in good agreement with other closteroviruses. Like all other closteroviruses, the expression of ORFlb is suspected to occur via a +1 ribosomal frameshift and the 3 'proximal ORFs are probably expressed via formation of a nested set of subgenomic RNAs. Since the slippery sequence, stem-loop and pseudoknot structure involved in the frameshift of BYV were absent in GLRaV-2, the +1 frameshift of GLRaV-2 might be the same as proposed for CTV (Karasev et al., "Complete Sequence of the Citrus Tristeza Virus RNA Genome," Virology 208:511-20 (1995), which is hereby incorporated by reference) and BYSV (Karasev et al., "Organization of the 3'- Terminal Half of Beet Yellow Stunt Virus Genome and Implications for the Evolution of Closteroviruses," Virology 221 : 199-207 (1996), which is hereby incorporated by reference). Overall, GLRaV-2 is more closely related to monopartite closteroviruses
BYV, BYSV, and CTV than to GLRaV-3 (Figure 7) (Ling et al., "Nucleotide Sequence of the 3' Terminal Two-Thirds of the Grapevine Leafroll Associated Virus-3 Genome Reveals a Typical Monopartite Closterovirus," J. General Virology 79(5):1289-1301 (1998), which is hereby incorporated by reference), even though the latter causes similar leafroll symptoms in grapevine (Rosciglione and Gugerli, "Maladies de I'Enroulement et du Bois Strie de la Vigne: Analyse Microscopique et Serologique (Leafroll and Stem Pitting of Grapevine: Microscopical and Serological Analysis)," Rev Suisse Viticult Arboricult Florticulture 18:207-1 1 (1986); Hu et al., "Characterization of Closterovirus-Like Particles Associated with Grapevine Leafroll Disease," J. Phytopathology 128:1-14 (1990), both of which are hereby incoφorated by reference).
Closteroviruses are a diverse group with complex and heterogeneous genome organizations. So far, GLRaV-2 is the only closterovirus that matches with the genome organization of BYV, the type member of the genus Closterovirus. In addition, the genomic RNA of GLRaV-2 is about the same size as that of BYV; however, the transmission vector of GLRaV-2 is unknown. The genome organization of GLRaV-2 is more closely related to the aphid transmissible closteroviruses (BYV and CTV) than to whitefly (LIYV) or mealybug transmissible closteroviruses (LChV and GLRaV-3). Thus, it is possible that GLRaV-2 is transmitted by aphids. Aphid transmission experiments with GLRaV-2 should provide information that might help develop methods for further control of GLRaV-2. A total of 15,500 nucleotides or over 95%> of the estimated GLRaV-2 genome has been cloned and sequenced. GLRaV-2 and GLRaV-3 (Ling et al., "Nucleotide Sequence of the 3' Terminal Two-Thirds of the Grapevine Leafroll Associated Virus-3 Genome Reveals a Typical Monopartite Closterovirus," J. General Virology 79(5):1289-1301 (1998), which is hereby incoφorated by reference) are the first grapevine leafroll associated closteroviruses that have been almost completely sequenced. The above data clearly justify the inclusion of GLRaV-2 into the genus Closterovirus. In addition, the information regarding the genome of GLRaV-2 would provide a better understanding of this and related GLRaVs, and add fundamental knowledge to the group of closteroviruses. Example 7 - Construction of the CP Gene of GLRaV-2 in Plant Expression Vector
GLRaV-2 infected Vitis vinifera, cv Pinot Noir grapevines originated from a vineyard in central New York was used as the virus isolate, from which the cp gene of GLRaV-2 was identified. Based on the sequence information, two oligonucleotide primers have been designed. The sense primer CP-96F (SEQ. ID. No. 21) starts from the ATG initiation codon of the coat protein gene and the complementary primer CP-96R (SEQ. ID. No. 22) starts from 56 nucleotides downstream of the stop codon of the CP gene. A Nco I restriction site (11 bp in SEQ. ID. No. 21 and 13 bp in SEQ. ID. No. 22) is introduced in the beginning of both primers to facilitate the cloning. The coat protein gene of GLRaV-2 was amplified from dsRNA extracted from GLRaV-2 infected grapevine using reverse transcriptase polymerase chain reaction (RT-PCR). The PCR- amplified CP product was purified from low melting temperature agarose gel, digested with Nco I and cloned into the same enzyme digested plant expression vector pEPT8 (shown at Figure 1 1). After screening, the orientation of recombinant construct was checked by using the internal restriction site of the CP gene and directly sequencing the CP gene. The recombinant construct with translatable (sense) full length coat protein gene, pEPT8CP-GLRaV2, was going through for the further cloning. The plant expression cassette, which consisted of a double cauliflower mosaic virus (CaMV) 35S-enhancer, a CaMV 35S-promoter, an alfalfa mosaic virus (ALMV) RNA4 5' leader sequence, a coat protein gene of GLRaV-2 (CP-GLRaV-2), and a CaMV 35S 3' untranslated region as a terminator, was cut using the EcoR I restriction enzyme, isolated from low melting point temperature agarose gel, and cloned into the same restriction enzyme treated binary vector pGA482GG or pGA482G (a derivative of pGA482 (An et al., "Binary Vectors," in Plant Molecular Biology Manual, pp. A3: 1-19, Gelvin and Schilperoot, eds., Kinwer Academic Publishers, Dordrecht, Netherlands (1988), which is hereby incorporated by reference). The resulting recombinants constructs are pGA482GG/EPT8CP-GLRaV2 (shown at Figure 11 A), which contain both neomycin phosphotransferase (npt II) and β-glucuronidase (GUS) at the internal region of the T-DNA, and pGA482G/EPT8CP-GLRaV2 (shown at Figure 1 IB) without GUS. These recombinants constructs were separately introduced by electroporation into disarmed avirulent
Agrobacterium tumefaciens strain C58Z707. The Agrobacterium tumefaciens containing the vector was used to infect Nicotiana benthamiana wounded leaf disks according to the procedure essentially described by Horsch et al., "A Simple and General Method for Transferring Genes into Plants," Science 277:1229-1231 (1985), which is incorporated herein by reference.
Example 8 - Analysis of Transgenic Nicotiana benthamiana Plants with the CP Gene of GLRaV-2
NPT II-ELISA: Double-antibody sandwich enzyme linked immnuosorbent assay (DAS-ELISA) was used to detect the npt II enzyme with an NPT II-ELISA kit (5' prime to 3' prime, Inc., Boulder, Co.). Indirect ELISA: Polyclonal antibodies to GLRaV-2, which were prepared from the coat protein expressed in E. coli, were used. Plates were coated with homogenized samples in extraction buffer (1 :10, w/v) (phosphate buffered saline containing 0.05%> Tween 20 and 2%o polyvinyl pyrrolidone) and incubated overnight at 4°C. After washing with phosphate buffered saline containing 0.05%> Tween 20 (PBST), the plates were blocked with blocking buffer (phosphate buffered saline containing 2% BSA) and incubated at room temperature for 1 hr. The anti-GLRaV-2 IgG was added at 2 μg/ml after washing with PBST. After incubation at 30 C for 4 hr, the plates were washed with PBST, and the goat anti-rabbit IgG conjugate of alkaline phosphotase (Sigma) was added at 1 : 10,000 dilution. The absorbance was measured at 405 nm with a MicroELISA AutoReader. In addition, Western blot was also performed according to the method described by Hu et al.,
"Characterization of Closterovirus-like Particle Associated Grapevine Leafroll Disease," J. Phytophathology 128:1-14, (1990), which is incoφorated herein by reference.
PCR analysis: Genomic DNA was extracted from leaves of putative transgenic and non-transgenic plants according to the method described by Cheung et al, "A Simple and Rapid DNA Microextraction Method for Plants, Animal, and Insect Suitable for RAPD and other PCR analysis," PCR Methods and Applications 3:69 (1996), which is incoφorated herein by reference. The extracted total DNA served as the template for PCR reaction. The primers CP-96F and CP-96R (SEQ. ID. Nos. 21 and 22, respectively) for the CP gene of GLRaV-2, as well as npt II 5'- and 3'- primers were used for PCR analysis. PCR reaction was performed at the 94°C x 3 min for one cycle, followed by 30 cycles of 94° C x 1 min, 50° C x 1 min, and 72° C x 2:30 min with an additional extension at 72° C for 10 min. The PCR product was analyzed on agarose gel.
After transformation, a total of 42 kanamycin resistant Nicotiana benthamiana lines (R0) were obtained, of which the leaf samples were tested by NPT II enzyme activity. Among them, 37 lines were NPT II positive by ELISA, which took about 88.0%o of total transformants. However, some of NPT II negative plants were obtained among these selected kanamycin resistant plants. All of the transgenic plants were self-pollinated in a greenhouse, and the seeds from these transgenic lines were germinated for further analysis. The production of GLRaV-2 CP in transgenic plants was detected by indirect
ELISA prior to inoculation, and the results showed that GLRaV-2 CP gene expression was not detectable in all transgenic plants tested. This result was further confirmed with Western blot. Using the antibody to GLRaV-2, the production of the CP was not detected in the transgenic and nontransgenic control plants. However, a protein of expected size (-22 kDa) was detected in GLRaV-2 infected positive control plants. This result was consistent with the ELISA result. The presence of the CP gene of GLRaV -2 in transgenic plants was detected from total genomic DNA extracted from plants tissue by PCR analysis (Figure 12). The DNA product of expected size (653 bp) was amplified from twenty tested transgenic lines, but not in non-transgenic plants. The result indicated that the CP gene of GLRaV-2 was present at these transgenic lines, which was also confirmed by Northern blot analysis.
Example 9 - Ri and R2 transgenic Nicotiana benthamiana Plants Are Resistant to GLRaV-2
Inoculation of transgenic plants: GLRaV-2 isolate 94/970, which was originally identified and transmitted from grapevine to Nicotiana benthamiana in South Africa (Goszczynski et al., "Detection of Two Strains of Grapevine Leafroll-Associated Virus 2," Vitis 35:133-35 (1996), which is incorporated herein by reference), was used as inoculum. The CP gene of isolate 94/970 was sequenced; and it is identical to the CP gene used in construction. Nicotiana benthamiana is an experimental host of GLRaV-2. The infection on it produces chlorotic and occasional necrotic lesions followed by systemic vein clearing. The vein clearing results in vein necrosis. Eventually the infected plants died, starting from the top to the bottom.
At five to seven leaf stage, two youngest apical leaves were challenged with GLRaV-2 isolate 94/970. Inoculum was prepared by grinding 1.0 g GLRaV-2 infected
Nicotiana benthamiana leaf tissue in 5 ml of phosphate buffer (0.0 IM K2HP04, PH7.0). The tested plants were dusted with carborundum and rubbed with the prepared inoculum. Non- transformed plants were simultaneously inoculated as above. The plants were observed for symptom development every other day for 60 days after inoculation. Resistant Rl transgenic plants were carried on to R2 generation for further evaluation.
Transgenic progenies from 20 R0 lines were initially screened for the resistance to GLRaV-2 followed by inoculation with GLRaV-2 isolate 94/970. The seedlings of the transgenic plants (NPT II positive), and nontransformed control plants were inoculated with GLRaV-2. After inoculation, the reaction of tested plants were divided into three types: highly susceptible (i.e. typical symptoms were observed two to four weeks postinoculation); tolerant (i.e. no symptom was developed in the early stage and typical symptoms was shown four to eight weeks postinoculation); and resistant (i.e. the plants remained asymptomatic eight weeks postinoculation). Based on the plant reaction, the resistant plants were obtained from fourteen different lines (listed in Table 1 below). In each of these fourteen lines, there was no virus detected within these plants by ELISA at 6 weeks postinoculation. In contrast, GLRaV-2 was detected in symptomatic plants by indirect ELISA. In the other six lines, although there were a few plants with some kind of delay in symptom development, all the inoculated transgenic plants died at three to eight weeks postinoculation. Based on the initial screening results, five representative lines consisting of three resistant lines (1 , 4, and 19) and two susceptible lines (12 and 13) were selected for the further analysis.
Table 1
Reaction of Tested Plants
No. Line No. HS T HR line 1 39 14 3 22 line 2 36 7 6 23 line 3 38 11 4 23 line 4 31 4 5 22 line 5 33 6 13 14 line 6 36 4 16 16 line 7 32 5 9 18 line 8 37 22 9 6 line 9 36 9 12 15 line 10 14 13 1 0 line 1 1 13 1 1 2 0 line 12 17 16 1 0 line 13 16 14 0 0 line 14 17 17 0 0 line 15 32 30 2 0 line 16 33 6 13 14 line 17 12 0 1 1 1 line 19 15 0 0 15 line 20 19 3 0 16 line 21 14 1 - 10 control 15 15 0 0 Table 1
Reaction of Tested Plants
No. Line No. HS T HR
No Line: include transgenic lines and nontransformed control;
No: the number of transgenic and nontransformed plants;
HS: highly susceptible, typical symptoms were observed two to four weeks after inoculation;
T: tolerant, the symptoms were observed five to eight weeks after inoculation; and
HR: plants remain without asymptoms after eight weeks inoculation.
Table 2 below shows the symptom development in transgenic plants relative to non- transgenic control plants in the five selected lines in separate experiments. Non- transgenic control plants were all infected two to four weeks after inoculation, which showed typical GLRaV-2 symptoms on Nicotiana benthamiana, including chlorotic and local lesions followed by systemic vein clearing and vein necrosis on the leaves. Three of the tested lines (1, 4, and 19) showed some resistance that was manifested by either an absence or a delay in symptom development. Two other lines, 12 and 13, developed symptoms at nearly the same time as the non-transformed control plants. From top to bottom, the leaves of infected plants gradually became yellow, wilted, and dried, and, eventually, the whole plants died. No matter when infection occurred, the eventual result was the same. Six weeks after inoculation, all non-transgenic plants and the susceptible plants were dead. Some tolerant plants started to die. In contrast, the asymptomatic plants were flowering normally and pollinating as the non-inoculated healthy control plants (Figure 13).
Table 2
Reaction of Tested Plants
No. Line No. HS T HR line 1 19 5 6 8 line 4 15 9 1 5 line 12 16 14 2 0 line 13 18 13 5 0 line 19 13 10 0 3 non-transgenic 24 23 1 0
No. Line: incude transgenic lines and nontransformed control;
No.: Number of transgenic and nontransformed plants tested;
HS: highly susceptible; typical symptoms were observed two to four weeks after inoculation;
T: tolerant, the symptoms were observed five to eight weeks postinoculation; and
HR: plants remain without asymptoms after eight weeks inoculation.
ELISA was performed at 6 weeks postinoculation to test the GLRaV-2 replication in the plants. Presumably, the increased level of CP reflected virus replication. The result showed that the absorbance value in symptomatic plants reached (OD) 0.7 to 3.2, compared to (OD) 0.10-0.13 prior to inoculation. In contrast, GLRaV-2 was not detected in asymptomatic plants, of which the absorbance value was the same or nearly the same as that of healthy nontransformed control plants. The data confirmed that virus replicated in symptomatic plants, but not in asymptomatic plants. The replication of GLRaV-2 was suppressed in asymptomatic plants. This result implicated that another mechanism other than the CP-mediated resistance was probably involved.
Three R2 progenies derived from transgenic resistant plants of lines 1 , 4, and 19 were generated and utilized to examine the stable transmission and whether resistance was maintained in R2 generation. These results are shown in Table 3 below. NPT II analysis revealed that R2 progeny were still segregating. The CP expression in R2 progeny was still undetectable. After inoculation, all the nontransgenic plants were infected and showed GLRaV-2 symptoms on the leaves after 24 days postinoculation. In contrast, the inoculated transgenic R2 progeny showed different levels of resistance from those highly susceptible to highly resistant. The tolerant and resistant plants were manifested by a delay in symptom development and absence of symptoms, respectively. At 6 weeks postinoculation, GLRaV-2 was detected in the tolerant symptomatic infected plants by indirect ELISA; but not in asymptomatic plants. This result indicated that virus replication was suppressed in these resistant plants, which was confirmed by Western blot. These resistant plants remained asymptomatic eight weeks postinoculation, and they were flowering normally and pollinating.
Table 3
NPT II Reaction of Tested Plants
No. Line No. Plants positive/negative HS T HR line 1/22 12 12/20 3 6 line 1/30 1 1 8/3 7 2 2 line 1/31 1 1 10/1 6 3 2 line 1/35 10 10/0 4 6 0 line 1/41 8 7/1 2 2 4 line 4/139 12 11/1 4 4 3 line 4/149 10 7/3 4 5 1 line 4/152 10 8/2 9 0 1 line 4/174 9 8/1 4 0 4 line 19/650 11 10/1 7 0 2 line 19/657 12 12/0 6 2 4 line 19/659 12 8/4 5 2 5 line 19/660 10 8/2 3 6 1 non-transformed 12 0/12 12 0 0
CK
HS: highly susceptible, typical symptoms were observed two to four weeks after inoculation; T: tolerant, the symptoms were observed five to eight weeks postinoculation; and HR: plants remain asymptomatic at eight weeks postinoculation. Example 10 - Evidence for RNA-Mediated Protection in Transgenic Plants
Northern blot analysis: Total RNA was extracted from leaves prior to inoculation following the method described by Napoli et al., Plant Cell 2:279-89 (1990), which is hereby incorporatd by reference. The concentration of the extracted RNA was measured by spectrophotometer at OD 260. About 10 g of total RNA was used for each sample. The probe used was the 3' one third of GLRaV-2 CP gene, which was randomly labeled with P (α-dATP) using Klenow fragment of DNA polymerase I.
Using a DNA corresponding to the 3 ' one third CP gene sequence as probe, a single band was detected in the RNA extracted from susceptible plants from Rl progeny of lines 5, 12, and 13 by Northern hybridization. There was little or no signal detected in the transgenic plants from Rl progeny of line 1, 4, and 19. This RNA is not present in nontransformed control plants. The size of the hybridization signal was estimated to an approximately 0.9 kb nucleic acid, which was about the same as estimated (Figure 14). In lines of 1 , 4, and 19, the steady state level of RNA expression was also low in R2 progeny. This data showed that susceptible plants from lines 12 and 13 had high mRNA level and all transgenic plants from lines 1, 4, and 19 had low mRNA level.
Example 11 - Transformation and Analysis of Transgenic Grapevines with the CP Gene of GLRaV-2
Plant materials: The rootstock cultivars Couderc 3309 (3309C) (V. riparia x V. rupestris), Vitis riparia 'Gloire de Montpellier' (Gloire), Teleki 5C (5C) (V berlandieri x V riparia), Millardet et De Grasset 101-14 (101-14 MGT) (V. riparia x V rupestris), and Richter 110 (110R) (V rupestris x V berlandieri) were utilized. Initial embryogenic calli of Gloire were provided by Mozsar and Sule (Plant Protection Institute, Hungarian Academy of Science, Budapest). All other plant materials came from a vineyard at the New York State Agricultural Experiment Station, Geneva, NY. Buds were removed from the clusters and surface sterilized in 70% ethanol for 1 -2 min. The buds (from the greenhouse and the field) were transferred to 1%> sodium hypochlorite for 15 min, then rinsed three times in sterile, double-distilled water. Anthers were excised aseptically from flower buds with the aid of a stereo microscope. The pollen was crushed on a microscope slide under a coverslip with a drop of acetocarmine to observe the cytological stage. This was done to determine which stage was most favorable for callus induction. Somatic embryogenesis and regeneration: Anthers were plated under aseptic conditions at a density of 40 to 50 per 9 cm diameter Petri dish containing MSE. Plates were cultured at 28°C in the dark. Callus was initiated, and, after 60 days, embryos were induced and were transferred to hormone-free HMG medium for differentiation. Torpedo stage embryos were then transferred from HMG to MGC medium to promote embryo germination. Cultures were maintained in the dark at 26-28°C and transferred to fresh medium at 3-4 week intervals. Elongated embryos were transferred to rooting medium in baby food jars (5-8 embryos per jar). The embryos were grown in a tissue culture room at 25°C with a daily 16 h photoperiod (76 :mol. s) to induce shoot and root formation. After plants developed roots, they were transplanted to soil in the greenhouse.
Transformation: The protocols used for transformation were modified from those described by Scorza et.al., "Transformation of Grape (Vitis vinifera L.) Zygotic-derived Somatic Embryos and Regeneration of Transgenic Plants," Plant Cell Rpt. 14:589-92 (1995), which is hereby incoφorated by reference. Overnight cultures of Agrobacterium strain C58Z707 or LBA4404 were grown in LB medium at 28°C in a shaking incubator. Bacteria were centrifuged for 5 min at 3000-5000 φm and resuspended in MS liquid medium (OD 1.0 at A600 nm ). Calli with embryos were immersed in the bacterial suspension for 15-30 min, blotted dry, and transferred to HMG medium with or without acetosyringone (100 μM). Embryogenic calli were co-cultivated with the bacteria for 48 h in the dark at 28°C. Then, the plant material was washed in MS liquid plus cefotaxime (300 mg/ml) and carbenicillin (200 mg/ml) 2-3 times. To select transgenic embryos, the material was transferred to HMG medium containing either 20 or 40 mg/L kanamycin, 300 mg/L cefotaxime, and 200 mg/L carbenicillin. Alternatively, after co-cultivation, embryogenic calli were transferred to initiation MSE medium containing 25 mg/l kanamycin plus the same antibiotics listed above. All plant materials were incubated in continuous dark at 28°C. After growth on selection medium for 3 months, embryos were transferred to HMG or MGC without kanamycin to promote elongation of embryos. They were then transferred to rooting medium without antibiotics. Nontransformed calli were grown on the same media with and without kanamycin to verify the efficiency of the kanamycin selection process. Although the invention has been described in detail for the purpose of illustration, it is understood that such detail is solely for that purpose, and variations can be made therein by those skilled in the art without departing from the spirit and scope of the invention which is defined by the following claims. SEQUENCE LISTING
(1) GENERAL INFORMATION:
(i) APPLICANT: Cornell Research Foundation, Inc.
(ii) TITLE OF INVENTION: GRAPEVINE LEAFROLL VIRUS TYPE 2 PROTEINS
AND THEIR USES
(iii) NUMBER OF SEQUENCES: 23
(iv) CORRESPONDENCE ADDRESS:
(A) ADDRESSEE: Nixon, Hargrave, Devans & Doyle LLP
(B) STREET: Clinton Square, P.O. Box 1051
(C) CITY: Rochester
(D) STATE: New York
(E) COUNTRY: U.S.A.
(F) ZIP: 14603
(v) COMPUTER READABLE FORM:
(A) MEDIUM TYPE: Floppy disk
(B) COMPUTER: IBM PC compatible
(C) OPERATING SYSTEM: PC-DOS/MS-DOS
(D) SOFTWARE: PatentIn Release #1.0, Version #1.30
(vi) CURRENT APPLICATION DATA:
(A) APPLICATION NUMBER:
(B) FILING DATE:
(C) CLASSIFICATION:
(vii) PRIOR APPLICATION DATA:
(A) APPLICATION NUMBER: US 60/047,194
(B) FILING DATE: 20-MAY-1997
(viii) ATTORNEY/AGENT INFORMATION:
(A) NAME: Goldman, Michael L.
(B) REGISTRATION NUMBER: 30,727
(C) REFERENCE/DOCKET NUMBER: 19603/1632
(ix) TELECOMMUNICATION INFORMATION:
(A) TELEPHONE: (716) 263-1304
(B) TELEFAX: (716) 263-1600
(2) INFORMATION FOR SEQ ID NO : 1 :
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 15500 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS : single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: cDNA (ii) MOLECULE TYPE: cDNA
(xi) SEQUENCE DESCRIPTION: SEQ ID NO : 1 :
TAAACATTGC GAGAGAACCC CATTAGCGTC TCCGGGGTGA ACTTGGGAAG GTCTGCCGCC 60
GCTCAGGTTA TTTATTTCGG CAGTTTCACG CAGCCCTTCG CGTTGTATCC GCGCCAAGAG 120
AGCGCGATCG TAAAAACGCA ACTTCCACCG GTCAGTGTAG TGAAGGTGGA GTGCGTAGCT 180
GCGGAGGTAG CTCCCGACAG GGGCGTGGTC GACAAGAAAC CTACGTCTGT TGGCGTTCCC 240
CCGCAGCGCG GTGTGCTTTC TTTTCCGACG GTGGTTCGGA ACCGCGGCGA CGTGATAATC 300
ACAGGGGTGG TGCATGAAGC CCTGAAGAAA ATTAAAGACG GGCTCTTACG CTTCCGCGTA 360
GGCGGTGACA TGCGTTTTTC GAGATTTTTC TCATCGAACT ACGGCTGCAG ATTCGTCGCG 420
AGCGTGCGTA CGAACACTAC AGTTTGGCTA AATTGCACGA AAGCGAGTGG TGAGAAATTC 480
TCACTCGCCG CCGCGTGCAC GGCGGATTAC GTGGCGATGC TGCGTTATGT GTGTGGCGGG 540
AAATTTCCAC TCGTCCTCAT GAGTAGAGTT ATTTACCCGG ATGGGCGCTG TTACTTGGCC 600
CATATGAGGT ATTTGTGCGC CTTTTACTGT CGCCCGTTTA GAGAGTCGGA TTATGCCCTC 660
GGAATGTGGC CTACGGTGGC GCGTCTCAGG GCATGCGTTG AGAAGAACTT CGGTGTCGAA 720
GCTTGTGGCA TAGCTCTTCG TGGCTATTAC ACCTCTCGCA ATGTTTATCA CTGTGATTAT 780
GACTCTGCTT ATGTAAAATA TTTTAGAAAC CTTTCCGGCC GCATTGGCGG TGGTTCGTTC 840
GATCCGACAT CTTTAACCTC CGTAATAACG GTGAAGATTA GCGGTCTTCC AGGTGGTCTT 900
CCTAAAAATA TAGCGTTTGG TGCCTTCCTG TGCGATATAC GTTACGTCGA ACCGGTAGAC 960
TCGGGCGGCA TTCAATCGAG CGTTAAGACG AAACGTGAAG ATGCGCACCG AACCGTAGAG 1020
GAACGGGCGG CCGGCGGATC CGTCGAGCAA CCGCGACAAA AGAGGATAGA TGAGAAAGGT 1080
TGCGGCAGAG TTCCTAGTGG AGGTTTTTCG CATCTCCTGG TCGGCAACCT TAACGAAGTT 1140
AGGAGGAAGG TAGCTGCCGG ACTTCTACGC TTTCGCGTTG GCGGTGATAT GGATTTTCAT 1200
CGCTCGTTCT CCACCCAAGC GGGCCACCGC TTGCTGGTGT GGCGCCGCTC GAGCCGGAGC 1260
GTGTGCCTTG AACTTTACTC ACCATCTAAA AACTTTTTGC GTTACGATGT CTTGCCCTGT 1320
TCTGGAGACT ATGCAGCGAT GTTTTCTTTC GCGGCGGGCG GCCGTTTCCC TTTAGTTTTG 1380
ATGACTAGAA TTAGATACCC GAACGGGTTT TGTTACTTGG CTCACTGCCG GTACGCGTGC 1440
GCGTTTCTCT TAAGGGGTTT TGATCCGAAG CGTTTCGACA TCGGTGCTTT CCCCACCGCG 1500
GCCAAGCTCA GAAACCGTAT GGTTTCGGAG CTTGGTGAAA GAAGTTTAGG TTTGAACTTG 1560
TACGGCGCAT ATACGTCACG CGGCGTCTTT CACTGCGATT ATGACGCTAA GTTTATAAAG 1620 GATTTGCGTC TTATGTCAGC AGTTATAGCT GGAAAGGACG GGGTGGAAGA GGTGGTACCT 1680
TCTGACATAA CTCCTGCCAT GAAGCAGAAA ACGATCGAAG CCGTGTATGA TAGATTATAT 1740
GGCGGCACTG ACTCGTTGCT GAAACTGAGC ATCGAGAAAG ACTTAATCGA TTTCAAAAAT 1800
GACGTGCAGA GTTTGAAGAA AGATCGGCCG ATTGTCAAAG TGCCCTTTTA CATGTCGGAA 1860
GCAACACAGA ATTCGCTGAC GCGTTTCTAC CCTCAGTTCG AACTTAAGTT TTCGCACTCC 1920
TCGCATTCAG ATCATCCCGC CGCCGCCGCT TCTAGACTGC TGGAAAATGA AACGTTAGTG 1980
CGCTTATGTG GTAATAGCGT TTCAGATATT GGAGGTTGTC CTCTTTTCCA TTTGCATTCC 2040
AAGACGCAAA GACGGGTTCA CGTATGTAGG CCTGTGTTGG ATGGCAAGGA TGCGCAGCGT 2100
CGCGTGGTGC GTGATTTGCA GTATTCCAAC GTGCGTTTGG GAGACGATGA TAAAATTTTG 2160
GAAGGGCCAC GCAATATCGA CATTTGCCAC TATCCTCTGG GCGCGTGTGA CCACGAAAGT 2220
AGTGCTATGA TGATGGTGCA GGTGTATGAC GCGTCCCTTT ATGAGATATG TGGCGCCATG 2280
ATCAAGAAGA AAAGCCGCAT AACGTACTTA ACCATGGTCA CGCCCGGCGA GTTTCTTGAC 2340
GGACGCGAAT GCGTCTACAT GGAGTCGTTA GACTGTGAGA TTGAAGTTGA TGTGCACGCG 2400
GACGTCGTAA TGTACAAATT CGGTAGTTCT TGCTATTCGC ACAAGCTTTC AATCATCAAG 2460
GACATCATGA CCACTCCGTA CTTGACACTA GGTGGTTTTC TATTCAGCGT GGAGATGTAT 2520
GAGGTGCGTA TGGGCGTGAA TTACTTCAAG ATTACGAAGT CCGAAGTATC GCCTAGCATT 2580
AGCTGCACCA AGCTCCTGAG ATACCGAAGA GCTAATAGTG ACGTGGTTAA AGTTAAACTT 2640
CCACGTTTCG ATAAGAAACG TCGCATGTGT CTGCCTGGGT ATGACACCAT ATACCTAGAT 2700
TCGAAGTTTG TGAGTCGCGT TTTCGATTAT GTCGTGTGTA ATTGCTCTGC CGTGAACTCA 2760
AAAACTTTCG AGTGGGTGTG GAGTTTCATT AAGTCTAGTA AGTCGAGGGT GATTATTAGC 2820
GGTAAAATAA TTCACAAGGA TGTGAATTTG GACCTCAAGT ACGTCGAGAG TTTCGCCGCG 2880
GTTATGTTGG CCTCTGGCGT GCGCAGTAGA CTAGCGTCCG AGTACCTTGC TAAGAACCTT 2940
AGTCATTTTT CGGGAGATTG CTCCTTTATT GAAGCCACGT CTTTCGTGTT GCGTGAGAAA 3000
ATCAGAAACA TGACTCTGAA TTTTAACGAA AGACTTTTAC AGTTAGTGAA GCGCGTTGCC 3060
TTTGCGACCT TGGACGTGAG TTTTCTAGAT TTAGATTCAA CTCTTGAATC AATAACTGAT 3120
TTTGCCGAGT GTAAGGTAGC GATTGAACTC GACGAGTTGG GTTGCTTGAG AGCGGAGGCC 3180
GAGAATGAAA AAATCAGGAA TCTGGCGGGA GATTCGATTG CGGCTAAACT CGCGAGCGAG 3240
ATAGTGGTCG ATATTGACTC TAAGCCTTCA CCGAAGCAGG TGGGTAATTC GTCATCCGAA 3300 AACGCCGATA AGCGGGAAGT TCAGAGGCCC GGTTTGCGTG GTGGTTCTAG AAACGGGGTT 3360
GTTGGGGAGT TCCTTCACTT CGTCGTGGAT TCTGCCTTGC GTCTTTTCAA ATACGCGACG 3420
GATCAACAAC GGATCAAGTC TTACGTGCGT TTCTTGGACT CGGCGGTCTC ATTCTTGGAT 3480
TACAACTACG ATAATCTATC GTTTATACTG CGAGTGCTTT CGGAAGGTTA TTCGTGTATG 3540
TTCGCGTTTT TGGCGAATCG CGGCGACTTA TCTAGTCGTG TCCGTAGCGC GGTGTGTGCT 3600
GTGAAAGAAG TTGCTACCTC ATGCGCGAAC GCGAGCGTTT CTAAAGCCAA GGTTATGATT 3660
ACCTTCGCAG CGGCCGTGTG TGCTATGATG TTTAATAGCT GCGGTTTTTC AGGCGACGGT 3720
CGGGAGTATA AATCGTATAT ACATCGTTAC ACGCAAGTAT TGTTTGACAC TATCTTTTTT 3780
GAGGACAGCA GTTACCTACC CATAGAAGTT CTGAGTTCGG CGATATGCGG TGCTATCGTC 3840
ACACTTTTCT CCTCGGGCTC GTCCATAAGT TTAAACGCCT TCTTACTTCA AATTACCAAA 3900
GGATTCTCCC TAGAGGTTGT CGTCCGGAAT GTTGTGCGAG TCACGCATGG TTTGAGCACC 3960
ACAGCGACCG ACGGCGTCAT ACGTGGGGTT TTCTCCCAAA TTGTGTCTCA CTTACTTGTT 4020
GGAAATACGG GTAATGTGGC TTACCAGTCA GCTTTCATTG CCGGGGTGGT GCCTCTTTTA 4080
GTTAAAAAGT GTGTGAGCTT AATCTTCATC TTGCGTGAAG ATACTTATTC CGGTTTTATT 4140
AAGCACGGAA TCAGTGAATT CTCTTTCCTT AGTAGTATTC TGAAGTTCTT GAAGGGTAAG 4200
CTTGTGGACG AGTTGAAATC GATTATTCAA GGGGTTTTTG ATTCCAACAA GCACGTGTTT 4260
AAAGAAGCTA CTCAGGAAGC GATTCGTACG ACGGTCATGC AAGTGCCTGT CGCTGTAGTG 4320
GATGCCCTTA AGAGCGCCGC GGGAAAAATT TATAACAATT TTACTAGTCG ACGTACCTTT 4380
GGTAAGGATG AAGGCTCCTC TAGCGACGGC GCATGTGAAG AGTATTTCTC ATGCGACGAA 4440
GGTGAAGGTC CGGGTCTGAA AGGGGGTTCC AGCTATGGCT TCTCAATTTT AGCGTTCTTT 4500
TCACGCATTA TGTGGGGAGC TCGTCGGCTT ATTGTTAAGG TGAAGCATGA GTGTTTTGGG 4560
AAACTTTTTG AATTTCTATC GCTCAAGCTT CACGAATTCA GGACTCGCGT TTTTGGGAAG 4620
AATAGAACGG ACGTGGGAGT TTACGATTTT TTGCCCACGG GCATCGTGGA AACGCTCTCA 4680
TCGATAGAAG AGTGCGACCA AATTGAAGAA CTTCTCGGCG ACGACCTGAA AGGTGACAAG 4740
GATGCTTCGT TGACCGATAT GAATTACTTT GAGTTCTCAG AAGACTTCTT AGCCTCTATC 4800
GAGGAGCCGC CTTTCGCTGG ATTGCGAGGA GGTAGCAAGA ACATCGCGAT TTTGGCGATT 4860
TTGGAATACG CGCATAATTT GTTTCGCATT GTCGCAAGCA AGTGTTCGAA ACGACCTTTA 4920
TTTCTTGCTT TCGCCGAACT CTCAAGCGCC CTTATCGAGA AATTTAAGGA GGTTTTCCCT 4980
CGTAAGAGCC AGCTCGTCGC TATCGTGCGC GAGTATACTC AGAGATTCCT CCGAAGTCGC 5040 ATGCGTGCGT TGGGTTTGAA TAACGAGTTC GTGGTAAAAT CTTTCGCCGA TTTGCTACCC 5100
GCATTAATGA AGCGGAAGGT TTCAGGTTCG TTCTTAGCTA GTGTTTATCG CCCACTTAGA 5160
GGTTTCTCAT ATATGTGTGT TTCAGCGGAG CGACGTGAAA AGTTTTTTGC TCTCGTGTGT 5220
TTAATCGGGT TAAGTCTCCC TTTCTTCGTG CGCATCGTAG GAGCGAAAGC GTGCGAAGAA 5280
CTCGTGTCCT CAGCGCGTCG CTTTTATGAG CGTATTAAAA TTTTTCTAAG GCAGAAGTAT 5340
GTCTCTCTTT CTAATTTCTT TTGTCACTTG TTTAGCTCTG ACGTTGATGA CAGTTCCGCA 5400
TCTGCAGGGT TGAAAGGTGG TGCGTCGCGA ATGACGCTCT TCCACCTTCT GGTTCGCCTT 5460
GCTAGTGCCC TCCTATCGTT AGGGTGGGAA GGGTTAAAGC TACTCTTATC GCACCACAAC 5520
TTGTTATTTT TGTGTTTTGC ATTGGTTGAC GATGTGAACG TCCTTATCAA AGTTCTTGGG 5580
GGTCTTTCTT TCTTTGTGCA ACCAATCTTT TCCTTGTTTG CGGCGATGCT TCTACAACCG 5640
GACAGGTTTG TGGAGTATTC CGAGAAACTT GTTACAGCGT TTGAATTTTT CTTAAAATGT 5700
TCGCCTCGCG CGCCTGCACT ACTCAAAGGG TTTTTTGAGT GCGTGGCGAA CAGCACTGTG 5760
TCAAAAACCG TTCGAAGACT TCTTCGCTGT TTCGTGAAGA TGCTCAAACT TCGAAAAGGG 5820
CGAGGGTTGC GTGCGGATGG TAGGGGTCTC CATCGGCAGA AAGCCGTACC CGTCATACCT 5880
TCTAATCGGG TCGTGACCGA CGGGGTTGAA AGACTTTCGG TAAAGATGCA AGGAGTTGAA 5940
GCGTTGCGTA CCGAATTGAG AATCTTAGAA GATTTAGATT CTGCCGTGAT CGAAAAACTC 6000
AATAGACGCA GAAATCGTGA CACTAATGAC GACGAATTTA CGCGCCCTGC TCATGAGCAG 6060
ATGCAAGAAG TCACCACTTT CTGTTCGAAA GCCAACTCTG CTGGTTTGGC CCTGGAAAGG 6120
GCAGTGCTTG TGGAAGACGC TATAAAGTCG GAGAAACTTT CTAAGACGGT TAATGAGATG 6180
GTGAGGAAAG GGAGTACCAC CAGCGAAGAA GTGGCCGTCG CTTTGTCGGA CGATGAAGCC 6240
GTGGAAGAAA TCTCTGTTGC TGACGAGCGA GACGATTCGC CTAAGACAGT CAGGATAAGC 6300
GAATACCTAA ATAGGTTAAA CTCAAGCTTC GAATTCCCGA AGCCTATTGT TGTGGACGAC 6360
AACAAGGATA CCGGGGGTCT AACGAACGCC GTGAGGGAGT TTTATTATAT GCAAGAACTT 6420
GCTCTTTTCG AAATCCACAG CAAACTGTGC ACCTACTACG ATCAACTGCG CATAGTCAAC 6480
TTCGATCGTT CCGTAGCACC ATGCAGCGAA GATGCTCAGC TGTACGTACG GAAGAACGGC 6540
TCAACGATAG TGCAGGGTAA AGAGGTACGT TTGCACATTA AGGATTTCCA CGATCACGAT 6600
TTCCTGTTTG ACGGAAAAAT TTCTATTAAC AAGCGGCGGC GAGGCGGAAA TGTTTTATAT 6660
CACGACAACC TCGCGTTCTT GGCGAGTAAT TTGTTCTTAG CCGGCTACCC CTTTTCAAGG 6720 AGCTTCGTCT TCACGAATTC GTCGGTCGAT ATTCTCCTCT ACGAAGCTCC ACCCGGAGGT 6780
GGTAAGACGA CGACGCTGAT TGACTCGTTC TTGAAGGTCT TCAAGAAAGG TGAGGTTTCC 6840
ACCATGATCT TAACCGCCAA CAAAAGTTCG CAGGTTGAGA TCCTAAAGAA AGTGGAGAAG 6900
GAAGTGTCTA ACATTGAATG CCAGAAACGT AAAGACAAAA GATCTCCGAA AAAGAGCATT 6960
TACACCATCG ACGCTTATTT AATGCATCAC CGTGGTTGTG ATGCAGACGT TCTTTTCATC 7020
GATGAGTGTT TCATGGTTCA TGCGGGTAGC GTACTAGCTT GCATTGAGTT CACGAGGTGT 7080
CATAAAGTAA TGATCTTCGG GGATAGCCGG CAGATTCACT ACATTGAAAG GAACGAATTG 7140
GACAAGTGTT TGTATGGGGA TCTCGACAGG TTCGTGGACC TGCAGTGTCG GGTTTATGGT 7200
AATATTTCGT ACCGTTGTCC ATGGGATGTG TGCGCTTGGT TAAGCACAGT GTATGGCAAC 7260
CTAATCGCCA CCGTGAAGGG TGAAAGCGAA GGTAAGAGCA GCATGCGCAT TAACGAAATT 7320
AATTCAGTCG ACGATTTAGT CCCCGACGTG GGTTCCACGT TTCTGTGTAT GCTTCAGTCG 7380
GAGAAGTTGG AAATCAGCAA GCACTTTATT CGCAAGGGTT TGACTAAACT TAACGTTCTA 7440
ACGGTGCATG AGGCGCAAGG TGAGACGTAT GCGCGTGTGA ACCTTGTGCG ACTTAAGTTT 7500
CAGGAGGATG AACCCTTTAA ATCTATCAGG CACATAACCG TCGCTCTTTC TCGTCACACC 7560
GACAGCTTAA CTTATAACGT CTTAGCTGCT CGTCGAGGTG ACGCCACTTG CGATGCCATC 7620
CAGAAGGCTG CGGAATTGGT GAACAAGTTT CGCGTTTTTC CTACATCTTT TGGTGGTAGT 7680
GTTATCAATC TCAACGTGAA GAAGGACGTG GAAGATAACA GTAGGTGCAA GGCTTCGTCG 7740
GCACCATTGA GCGTAATCAA CGACTTTTTG AACGAAGTTA ATCCCGGTAC TGCGGTGATT 7800
GATTTTGGTG ATTTGTCCGC GGACTTCAGT ACTGGGCCTT TTGAGTGCGG TGCCAGCGGT 7860
ATTGTGGTGC GGGACAACAT CTCCTCCAGC AACATCACTG ATCACGATAA GCAGCGTGTT 7920
TAGCGTAGTT CGGTCGCAGG CGATTCCGCG TAGAAAACCT TCTCTACAAG AAAATTTGTA 7980
TTCGTTTGAA GCGCGGAATT ATAACTTCTC GACTTGCGAC CGTAACACAT CTGCTTCAAT 8040
GTTCGGAGAG GCTATGGCGA TGAACTGTCT TCGTCGTTGC TTCGACCTAG ATGCCTTTTC 8100
GTCCCTGCGT GATGATGTGA TTAGTATCAC ACGTTCAGGC ATCGAACAAT GGCTGGAGAA 8160
ACGTACTCCT AGTCAGATTA AAGCATTAAT GAAGGATGTT GAATCGCCTT TGGAAATTGA 8220
CGATGAAATT TGTCGTTTTA AGTTGATGGT GAAGCGTGAC GCTAAGGTGA AGTTAGACTC 8280
TTCTTGTTTA ACTAAACACA GCGCCGCTCA AAATATCATG TTTCATCGCA AGAGCATTAA 8340
TGCTATCTTC TCTCCTATCT TTAATGAGGT GAAAAACCGA ATAATGTGCT GTCTTAAGCC 8400
TAACATAAAG TTTTTTACGG AGATGACTAA CAGGGATTTT GCTTCTGTTG TCAGCAACAT 8460 GCTTGGTGAC GACGATGTGT ACCATATAGG TGAAGTTGAT TTCTCAAAGT ACGACAAGTC 8520
TCAAGATGCT TTCGTGAAGG CTTTTGAAGA AGTAATGTAT AAGGAACTCG GTGTTGATGA 8580
AGAGTTGCTG GCTATCTGGA TGTGCGGCGA GCGGTTATCG ATAGCTAACA CTCTCGATGG 8640
TCAGTTGTCC TTCACGATCG AGAATCAAAG GAAGTCGGGA GCTTCGAACA CTTGGATTGG 8700
TAACTCTCTC GTCACTTTGG GTATTTTAAG TCTTTACTAC GACGTTAGAA ATTTCGAGGC 8760
GTTGTACATC TCGGGCGATG ATTCTTTAAT TTTTTCTCGC AGCGAGATTT CGAATTATGC 8820
CGACGACATA TGCACTGACA TGGGTTTTGA GACAAAATTT ATGTCCCCAA GTGTCCCGTA 8880
CTTTTGTTCT AAATTTGTTG TTATGTGTGG TCATAAGACG TTTTTTGTTC CCGACCCGTA 8940
CAAGCTTTTT GTCAAGTTGG GAGCAGTCAA AGAGGATGTT TCAATGGATT TCCTTTTCGA 9000
GACTTTTACC TCCTTTAAAG ACTTAACCTC CGATTTTAAC GACGAGCGCT TAATTCAAAA 9060
GCTCGCTGAA CTTGTGGCTT TAAAATATGA GGTTCAAACC GGCAACACCA CCTTGGCGTT 9120
AAGTGTGATA CATTGTTTGC GTTCGAATTT CCTCTCGTTT AGCAAGTTAT ATCCTCGCGT 9180
GAAGGGATGG CAGGTTTTTT ACACGTCGGT TAAGAAAGCG CTTCTCAAGA GTGGGTGTTC 9240
TCTCTTCGAC AGTTTCATGA CCCCTTTTGG TCAGGCTGTC ATGGTTTGGG ATGATGAGTA 9300
GCGCTAACTT GTGCGCAGTT TCTTTGTTCG TGACATACAC CTTGTGTGTC ACCGTGCGTT 9360
TATAATGAAT CAGGTTTTGC AGTTTGAATG TTTGTTTCTG CTGAATCTCG CGGTTTTTGC 9420
TGTGACTTTC ATTTTCATTC TTCTGGTCTT CCGCGTGATT AAGTCTTTTC GCCAGAAGGG 9480
TCACGAAGCA CCTGTTCCCG TTGTTCGTGG CGGGGGTTTT TCAACCGTAG TGTAGTCAAA 9540
AGACGCGCAT ATGGTAGTTT TCGGTTTGGA CTTTGGCACC ACATTCTCTA CGGTGTGTGT 9600
GTACAAGGAT GGACGAGTTT TTTCATTCAA GCAGAATAAT TCGGCGTACA TCCCCACTTA 9660
CCTCTATCTC TTCTCCGATT CTAACCACAT GACTTTTGGT TACGAGGCCG AATCACTGAT 9720
GAGTAATCTG AAAGTTAAAG GTTCGTTTTA TAGAGATTTA AAACGTTGGG TGGGTTGCGA 9780
TTCGAGTAAC CTCGACGCGT ACCTTGACCG TTTAAAACCT CATTACTCGG TCCGCTTGGT 9840
TAAGATCGGC TCTGGCTTGA ACGAAACTGT TTCAATTGGA AACTTCGGGG GCACTGTTAA 9900
GTCTGAGGCT CATCTGCCAG GGTTGATAGC TCTCTTTATT AAGGCTGTCA TTAGTTGCGC 9960
GGAGGGCGCG TTTGCGTGCA CTTGCACCGG GGTTATTTGT TCAGTACCTG CCAATTATGA 10020
TAGCGTTCAA AGGAATTTCA CTGATCAGTG TGTTTCACTC AGCGGTTATC AGTGCGTATA 10080
TATGATCAAT GAACCTTCAG CGGCTGCGCT ATCTGCGTGT AATTCGATTG GAAAGAAGTC 10140 CGCAAATTTG GCTGTTTACG ATTTCGGTGG TGGGACCTTC GACGTGTCTA TCATTTCATA 10200
CCGCAACAAT ACTTTTGTTG TGCGAGCTTC TGGAGGCGAT CTAAATCTCG GTGGAAGGGA 10260
TGTTGATCGT GCGTTTCTCA CGCACCTCTT CTCTTTAACA TCGCTGGAAC CTGACCTCAC 10320
TTTGGATATC TCGAATCTGA AAGAATCTTT ATCAAAAACG GACGCAGAGA TAGTTTACAC 10380
TTTGAGAGGT GTCGATGGAA GAAAAGAAGA CGTTAGAGTA AACAAAAACA TTCTTACGTC 10440
GGTGATGCTC CCCTACGTGA ACAGAACGCT TAAGATATTA GAGTCAACCT TAAAATCGTA 10500
TGCTAAGAGT ATGAATGAGA GTGCGCGAGT TAAGTGCGAT TTAGTGCTGA TAGGAGGATC 10560
TTCATATCTT CCTGGCCTGG CAGACGTACT AACGAAGCAT CAGAGCGTTG ATCGTATCTT 10620
AAGAGTTTCG GATCCTCGGG CTGCCGTGGC CGTCGGTTGC GCATTATATT CTTCATGCCT 10680
CTCAGGATCT GGGGGGTTGC TACTGATCGA CTGTGCAGCT CACACTGTCG CTATAGCGGA 10740
CAGAAGTTGT CATCAAATCA TTTGCGCTCC AGCGGGGGCA CCGATCCCCT TTTCAGGAAG 10800
CATGCCTTTG TACTTAGCCA GGGTCAACAA GAACTCGCAG CGTGAAGTCG CCGTGTTTGA 10860
AGGGGAGTAC GTTAAGTGCC CTAAGAACAG AAAGATCTGT GGAGCAAATA TAAGATTTTT 10920
TGATATAGGA GTGACGGGTG ATTCGTACGC ACCCGTTACC TTCTATATGG ATTTCTCCAT 10980
TTCAAGCGTA GGAGCCGTTT CATTCGTGGT GAGAGGTCCT GAGGGTAAGC AAGTGTCACT 11040
CACTGGAACT CCAGCGTATA ACTTTTCGTC TGTGGCTCTC GGATCACGCA GTGTCCGAGA 11100
ATTGCATATT AGTTTAAATA ATAAAGTTTT TCTCGGTTTG CTTCTACATA GAAAGGCGGA 11160
TCGACGAATA CTTTTCACTA AGGATGAAGC GATTCGATAC GCCGATTCAA TTGATATCGC 11220
GGATGTGCTA AAGGAATATA AAAGTTACGC GGCCAGTGCC TTACCACCAG ACGAGGATGT 11280
CGAATTACTC CTGGGAAAGT CTGTTCAAAA AGTTTTACGG GGAAGCAGAC TGGAAGAAAT 11340
ACCTCTCTAG GAGCATAGCA GCACACTCAA GTGAAATTAA AACTCTACCA GACATTCGAT 11400
TGTACGGCGG TAGGGTTGTA AAGAAGTCCG AATTCGAATC AGCACTTCCT AATTCTTTTG 11460
AACAGGAATT AGGACTGTTC ATACTGAGCG AACGGGAAGT GGGATGGAGC AAATTATGCG 11520
GAATAACGGT GGAAGAAGCA GCATACGATC TTACGAATCC CAAGGCTTAT AAATTCACTG 11580
CCGAGACATG TAGCCCGGAT GTAAAAGGTG AAGGACAAAA ATACTCTATG GAAGACGTGA 11640
TGAATTTCAT GCGTTTATCA AATCTGGATG TTAACGACAA GATGCTGACG GAACAGTGTT 11700
GGTCGCTGTC CAATTCATGC GGTGAATTGA TCAACCCAGA CGACAAAGGG CGATTCGTGG 11760
CTCTCACCTT TAAGGACAGA GACACAGCTG ATGACACGGG TGCCGCCAAC GTGGAATGTC 11820
GCGTGGGCGA CTATCTAGTT TACGCTATGT CCCTGTTTGA GCAGAGGACC CAAAAATCGC 11880 AGTCTGGCAA CATCTCTCTG TACGAAAAGT ACTGTGAATA CATCAGGACC TACTTAGGGA 11940
GTACAGACCT GTTCTTCACA GCGCCGGACA GGATTCCGTT ACTTACGGGC ATCCTATACG 12000
ATTTTTGTAA GGAATACAAC GTTTTCTACT CGTCATATAA GAGAAACGTC GATAATTTCA 12060
GATTCTTCTT GGCGAATTAT ATGCCTTTGA TATCTGACGT CTTTGTCTTC CAGTGGGTAA 12120
AACCCGCGCC GGATGTTCGG CTGCTTTTTG AGTTAAGTGC AGCGGAACTA ACGCTGGAGG 12180
TTCCCACACT GAGTTTGATA GATTCTCAAG TTGTGGTAGG TCATATCTTA AGATACGTAG 12240
AATCCTACAC ATCAGATCCA GCCATCGACG CGTTAGAAGA CAAACTGGAA GCGATACTGA 12300
AAAGTAGCAA TCCCCGTCTA TCGACAGCGC AACTATGGGT TGGTTTCTTT TGTTACTATG 12360
GTGAGTTTCG TACGGCTCAA AGTAGAGTAG TGCAAAGACC AGGCGTATAC AAAACACCTG 12420
ACTCAGTGGG TGGATTTGAA ATAAACATGA AAGATGTTGA GAAATTCTTC GATAAACTTC 12480
AGAGAGAATT GCCTAATGTA TCTTTGCGGC GTCAGTTTAA CGGAGCTAGA GCGCATGAGG 12540
CTTTCAAAAT ATTTAAAAAC GGAAATATAA GTTTCAGACC TATATCGCGT TTAAACGTGC 12600
CTAGAGAGTT CTGGTATCTG AACATAGACT ACTTCAGGCA CGCGAATAGG TCCGGGTTAA 12660
CCGAAGAAGA AATACTCATC CTAAACAACA TAAGCGTTGA TGTTAGGAAG TTATGCGCTG 12720
AGAGAGCGTG CAATACCCTA CCTAGCGCGA AGCGCTTTAG TAAAAATCAT AAGAGTAATA 12780
TACAATCATC ACGCCAAGAG CGGAGGATTA AAGACCCATT GGTAGTCCTG AAAGACACTT 12840
TATATGAGTT CCAACACAAG CGTGCCGGTT GGGGGTCTCG AAGCACTCGA GACCTCGGGA 12900
GTCGTGCTGA CCACGCGAAA GGAAGCGGTT GATAAGTTTT TTAATGAACT AAAAAACGAA 12960
AATTACTCAT CAGTTGACAG CAGCCGATTA AGCGATTCGG AAGTAAAAGA AGTGTTAGAG 13020
AAAAGTAAAG AAAGTTTCAA AAGCGAACTG GCCTCCACTG ACGAGCACTT CGTCTACCAC 13080
ATTATATTTT TCTTAATCCG ATGTGCTAAG ATATCGACAA GTGAAAAGGT GAAGTACGTT 13140
GGTAGTCATA CGTACGTGGT CGACGGAAAA ACGTACACCG TTCTTGACGC TTGGGTATTC 13200
AACATGATGA AAAGTCTCAC GAAGAAGTAC AAACGAGTGA ATGGTCTGCG TGCGTTCTGT 13260
TGCGCGTGCG AAGATCTATA TCTAACCGTC GCACCAATAA TGTCAGAACG CTTTAAGACT 13320
AAAGCCGTAG GGATGAAAGG TTTGCCTGTT GGAAAGGAAT ACTTAGGCGC CGACTTTCTT 13380
TCGGGAACTA GCAAACTGAT GAGCGATCAC GACAGGGCGG TCTCCATCGT TGCAGCGAAA 13440
AACGCTGTCG ATCGTAGCGC TTTCACGGGT GGGGAGAGAA AGATAGTTAG TTTGTATGAT 13500
CTAGGGAGGT ACTAAGCACG GTGTGCTATA GTGCGTGCTA TAATAATAAA CACTAGTGCT 13560 TAAGTCGCGC AGAAGAAAAC GCTATGGAGT TGATGTCCGA CAGCAACCTT AGCAACCTGG 13620
TGATAACCGA CGCCTCTAGT CTAAATGGTG TCGACAAGAA GCTTTTATCT GCTGAAGTTG 13680
AAAAAATGTT GGTGCAGAAA GGGGCTCCTA ACGAGGGTAT AGAAGTGGTG TTCGGTCTAC 13740
TCCTTTACGC ACTCGCGGCA AGAACCACGT CTCCTAAGGT TCAGCGCGCA GATTCAGACG 13800
TTATATTTTC AAATAGTTTC GGAGAGAGGA ATGTGGTAGT AACAGAGGGT GACCTTAAGA 13860
AGGTACTCGA CGGGTGTGCG CCTCTCACTA GGTTCACTAA TAAACTTAGA ACGTTCGGTC 13920
GTACTTTCAC TGAGGCTTAC GTTGACTTTT GTATCGCGTA TAAGCACAAA TTACCCCAAC 13980
TCAACGCCGC GGCGGAATTG GGGATTCCAG CTGAAGATTC GTACTTAGCT GCAGATTTTC 14040
TGGGTACTTG CCCGAAGCTC TCTGAATTAC AGCAAAGTAG GAAGATGTTC GCGAGTATGT 14100
ACGCTCTAAA AACTGAAGGT GGAGTGGTAA ATACACCAGT GAGCAATCTG CGTCAGCTAG 14160
GTAGAAGGGA AGTTATGTAA TGGAAGATTA CGAAGAAAAA TCCGAATCGC TCATACTGCT 14220
ACGCACGAAT CTGAACACTA TGCTTTTAGT GGTCAAGTCC GATGCTAGTG TAGAGCTGCC 14280
TAAACTACTA ATTTGCGGTT ACTTACGAGT GTCAGGACGT GGGGAGGTGA CGTGTTGCAA 14340
CCGTGAGGAA TTAACAAGAG ATTTTGAGGG CAATCATCAT ACGGTGATCC GTTCTAGAAT 14400
CATACAATAT GACAGCGAGT CTGCTTTTGA GGAATTCAAC AACTCTGATT GCGTAGTGAA 14460
GTTTTTCCTA GAGACTGGTA GTGTCTTTTG GTTTTTCCTT CGAAGTGAAA CCAAAGGTAG 14520
AGCGGTGCGA CATTTGCGCA CCTTCTTCGA AGCTAACAAT TTCTTCTTTG GATCGCATTG 14580
CGGTACCATG GAGTATTGTT TGAAGCAGGT ACTAACTGAA ACTGAATCTA TAATCGATTC 14640
TTTTTGCGAA GAAAGAAATC GTTAAGATGA GGGTTATAGT GTCTCCTTAT GAAGCTGAAG 14700
ACATTCTGAA AAGATCGACT GACATGTTAC GAAACATAGA CAGTGGGGTC TTGAGCACTA 14760
AAGAATGTAT CAAGGCATTC TCGACGATAA CGCGAGACCT ACATTGTGCG AAGGCTTCCT 14820
ACCAGTGGGG TGTTGACACT GGGTTATATC AGCGTAATTG CGCTGAAAAA CGTTTAATTG 14880
ACACGGTGGA GTCAAACATA CGGTTGGCTC AACCTCTCGT GCGTGAAAAA GTGGCGGTTC 14940
ATTTTTGTAA GGATGAACCA AAAGAGCTAG TAGCATTCAT CACGCGAAAG TACGTGGAAC 15000
TCACGGGCGT GGGAGTGAGA GAAGCGGTGA AGAGGGAAAT GCGCTCTCTT ACCAAAACAG 15060
TTTTAAATAA AATGTCTTTG GAAATGGCGT TTTACATGTC ACCACGAGCG TGGAAAAACG 15120
CTGAATGGTT AGAACTAAAA TTTTCACCTG TGAAAATCTT TAGAGATCTG CTATTAGACG 15180
TGGAAACGCT CAACGAATTG TGCGCCGAAG ATGATGTTCA CGTCGACAAA GTAAATGAGA 15240
ATGGGGACGA AAATCACGAC CTCGAACTCC AAGACGAATG TTAAACATTG GTTAAGTTTA 15300 ACGAAAATGA TTAGTAAATA ATAAATCGAA CGTGGGTGTA TCTACCTGAC GTATCAACTT 15360
AAGCTGTTAC TGAGTAATTA AACCAACAAG TGTTGGTGTA ATGTGTATGT TGATGTAGAG 15420
AAAAATCCGT TTGTAGAACG GTGTTTTTCT CTTCTTTATT TTTAAAAAAA AAATAAAAAA 15480
AAAAAAAAAA AAGCGGCCGC 15500 (2) INFORMATION FOR SEQ ID NO : 2 :
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 7920 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS : single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: cDNA
(xi) SEQUENCE DESCRIPTION: SEQ ID NO : 2 :
ACATTGCGAG AGAACCCCAT TAGCGTCTCC GGGGTGAACT TGGGAAGGTC TGCCGCCGCT 60
CAGGTTATTT ATTTCGGCAG TTTCACGCAG CCCTTCGCGT TGTATCCGCG CCAAGAGAGC 120
GCGATCGTAA AAACGCAACT TCCACCGGTC AGTGTAGTGA AGGTGGAGTG CGTAGCTGCG 180
GAGGTAGCTC CCGACAGGGG CGTGGTCGAC AAGAAACCTA CGTCTGTTGG CGTTCCCCCG 240
CAGCGCGGTG TGCTTTCTTT TCCGACGGTG GTTCGGAACC GCGGCGACGT GATAATCACA 300
GGGGTGGTGC ATGAAGCCCT GAAGAAAATT AAAGACGGGC TCTTACGCTT CCGCGTAGGC 360
GGTGACATGC GTTTTTCGAG ATTTTTCTCA TCGAACTACG GCTGCAGATT CGTCGCGAGC 420
GTGCGTACGA ACACTACAGT TTGGCTAAAT TGCACGAAAG CGAGTGGTGA GAAATTCTCA 480
CTCGCCGCCG CGTGCACGGC GGATTACGTG GCGATGCTGC GTTATGTGTG TGGCGGGAAA 540
TTTCCACTCG TCCTCATGAG TAGAGTTATT TACCCGGATG GGCGCTGTTA CTTGGCCCAT 600
ATGAGGTATT TGTGCGCCTT TTACTGTCGC CCGTTTAGAG AGTCGGATTA TGCCCTCGGA 660
ATGTGGCCTA CGGTGGCGCG TCTCAGGGCA TGCGTTGAGA AGAACTTCGG TGTCGAAGCT 720
TGTGGCATAG CTCTTCGTGG CTATTACACC TCTCGCAATG TTTATCACTG TGATTATGAC 780
TCTGCTTATG TAAAATATTT TAGAAACCTT TCCGGCCGCA TTGGCGGTGG TTCGTTCGAT 840
CCGACATCTT TAACCTCCGT AATAACGGTG AAGATTAGCG GTCTTCCAGG TGGTCTTCCT 900
AAAAATATAG CGTTTGGTGC CTTCCTGTGC GATATACGTT ACGTCGAACC GGTAGACTCG 960
GGCGGCATTC AATCGAGCGT TAAGACGAAA CGTGAAGATG CGCACCGAAC CGTAGAGGAA 1020
CGGGCGGCCG GCGGATCCGT CGAGCAACCG CGACAAAAGA GGATAGATGA GAAAGGTTGC 1080 GGCAGAGTTC CTAGTGGAGG TTTTTCGCAT CTCCTGGTCG GCAACCTTAA CGAAGTTAGG 1140
AGGAAGGTAG CTGCCGGACT TCTACGCTTT CGCGTTGGCG GTGATATGGA TTTTCATCGC 1200
TCGTTCTCCA CCCAAGCGGG CCACCGCTTG CTGGTGTGGC GCCGCTCGAG CCGGAGCGTG 1260
TGCCTTGAAC TTTACTCACC ATCTAAAAAC TTTTTGCGTT ACGATGTCTT GCCCTGTTCT 1320
GGAGACTATG CAGCGATGTT TTCTTTCGCG GCGGGCGGCC GTTTCCCTTT AGTTTTGATG 1380
ACTAGAATTA GATACCCGAA CGGGTTTTGT TACTTGGCTC ACTGCCGGTA CGCGTGCGCG 1440
TTTCTCTTAA GGGGTTTTGA TCCGAAGCGT TTCGACATCG GTGCTTTCCC CACCGCGGCC 1500
AAGCTCAGAA ACCGTATGGT TTCGGAGCTT GGTGAAAGAA GTTTAGGTTT GAACTTGTAC 1560
GGCGCATATA CGTCACGCGG CGTCTTTCAC TGCGATTATG ACGCTAAGTT TATAAAGGAT 1620
TTGCGTCTTA TGTCAGCAGT TATAGCTGGA AAGGACGGGG TGGAAGAGGT GGTACCTTCT 1680
GACATAACTC CTGCCATGAA GCAGAAAACG ATCGAAGCCG TGTATGATAG ATTATATGGC 1740
GGCACTGACT CGTTGCTGAA ACTGAGCATC GAGAAAGACT TAATCGATTT CAAAAATGAC 1800
GTGCAGAGTT TGAAGAAAGA TCGGCCGATT GTCAAAGTGC CCTTTTACAT GTCGGAAGCA 1860
ACACAGAATT CGCTGACGCG TTTCTACCCT CAGTTCGAAC TTAAGTTTTC GCACTCCTCG 1920
CATTCAGATC ATCCCGCCGC CGCCGCTTCT AGACTGCTGG AAAATGAAAC GTTAGTGCGC 1980
TTATGTGGTA ATAGCGTTTC AGATATTGGA GGTTGTCCTC TTTTCCATTT GCATTCCAAG 2040
ACGCAAAGAC GGGTTCACGT ATGTAGGCCT GTGTTGGATG GCAAGGATGC GCAGCGTCGC 2100
GTGGTGCGTG ATTTGCAGTA TTCCAACGTG CGTTTGGGAG ACGATGATAA AATTTTGGAA 2160
GGGCCACGCA ATATCGACAT TTGCCACTAT CCTCTGGGCG CGTGTGACCA CGAAAGTAGT 2220
GCTATGATGA TGGTGCAGGT GTATGACGCG TCCCTTTATG AGATATGTGG CGCCATGATC 2280
AAGAAGAAAA GCCGCATAAC GTACTTAACC ATGGTCACGC CCGGCGAGTT TCTTGACGGA 2340
CGCGAATGCG TCTACATGGA GTCGTTAGAC TGTGAGATTG AAGTTGATGT GCACGCGGAC 2400
GTCGTAATGT ACAAATTCGG TAGTTCTTGC TATTCGCACA AGCTTTCAAT CATCAAGGAC 2460
ATCATGACCA CTCCGTACTT GACACTAGGT GGTTTTCTAT TCAGCGTGGA GATGTATGAG 2520
GTGCGTATGG GCGTGAATTA CTTCAAGATT ACGAAGTCCG AAGTATCGCC TAGCATTAGC 2580
TGCACCAAGC TCCTGAGATA CCGAAGAGCT AATAGTGACG TGGTTAAAGT TAAACTTCCA 2640
CGTTTCGATA AGAAACGTCG CATGTGTCTG CCTGGGTATG ACACCATATA CCTAGATTCG 2700
AAGTTTGTGA GTCGCGTTTT CGATTATGTC GTGTGTAATT GCTCTGCCGT GAACTCAAAA 2760 ACTTTCGAGT GGGTGTGGAG TTTCATTAAG TCTAGTAAGT CGAGGGTGAT TATTAGCGGT 2820
AAAATAATTC ACAAGGATGT GAATTTGGAC CTCAAGTACG TCGAGAGTTT CGCCGCGGTT 2880
ATGTTGGCCT CTGGCGTGCG CAGTAGACTA GCGTCCGAGT ACCTTGCTAA GAACCTTAGT 2940
CATTTTTCGG GAGATTGCTC CTTTATTGAA GCCACGTCTT TCGTGTTGCG TGAGAAAATC 3000
AGAAACATGA CTCTGAATTT TAACGAAAGA CTTTTACAGT TAGTGAAGCG CGTTGCCTTT 3060
GCGACCTTGG ACGTGAGTTT TCTAGATTTA GATTCAACTC TTGAATCAAT AACTGATTTT 3120
GCCGAGTGTA AGGTAGCGAT TGAACTCGAC GAGTTGGGTT GCTTGAGAGC GGAGGCCGAG 3180
AATGAAAAAA TCAGGAATCT GGCGGGAGAT TCGATTGCGG CTAAACTCGC GAGCGAGATA 3240
GTGGTCGATA TTGACTCTAA GCCTTCACCG AAGCAGGTGG GTAATTCGTC ATCCGAAAAC 3300
GCCGATAAGC GGGAAGTTCA GAGGCCCGGT TTGCGTGGTG GTTCTAGAAA CGGGGTTGTT 3360
GGGGAGTTCC TTCACTTCGT CGTGGATTCT GCCTTGCGTC TTTTCAAATA CGCGACGGAT 3420
CAACAACGGA TCAAGTCTTA CGTGCGTTTC TTGGACTCGG CGGTCTCATT CTTGGATTAC 3480
AACTACGATA ATCTATCGTT TATACTGCGA GTGCTTTCGG AAGGTTATTC GTGTATGTTC 3540
GCGTTTTTGG CGAATCGCGG CGACTTATCT AGTCGTGTCC GTAGCGCGGT GTGTGCTGTG 3600
AAAGAAGTTG CTACCTCATG CGCGAACGCG AGCGTTTCTA AAGCCAAGGT TATGATTACC 3660
TTCGCAGCGG CCGTGTGTGC TATGATGTTT AATAGCTGCG GTTTTTCAGG CGACGGTCGG 3720
GAGTATAAAT CGTATATACA TCGTTACACG CAAGTATTGT TTGACACTAT CTTTTTTGAG 3780
GACAGCAGTT ACCTACCCAT AGAAGTTCTG AGTTCGGCGA TATGCGGTGC TATCGTCACA 3840
CTTTTCTCCT CGGGCTCGTC CATAAGTTTA AACGCCTTCT TACTTCAAAT TACCAAAGGA 3900
TTCTCCCTAG AGGTTGTCGT CCGGAATGTT GTGCGAGTCA CGCATGGTTT GAGCACCACA 3960
GCGACCGACG GCGTCATACG TGGGGTTTTC TCCCAAATTG TGTCTCACTT ACTTGTTGGA 4020
AATACGGGTA ATGTGGCTTA CCAGTCAGCT TTCATTGCCG GGGTGGTGCC TCTTTTAGTT 4080
AAAAAGTGTG TGAGCTTAAT CTTCATCTTG CGTGAAGATA CTTATTCCGG TTTTATTAAG 4140
CACGGAATCA GTGAATTCTC TTTCCTTAGT AGTATTCTGA AGTTCTTGAA GGGTAAGCTT 4200
GTGGACGAGT TGAAATCGAT TATTCAAGGG GTTTTTGATT CCAACAAGCA CGTGTTTAAA 4260
GAAGCTACTC AGGAAGCGAT TCGTACGACG GTCATGCAAG TGCCTGTCGC TGTAGTGGAT 4320
GCCCTTAAGA GCGCCGCGGG AAAAATTTAT AACAATTTTA CTAGTCGACG TACCTTTGGT 4380
AAGGATGAAG GCTCCTCTAG CGACGGCGCA TGTGAAGAGT ATTTCTCATG CGACGAAGGT 4440
GAAGGTCCGG GTCTGAAAGG GGGTTCCAGC TATGGCTTCT CAATTTTAGC GTTCTTTTCA 4500 CGCATTATGT GGGGAGCTCG TCGGCTTATT GTTAAGGTGA AGCATGAGTG TTTTGGGAAA 4560
CTTTTTGAAT TTCTATCGCT CAAGCTTCAC GAATTCAGGA CTCGCGTTTT TGGGAAGAAT 4620
AGAACGGACG TGGGAGTTTA CGATTTTTTG CCCACGGGCA TCGTGGAAAC GCTCTCATCG 4680
ATAGAAGAGT GCGACCAAAT TGAAGAACTT CTCGGCGACG ACCTGAAAGG TGACAAGGAT 4740
GCTTCGTTGA CCGATATGAA TTACTTTGAG TTCTCAGAAG ACTTCTTAGC CTCTATCGAG 4800
GAGCCGCCTT TCGCTGGATT GCGAGGAGGT AGCAAGAACA TCGCGATTTT GGCGATTTTG 4860
GAATACGCGC ATAATTTGTT TCGCATTGTC GCAAGCAAGT GTTCGAAACG ACCTTTATTT 4920
CTTGCTTTCG CCGAACTCTC AAGCGCCCTT ATCGAGAAAT TTAAGGAGGT TTTCCCTCGT 4980
AAGAGCCAGC TCGTCGCTAT CGTGCGCGAG TATACTCAGA GATTCCTCCG AAGTCGCATG 5040
CGTGCGTTGG GTTTGAATAA CGAGTTCGTG GTAAAATCTT TCGCCGATTT GCTACCCGCA 5100
TTAATGAAGC GGAAGGTTTC AGGTTCGTTC TTAGCTAGTG TTTATCGCCC ACTTAGAGGT 5160
TTCTCATATA TGTGTGTTTC AGCGGAGCGA CGTGAAAAGT TTTTTGCTCT CGTGTGTTTA 5220
ATCGGGTTAA GTCTCCCTTT CTTCGTGCGC ATCGTAGGAG CGAAAGCGTG CGAAGAACTC 5280
GTGTCCTCAG CGCGTCGCTT TTATGAGCGT ATTAAAATTT TTCTAAGGCA GAAGTATGTC 5340
TCTCTTTCTA ATTTCTTTTG TCACTTGTTT AGCTCTGACG TTGATGACAG TTCCGCATCT 5400
GCAGGGTTGA AAGGTGGTGC GTCGCGAATG ACGCTCTTCC ACCTTCTGGT TCGCCTTGCT 5460
AGTGCCCTCC TATCGTTAGG GTGGGAAGGG TTAAAGCTAC TCTTATCGCA CCACAACTTG 5520
TTATTTTTGT GTTTTGCATT GGTTGACGAT GTGAACGTCC TTATCAAAGT TCTTGGGGGT 5580
CTTTCTTTCT TTGTGCAACC AATCTTTTCC TTGTTTGCGG CGATGCTTCT ACAACCGGAC 5640
AGGTTTGTGG AGTATTCCGA GAAACTTGTT ACAGCGTTTG AATTTTTCTT AAAATGTTCG 5700
CCTCGCGCGC CTGCACTACT CAAAGGGTTT TTTGAGTGCG TGGCGAACAG CACTGTGTCA 5760
AAAACCGTTC GAAGACTTCT TCGCTGTTTC GTGAAGATGC TCAAACTTCG AAAAGGGCGA 5820
GGGTTGCGTG CGGATGGTAG GGGTCTCCAT CGGCAGAAAG CCGTACCCGT CATACCTTCT 5880
AATCGGGTCG TGACCGACGG GGTTGAAAGA CTTTCGGTAA AGATGCAAGG AGTTGAAGCG 5940
TTGCGTACCG AATTGAGAAT CTTAGAAGAT TTAGATTCTG CCGTGATCGA AAAACTCAAT 6000
AGACGCAGAA ATCGTGACAC TAATGACGAC GAATTTACGC GCCCTGCTCA TGAGCAGATG 6060
CAAGAAGTCA CCACTTTCTG TTCGAAAGCC AACTCTGCTG GTTTGGCCCT GGAAAGGGCA 6120
GTGCTTGTGG AAGACGCTAT AAAGTCGGAG AAACTTTCTA AGACGGTTAA TGAGATGGTG 6180 AGGAAAGGGA GTACCACCAG CGAAGAAGTG GCCGTCGCTT TGTCGGACGA TGAAGCCGTG 6240
GAAGAAATCT CTGTTGCTGA CGAGCGAGAC GATTCGCCTA AGACAGTCAG GATAAGCGAA 6300
TACCTAAATA GGTTAAACTC AAGCTTCGAA TTCCCGAAGC CTATTGTTGT GGACGACAAC 6360
AAGGATACCG GGGGTCTAAC GAACGCCGTG AGGGAGTTTT ATTATATGCA AGAACTTGCT 6420
CTTTTCGAAA TCCACAGCAA ACTGTGCACC TACTACGATC AACTGCGCAT AGTCAACTTC 6480
GATCGTTCCG TAGCACCATG CAGCGAAGAT GCTCAGCTGT ACGTACGGAA GAACGGCTCA 6540
ACGATAGTGC AGGGTAAAGA GGTACGTTTG CACATTAAGG ATTTCCACGA TCACGATTTC 6600
CTGTTTGACG GAAAAATTTC TATTAACAAG CGGCGGCGAG GCGGAAATGT TTTATATCAC 6660
GACAACCTCG CGTTCTTGGC GAGTAATTTG TTCTTAGCCG GCTACCCCTT TTCAAGGAGC 6720
TTCGTCTTCA CGAATTCGTC GGTCGATATT CTCCTCTACG AAGCTCCACC CGGAGGTGGT 6780
AAGACGACGA CGCTGATTGA CTCGTTCTTG AAGGTCTTCA AGAAAGGTGA GGTTTCCACC 6840
ATGATCTTAA CCGCCAACAA AAGTTCGCAG GTTGAGATCC TAAAGAAAGT GGAGAAGGAA 6900
GTGTCTAACA TTGAATGCCA GAAACGTAAA GACAAAAGAT CTCCGAAAAA GAGCATTTAC 6960
ACCATCGACG CTTATTTAAT GCATCACCGT GGTTGTGATG CAGACGTTCT TTTCATCGAT 7020
GAGTGTTTCA TGGTTCATGC GGGTAGCGTA CTAGCTTGCA TTGAGTTCAC GAGGTGTCAT 7080
AAAGTAATGA TCTTCGGGGA TAGCCGGCAG ATTCACTACA TTGAAAGGAA CGAATTGGAC 7140
AAGTGTTTGT ATGGGGATCT CGACAGGTTC GTGGACCTGC AGTGTCGGGT TTATGGTAAT 7200
ATTTCGTACC GTTGTCCATG GGATGTGTGC GCTTGGTTAA GCACAGTGTA TGGCAACCTA 7260
ATCGCCACCG TGAAGGGTGA AAGCGAAGGT AAGAGCAGCA TGCGCATTAA CGAAATTAAT 7320
TCAGTCGACG ATTTAGTCCC CGACGTGGGT TCCACGTTTC TGTGTATGCT TCAGTCGGAG 7380
AAGTTGGAAA TCAGCAAGCA CTTTATTCGC AAGGGTTTGA CTAAACTTAA CGTTCTAACG 7440
GTGCATGAGG CGCAAGGTGA GACGTATGCG CGTGTGAACC TTGTGCGACT TAAGTTTCAG 7500
GAGGATGAAC CCTTTAAATC TATCAGGCAC ATAACCGTCG CTCTTTCTCG TCACACCGAC 7560
AGCTTAACTT ATAACGTCTT AGCTGCTCGT CGAGGTGACG CCACTTGCGA TGCCATCCAG 7620
AAGGCTGCGG AATTGGTGAA CAAGTTTCGC GTTTTTCCTA CATCTTTTGG TGGTAGTGTT 7680
ATCAATCTCA ACGTGAAGAA GGACGTGGAA GATAACAGTA GGTGCAAGGC TTCGTCGGCA 7740
CCATTGAGCG TAATCAACGA CTTTTTGAAC GAAGTTAATC CCGGTACTGC GGTGATTGAT 7800
TTTGGTGATT TGTCCGCGGA CTTCAGTACT GGGCCTTTTG AGTGCGGTGC CAGCGGTATT 7860
GTGGTGCGGG ACAACATCTC CTCCAGCAAC ATCACTGATC ACGATAAGCA GCGTGTTTAG 7920 (2) INFORMATION FOR SEQ ID NO : 3 :
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 2639 amino acids
(B) TYPE: amino acid
(C) STRANDEDNESS :
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: protein
(xi) SEQUENCE DESCRIPTION: SEQ ID NO : 3 :
Thr Leu Arg Glu Asn Pro lie Ser Val Ser Gly Val Asn Leu Gly Arg 1 5 10 15
Ser Ala Ala Ala Gin Val lie Tyr Phe Gly Ser Phe Thr Gin Pro Phe 20 25 30
Ala Leu Tyr Pro Arg Gin Glu Ser Ala lie Val Lys Thr Gin Leu Pro 35 40 45
Pro Val Ser Val Val Lys Val Glu Cys Val Ala Ala Glu Val Ala Pro 50 55 60
Asp Arg Gly Val Val Asp Lys Lys Pro Thr Ser Val Gly Val Pro Pro 65 70 75 80
Gin Arg Gly Val Leu Ser Phe Pro Thr Val Val Arg Asn Arg Gly Asp 85 90 95
Val lie lie Thr Gly Val Val His Glu Ala Leu Lys Lys lie Lys Asp 100 105 110
Gly Leu Leu Arg Phe Arg Val Gly Gly Asp Met Arg Phe Ser Arg Phe 115 120 125
Phe Ser Ser Asn Tyr Gly Cys Arg Phe Val Ala Ser Val Arg Thr Asn 130 135 140
Thr Thr Val Trp Leu Asn Cys Thr Lys Ala Ser Gly Glu Lys Phe Ser 145 150 155 160
Leu Ala Ala Ala Cys Thr Ala Asp Tyr Val Ala Met Leu Arg Tyr Val 165 170 175
Cys Gly Gly Lys Phe Pro Leu Val Leu Met Ser Arg Val lie Tyr Pro 180 185 190
Asp Gly Arg Cys Tyr Leu Ala His Met Arg Tyr Leu Cys Ala Phe Tyr 195 200 205
Cys Arg Pro Phe Arg Glu Ser Asp Tyr Ala Leu Gly Met Trp Pro Thr 210 215 220 Val Ala Arg Leu Arg Ala Cys Val Glu Lys Asn Phe Gly Val Glu Ala 225 230 235 240
Cys Gly lie Ala Leu Arg Gly Tyr Tyr Thr Ser Arg Asn Val Tyr His 245 250 255
Cys Asp Tyr Asp Ser Ala Tyr Val Lys Tyr Phe Arg Asn Leu Ser Gly 260 265 270
Arg lie Gly Gly Gly Ser Phe Asp Pro Thr Ser Leu Thr Ser Val lie 275 280 285
Thr Val Lys lie Ser Gly Leu Pro Gly Gly Leu Pro Lys Asn lie Ala 290 295 300
Phe Gly Ala Phe Leu Cys Asp He Arg Tyr Val Glu Pro Val Asp Ser 305 310 315 320
Gly Gly He Gin Ser Ser Val Lys Thr Lys Arg Glu Asp Ala His Arg 325 330 335
Thr Val Glu Glu Arg Ala Ala Gly Gly Ser Val Glu Gin Pro Arg Gin 340 345 350
Lys Arg He Asp Glu Lys Gly Cys Gly Arg Val Pro Ser Gly Gly Phe 355 360 365
Ser His Leu Leu Val Gly Asn Leu Asn Glu Val Arg Arg Lys Val Ala 370 375 380
Ala Gly Leu Leu Arg Phe Arg Val Gly Gly Asp Met Asp Phe His Arg 385 390 395 400
Ser Phe Ser Thr Gin Ala Gly His Arg Leu Leu Val Trp Arg Arg Ser 405 410 415
Ser Arg Ser Val Cys Leu Glu Leu Tyr Ser Pro Ser Lys Asn Phe Leu 420 425 430
Arg Tyr Asp Val Leu Pro Cys Ser Gly Asp Tyr Ala Ala Met Phe Ser 435 440 445
Phe Ala Ala Gly Gly Arg Phe Pro Leu Val Leu Met Thr Arg He Arg 450 455 460
Tyr Pro Asn Gly Phe Cys Tyr Leu Ala His Cys Arg Tyr Ala Cys Ala 465 470 475 480
Phe Leu Leu Arg Gly Phe Asp Pro Lys Arg Phe Asp He Gly Ala Phe 485 490 495
Pro Thr Ala Ala Lys Leu Arg Asn Arg Met Val Ser Glu Leu Gly Glu 500 505 510
Arg Ser Leu Gly Leu Asn Leu Tyr Gly Ala Tyr Thr Ser Arg Gly Val 515 520 525 Phe His Cys Asp Tyr Asp Ala Lys Phe He Lys Asp Leu Arg Leu Met 530 535 540
Ser Ala Val He Ala Gly Lys Asp Gly Val Glu Glu Val Val Pro Ser 545 550 555 560
Asp He Thr Pro Ala Met Lys Gin Lys Thr He Glu Ala Val Tyr Asp 565 570 575
Arg Leu Tyr Gly Gly Thr Asp Ser Leu Leu Lys Leu Ser He Glu Lys 580 585 590
Asp Leu He Asp Phe Lys Asn Asp Val Gin Ser Leu Lys Lys Asp Arg 595 600 605
Pro He Val Lys Val Pro Phe Tyr Met Ser Glu Ala Thr Gin Asn Ser 610 615 620
Leu Thr Arg Phe Tyr Pro Gin Phe Glu Leu Lys Phe Ser His Ser Ser 625 630 635 640
His Ser Asp His Pro Ala Ala Ala Ala Ser Arg Leu Leu Glu Asn Glu 645 650 655
Thr Leu Val Arg Leu Cys Gly Asn Ser Val Ser Asp He Gly Gly Cys 660 665 670
Pro Leu Phe His Leu His Ser Lys Thr Gin Arg Arg Val His Val Cys 675 680 685
Arg Pro Val Leu Asp Gly Lys Asp Ala Gin Arg Arg Val Val Arg Asp 690 695 700
Leu Gin Tyr Ser Asn Val Arg Leu Gly Asp Asp Asp Lys He Leu Glu 705 710 715 720
Gly Pro Arg Asn He Asp He Cys His Tyr Pro Leu Gly Ala Cys Asp 725 730 735
His Glu Ser Ser Ala Met Met Met Val Gin Val Tyr Asp Ala Ser Leu 740 745 750
Tyr Glu He Cys Gly Ala Met He Lys Lys Lys Ser Arg He Thr Tyr 755 760 765
Leu Thr Met Val Thr Pro Gly Glu Phe Leu Asp Gly Arg Glu Cys Val 770 775 780
Tyr Met Glu Ser Leu Asp Cys Glu He Glu Val Asp Val His Ala Asp 785 790 795 800
Val Val Met Tyr Lys Phe Gly Ser Ser Cys Tyr Ser His Lys Leu Ser 805 810 815
He He Lys Asp He Met Thr Thr Pro Tyr Leu Thr Leu Gly Gly Phe 820 825 830 Leu Phe Ser Val Glu Met Tyr Glu Val Arg Met Gly Val Asn Tyr Phe 835 840 845
Lys He Thr Lys Ser Glu Val Ser Pro Ser He Ser Cys Thr Lys Leu 850 855 860
Leu Arg Tyr Arg Arg Ala Asn Ser Asp Val Val Lys Val Lys Leu Pro 865 870 875 880
Arg Phe Asp Lys Lys Arg Arg Met Cys Leu Pro Gly Tyr Asp Thr He 885 890 895
Tyr Leu Asp Ser Lys Phe Val Ser Arg Val Phe Asp Tyr Val Val Cys 900 905 910
Asn Cys Ser Ala Val Asn Ser Lys Thr Phe Glu Trp Val Trp Ser Phe 915 920 925
He Lys Ser Ser Lys Ser Arg Val He He Ser Gly Lys He He His 930 935 940
Lys Asp Val Asn Leu Asp Leu Lys Tyr Val Glu Ser Phe Ala Ala Val 945 950 955 960
Met Leu Ala Ser Gly Val Arg Ser Arg Leu Ala Ser Glu Tyr Leu Ala 965 970 975
Lys Asn Leu Ser His Phe Ser Gly Asp Cys Ser Phe He Glu Ala Thr 980 985 990
Ser Phe Val Leu Arg Glu Lys He Arg Asn Met Thr Leu Asn Phe Asn 995 1000 1005
Glu Arg Leu Leu Gin Leu Val Lys Arg Val Ala Phe Ala Thr Leu Asp 1010 1015 1020
Val Ser Phe Leu Asp Leu Asp Ser Thr Leu Glu Ser He Thr Asp Phe 1025 1030 1035 1040
Ala Glu Cys Lys Val Ala He Glu Leu Asp Glu Leu Gly Cys Leu Arg 1045 1050 1055
Ala Glu Ala Glu Asn Glu Lys He Arg Asn Leu Ala Gly Asp Ser He 1060 1065 1070
Ala Ala Lys Leu Ala Ser Glu He Val Val Asp He Asp Ser Lys Pro 1075 1080 1085
Ser Pro Lys Gin Val Gly Asn Ser Ser Ser Glu Asn Ala Asp Lys Arg 1090 1095 1100
Glu Val Gin Arg Pro Gly Leu Arg Gly Gly Ser Arg Asn Gly Val Val 1105 1110 1115 1120
Gly Glu Phe Leu His Phe Val Val Asp Ser Ala Leu Arg Leu Phe Lys 1125 1130 1135 Tyr Ala Thr Asp Gin Gin Arg He Lys Ser Tyr Val Arg Phe Leu Asp 1140 1145 1150
Ser Ala Val Ser Phe Leu Asp Tyr Asn Tyr Asp Asn Leu Ser Phe He 1155 1160 1165
Leu Arg Val Leu Ser Glu Gly Tyr Ser Cys Met Phe Ala Phe Leu Ala 1170 1175 1180
Asn Arg Gly Asp Leu Ser Ser Arg Val Arg Ser Ala Val Cys Ala Val 1185 1190 1195 1200
Lys Glu Val Ala Thr Ser Cys Ala Asn Ala Ser Val Ser Lys Ala Lys 1205 1210 1215
Val Met He Thr Phe Ala Ala Ala Val Cys Ala Met Met Phe Asn Ser 1220 1225 1230
Cys Gly Phe Ser Gly Asp Gly Arg Glu Tyr Lys Ser Tyr He His Arg 1235 1240 1245
Tyr Thr Gin Val Leu Phe Asp Thr He Phe Phe Glu Asp Ser Ser Tyr 1250 1255 1260
Leu Pro He Glu Val Leu Ser Ser Ala He Cys Gly Ala He Val Thr 1265 1270 1275 1280
Leu Phe Ser Ser Gly Ser Ser He Ser Leu Asn Ala Phe Leu Leu Gin 1285 1290 1295
He Thr Lys Gly Phe Ser Leu Glu Val Val Val Arg Asn Val Val Arg 1300 1305 1310
Val Thr His Gly Leu Ser Thr Thr Ala Thr Asp Gly Val He Arg Gly 1315 1320 1325
Val Phe Ser Gin He Val Ser His Leu Leu Val Gly Asn Thr Gly Asn 1330 1335 1340
Val Ala Tyr Gin Ser Ala Phe He Ala Gly Val Val Pro Leu Leu Val 1345 1350 1355 1360
Lys Lys Cys Val Ser Leu He Phe He Leu Arg Glu Asp Thr Tyr Ser 1365 1370 1375
Gly Phe He Lys His Gly He Ser Glu Phe Ser Phe Leu Ser Ser He 1380 1385 1390
Leu Lys Phe Leu Lys Gly Lys Leu Val Asp Glu Leu Lys Ser He He 1395 1400 1405
Gin Gly Val Phe Asp Ser Asn Lys His Val Phe Lys Glu Ala Thr Gin 1410 1415 1420
Glu Ala He Arg Thr Thr Val Met Gin Val Pro Val Ala Val Val Asp 1425 1430 1435 1440 Ala Leu Lys Ser Ala Ala Gly Lys He Tyr Asn Asn Phe Thr Ser Arg 1445 1450 1455
Arg Thr Phe Gly Lys Asp Glu Gly Ser Ser Ser Asp Gly Ala Cys Glu 1460 1465 1470
Glu Tyr Phe Ser Cys Asp Glu Gly Glu Gly Pro Gly Leu Lys Gly Gly 1475 1480 1485
Ser Ser Tyr Gly Phe Ser He Leu Ala Phe Phe Ser Arg He Met Trp 1490 1495 1500
Gly Ala Arg Arg Leu He Val Lys Val Lys His Glu Cys Phe Gly Lys 1505 1510 1515 1520
Leu Phe Glu Phe Leu Ser Leu Lys Leu His Glu Phe Arg Thr Arg Val 1525 1530 1535
Phe Gly Lys Asn Arg Thr Asp Val Gly Val Tyr Asp Phe Leu Pro Thr 1540 1545 1550
Gly He Val Glu Thr Leu Ser Ser He Glu Glu Cys Asp Gin He Glu 1555 1560 1565
Glu Leu Leu Gly Asp Asp Leu Lys Gly Asp Lys Asp Ala Ser Leu Thr 1570 1575 1580
Asp Met Asn Tyr Phe Glu Phe Ser Glu Asp Phe Leu Ala Ser He Glu 1585 1590 1595 1600
Glu Pro Pro Phe Ala Gly Leu Arg Gly Gly Ser Lys Asn He Ala He 1605 1610 1615
Leu Ala He Leu Glu Tyr Ala His Asn Leu Phe Arg He Val Ala Ser 1620 1625 1630
Lys Cys Ser Lys Arg Pro Leu Phe Leu Ala Phe Ala Glu Leu Ser Ser 1635 1640 1645
Ala Leu He Glu Lys Phe Lys Glu Val Phe Pro Arg Lys Ser Gin Leu 1650 1655 1660
Val Ala He Val Arg Glu Tyr Thr Gin Arg Phe Leu Arg Ser Arg Met 1665 1670 1675 1680
Arg Ala Leu Gly Leu Asn Asn Glu Phe Val Val Lys Ser Phe Ala Asp 1685 1690 1695
Leu Leu Pro Ala Leu Met Lys Arg Lys Val Ser Gly Ser Phe Leu Ala 1700 1705 1710
Ser Val Tyr Arg Pro Leu Arg Gly Phe Ser Tyr Met Cys Val Ser Ala 1715 1720 1725
Glu Arg Arg Glu Lys Phe Phe Ala Leu Val Cys Leu He Gly Leu Ser 1730 1735 1740 Leu Pro Phe Phe Val Arg He Val Gly Ala Lys Ala Cys Glu Glu Leu 1745 1750 1755 1760
Val Ser Ser Ala Arg Arg Phe Tyr Glu Arg He Lys He Phe Leu Arg 1765 1770 1775
Gin Lys Tyr Val Ser Leu Ser Asn Phe Phe Cys His Leu Phe Ser Ser 1780 1785 1790
Asp Val Asp Asp Ser Ser Ala Ser Ala Gly Leu Lys Gly Gly Ala Ser 1795 1800 1805
Arg Met Thr Leu Phe His Leu Leu Val Arg Leu Ala Ser Ala Leu Leu 1810 1815 1820
Ser Leu Gly Trp Glu Gly Leu Lys Leu Leu Leu Ser His His Asn Leu 1825 1830 1835 1840
Leu Phe Leu Cys Phe Ala Leu Val Asp Asp Val Asn Val Leu He Lys 1845 1850 1855
Val Leu Gly Gly Leu Ser Phe Phe Val Gin Pro He Phe Ser Leu Phe 1860 1865 1870
Ala Ala Met Leu Leu Gin Pro Asp Arg Phe Val Glu Tyr Ser Glu Lys 1875 1880 1885
Leu Val Thr Ala Phe Glu Phe Phe Leu Lys Cys Ser Pro Arg Ala Pro 1890 1895 1900
Ala Leu Leu Lys Gly Phe Phe Glu Cys Val Ala Asn Ser Thr Val Ser 1905 1910 1915 1920
Lys Thr Val Arg Arg Leu Leu Arg Cys Phe Val Lys Met Leu Lys Leu 1925 1930 1935
Arg Lys Gly Arg Gly Leu Arg Ala Asp Gly Arg Gly Leu His Arg Gin 1940 1945 1950
Lys Ala Val Pro Val He Pro Ser Asn Arg Val Val Thr Asp Gly Val 1955 1960 1965
Glu Arg Leu Ser Val Lys Met Gin Gly Val Glu Ala Leu Arg Thr Glu 1970 1975 1980
Leu Arg He Leu Glu Asp Leu Asp Ser Ala Val He Glu Lys Leu Asn 1985 1990 1995 2000
Arg Arg Arg Asn Arg Asp Thr Asn Asp Asp Glu Phe Thr Arg Pro Ala 2005 2010 2015
His Glu Gin Met Gin Glu Val Thr Thr Phe Cys Ser Lys Ala Asn Ser 2020 2025 2030
Ala Gly Leu Ala Leu Glu Arg Ala Val Leu Val Glu Asp Ala He Lys 2035 2040 2045 Ser Glu Lys Leu Ser Lys Thr Val Asn Glu Met Val Arg Lys Gly Ser 2050 2055 2060
Thr Thr Ser Glu Glu Val Ala Val Ala Leu Ser Asp Asp Glu Ala Val 2065 2070 2075 2080
Glu Glu He Ser Val Ala Asp Glu Arg Asp Asp Ser Pro Lys Thr Val 2085 2090 2095
Arg He Ser Glu Tyr Leu Asn Arg Leu Asn Ser Ser Phe Glu Phe Pro 2100 2105 2110
Lys Pro He Val Val Asp Asp Asn Lys Asp Thr Gly Gly Leu Thr Asn 2115 2120 2125
Ala Val Arg Glu Phe Tyr Tyr Met Gin Glu Leu Ala Leu Phe Glu He 2130 2135 2140
His Ser Lys Leu Cys Thr Tyr Tyr Asp Gin Leu Arg He Val Asn Phe 2145 2150 2155 2160
Asp Arg Ser Val Ala Pro Cys Ser Glu Asp Ala Gin Leu Tyr Val Arg 2165 2170 2175
Lys Asn Gly Ser Thr He Val Gin Gly Lys Glu Val Arg Leu His He 2180 2185 2190
Lys Asp Phe His Asp His Asp Phe Leu Phe Asp Gly Lys He Ser He 2195 2200 2205
Asn Lys Arg Arg Arg Gly Gly Asn Val Leu Tyr His Asp Asn Leu Ala 2210 2215 2220
Phe Leu Ala Ser Asn Leu Phe Leu Ala Gly Tyr Pro Phe Ser Arg Ser 2225 2230 2235 2240
Phe Val Phe Thr Asn Ser Ser Val Asp He Leu Leu Tyr Glu Ala Pro 2245 2250 2255
Pro Gly Gly Gly Lys Thr Thr Thr Leu He Asp Ser Phe Leu Lys Val 2260 2265 2270
Phe Lys Lys Gly Glu Val Ser Thr Met He Leu Thr Ala Asn Lys Ser 2275 2280 2285
Ser Gin Val Glu He Leu Lys Lys Val Glu Lys Glu Val Ser Asn He 2290 2295 2300
Glu Cys Gin Lys Arg Lys Asp Lys Arg Ser Pro Lys Lys Ser He Tyr 2305 2310 2315 2320
Thr He Asp Ala Tyr Leu Met His His Arg Gly Cys Asp Ala Asp Val 2325 2330 2335
Leu Phe He Asp Glu Cys Phe Met Val His Ala Gly Ser Val Leu Ala 2340 2345 2350 Cys He Glu Phe Thr Arg Cys His Lys Val Met He Phe Gly Asp Ser 2355 2360 2365
Arg Gin He His Tyr He Glu Arg Asn Glu Leu Asp Lys Cys Leu Tyr 2370 2375 2380
Gly Asp Leu Asp Arg Phe Val Asp Leu Gin Cys Arg Val Tyr Gly Asn 2385 2390 2395 2400
He Ser Tyr Arg Cys Pro Trp Asp Val Cys Ala Trp Leu Ser Thr Val 2405 2410 2415
Tyr Gly Asn Leu He Ala Thr Val Lys Gly Glu Ser Glu Gly Lys Ser 2420 2425 2430
Ser Met Arg He Asn Glu He Asn Ser Val Asp Asp Leu Val Pro Asp 2435 2440 2445
Val Gly Ser Thr Phe Leu Cys Met Leu Gin Ser Glu Lys Leu Glu He 2450 2455 2460
Ser Lys His Phe He Arg Lys Gly Leu Thr Lys Leu Asn Val Leu Thr 2465 2470 2475 2480
Val His Glu Ala Gin Gly Glu Thr Tyr Ala Arg Val Asn Leu Val Arg 2485 2490 2495
Leu Lys Phe Gin Glu Asp Glu Pro Phe Lys Ser He Arg His He Thr 2500 2505 2510
Val Ala Leu Ser Arg His Thr Asp Ser Leu Thr Tyr Asn Val Leu Ala 2515 2520 2525
Ala Arg Arg Gly Asp Ala Thr Cys Asp Ala He Gin Lys Ala Ala Glu 2530 2535 2540
Leu Val Asn Lys Phe Arg Val Phe Pro Thr Ser Phe Gly Gly Ser Val 2545 2550 2555 2560
He Asn Leu Asn Val Lys Lys Asp Val Glu Asp Asn Ser Arg Cys Lys 2565 2570 2575
Ala Ser Ser Ala Pro Leu Ser Val He Asn Asp Phe Leu Asn Glu Val 2580 2585 2590
Asn Pro Gly Thr Ala Val He Asp Phe Gly Asp Leu Ser Ala Asp Phe 2595 2600 2605
Ser Thr Gly Pro Phe Glu Cys Gly Ala Ser Gly He Val Val Arg Asp 2610 2615 2620
Asn He Ser Ser Ser Asn He Thr Asp His Asp Lys Gin Arg Val 2625 2630 2635
(2) INFORMATION FOR SEQ ID NO : 4 (i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 1380 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS : single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: cDNA
(xi) SEQUENCE DESCRIPTION: SEQ ID NO : 4 :
AGCGTAGTTC GGTCGCAGGC GATTCCGCGT AGAAAACCTT CTCTACAAGA AAATTTGTAT 60
TCGTTTGAAG CGCGGAATTA TAACTTCTCG ACTTGCGACC GTAACACATC TGCTTCAATG 120
TTCGGAGAGG CTATGGCGAT GAACTGTCTT CGTCGTTGCT TCGACCTAGA TGCCTTTTCG 180
TCCCTGCGTG ATGATGTGAT TAGTATCACA CGTTCAGGCA TCGAACAATG GCTGGAGAAA 240
CGTACTCCTA GTCAGATTAA AGCATTAATG AAGGATGTTG AATCGCCTTT GGAAATTGAC 300
GATGAAATTT GTCGTTTTAA GTTGATGGTG AAGCGTGACG CTAAGGTGAA GTTAGACTCT 360
TCTTGTTTAA CTAAACACAG CGCCGCTCAA AATATCATGT TTCATCGCAA GAGCATTAAT 420
GCTATCTTCT CTCCTATCTT TAATGAGGTG AAAAACCGAA TAATGTGCTG TCTTAAGCCT 480
AACATAAAGT TTTTTACGGA GATGACTAAC AGGGATTTTG CTTCTGTTGT CAGCAACATG 540
CTTGGTGACG ACGATGTGTA CCATATAGGT GAAGTTGATT TCTCAAAGTA CGACAAGTCT 600
CAAGATGCTT TCGTGAAGGC TTTTGAAGAA GTAATGTATA AGGAACTCGG TGTTGATGAA 660
GAGTTGCTGG CTATCTGGAT GTGCGGCGAG CGGTTATCGA TAGCTAACAC TCTCGATGGT 720
CAGTTGTCCT TCACGATCGA GAATCAAAGG AAGTCGGGAG CTTCGAACAC TTGGATTGGT 780
AACTCTCTCG TCACTTTGGG TATTTTAAGT CTTTACTACG ACGTTAGAAA TTTCGAGGCG 840
TTGTACATCT CGGGCGATGA TTCTTTAATT TTTTCTCGCA GCGAGATTTC GAATTATGCC 900
GACGACATAT GCACTGACAT GGGTTTTGAG ACAAAATTTA TGTCCCCAAG TGTCCCGTAC 960
TTTTGTTCTA AATTTGTTGT TATGTGTGGT CATAAGACGT TTTTTGTTCC CGACCCGTAC 1020
AAGCTTTTTG TCAAGTTGGG AGCAGTCAAA GAGGATGTTT CAATGGATTT CCTTTTCGAG 1080
ACTTTTACCT CCTTTAAAGA CTTAACCTCC GATTTTAACG ACGAGCGCTT AATTCAAAAG 1140
CTCGCTGAAC TTGTGGCTTT AAAATATGAG GTTCAAACCG GCAACACCAC CTTGGCGTTA 1200
AGTGTGATAC ATTGTTTGCG TTCGAATTTC CTCTCGTTTA GCAAGTTATA TCCTCGCGTG 1260
AAGGGATGGC AGGTTTTTTA CACGTCGGTT AAGAAAGCGC TTCTCAAGAG TGGGTGTTCT 1320
CTCTTCGACA GTTTCATGAC CCCTTTTGGT CAGGCTGTCA TGGTTTGGGA TGATGAGTAG 1380 (2) INFORMATION FOR SEQ ID NO : 5 :
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 459 amino acids
(B) TYPE: amino acid
(C) STRANDEDNESS :
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: protein
(xi) SEQUENCE DESCRIPTION: SEQ ID NO : 5 :
Ser Val Val Arg Ser Gin Ala He Pro Arg Arg Lys Pro Ser Leu Gin 1 5 10 15
Glu Asn Leu Tyr Ser Phe Glu Ala Arg Asn Tyr Asn Phe Ser Thr Cys 20 25 30
Asp Arg Asn Thr Ser Ala Ser Met Phe Gly Glu Ala Met Ala Met Asn 35 40 45
Cys Leu Arg Arg Cys Phe Asp Leu Asp Ala Phe Ser Ser Leu Arg Asp 50 55 60
Asp Val He Ser He Thr Arg Ser Gly He Glu Gin Trp Leu Glu Lys 65 70 75 80
Arg Thr Pro Ser Gin He Lys Ala Leu Met Lys Asp Val Glu Ser Pro 85 90 95
Leu Glu He Asp Asp Glu He Cys Arg Phe Lys Leu Met Val Lys Arg 100 105 110
Asp Ala Lys Val Lys Leu Asp Ser Ser Cys Leu Thr Lys His Ser Ala 115 120 125
Ala Gin Asn He Met Phe His Arg Lys Ser He Asn Ala He Phe Ser 130 135 140
Pro He Phe Asn Glu Val Lys Asn Arg He Met Cys Cys Leu Lys Pro 145 150 155 160
Asn He Lys Phe Phe Thr Glu Met Thr Asn Arg Asp Phe Ala Ser Val 165 170 175
Val Ser Asn Met Leu Gly Asp Asp Asp Val Tyr His He Gly Glu Val 180 185 190
Asp Phe Ser Lys Tyr Asp Lys Ser Gin Asp Ala Phe Val Lys Ala Phe 195 200 205
Glu Glu Val Met Tyr Lys Glu Leu Gly Val Asp Glu Glu Leu Leu Ala 210 215 220
He Trp Met Cys Gly Glu Arg Leu Ser He Ala Asn Thr Leu Asp Gly 225 230 235 240
Gin Leu Ser Phe Thr He Glu Asn Gin Arg Lys Ser Gly Ala Ser Asn 245 250 255
Thr Trp He Gly Asn Ser Leu Val Thr Leu Gly He Leu Ser Leu Tyr 260 265 270
Tyr Asp Val Arg Asn Phe Glu Ala Leu Tyr He Ser Gly Asp Asp Ser 275 280 285
Leu He Phe Ser Arg Ser Glu He Ser Asn Tyr Ala Asp Asp He Cys 290 295 300
Thr Asp Met Gly Phe Glu Thr Lys Phe Met Ser Pro Ser Val Pro Tyr 305 310 315 320
Phe Cys Ser Lys Phe Val Val Met Cys Gly His Lys Thr Phe Phe Val 325 330 335
Pro Asp Pro Tyr Lys Leu Phe Val Lys Leu Gly Ala Val Lys Glu Asp 340 345 350
Val Ser Met Asp Phe Leu Phe Glu Thr Phe Thr Ser Phe Lys Asp Leu 355 360 365
Thr Ser Asp Phe Asn Asp Glu Arg Leu He Gin Lys Leu Ala Glu Leu 370 375 380
Val Ala Leu Lys Tyr Glu Val Gin Thr Gly Asn Thr Thr Leu Ala Leu 385 390 395 400
Ser Val He His Cys Leu Arg Ser Asn Phe Leu Ser Phe Ser Lys Leu 405 410 415
Tyr Pro Arg Val Lys Gly Trp Gin Val Phe Tyr Thr Ser Val Lys Lys 420 425 430
Ala Leu Leu Lys Ser Gly Cys Ser Leu Phe Asp Ser Phe Met Thr Pro 435 440 445
Phe Gly Gin Ala Val Met Val Trp Asp Asp Glu 450 455
(2) INFORMATION FOR SEQ ID NO : 6 :
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 171 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS : single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: cDNA
(xi) SEQUENCE DESCRIPTION: SEQ ID NO : 6 : ATGAATCAGG TTTTGCAGTT TGAATGTTTG TTTCTGCTGA ATCTCGCGGT TTTTGCTGTG 60
ACTTTCATTT TCATTCTTCT GGTCTTCCGC GTGATTAAGT CTTTTCGCCA GAAGGGTCAC 120
GAAGCACCTG TTCCCGTTGT TCGTGGCGGG GGTTTTTCAA CCGTAGTGTA G 171 (2) INFORMATION FOR SEQ ID NO : 7 :
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 56 amino acids
(B) TYPE: amino acid
(C) STRANDEDNESS :
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: protein
(xi) SEQUENCE DESCRIPTION: SEQ ID NO : 7 :
Met Asn Gin Val Leu Gin Phe Glu Cys Leu Phe Leu Leu Asn Leu Ala 1 5 10 15
Val Phe Ala Val Thr Phe He Phe He Leu Leu Val Phe Arg Val He 20 25 30
Lys Ser Phe Arg Gin Lys Gly His Glu Ala Pro Val Pro Val Val Arg 35 40 45
Gly Gly Gly Phe Ser Thr Val Val 50 55
(2) INFORMATION FOR SEQ ID NO : 8 :
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 1800 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: cDNA
(xi) SEQUENCE DESCRIPTION: SEQ ID NO : 8 :
ATGGTAGTTT TCGGTTTGGA CTTTGGCACC ACATTCTCTA CGGTGTGTGT GTACAAGGAT 60
GGACGAGTTT TTTCATTCAA GCAGAATAAT TCGGCGTACA TCCCCACTTA CCTCTATCTC 120
TTCTCCGATT CTAACCACAT GACTTTTGGT TACGAGGCCG AATCACTGAT GAGTAATCTG 180
AAAGTTAAAG GTTCGTTTTA TAGAGATTTA AAACGTTGGG TGGGTTGCGA TTCGAGTAAC 240
CTCGACGCGT ACCTTGACCG TTTAAAACCT CATTACTCGG TCCGCTTGGT TAAGATCGGC 300
TCTGGCTTGA ACGAAACTGT TTCAATTGGA AACTTCGGGG GCACTGTTAA GTCTGAGGCT 360
CATCTGCCAG GGTTGATAGC TCTCTTTATT AAGGCTGTCA TTAGTTGCGC GGAGGGCGCG 420 TTTGCGTGCA CTTGCACCGG GGTTATTTGT TCAGTACCTG CCAATTATGA TAGCGTTCAA 480
AGGAATTTCA CTGATCAGTG TGTTTCACTC AGCGGTTATC AGTGCGTATA TATGATCAAT 540
GAACCTTCAG CGGCTGCGCT ATCTGCGTGT AATTCGATTG GAAAGAAGTC CGCAAATTTG 600
GCTGTTTACG ATTTCGGTGG TGGGACCTTC GACGTGTCTA TCATTTCATA CCGCAACAAT 660
ACTTTTGTTG TGCGAGCTTC TGGAGGCGAT CTAAATCTCG GTGGAAGGGA TGTTGATCGT 720
GCGTTTCTCA CGCACCTCTT CTCTTTAACA TCGCTGGAAC CTGACCTCAC TTTGGATATC 780
TCGAATCTGA AAGAATCTTT ATCAAAAACG GACGCAGAGA TAGTTTACAC TTTGAGAGGT 840
GTCGATGGAA GAAAAGAAGA CGTTAGAGTA AACAAAAACA TTCTTACGTC GGTGATGCTC 900
CCCTACGTGA ACAGAACGCT TAAGATATTA GAGTCAACCT TAAAATCGTA TGCTAAGAGT 960
ATGAATGAGA GTGCGCGAGT TAAGTGCGAT TTAGTGCTGA TAGGAGGATC TTCATATCTT 1020
CCTGGCCTGG CAGACGTACT AACGAAGCAT CAGAGCGTTG ATCGTATCTT AAGAGTTTCG 1080
GATCCTCGGG CTGCCGTGGC CGTCGGTTGC GCATTATATT CTTCATGCCT CTCAGGATCT 1140
GGGGGGTTGC TACTGATCGA CTGTGCAGCT CACACTGTCG CTATAGCGGA CAGAAGTTGT 1200
CATCAAATCA TTTGCGCTCC AGCGGGGGCA CCGATCCCCT TTTCAGGAAG CATGCCTTTG 1260
TACTTAGCCA GGGTCAACAA GAACTCGCAG CGTGAAGTCG CCGTGTTTGA AGGGGAGTAC 1320
GTTAAGTGCC CTAAGAACAG AAAGATCTGT GGAGCAAATA TAAGATTTTT TGATATAGGA 1380
GTGACGGGTG ATTCGTACGC ACCCGTTACC TTCTATATGG ATTTCTCCAT TTCAAGCGTA 1440
GGAGCCGTTT CATTCGTGGT GAGAGGTCCT GAGGGTAAGC AAGTGTCACT CACTGGAACT 1500
CCAGCGTATA ACTTTTCGTC TGTGGCTCTC GGATCACGCA GTGTCCGAGA ATTGCATATT 1560
AGTTTAAATA ATAAAGTTTT TCTCGGTTTG CTTCTACATA GAAAGGCGGA TCGACGAATA 1620
CTTTTCACTA AGGATGAAGC GATTCGATAC GCCGATTCAA TTGATATCGC GGATGTGCTA 1680
AAGGAATATA AAAGTTACGC GGCCAGTGCC TTACCACCAG ACGAGGATGT CGAATTACTC 1740
CTGGGAAAGT CTGTTCAAAA AGTTTTACGG GGAAGCAGAC TGGAAGAAAT ACCTCTCTAG 1800
(2) INFORMATION FOR SEQ ID NO : 9 :
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 599 amino acids
(B) TYPE: amino acid
(C) STRANDEDNESS:
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO : 9 :
Met Val Val Phe Gly Leu Asp Phe Gly Thr Thr Phe Ser Thr Val Cys
1 5 10 15
Val Tyr Lys Asp Gly Arg Val Phe Ser Phe Lys Gin Asn Asn Ser Ala 20 25 30
Tyr He Pro Thr Tyr Leu Tyr Leu Phe Ser Asp Ser Asn His Met Thr 35 40 45
Phe Gly Tyr Glu Ala Glu Ser Leu Met Ser Asn Leu Lys Val Lys Gly 50 55 60
Ser Phe Tyr Arg Asp Leu Lys Arg Trp Val Gly Cys Asp Ser Ser Asn 65 70 75 80
Leu Asp Ala Tyr Leu Asp Arg Leu Lys Pro His Tyr Ser Val Arg Leu 85 90 95
Val Lys He Gly Ser Gly Leu Asn Glu Thr Val Ser He Gly Asn Phe 100 105 110
Gly Gly Thr Val Lys Ser Glu Ala His Leu Pro Gly Leu He Ala Leu 115 120 125
Phe He Lys Ala Val He Ser Cys Ala Glu Gly Ala Phe Ala Cys Thr 130 135 140
Cys Thr Gly Val He Cys Ser Val Pro Ala Asn Tyr Asp Ser Val Gin 145 150 155 160
Arg Asn Phe Thr Asp Gin Cys Val Ser Leu Ser Gly Tyr Gin Cys Val 165 170 175
Tyr Met He Asn Glu Pro Ser Ala Ala Ala Leu Ser Ala Cys Asn Ser 180 185 190
He Gly Lys Lys Ser Ala Asn Leu Ala Val Tyr Asp Phe Gly Gly Gly 195 200 205
Thr Phe Asp Val Ser He He Ser Tyr Arg Asn Asn Thr Phe Val Val 210 215 220
Arg Ala Ser Gly Gly Asp Leu Asn Leu Gly Gly Arg Asp Val Asp Arg 225 230 235 240
Ala Phe Leu Thr His Leu Phe Ser Leu Thr Ser Leu Glu Pro Asp Leu 245 250 255
Thr Leu Asp He Ser Asn Leu Lys Glu Ser Leu Ser Lys Thr Asp Ala 260 265 270
Glu He Val Tyr Thr Leu Arg Gly Val Asp Gly Arg Lys Glu Asp Val 275 280 285 Arg Val Asn Lys Asn He Leu Thr Ser Val Met Leu Pro Tyr Val Asn 290 295 300
Arg Thr Leu Lys He Leu Glu Ser Thr Leu Lys Ser Tyr Ala Lys Ser 305 310 315 320
Met Asn Glu Ser Ala Arg Val Lys Cys Asp Leu Val Leu He Gly Gly 325 330 335
Ser Ser Tyr Leu Pro Gly Leu Ala Asp Val Leu Thr Lys His Gin Ser 340 345 350
Val Asp Arg He Leu Arg Val Ser Asp Pro Arg Ala Ala Val Ala Val 355 360 365
Gly Cys Ala Leu Tyr Ser Ser Cys Leu Ser Gly Ser Gly Gly Leu Leu 370 375 380
Leu He Asp Cys Ala Ala His Thr Val Ala He Ala Asp Arg Ser Cys 385 390 395 400
His Gin He He Cys Ala Pro Ala Gly Ala Pro He Pro Phe Ser Gly 405 410 415
Ser Met Pro Leu Tyr Leu Ala Arg Val Asn Lys Asn Ser Gin Arg Glu 420 425 430
Val Ala Val Phe Glu Gly Glu Tyr Val Lys Cys Pro Lys Asn Arg Lys 435 440 445
He Cys Gly Ala Asn He Arg Phe Phe Asp He Gly Val Thr Gly Asp 450 455 460
Ser Tyr Ala Pro Val Thr Phe Tyr Met Asp Phe Ser He Ser Ser Val 465 470 475 480
Gly Ala Val Ser Phe Val Val Arg Gly Pro Glu Gly Lys Gin Val Ser 485 490 495
Leu Thr Gly Thr Pro Ala Tyr Asn Phe Ser Ser Val Ala Leu Gly Ser 500 505 510
Arg Ser Val Arg Glu Leu His He Ser Leu Asn Asn Lys Val Phe Leu 515 520 525
Gly Leu Leu Leu His Arg Lys Ala Asp Arg Arg He Leu Phe Thr Lys 530 535 540
Asp Glu Ala He Arg Tyr Ala Asp Ser He Asp He Ala Asp Val Leu 545 550 555 560
Lys Glu Tyr Lys Ser Tyr Ala Ala Ser Ala Leu Pro Pro Asp Glu Asp 565 570 575
Val Glu Leu Leu Leu Gly Lys Ser Val Gin Lys Val Leu Arg Gly Ser 580 585 590 Arg Leu Glu Glu He Pro Leu 595
(2) INFORMATION FOR SEQ ID NO: 10:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 1656 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: cDNA
(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 10:
ATGTCGAATT ACTCCTGGGA AAGTCTGTTC AAAAAGTTTT ACGGGGAAGC AGACTGGAAG 60
AAATACCTCT CTAGGAGCAT AGCAGCACAC TCAAGTGAAA TTAAAACTCT ACCAGACATT 120
CGATTGTACG GCGGTAGGGT TGTAAAGAAG TCCGAATTCG AATCAGCACT TCCTAATTCT 180
TTTGAACAGG AATTAGGACT GTTCATACTG AGCGAACGGG AAGTGGGATG GAGCAAATTA 240
TGCGGAATAA CGGTGGAAGA AGCAGCATAC GATCTTACGA ATCCCAAGGC TTATAAATTC 300
ACTGCCGAGA CATGTAGCCC GGATGTAAAA GGTGAAGGAC AAAAATACTC TATGGAAGAC 360
GTGATGAATT TCATGCGTTT ATCAAATCTG GATGTTAACG ACAAGATGCT GACGGAACAG 420
TGTTGGTCGC TGTCCAATTC ATGCGGTGAA TTGATCAACC CAGACGACAA AGGGCGATTC 480
GTGGCTCTCA CCTTTAAGGA CAGAGACACA GCTGATGACA CGGGTGCCGC CAACGTGGAA 540
TGTCGCGTGG GCGACTATCT AGTTTACGCT ATGTCCCTGT TTGAGCAGAG GACCCAAAAA 600
TCGCAGTCTG GCAACATCTC TCTGTACGAA AAGTACTGTG AATACATCAG GACCTACTTA 660
GGGAGTACAG ACCTGTTCTT CACAGCGCCG GACAGGATTC CGTTACTTAC GGGCATCCTA 720
TACGATTTTT GTAAGGAATA CAACGTTTTC TACTCGTCAT ATAAGAGAAA CGTCGATAAT 780
TTCAGATTCT TCTTGGCGAA TTATATGCCT TTGATATCTG ACGTCTTTGT CTTCCAGTGG 840
GTAAAACCCG CGCCGGATGT TCGGCTGCTT TTTGAGTTAA GTGCAGCGGA ACTAACGCTG 900
GAGGTTCCCA CACTGAGTTT GATAGATTCT CAAGTTGTGG TAGGTCATAT CTTAAGATAC 960
GTAGAATCCT ACACATCAGA TCCAGCCATC GACGCGTTAG AAGACAAACT GGAAGCGATA 1020
CTGAAAAGTA GCAATCCCCG TCTATCGACA GCGCAACTAT GGGTTGGTTT CTTTTGTTAC 1080
TATGGTGAGT TTCGTACGGC TCAAAGTAGA GTAGTGCAAA GACCAGGCGT ATACAAAACA 1140
CCTGACTCAG TGGGTGGATT TGAAATAAAC ATGAAAGATG TTGAGAAATT CTTCGATAAA 1200 CTTCAGAGAG AATTGCCTAA TGTATCTTTG CGGCGTCAGT TTAACGGAGC TAGAGCGCAT 1260
GAGGCTTTCA AAATATTTAA AAACGGAAAT ATAAGTTTCA GACCTATATC GCGTTTAAAC 1320
GTGCCTAGAG AGTTCTGGTA TCTGAACATA GACTACTTCA GGCACGCGAA TAGGTCCGGG 1380
TTAACCGAAG AAGAAATACT CATCCTAAAC AACATAAGCG TTGATGTTAG GAAGTTATGC 1440
GCTGAGAGAG CGTGCAATAC CCTACCTAGC GCGAAGCGCT TTAGTAAAAA TCATAAGAGT 1500
AATATACAAT CATCACGCCA AGAGCGGAGG ATTAAAGACC CATTGGTAGT CCTGAAAGAC 1560
ACTTTATATG AGTTCCAACA CAAGCGTGCC GGTTGGGGGT CTCGAAGCAC TCGAGACCTC 1620
GGGAGTCGTG CTGACCACGC GAAAGGAAGC GGTTGA 1656 (2) INFORMATION FOR SEQ ID NO: 11:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 551 amino acids
(B) TYPE: amino acid
(C) STRANDEDNESS:
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: protein
(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 11:
Met Ser Asn Tyr Ser Trp Glu Ser Leu Phe Lys Lys Phe Tyr Gly Glu 1 5 10 15
Ala Asp Trp Lys Lys Tyr Leu Ser Arg Ser He Ala Ala His Ser Ser 20 25 30
Glu He Lys Thr Leu Pro Asp He Arg Leu Tyr Gly Gly Arg Val Val 35 40 45
Lys Lys Ser Glu Phe Glu Ser Ala Leu Pro Asn Ser Phe Glu Gin Glu 50 55 60
Leu Gly Leu Phe He Leu Ser Glu Arg Glu Val Gly Trp Ser Lys Leu 65 70 75 80
Cys Gly He Thr Val Glu Glu Ala Ala Tyr Asp Leu Thr Asn Pro Lys 85 90 95
Ala Tyr Lys Phe Thr Ala Glu Thr Cys Ser Pro Asp Val Lys Gly Glu 100 105 110
Gly Gin Lys Tyr Ser Met Glu Asp Val Met Asn Phe Met Arg Leu Ser 115 120 125
Asn Leu Asp Val Asn Asp Lys Met Leu Thr Glu Gin Cys Trp Ser Leu 130 135 140
Ser Asn Ser Cys Gly Glu Leu He Asn Pro Asp Asp Lys Gly Arg Phe 145 150 155 160
Val Ala Leu Thr Phe Lys Asp Arg Asp Thr Ala Asp Asp Thr Gly Ala 165 170 175
Ala Asn Val Glu Cys Arg Val Gly Asp Tyr Leu Val Tyr Ala Met Ser 180 185 190
Leu Phe Glu Gin Arg Thr Gin Lys Ser Gin Ser Gly Asn He Ser Leu 195 200 205
Tyr Glu Lys Tyr Cys Glu Tyr He Arg Thr Tyr Leu Gly Ser Thr Asp 210 215 220
Leu Phe Phe Thr Ala Pro Asp Arg He Pro Leu Leu Thr Gly He Leu 225 230 235 240
Tyr Asp Phe Cys Lys Glu Tyr Asn Val Phe Tyr Ser Ser Tyr Lys Arg 245 250 255
Asn Val Asp Asn Phe Arg Phe Phe Leu Ala Asn Tyr Met Pro Leu He 260 265 270
Ser Asp Val Phe Val Phe Gin Trp Val Lys Pro Ala Pro Asp Val Arg 275 280 285
Leu Leu Phe Glu Leu Ser Ala Ala Glu Leu Thr Leu Glu Val Pro Thr 290 295 300
Leu Ser Leu He Asp Ser Gin Val Val Val Gly His He Leu Arg Tyr 305 310 315 320
Val Glu Ser Tyr Thr Ser Asp Pro Ala He Asp Ala Leu Glu Asp Lys 325 330 335
Leu Glu Ala He Leu Lys Ser Ser Asn Pro Arg Leu Ser Thr Ala Gin 340 345 350
Leu Trp Val Gly Phe Phe Cys Tyr Tyr Gly Glu Phe Arg Thr Ala Gin 355 360 365
Ser Arg Val Val Gin Arg Pro Gly Val Tyr Lys Thr Pro Asp Ser Val 370 375 380
Gly Gly Phe Glu He Asn Met Lys Asp Val Glu Lys Phe Phe Asp Lys 385 390 395 400
Leu Gin Arg Glu Leu Pro Asn Val Ser Leu Arg Arg Gin Phe Asn Gly 405 410 415
Ala Arg Ala His Glu Ala Phe Lys He Phe Lys Asn Gly Asn He Ser 420 425 430
Phe Arg Pro He Ser Arg Leu Asn Val Pro Arg Glu Phe Trp Tyr Leu 435 440 445
Asn He Asp Tyr Phe Arg His Ala Asn Arg Ser Gly Leu Thr Glu Glu 450 455 460
Glu He Leu He Leu Asn Asn He Ser Val Asp Val Arg Lys Leu Cys 465 470 475 480
Ala Glu Arg Ala Cys Asn Thr Leu Pro Ser Ala Lys Arg Phe Ser Lys 485 490 495
Asn His Lys Ser Asn He Gin Ser Ser Arg Gin Glu Arg Arg He Lys 500 505 510
Asp Pro Leu Val Val Leu Lys Asp Thr Leu Tyr Glu Phe Gin His Lys 515 520 525
Arg Ala Gly Trp Gly Ser Arg Ser Thr Arg Asp Leu Gly Ser Arg Ala 530 535 540
Asp His Ala Lys Gly Ser Gly 545 550
(2) INFORMATION FOR SEQ ID NO: 12:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 672 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: cDNA
(xi) SEQUENCE DESCRIPTION: SEQ ID NO : 12 :
ATGAGTTCCA ACACAAGCGT GCCGGTTGGG GGTCTCGAAG CACTCGAGAC CTCGGGAGTC 60
GTGCTGACCA CGCGAAAGGA AGCGGTTGAT AAGTTTTTTA ATGAACTAAA AAACGAAAAT 120
TACTCATCAG TTGACAGCAG CCGATTAAGC GATTCGGAAG TAAAAGAAGT GTTAGAGAAA 180
AGTAAAGAAA GTTTCAAAAG CGAACTGGCC TCCACTGACG AGCACTTCGT CTACCACATT 240
ATATTTTTCT TAATCCGATG TGCTAAGATA TCGACAAGTG AAAAGGTGAA GTACGTTGGT 300
AGTCATACGT ACGTGGTCGA CGGAAAAACG TACACCGTTC TTGACGCTTG GGTATTCAAC 360
ATGATGAAAA GTCTCACGAA GAAGTACAAA CGAGTGAATG GTCTGCGTGC GTTCTGTTGC 420
GCGTGCGAAG ATCTATATCT AACCGTCGCA CCAATAATGT CAGAACGCTT TAAGACTAAA 480
GCCGTAGGGA TGAAAGGTTT GCCTGTTGGA AAGGAATACT TAGGCGCCGA CTTTCTTTCG 540
GGAACTAGCA AACTGATGAG CGATCACGAC AGGGCGGTCT CCATCGTTGC AGCGAAAAAC 600
GCTGTCGATC GTAGCGCTTT CACGGGTGGG GAGAGAAAGA TAGTTAGTTT GTATGATCTA 660
GGGAGGTACT AA 672 (2) INFORMATION FOR SEQ ID NO: 13:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 223 amino acids
(B) TYPE: amino acid
(C) STRANDEDNESS:
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: protein
(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 13:
Met Ser Ser Asn Thr Ser Val Pro Val Gly Gly Leu Glu Ala Leu Glu 1 5 10 15
Thr Ser Gly Val Val Leu Thr Thr Arg Lys Glu Ala Val Asp Lys Phe 20 25 30
Phe Asn Glu Leu Lys Asn Glu Asn Tyr Ser Ser Val Asp Ser Ser Arg 35 40 45
Leu Ser Asp Ser Glu Val Lys Glu Val Leu Glu Lys Ser Lys Glu Ser 50 55 60
Phe Lys Ser Glu Leu Ala Ser Thr Asp Glu His Phe Val Tyr His He 65 70 75 80
He Phe Phe Leu He Arg Cys Ala Lys He Ser Thr Ser Glu Lys Val 85 90 95
Lys Tyr Val Gly Ser His Thr Tyr Val Val Asp Gly Lys Thr Tyr Thr 100 105 110
Val Leu Asp Ala Trp Val Phe Asn Met Met Lys Ser Leu Thr Lys Lys 115 120 125
Tyr Lys Arg Val Asn Gly Leu Arg Ala Phe Cys Cys Ala Cys Glu Asp 130 135 140
Leu Tyr Leu Thr Val Ala Pro He Met Ser Glu Arg Phe Lys Thr Lys 145 150 155 160
Ala Val Gly Met Lys Gly Leu Pro Val Gly Lys Glu Tyr Leu Gly Ala 165 170 175
Asp Phe Leu Ser Gly Thr Ser Lys Leu Met Ser Asp His Asp Arg Ala 180 185 190
Val Ser He Val Ala Ala Lys Asn Ala Val Asp Arg Ser Ala Phe Thr 195 200 205
Gly Gly Glu Arg Lys He Val Ser Leu Tyr Asp Leu Gly Arg Tyr 210 215 220
(2) INFORMATION FOR SEQ ID NO: 14: (i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 597 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: cDNA
(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 14:
ATGGAGTTGA TGTCCGACAG CAACCTTAGC AACCTGGTGA TAACCGACGC CTCTAGTCTA 60
AATGGTGTCG ACAAGAAGCT TTTATCTGCT GAAGTTGAAA AAATGTTGGT GCAGAAAGGG 120
GCTCCTAACG AGGGTATAGA AGTGGTGTTC GGTCTACTCC TTTACGCACT CGCGGCAAGA 180
ACCACGTCTC CTAAGGTTCA GCGCGCAGAT TCAGACGTTA TATTTTCAAA TAGTTTCGGA 240
GAGAGGAATG TGGTAGTAAC AGAGGGTGAC CTTAAGAAGG TACTCGACGG GTGTGCGCCT 300
CTCACTAGGT TCACTAATAA ACTTAGAACG TTCGGTCGTA CTTTCACTGA GGCTTACGTT 360
GACTTTTGTA TCGCGTATAA GCACAAATTA CCCCAACTCA ACGCCGCGGC GGAATTGGGG 420
ATTCCAGCTG AAGATTCGTA CTTAGCTGCA GATTTTCTGG GTACTTGCCC GAAGCTCTCT 480
GAATTACAGC AAAGTAGGAA GATGTTCGCG AGTATGTACG CTCTAAAAAC TGAAGGTGGA 540
GTGGTAAATA CACCAGTGAG CAATCTGCGT CAGCTAGGTA GAAGGGAAGT TATGTAA 597 (2) INFORMATION FOR SEQ ID NO: 15:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 198 amino acids
(B) TYPE: amino acid
(C) STRANDEDNESS:
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: protein
(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 15:
Met Glu Leu Met Ser Asp Ser Asn Leu Ser Asn Leu Val He Thr Asp 1 5 10 15
Ala Ser Ser Leu Asn Gly Val Asp Lys Lys Leu Leu Ser Ala Glu Val 20 25 30
Glu Lys Met Leu Val Gin Lys Gly Ala Pro Asn Glu Gly He Glu Val 35 40 45
Val Phe Gly Leu Leu Leu Tyr Ala Leu Ala Ala Arg Thr Thr Ser Pro 50 55 60
Lys Val Gin Arg Ala Asp Ser Asp Val He Phe Ser Asn Ser Phe Gly 65 70 75 80
Glu Arg Asn Val Val Val Thr Glu Gly Asp Leu Lys Lys Val Leu Asp 85 90 95
Gly Cys Ala Pro Leu Thr Arg Phe Thr Asn Lys Leu Arg Thr Phe Gly 100 105 110
Arg Thr Phe Thr Glu Ala Tyr Val Asp Phe Cys He Ala Tyr Lys His 115 120 125
Lys Leu Pro Gin Leu Asn Ala Ala Ala Glu Leu Gly He Pro Ala Glu 130 135 140
Asp Ser Tyr Leu Ala Ala Asp Phe Leu Gly Thr Cys Pro Lys Leu Ser 145 150 155 160
Glu Leu Gin Gin Ser Arg Lys Met Phe Ala Ser Met Tyr Ala Leu Lys 165 170 175
Thr Glu Gly Gly Val Val Asn Thr Pro Val Ser Asn Leu Arg Gin Leu 180 185 190
Gly Arg Arg Glu Val Met 195
(2) INFORMATION FOR SEQ ID NO: 16:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 486 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: cDNA
(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 16:
ATGGAAGATT ACGAAGAAAA ATCCGAATCG CTCATACTGC TACGCACGAA TCTGAACACT 60
ATGCTTTTAG TGGTCAAGTC CGATGCTAGT GTAGAGCTGC CTAAACTACT AATTTGCGGT 120
TACTTACGAG TGTCAGGACG TGGGGAGGTG ACGTGTTGCA ACCGTGAGGA ATTAACAAGA 180
GATTTTGAGG GCAATCATCA TACGGTGATC CGTTCTAGAA TCATACAATA TGACAGCGAG 240
TCTGCTTTTG AGGAATTCAA CAACTCTGAT TGCGTAGTGA AGTTTTTCCT AGAGACTGGT 300
AGTGTCTTTT GGTTTTTCCT TCGAAGTGAA ACCAAAGGTA GAGCGGTGCG ACATTTGCGC 360
ACCTTCTTCG AAGCTAACAA TTTCTTCTTT GGATCGCATT GCGGTACCAT GGAGTATTGT 420
TTGAAGCAGG TACTAACTGA AACTGAATCT ATAATCGATT CTTTTTGCGA AGAAAGAAAT 480
CGTTAA 486 (2) INFORMATION FOR SEQ ID NO: 17:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 161 amino acids
(B) TYPE: amino acid
(C) STRANDEDNESS:
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: protein
(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 17:
Met Glu Asp Tyr Glu Glu Lys Ser Glu Ser Leu He Leu Leu Arg Thr 1 5 10 15
Asn Leu Asn Thr Met Leu Leu Val Val Lys Ser Asp Ala Ser Val Glu 20 25 30
Leu Pro Lys Leu Leu He Cys Gly Tyr Leu Arg Val Ser Gly Arg Gly 35 40 45
Glu Val Thr Cys Cys Asn Arg Glu Glu Leu Thr Arg Asp Phe Glu Gly 50 55 60
Asn His His Thr Val He Arg Ser Arg He He Gin Tyr Asp Ser Glu 65 70 75 80
Ser Ala Phe Glu Glu Phe Asn Asn Ser Asp Cys Val Val Lys Phe Phe 85 90 95
Leu Glu Thr Gly Ser Val Phe Trp Phe Phe Leu Arg Ser Glu Thr Lys 100 105 110
Gly Arg Ala Val Arg His Leu Arg Thr Phe Phe Glu Ala Asn Asn Phe 115 120 125
Phe Phe Gly Ser His Cys Gly Thr Met Glu Tyr Cys Leu Lys Gin Val 130 135 140
Leu Thr Glu Thr Glu Ser He He Asp Ser Phe Cys Glu Glu Arg Asn 145 150 155 160
Arg
(2) INFORMATION FOR SEQ ID NO: 18:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 618 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: cDNA (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 18:
ATGAGGGTTA TAGTGTCTCC TTATGAAGCT GAAGACATTC TGAAAAGATC GACTGACATG 60
TTACGAAACA TAGACAGTGG GGTCTTGAGC ACTAAAGAAT GTATCAAGGC ATTCTCGACG 120
ATAACGCGAG ACCTACATTG TGCGAAGGCT TCCTACCAGT GGGGTGTTGA CACTGGGTTA 180
TATCAGCGTA ATTGCGCTGA AAAACGTTTA ATTGACACGG TGGAGTCAAA CATACGGTTG 240
GCTCAACCTC TCGTGCGTGA AAAAGTGGCG GTTCATTTTT GTAAGGATGA ACCAAAAGAG 300
CTAGTAGCAT TCATCACGCG AAAGTACGTG GAACTCACGG GCGTGGGAGT GAGAGAAGCG 360
GTGAAGAGGG AAATGCGCTC TCTTACCAAA ACAGTTTTAA ATAAAATGTC TTTGGAAATG 420
GCGTTTTACA TGTCACCACG AGCGTGGAAA AACGCTGAAT GGTTAGAACT AAAATTTTCA 480
CCTGTGAAAA TCTTTAGAGA TCTGCTATTA GACGTGGAAA CGCTCAACGA ATTGTGCGCC 540
GAAGATGATG TTCACGTCGA CAAAGTAAAT GAGAATGGGG ACGAAAATCA CGACCTCGAA 600
CTCCAAGACG AATGTTAA 618 (2) INFORMATION FOR SEQ ID NO: 19:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 205 amino acids
(B) TYPE: amino acid
(C) STRANDEDNESS:
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: protein
(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 19:
Met Arg Val He Val Ser Pro Tyr Glu Ala Glu Asp He Leu Lys Arg 1 5 10 15
Ser Thr Asp Met Leu Arg Asn He Asp Ser Gly Val Leu Ser Thr Lys 20 25 30
Glu Cys He Lys Ala Phe Ser Thr He Thr Arg Asp Leu His Cys Ala 35 40 45
Lys Ala Ser Tyr Gin Trp Gly Val Asp Thr Gly Leu Tyr Gin Arg Asn 50 55 60
Cys Ala Glu Lys Arg Leu He Asp Thr Val Glu Ser Asn He Arg Leu 65 70 75 80
Ala Gin Pro Leu Val Arg Glu Lys Val Ala Val His Phe Cys Lys Asp 85 90 95
Glu Pro Lys Glu Leu Val Ala Phe He Thr Arg Lys Tyr Val Glu Leu 100 105 110 Thr Gly Val Gly Val Arg Glu Ala Val Lys Arg Glu Met Arg Ser Leu 115 120 125
Thr Lys Thr Val Leu Asn Lys Met Ser Leu Glu Met Ala Phe Tyr Met 130 135 140
Ser Pro Arg Ala Trp Lys Asn Ala Glu Trp Leu Glu Leu Lys Phe Ser 145 150 155 160
Pro Val Lys He Phe Arg Asp Leu Leu Leu Asp Val Glu Thr Leu Asn 165 170 175
Glu Leu Cys Ala Glu Asp Asp Val His Val Asp Lys Val Asn Glu Asn 180 185 190
Gly Asp Glu Asn His Asp Leu Glu Leu Gin Asp Glu Cys 195 200 205
(2) INFORMATION FOR SEQ ID NO: 20:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 21 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: cDNA
(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 20: TGCTGGAGCT TGAGGTTCTG C 21
(2) INFORMATION FOR SEQ ID NO: 21:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 31 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: cDNA
(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 21: CGGAATTCAC CATGGAGTTG ATGTCCGACA G 31
(2) INFORMATION FOR SEQ ID NO:22:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 33 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear (ii) MOLECULE TYPE: cDNA
(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 22: AGCGGATCCA TGGCAGATTC GTGCGTAGCA GTA 33
(2) INFORMATION FOR SEQ ID NO: 23:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 216 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: cDNA
(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 23:
ACATTGGTTA AGTTTAACGA AAATGATTAG TAAATAATAA ATCGAACGTG GGTGTATCTA 60
CCTGACGTAT CAACTTAAGC TGTTACTGAG TAATTAAACC AACAAGTGTT GGTGTAATGT 120
GTATGTTGAT GTAGAGAAAA ATCCGTTTGT AGAACGGTGT TTTTCTCTTC TTTATTTTTA 180
AAAAAAAAAT AAAAAAAAAA AAAAAAAAGC GGCCGC 216

Claims

WHAT IS CLAIMED:
1. An isolated protein or polypeptide corresponding to a protein or polypeptide of a grapevine leafroll virus (type 2).
2. An isolated protein or polypeptide according to claim 1 , wherein the protein or polypeptide is selected from a group consisting of a polyprotein, an RNA- dependent RNA polymerase, a heat shock 70 protein, a heat shock 90 protein, a diverged coat protein, and a coat protein.
3. An isolated protein or polypeptide according to claim 2, wherein the protein or polypeptide is a polyprotein.
4. An isolated protein or polypeptide according to claim 3, wherein the protein or polypeptide comprises an amino acid sequence corresponding to SEQ. ID.
No. 3.
5. An isolated protein or polypeptide according to claim 2, wherein the protein or polypeptide is an RNA-dependent RNA polymerase having a molecular weight of from about 50 to about 54 kDa.
6. An isolated protein or polypeptide according to claim 5, wherein the protein or polypeptide comprises an amino acid sequence corresponding to SEQ. ID.
No. 5.
7. An isolated protein or polypeptide according to claim 2, wherein the protein or polypeptide is a heat shock 70 protein having a molecular weight of from about 63 to about 67 kDa.
8. An isolated protein or polypeptide according to claim 7, wherein the protein or polypeptide comprises an amino acid sequence corresponding to SEQ. ID. No. 9.
9. An isolated protein or polypeptide according to claim 2, wherein the protein or polypeptide is a heat shock 90 protein having a molecular weight of from about 61 to about 65 kDa.
10. An isolated protein or polypeptide according to claim 9, wherein the protein or polypeptide comprises an amino acid sequence corresponding to SEQ. ID. No. 1 1.
11. An isolated protein or polypeptide according to claim 2, wherein the protein or polypeptide is a coat protein having a molecular weight of from about 20 to about 24 kDa.
12. An isolated protein or polypeptide according to claim 1 1 , wherein the protein or polypeptide comprises an amino acid sequence corresponding to SEQ. ID.
No. 15.
13. An isolated protein or polypeptide according to claim 2, wherein the protein or polypeptide is a diverged coat protein having a molecular weight of from about 23 to about 27 kDa.
14. An isolated protein or polypeptide according to claim 13, wherein the protein or polypeptide comprises an amino acid sequence corresponding to SEQ. ID. No. 13.
15. An isolated protein or polypeptide according to claim 1 , wherein the protein or polypeptide comprises an amino acid sequence corresponding to SEQ. ID.
No. 7.
16. An isolated protein or polypeptide according to claim 1 , wherein the protein or polypeptide comprises an amino acid sequence corresponding to SEQ. ID. No. 17.
17. An isolated protein or polypeptide according to claim 1 , wherein the protein or polypeptide comprises an amino acid sequence corresponding to SEQ. ID. No. 19.
18. An isolated protein or polypeptide according to claim 1 , wherein the protein or polypeptide is purified.
19. An isolated protein or polypeptide according to claim 1 , wherein the protein or polypeptide is recombinant.
20. An isolated RNA molecule encoding a protein or polypeptide according to claim 1.
21. An isolated RNA molecule according to claim 20, wherein the protein or polypeptide is selected from a group consisting of a polyprotein, an RNA-dependent RNA polymerase, a heat shock 70 protein, a heat shock 90 protein, a diverged coat protein, and a coat protein.
22. An isolated DNA molecule encoding a protein or polypeptide according to claim 1.
23. An isolated DNA molecule according to claim 22, wherein the protein or polypeptide is selected from a group consisting of a polyprotein, an RNA-dependent RNA polymerase, a heat shock 70 protein, a heat shock 90 protein, a diverged coat protein, and a coat protein.
24. An isolated DNA molecule according to claim 23, wherein the protein or polypeptide is a polyprotein comprising conserved regions of a helicase, a papain-like protease, and a methyltransferase.
25. An isolated DNA molecule according to claim 24, wherein the protein or polypeptide comprises an amino acid sequence corresponding to SEQ. ID. No. 3.
26. An isolated DNA molecule according to claim 25, wherein the DNA molecule has a nucleotide sequence corresponding to SEQ. ID. No. 2.
27. An isolated DNA molecule according to claim 23, wherein the protein or polypeptide is an RNA-dependent RNA polymerase having a molecular weight of from about 50 to about 54 kDa.
28. An isolated DNA molecule according to claim 27, wherein the protein or polypeptide comprises an amino acid sequence corresponding to SEQ. ID. No. 5.
29. An isolated DNA molecule according to claim 28, wherein the DNA molecule has a nucleotide sequence corresponding to SEQ. ID. No. 4.
30. An isolated DNA molecule according to claim 23, wherein the protein or polypeptide is a heat shock 70 protein having a molecular weight of from about 63 to about 67 kDa.
31. An isolated DNA molecule according to claim 30, wherein the protein or polypeptide comprises an amino acid sequence corresponding to SEQ. ID. No. 9.
32. An isolated DNA molecule according to claim 31 , wherein the DNA molecule has a nucleotide sequence corresponding to SEQ. ID. No. 8.
33. An isolated DNA molecule according to claim 23, wherein the protein or polypeptide is a heat shock 90 protein having a molecular weight of from about 61 to about 65 kDa.
34. An isolated DNA molecule according to claim 33, wherein the protein or polypeptide comprises an amino acid sequence corresponding to SEQ. ID. No. 11.
35. An isolated DNA molecule according to claim 34, wherein the DNA molecule has a nucleotide sequence corresponding to SEQ. ID. No. 10.
36. An isolated DNA molecule according to claim 23, wherein the protein or polypeptide is a coat protein having a molecular weight of from about 20 to about 24 kDa.
37. An isolated DNA molecule according to claim 36, wherein the protein or polypeptide comprises an amino acid sequence corresponding to SEQ. ID. No. 15.
38. An isolated DNA molecule according to claim 37, wherein the DNA molecule comprises a nucleotide sequence corresponding to SEQ. ID. No. 14.
39. An isolated DNA molecule according to claim 23, wherein the protein or polypeptide is a diverged coat protein having a molecular weight of from about 23 to about 27 kDa.
40. An isolated DNA molecule according to claim 39, wherein the protein or polypeptide comprises an amino acid sequence corresponding to SEQ. ID. No. 13.
41. An isolated DNA molecule according to claim 40, wherein the DNA molecule comprises a nucleotide sequence corresponding to SEQ. ID. No. 12.
42. An isolated DNA molecule according to claim 22, wherein the protein or polypeptide comprises an amino acid sequence corresponding to SEQ. ID. No. 7.
43. An isolated DNA molecule according to claim 42, wherein the DNA molecule comprises a nucleotide sequence corresponding to SEQ. ID. No. 6.
44. An isolated DNA molecule according to claim 22, wherein the protein or polypeptide comprises an amino acid sequence corresponding to SEQ. ID. No. 17.
45. An isolated DNA molecule according to claim 44, wherein the DNA molecule comprises a nucleotide sequence corresponding to SEQ. ID. No. 16.
46. An isolated DNA molecule according to claim 22, wherein the protein or polypeptide comprises an amino acid sequence corresponding to SEQ. ID. No. 19.
47. An isolated DNA molecule according to claim 46, wherein the DNA molecule comprises a nucleotide sequence corresponding to SEQ. ID. No. 18.
48. An isolated DNA molecule according to claim 22, wherein the DNA molecule comprises a nucleotide sequence corresponding to SEQ. ID. No. 23.
49. An expression system comprising an DNA molecule according to claim 22 in a vector heterologous to the DNA molecule.
50. An expression system according to claim 49, wherein the protein or polypeptide is selected from a group consisting of a polyprotein, an RNA-dependent RNA polymerase, a heat shock 70 protein, a heat shock 90 protein, a diverged coat protein, and a coat protein.
51. A host cell transformed with a heterologous DNA molecule according to claim 22.
52. A host cell according to claim 51 , wherein the host cell is selected from the group consisting of Agrobacterium vitis and Agrobacterium tumefaciens.
53. A host cell according to claim 51 , wherein the host cell is selected from a group consisting of a grape cell, a citrus cell, a beet cell, and a tobacco cell.
54. A host cell according to claim 51 , wherein the protein or polypeptide is selected from a group consisting of a polyprotein, an RNA-dependent RNA polymerase, a heat shock 70 protein, a heat shock 90 protein, a diverged coat protein, and a coat protein.
55. A transgenic plant cultivar comprising the DNA molecule according to claim 22.
56. A transgenic plant cultivar according to claim 55, wherein the plant cultivar is selected from a group consisting of a grape plant cultivar, a citrus plant cultivar, a beet plant cultivar, and a tobacco plant cultivar.
57. A transgenic plant cultivar according to claim 55, wherein the protein or polypeptide is selected from a group consisting of a polyprotein, an RNA-dependent RNA polymerase, a heat shock 70 protein, a heat shock 90 protein, a diverged coat protein, and a coat protein.
58. A method of imparting grapevine leafroll virus resistance to a Vitis scion or rootstock cultivar or a Nicotiana cultivar comprising: transforming a Vitis scion or rootstock cultivar or a Nicotiana cultivar with a DNA molecule according to claim 22.
59. A method according to claim 58, wherein the protein or polypeptide is selected from a group consisting of a polyprotein, an RNA-dependent RNA polymerase, a heat shock 70 protein, a heat shock 90 protein, a diverged coat protein, and a coat protein.
60. A method according to claim 58, wherein the grapevine leafroll virus is GLRaV-2.
61. A method according to claim 58, wherein said transforming is Agrobacterium mediated.
62. A method according to claim 58, wherein said transforming comprises: propelling particles at grape or tobacco plant cells under conditions effective for the particles to penetrate into the cell interior and introducing an expression vector comprising the DNA molecule into the cell interior.
63. A method of imparting beet yellows virus resistance to a beet cultivar comprising: transforming a beet cultivar with a DNA molecule according to claim 22.
64. A method according to claim 63, wherein the protein or polypeptide is selected from a group consisting of a polyprotein, an RNA-dependent RNA polymerase, a heat shock 70 protein, a heat shock 90 protein, a diverged coat protein, and a coat protein.
65. A method according to claim 63, wherein said transforming is Agrobacterium mediated.
66. A method according to claim 63, wherein said transforming comprises: propelling particles at beet plant cells under conditions effective for the particles to penetrate into the cell interior and introducing an expression vector comprising the DNA molecule into the cell interior.
67. A method of imparting tristeza virus resistance to a citrus scion cultivar or rootstock cultivar comprising: transforming a citrus scion cultivar or rootstock cultivar with a DNA molecule according to claim 22.
68. A method according to claim 67, wherein the protein or polypeptide is selected from a group consisting of a polyprotein, an RNA-dependent RNA polymerase, a heat shock 70 protein, a heat shock 90 protein, a diverged coat protein, and a coat protein.
69. A method according to claim 67, wherein said transforming is Agrobacterium mediated.
70. A method according to claim 67, wherein said transforming comprises: propelling particles at citrus plant cells under conditions effective for the particles to penetrate into the cell interior and introducing an expression vector comprising the DNA molecule into the cell interior.
71. An antibody or binding portion thereof or probe recognizing the protein or polypeptide according to claim 1.
72. An antibody or binding portion thereof or probe according to claim 71 , wherein the protein or polypeptide is selected from a group consisting of a polyprotein, an RNA-dependent RNA polymerase, a heat shock 70 protein, a heat shock 90 protein, a diverged coat protein, and a coat protein.
73. A method for detection of grapevine leafroll virus in a sample, said method comprising: providing an antibody or binding portion thereof recognizing the protein or polypeptide according to claim 1 ; contacting the sample with the antibody or binding portion thereof; and detecting any reaction which indicates that grapevine leafroll virus is present in the sample using an assay system.
74. A method according to claim 73, wherein the assay system is selected from a group consisting of enzyme-linked immunoabsorbent assay, radioimmunoassay, gel diffusion precipitin reaction assay, immunodiffusion assay, agglutination assay, fluorescent immunoassay, protein A immunoassay, and immunoelectrophoresis assay.
75. A method for detection of grapevine leafroll virus in a sample, said method comprising: providing a nucleotide sequence of the DNA molecule according to claim 22 as a probe in a nucleic acid hybridization assay; contacting the sample with the probe; and detecting any reaction which indicates that grapevine leafroll virus is present in the sample.
76. A method according to claim 75, wherein the nucleic acid hybridization assay is selected from a group consisting of dot blot hybridization, tissue printing, southern hybridization, and northern hybridization.
77. A method for detection of grapevine leafroll virus in a sample: providing a nucleotide sequence of the DNA molecule according to claim 22 as a probe in a gene amplification detection procedure; contacting the sample with the probe; and detecting any reaction which indicates that grapevine leafroll virus is present in the sample.
78. A method according to claim 77, wherein the gene amplification detection procedure is selected from a group consisting of polymerase chain reaction and immunocapture polymerase chain reaction.
PCT/US1998/010313 1997-05-20 1998-05-20 Grapevine leafroll virus (type 2) proteins and their uses WO1998053055A1 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
MDA20000034A MD20000034A (en) 1997-05-20 1998-05-20 Grapevine leafroll virus proteins (type 2) and use thereof
SK1585-99A SK158599A3 (en) 1997-05-20 1998-05-20 Grapevine leafroll virus (type 2) proteins and their uses
CA002290551A CA2290551A1 (en) 1997-05-20 1998-05-20 Grapevine leafroll virus (type 2) proteins and their uses
EP98923568A EP0986641A4 (en) 1997-05-20 1998-05-20 Grapevine leafroll virus (type 2) proteins and their uses
AU75831/98A AU746187B2 (en) 1997-05-20 1998-05-20 Grapevine leafroll virus (type 2) proteins and their uses
BR9809450-5A BR9809450A (en) 1997-05-20 1998-05-20 Grape leaf virus (type 2) proteins and their uses
DE0986641T DE986641T1 (en) 1997-05-20 1998-05-20 VINEYARD VINE VINE PROTEINS (TYPE 2) AND THEIR USE.
IL13297598A IL132975A0 (en) 1997-05-20 1998-05-20 Grapevine leaf roll virus (type 2) proteins and their uses
BG103906A BG103906A (en) 1997-05-20 1999-11-19 Proteins of the virus of leaf twisting of vinetrees (type 2) and methods for their application

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4719497P 1997-05-20 1997-05-20
US60/047,194 1997-05-20

Publications (1)

Publication Number Publication Date
WO1998053055A1 true WO1998053055A1 (en) 1998-11-26

Family

ID=21947574

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1998/010313 WO1998053055A1 (en) 1997-05-20 1998-05-20 Grapevine leafroll virus (type 2) proteins and their uses

Country Status (16)

Country Link
US (3) US6197948B1 (en)
EP (1) EP0986641A4 (en)
AR (1) AR011740A1 (en)
AU (1) AU746187B2 (en)
BG (1) BG103906A (en)
BR (1) BR9809450A (en)
CA (1) CA2290551A1 (en)
DE (1) DE986641T1 (en)
ES (1) ES2146193T1 (en)
HU (1) HUP0003327A3 (en)
IL (1) IL132975A0 (en)
MD (1) MD20000034A (en)
SK (1) SK158599A3 (en)
TR (1) TR199902852T2 (en)
WO (1) WO1998053055A1 (en)
ZA (1) ZA984232B (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001005957A2 (en) * 1999-07-19 2001-01-25 Agritope, Inc. Grapevine leafroll-associated virus proteins
US6558953B1 (en) 1995-12-21 2003-05-06 Cornell Research Foundation, Inc. Grapevine leafroll virus proteins and their uses
US6858426B1 (en) 1997-05-20 2005-02-22 Cornell Research Foundation, Inc. Grapevine leafroll virus (type 2) proteins and their uses

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004044161A2 (en) * 2002-11-06 2004-05-27 Fraunhofer Usa Expression of foreign sequences in plants using trans-activation system
US7692063B2 (en) * 2002-11-12 2010-04-06 Ibio, Inc. Production of foreign nucleic acids and polypeptides in sprout systems
US7683238B2 (en) * 2002-11-12 2010-03-23 iBio, Inc. and Fraunhofer USA, Inc. Production of pharmaceutically active proteins in sprouted seedlings
AU2004209660A1 (en) 2003-02-03 2004-08-19 Fraunhofer Usa, Inc. System for expression of genes in plants
WO2005081905A2 (en) * 2004-02-20 2005-09-09 Fraunhofer Usa Inc. Systems and methods for clonal expression in plants
US8415147B2 (en) * 2008-01-31 2013-04-09 State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University Closterovirus vectors and methods
US8629334B2 (en) * 2008-07-16 2014-01-14 University Of Florida Research Foundation, Inc. Viral-based transient-expression vector system for trees
CN111298923B (en) * 2018-12-11 2021-11-30 中国食品药品检定研究院 Crushing and centrifuging integrated device

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997022700A2 (en) * 1995-12-21 1997-06-26 Cornell Research Foundation, Inc. Grapevine leafroll virus proteins and their uses

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4358535A (en) 1980-12-08 1982-11-09 Board Of Regents Of The University Of Washington Specific DNA probes in diagnostic microbiology
US4480040A (en) 1981-12-03 1984-10-30 The United States Of America As Represented By The Secretary Of Agriculture Sensitive and rapid diagnosis of viroid diseases and viruses
US5288611A (en) 1983-01-10 1994-02-22 Gen-Probe Incorporated Method for detecting, identifying, and quantitating organisms and viruses
US5322770A (en) 1989-12-22 1994-06-21 Hoffman-Laroche Inc. Reverse transcription with thermostable DNA polymerases - high temperature reverse transcription
US5043272A (en) 1989-04-27 1991-08-27 Life Technologies, Incorporated Amplification of nucleic acid sequences using oligonucleotides of random sequence as primers
US5106727A (en) 1989-04-27 1992-04-21 Life Technologies, Inc. Amplification of nucleic acid sequences using oligonucleotides of random sequences as primers
US5196305A (en) 1989-09-12 1993-03-23 Eastman Kodak Company Diagnostic and amplification methods using primers having thymine at 3' end to overcome primer-target mismatch at the 3' end
US5104792A (en) 1989-12-21 1992-04-14 The United States Of America As Represented By The Department Of Health And Human Services Method for amplifying unknown nucleic acid sequences
CA2031659A1 (en) 1990-01-26 1991-07-27 John B. Findlay Water-insoluble reagent, nucleic acid probe, test kit and diagnostic and purification methods
ES2044784B1 (en) 1992-06-12 1994-09-01 Inia PROCEDURE FOR THE DETECTION AND IDENTIFICATION OF VIRAL AND SUBVIRAL PATHOGENS.
US5872241A (en) 1995-01-25 1999-02-16 The Trustees Of Columbia University In The City Of New York Multiple component RNA catalysts and uses thereof
US5990388A (en) 1995-06-07 1999-11-23 Research Corporation Technologies, Inc. Resistance to viruses and viroids in transgenic plants and animals expressing dsRNA-binding protein
US5965355A (en) 1995-09-21 1999-10-12 Agritope, Inc. Antibodies and proteins useful for assaying virus infection in grape plants
ZA984232B (en) 1997-05-20 1998-12-01 Cornell Res Foundation Inc Grapevine leafroll virus type 2 proteins coding sequences and methods
AR019118A1 (en) 1998-04-29 2001-12-26 Cornell Res Foundation Inc PROTEIN OR POLYPEPTIDE OF THE MOSAIC VIRUS OF THE LEAVES OF THE VINE, DNA MOLECULA AND ISOLATED RNA, EXPRESSION SYSTEM, GUEST CELL, TRANSGEN PLANT OR A COMPONENT OF THE SAME, METHOD TO CONFERENCE RESISTANCE TO VIRAL DISEASE IN A VIRAL PLAN ANTIBODY OR PORTION OF ADHESIUM

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997022700A2 (en) * 1995-12-21 1997-06-26 Cornell Research Foundation, Inc. Grapevine leafroll virus proteins and their uses

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DATABASE STN CAPLUS 1 January 1900 (1900-01-01), XP002914099, Database accession no. 125:138016 *
HABILI N., ET AL.: "NATURAL SPREAD AND MOLECULAR ANALYSIS OF GRAPEVINE LEAFROLL-ASSOCIATED VIRUS 3 IN AUSTRALIA.", PLANT PATHOLOGY, WILEY-BLACKWELL PUBLISHING LTD., GB, vol. 85., no. 11., 1 November 1995 (1995-11-01), GB, pages 1418 - 1422., XP002914100, ISSN: 0032-0862 *
LING K.-S., ET AL.: "PARTIAL GENOME ORGANIZATION OF GRAPEVINE LEAFROLL-ASSOCIATED CLOSTEROVIRUS 3.", PHYTOPATHOLOGY, AMERICAN PHYTOPATHOLOGICAL SOCIETY, US, vol. 85., no. 10., 1 October 1995 (1995-10-01), US, pages 1152., XP002914102, ISSN: 0031-949X *
SALDARELLI P., ET AL.: "DETECTION OF GRAPEVINE LEAFROLL-ASSOCIATED CLOSTEROVIRUS III BY MOLECULAR HYBRIDIZATION.", PLANT PATHOLOGY, WILEY-BLACKWELL PUBLISHING LTD., GB, vol. 43., no. 01., 1 January 1994 (1994-01-01), GB, pages 91 - 96., XP002914101, ISSN: 0032-0862 *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6558953B1 (en) 1995-12-21 2003-05-06 Cornell Research Foundation, Inc. Grapevine leafroll virus proteins and their uses
US6638720B1 (en) 1995-12-21 2003-10-28 Cornell Research Foundation, Inc. Grapevine leafroll virus proteins and their uses
US6916617B2 (en) 1995-12-21 2005-07-12 Cornell Research Foundation, Inc. Grapevine leafroll virus proteins and their uses
US6858426B1 (en) 1997-05-20 2005-02-22 Cornell Research Foundation, Inc. Grapevine leafroll virus (type 2) proteins and their uses
WO2001005957A2 (en) * 1999-07-19 2001-01-25 Agritope, Inc. Grapevine leafroll-associated virus proteins
WO2001005957A3 (en) * 1999-07-19 2001-10-25 Agritope Inc Grapevine leafroll-associated virus proteins

Also Published As

Publication number Publication date
IL132975A0 (en) 2001-03-19
BG103906A (en) 2000-06-30
ES2146193T1 (en) 2000-08-01
HUP0003327A2 (en) 2001-02-28
DE986641T1 (en) 2000-09-14
AU7583198A (en) 1998-12-11
AU746187B2 (en) 2002-04-18
EP0986641A4 (en) 2001-04-25
CA2290551A1 (en) 1998-11-26
US6858426B1 (en) 2005-02-22
MD20000034A (en) 2000-09-30
BR9809450A (en) 2002-02-13
EP0986641A1 (en) 2000-03-22
HUP0003327A3 (en) 2002-09-30
US20050183165A1 (en) 2005-08-18
ZA984232B (en) 1998-12-01
TR199902852T2 (en) 2001-09-21
AR011740A1 (en) 2000-08-30
SK158599A3 (en) 2000-06-12
US6197948B1 (en) 2001-03-06

Similar Documents

Publication Publication Date Title
US6916617B2 (en) Grapevine leafroll virus proteins and their uses
Sochor et al. Sharka: the past, the present and the future
EP1838847B1 (en) Plant virus designated tomato torrado virus
Minafra et al. Grapevine vitiviruses
US6197948B1 (en) Grapevine leafroll virus (type 2) proteins and their uses
Verchot et al. Evidence that soilborne wheat mosaic virus moves long distance through the xylem in wheat
Mei et al. A sugarcane mosaic virus vector for gene expression in maize
CA2510011A1 (en) Recessive plant viral resistance results from mutations in translation initiation factor eif4e
Chao et al. Characterization of Melon yellow spot virus Infecting Cucumber(Cucumis sativus L.) in Taiwan
CA2290779A1 (en) Rupestris stem pitting associated virus nucleic acids, proteins, and their uses
MXPA99010661A (en) Grapevine leafroll virus (type 2) proteins and their uses
He et al. Serological characterization of the 3′-proximal encoded proteins of beet yellows closterovirus
AU727208C (en) Grapevine leafroll virus proteins and their uses
AU762038B2 (en) Grapevine leafroll virus proteins and their uses
WO1998044803A9 (en) Dna molecule encoding tomato ringspot virus proteins and uses thereof
Brand Viruses implicated in the woodiness disease of South African passionfruit, and the molecular characterization of a new potyvirus
WO1998044803A1 (en) Dna molecule encoding tomato ringspot virus proteins and uses thereof
Hooker Analysis of the genetic diversity of Grapevine rupestris stem pitting-associated virus in Ontarian vineyards and construction of a full-length infectious clone
ZA200705959B (en) Plant virus designated Tomato Torrado virus
Rothmann An assessment of the mutation patterns in South African isolates of Potato leafroll virus and the expression of recombinant viral coat protein genes in Escherichia coli
Bovey et al. A short history of ICVG
Gentit et al. Characterization of a new nepovirus infecting apricot in Southeastern France: apricot latent ringspot virus
LAzAr et al. Grapevine virus diseases and clean grape stock program in Hungary
Robbins Molecular characterization of the interaction between cucumber necrosis virus and zoospores of the fungal vector olpidium bornovanus
Rampitsch The complete nucleotide sequence of prune dwarf ilarvirus RNA1 and virus detection by reverse transcription PCR and triple-antibody sandwich ELISA

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 132975

Country of ref document: IL

AK Designated states

Kind code of ref document: A1

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM GW HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 501123

Country of ref document: NZ

ENP Entry into the national phase

Ref document number: 2290551

Country of ref document: CA

Ref document number: 2290551

Country of ref document: CA

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 158599

Country of ref document: SK

Ref document number: PA/a/1999/010661

Country of ref document: MX

Ref document number: 1999/02852

Country of ref document: TR

Ref document number: 99-01229

Country of ref document: RO

WWE Wipo information: entry into national phase

Ref document number: 75831/98

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 1998923568

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: A 2000 0034

Country of ref document: MD

NENP Non-entry into the national phase

Ref document number: 1998550574

Country of ref document: JP

WWP Wipo information: published in national office

Ref document number: 1998923568

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWG Wipo information: grant in national office

Ref document number: 75831/98

Country of ref document: AU

WWW Wipo information: withdrawn in national office

Ref document number: 1998923568

Country of ref document: EP